High-Value Investment Insights
Discover articles with exceptional investment signals and actionable insights from earnings calls
Exceptional Signals (19-20)
Articles with the strongest investment signals, representing significant opportunities or risks
17 Education & Technology (YQ) Q1 2026: Yiqi Aixue Lifts Revenue 359%, AI Ecosystem Drives Margin Expansion
YQ demonstrates a long reinvestment runway, disruptive business model, accelerating growth, expanding margins, and clear evidence of improving unit economics and customer value. The company is in a strong growth phase with a self-reinforcing AI/data flywheel, making the signal both high and actionable.
Corset Therapeutics (CORT) Q2 2026: Lithioly Launch Adds $47.6M, Accelerating Oncology Expansion
Corset Therapeutics is demonstrating a long reinvestment runway with high returns, a transformative product launch (Lithioly) driving a step-change in growth, and improving unit economics. The business model is self-reinforcing with expanding network effects (guideline inclusion, payer coverage), and customers (physicians, patients) are becoming more valuable. Future growth is exceptional based on guidance and pipeline catalysts, with disruptive potential in both oncology and endocrinology. Cash flow is accelerating, and the company is transitioning into a high-growth phase.
Backblaze (BLZE) Q2 2026: $335M CoreWeave Deal Drives 67% Upmarket ARR Surge
Backblaze demonstrates a long reinvestment runway, a disruptive business model, and a significant inflection with the CoreWeave deal (67% upmarket ARR growth, record backlog). Unit economics and customer value are improving, with accelerating revenue, margin, and free cash flow. Guidance and backlog signal exceptional future growth, and the business is clearly transitioning into a high-growth AI infrastructure provider with lateral opportunities.
Oracle (ORCL) Q1 2026: RPO Surges 359%, Unlocking Multi-Year AI Cloud Revenue Visibility
Oracle demonstrates a rare and exceptional inflection: a 359% surge in RPO, multi-year backlog, accelerating cloud and database revenue, and a disruptive AI-driven business model with a long reinvestment runway. Unit economics, customer value, and cash flow potential are all improving at scale. The business is clearly transitioning into a high-growth, high-visibility phase with industry-wide implications, warranting the highest signal score.
Twist Bioscience (TWST) Q3 2026: AI-Enabled Discovery Orders Set to Double Again as Platform Scale Deepens
Twist Bioscience demonstrates a long reinvestment runway, disruptive business model, and accelerating growth in AI-driven drug discovery. Unit economics and margins are improving, and management is guiding to repeat triple-digit order growth. The business is not mature, has high customer stickiness, and is delivering exceptional growth, margin expansion, and operational leverage.
AeroVironment (AVAV) Q1 2027: Record $1.5B Backlog and Directed Energy Inflection Drive Growth
AeroVironment demonstrates an exceptional growth runway, with a record backlog, accelerating bookings, and a disruptive directed energy business at inflection. Unit economics and margins are improving, the business model is self-reinforcing, and customer value is deepening. Guidance and backlog signal exceptional future growth, and the company is transitioning into a high-growth, cash-generative defense technology leader with international expansion and franchise-building opportunities.
FTAI (FTAI) Q2 2026: Aerospace Module Output Surges 61%, Anchoring Asset-Light Shift
FTAI demonstrates a long reinvestment runway, recent significant growth and backlog uptick, improving unit economics, a self-reinforcing business model, and deepening customer value. The business is showing exceptional future potential based on backlog, is disruptive, cash flow is accelerating, and the company is poised for high annual growth. It is a clear growth business with substantial valuation upside.
York Space Systems (YSS) Q4 2025: Revenue Surges 52% as Backlog Hits 107 Satellites for Launch
York Space Systems demonstrates a long reinvestment runway, disruptive business model, accelerating growth, and exceptional backlog visibility. Margins are expanding, unit economics are improving, and the company is transitioning to a scaled, high-growth incumbent with clear competitive advantages. All factors point to a business with very high signal and material valuation upside.
SPX Technologies (SPXC) Q2 2026: Data Center Capacity Boosts to $1.1B, Driving 27% EBITDA Growth Outlook
SPX Technologies demonstrates a long reinvestment runway with high ROIC opportunities in data center infrastructure, a major recent capacity expansion, improving unit economics, and a self-reinforcing business model via M&A and integration. Customer value is increasing, guidance is being revised upward, and the business model is both disruptive and cash-generative. Revenue and EPS growth rates are accelerating, and the company is clearly in a high-growth phase with actionable upside.
Enovix (ENVX) Q1 2026: Korea Pipeline Surges to $130M as Drone and Eyewear Markets Accelerate
Enovix demonstrates a long reinvestment runway, disruptive technology, and accelerating growth across multiple verticals. Backlog and pipeline expansion, improving unit economics, and a shift from validation to commercial scaling all signal an exceptional business inflection. The business model is self-reinforcing and cash flow is poised to accelerate, with strong evidence of future revenue and EPS growth.
RedCat (RCAT) Q3 2025: Revenue Surges 200% on Defense Drone Ramp, Blue Ops Maritime Launch Expands TAM
RedCat shows a long reinvestment runway with new contracts and manufacturing scale. The 200% sequential revenue growth and large backlog expansion are clear signals of business evolution. Unit economics and margins are improving with scale, and the business model is becoming self-reinforcing via manufacturing and software integration. Customers (defense/government) are increasing in value, and future growth is exceptional based on backlog and guidance. The model is disruptive with lateral moves (maritime), and cash flow is set to accelerate. The business is transitioning into a high-growth phase with revenue and EPS likely to grow far above 20% annually.
Gardent Health (GH) Q2 2026: Oncology Test Volume Jumps 63% as SHIELD Coverage Expands
Gardent Health demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, and exceptional growth signals: 63% oncology volume growth, SHIELD quadrupling, and accelerating coverage. Unit economics and margins are improving, with clear levers for future cash flow. The article highlights a business transitioning to high-growth, with strong operational and commercial inflections, making it highly relevant for investors seeking upside.
AXTI (AXTI) Q2 2026: Indium Phosphide Revenue Surges 164%, Backlog Exceeds $100M as AI Demand Outpaces Capacity
AXTI demonstrates a transformational inflection: explosive revenue and margin growth, a massive backlog, and clear avenues for reinvestment at high returns. The business is transitioning into a dominant AI infrastructure supplier with disruptive potential, compounding network effects, and accelerating cash flow. Guidance, backlog, and customer prepayments all signal exceptional future growth, with industry-leading economics and runway.
ASX Q2 2026: ATM Operating Margin Jumps 6.2pts as AI Packaging Demand Stretches Capacity
ASX demonstrates a rare combination of long reinvestment runway, disruptive business model, and accelerating growth. The article substantiates margin expansion, backlog/guidance inflection, and a clear path to sustained high returns on capital. All signal questions are fully supported by the call details and outlook, justifying top marks.
Lemonade (LMND) Q2 2026: LAE Ratio Falls to 5%, Driving Operating Leverage and AI Edge
Lemonade demonstrates a long reinvestment runway with high ROIC potential, a disruptive AI-driven model, and accelerating growth in both top-line and key business segments. The LAE ratio and margin improvements are exceptional, with clear evidence of compounding advantages and cash flow inflection. The business is in a high-growth phase with expanding opportunities and clear signals of sustained outperformance.
Silvaco (SVCO) Q2 2026: IP Revenue Surges 238% as Strategic Partnerships Anchor AI Manufacturing Push
Silvaco demonstrates a long reinvestment runway, disruptive business model, and clear inflection in both revenue and profitability. The IP segment's explosive growth and strategic partnerships indicate compounding advantages, improved unit economics, and accelerating cash flow. Forward guidance and backlog signal exceptional future growth. The business is transitioning from legacy to high-growth, with all signal criteria strongly met.
CBRE (CBRE) Q2 2026: Infrastructure Services Revenue Surges 45%, Anchoring Multi-Year Growth Outlook
CBRE demonstrates a long reinvestment runway in high-ROIC infrastructure/data center services, with exceptional growth rates, improving unit economics, and strong compounding business model characteristics. The business is disruptive within its space, cash flow is accelerating, and management guides to >20% EPS growth. This is a clear growth business with secular and cyclical tailwinds, and the article surfaces these signals well.
SoFi (SOFI) Q2 2026: Cross-Buy Rate Jumps 16 Points, Accelerating “Everything App” Flywheel
SoFi demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and a self-reinforcing platform model. Customers are becoming more valuable, and the business is shifting to recurring, high-margin revenue. The business model is disruptive, cash flow is accelerating, and guidance/metrics indicate >40% growth, classifying it as a high-growth company with significant upside.
Impinj (PI) Q2 2026: Endpoint IC Revenue Jumps 53% as Food and Logistics Demand Accelerate
Impinj exhibits all hallmarks of a high-signal, inflecting business: expanding reinvestment runway, accelerating growth, improving unit economics, deepening competitive moat, and clear customer value expansion. The business is transitioning from cyclical recovery to structural growth, with industry read-throughs and strategic pivots that are highly relevant for investors seeking upside.
Vertiv (VRT) Q2 2026: Operating Margin Expands 410bps as Data Center Demand Accelerates
Vertiv demonstrates a long reinvestment runway, exceptional growth (net sales up 24%, guidance for 37% YoY, EPS up 60%, backlog acceleration), improving unit economics (margin expansion), and a self-reinforcing business model with increasing customer value. The business is clearly in a high-growth phase, with disruptive elements in AI/data center infrastructure, strong cash flow growth, and is not a legacy or transitioning business.
SailPoint (SAIL) Q2 2027: AI-Driven ARR Surges Past $70M, Accelerating Identity Security Leadership
SailPoint demonstrates a long reinvestment runway, accelerating AI-driven ARR, improving unit economics, a self-reinforcing platform, deepening customer value, and is positioned as a disruptive, high-growth business with exceptional guidance and strong cash flow trends. The business is not mature or capped and shows clear evidence of compounding optionality and market expansion.
ASML (ASML) Q2 2026: DRAM Demand Drives 75% Memory Growth, Order Visibility Extends Through 2028
ASML is demonstrating a rare multi-year growth inflection with long reinvestment runway, accelerating demand, improving unit economics, and compounding business model advantages. The order book, margin trajectory, and technology leadership all point to exceptional future growth and cash flow. The business is disruptive with high strategic optionality, and guidance/backlog supports sustained >20% growth. Signal is extremely high for investors seeking upside.
Penguin Solutions (PENG) Q3 2026: AI-Driven Memory Sales Surge 111% as Backlog Builds for Inference Era
Penguin Solutions demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and clear self-reinforcing business model attributes. Customer value is rising, backlog and growth guidance are exceptional, and the business model is disruptive with accelerating cash flow and revenue. The article substantiates these points with transcript-based facts.
EquipmentShare (EQPT) Q2 2026: Rental Revenue Up 37% as T3 Drives Share in Mega Projects
EquipmentShare exhibits a long reinvestment runway, disruptive business model, accelerating growth and margins, and deepening customer value. Recent results and guidance revisions signal exceptional forward prospects, with the business model compounding and clear evidence of technology-driven share gains.
Frequency Electronics (FEIM) Q4 2026: Backlog Hits $111M, Catalyzing Multi-Year Growth Trajectory
FEIM demonstrates a rare combination of record backlog (multi-year revenue visibility), margin inflection, high-barrier market entry, and a clear transition to a scalable, high-ROIC business model. The business is exiting legacy drag, has accelerating growth (34% CAGR target, book-to-bill near 3.0), and is positioned for high incremental returns. The article details a disruptive, high-optional business at a key inflection, with evidence of accelerating earnings power and long runway.
Kestra Medical Technologies (KMTS) Q4 2026: Gross Margin Expands 1,100bps, Accelerating Market Penetration
Kestra displays all the hallmarks of a high-signal, high-upside business: a long reinvestment runway, disruptive model, accelerating growth (44%+ guided), expanding margins, improving unit economics, and strong customer value trends. The business is transitioning to cash generation, with clear evidence of compounding advantages and sector read-through.
Palo Alto Networks (PANW) Q3 2026: NGS ARR Soars 60% as AI-Driven Demand Redefines Security Landscape
PANW demonstrates a long reinvestment runway, disruptive business model, accelerating growth, improving unit economics, and strong customer retention. The business is benefiting from structural AI tailwinds, with significant recent developments and clear margin expansion. Guidance and backlog support the case for continued outperformance, making it highly actionable for investors.
PUBM Q1 2026: Emerging Revenue Surges 80%, AI-Driven Model Sets Up Double-Digit Growth
PubMatic demonstrates a long reinvestment runway, disruptive AI-driven business model, accelerating emerging revenue, and expanding margins. Unit economics are improving, the business is self-reinforcing, and customer value is increasing. Backlog/guidance signals exceptional future growth, and the model is highly scalable with cash flow acceleration. All signal criteria are strongly met.
AEHR (AEHR) Q4 2026: Backlog Surges 430% to $80.6M as AI and Photonics Burn-In Demand Accelerates
AEHR demonstrates a long reinvestment runway with high returns, a massive surge in backlog, and a business model pivoting to high-growth AI and photonics markets. Unit economics and margins are improving, the model is self-reinforcing, and customer value is increasing. The outlook is exceptional, with disruptive potential and accelerating cash flow. The business is in a clear growth phase with significant optionality.
Innovative Aerosystems (IA) Q3 2026: Organic Growth Surges 40% Excluding F-16, Backlog Nears $83M
The company exhibits a long reinvestment runway, disruptive business model, rapidly improving unit economics, and a strong growth outlook. Organic growth, backlog, and margin expansion are exceptional, with clear evidence of accelerating cash flow and a transition to a high-growth business.
17 Education & Technology Group (YQ) Q2 2026: AI-Powered Services Drive 255% Revenue Surge and First GAAP Profit
The business demonstrates an outstanding growth inflection, with a 255% revenue increase, first GAAP profitability, and a scalable, AI-driven model. The transition to service-based, recurring revenue, improving margins, and a clear reinvestment runway—backed by strong cash reserves and share buybacks—suggest exceptional signal. The business model is disruptive, with compounding advantages and evidence of accelerating growth.
Babcock & Wilcox Enterprises (BW) Q2 2026: Bookings Surge 1058% as AI Data Center Demand Accelerates Growth
Babcock & Wilcox demonstrates an exceptional growth inflection with over 1000% bookings increase, multi-gigawatt pipeline, and a disruptive position in AI data center power solutions. Unit economics are improving, backlog and revenue are accelerating, and the business model is evolving toward high-value, high-growth opportunities. The runway is long, and the company is clearly transitioning into a growth leader in a strategic space.
RUM Group (RUM) Q2 2026: 61% Revenue Surge Driven by Northern Data Acquisition and AI Infrastructure Expansion
RUM Group demonstrates a long reinvestment runway with high ROIC potential, a transformative acquisition driving rapid growth, improving unit economics, and a self-reinforcing business model combining AI compute and video data. Customers are becoming more valuable, backlog and guidance revisions are exceptional, and the business model is disruptive. Cash flow is set to accelerate, and the company is solidly in the high-growth category, with revenue/eps growth expected to exceed 40% annually.
RIOT (RIOT) Q2 2026: $9.1B AI Lab Lease Accelerates Data Center Transformation
Riot is demonstrating a long reinvestment runway with high ROIC, a massive uptick in contracted revenue, improving unit economics, and a self-reinforcing business model through vertical integration. Customer value is deepening, backlog is exceptional, and the business model is disruptive with accelerating cash flow. Revenue/EPS growth is likely to exceed 40%, and the business is clearly in a growth phase.
Planet Labs (PL) Q2 2027: 58% Revenue Growth Driven by Sovereign Satellite Services and AI-Enabled Solutions
Planet Labs exhibits a long reinvestment runway with high returns, significant recent growth, improving unit economics, a self-reinforcing business model, and deepening customer value. The business outlook is exceptional, with disruptive AI integration, accelerating cash flow, and strong revenue/EPS growth. The company is clearly in a high-growth phase, not a legacy or stalling business.
Viant Technology (DSP) Q2 2026: 34% Revenue Surge Anchored by 50% CTV Spend Growth
Viant demonstrates a long reinvestment runway with high returns, a disruptive and scalable model, and accelerating growth in CTV and AI-driven advertising. The business is delivering double-digit top-line growth, expanding margins, and improving unit economics, with clear evidence of a strong pipeline and durable competitive advantage. All signal criteria are met at the highest level.
LEGN Q2 2026: CARVYKTI Sales Surge 50% Amid In Vivo CAR-T Clinical Breakthroughs
LEGN demonstrates a long reinvestment runway, disruptive innovation with in vivo CAR-T, accelerating growth, improving unit economics, and a business model with expanding margins and global reach. Recent clinical milestones and strong commercial momentum point to exceptional future growth and investment upside.
Everpure (P) Q2 2027: 38% Revenue Growth Accelerates Market Share Gains Amid Pricing and Hyperscale Expansion
Everpure demonstrates a long reinvestment runway with high returns, significant recent developments (hyperscale wins, 38% growth), improving unit economics, a self-reinforcing model, deepening customer value, exceptional future guidance, a disruptive business model, accelerating cash flow, and is firmly a high-growth business. All signal criteria are fully met.
LightPath Technologies (LPTH) Q4 2026: 197% Backlog Surge Fuels Strategic Shift to Capacity Expansion
LightPath is demonstrating a rare and significant inflection: a 197% backlog surge, nearly doubled revenues, expanding margins, and a disruptive, regulatory-driven runway. The business is moving to production scale with clear reinvestment opportunities, compounding business model characteristics, and accelerating cash flow potential. All key signal criteria are strongly met.
QT Imaging (QTI) Q4 2025: Scanner Shipments Triple, Locking in $24M Gulf Distribution Backlog
QT Imaging demonstrates a long reinvestment runway, disruptive business model, and clear transition to recurring revenue. The article highlights a transformative quarter with significant backlog, accelerating growth, improving unit economics, and a platform shift that positions the company for exceptional future performance.
Mobia Medical (MOBI) Q2 2026: Revenue More Than Doubles on Commercial Expansion and IPO-Fueled Growth
Mobia Medical demonstrates a long reinvestment runway, disruptive business model, and accelerating growth (over 100% YoY). Unit economics are strong, the commercial model is self-reinforcing, and customer value is deepening. Guidance and backlog signal exceptional future growth, and the business is positioned as a growth story, not legacy or transition.
Ambiq (AMBQ) Q2 2026: Net Sales Surge 90% Amid Supply Constraints Signals Robust Edge AI Demand
Ambiq is demonstrating a very high signal profile: long reinvestment runway, explosive growth (nearly doubling revenue), improving unit economics and margins, self-reinforcing model via software/hardware ecosystem, deepening customer value, and strong backlog. The business is disruptive, cash flow is improving, and growth rates are exceptional. The company is clearly in a high-growth phase with strong future prospects.
Riskified (RSKD) Q2 2026: Revenue Growth Accelerates 22% Amid Expanding Platform and Market Complexity
Riskified demonstrates a long reinvestment runway with high returns on capital, evidenced by accelerating revenue growth (22% YoY), strong new business momentum, and strategic expansion into alternative payments and geographies. There are significant recent developments, including a surge in digital finance and ticketing, and a raised outlook. Unit economics and customer value are improving through multi-product adoption. The business model is self-reinforcing with network effects and data loops. Cash flow and profitability are accelerating, and the company is clearly transitioning into a high-growth, compounding business with disruptive potential.
Broadcom Inc. (AVGO) Q3 2026: AI Semiconductor Revenue Surges 221%, Driving Record Margins and Cash Flow
Broadcom is exhibiting extraordinary growth, with a long reinvestment runway, accelerating revenue and cash flow, and a disruptive business model focused on AI. The business is compounding, with exceptional backlog/guidance, improving unit economics, and clear customer value expansion. The signal for investors is extremely high.
Hyliion (HYLN) Q2 2026: Military Contracts Surge to $42M, Additive Manufacturing Throughput Triples
Hyliion demonstrates a long reinvestment runway, clear disruptive potential, and high growth signals (military contract surge, tripling of manufacturing throughput, 50% revenue guidance increase). Unit economics and cash flow are improving, and new contracts plus a robust commercial pipeline support strong future growth. The business model is self-reinforcing with military and commercial diversification, and the outlook is exceptional based on recent backlog and guidance revisions.
Global-e (GLBE) Q2 2026: 44% GMV Surge and 300 Basis Point Margin Expansion Signal Durable Growth and Operational Leverage
Global-e demonstrates a long reinvestment runway, disruptive business model, rapid top-line and margin growth, and improving unit economics. Recent developments like the Passport acquisition, Managed Markets 2.0, and AI-driven efficiency are highly material. Guidance and backlog indicate continued high growth, and the business is clearly transitioning into a cash flow and growth engine.
Kodiak (KDK) Q1 2026: Driverless Hours Surge 120% as Platform-Agnostic Autonomy Scales
Kodiak presents a rare combination of rapid revenue and operational growth, expanding backlog, improving unit economics, and a disruptive, platform-agnostic business model. The company is transitioning to scaled commercialization with strong capital backing, high customer value growth, and clear evidence of compounding business advantages. The signal for investors is exceptionally high.
Resolve AI (RZLV) Q2 2026: Revenue Surges Nearly 21x as Infrastructure Licensing Gains Traction
Resolve AI demonstrates a long reinvestment runway, exceptional recent growth (21x YoY), improving unit economics, a self-reinforcing business model, and deepening customer value. The Google infrastructure deal and accelerating ARR/guidance revisions indicate an exceptional future. The business is disruptive, cash flow is on an upward trajectory, and guidance implies >40% growth. The company is clearly a growth business, not legacy or stalling.
Fervo Energy (FRVO) Q2 2026: Pipeline Expansion and Drilling Records Propel 1.1 GW 2030 Target
Fervo demonstrates a long reinvestment runway, disruptive business model, and exceptional growth signals (pipeline expansion, record drilling, increased capacity targets). Unit economics are improving, backlog and customer value are increasing, and the business is transitioning to rapid growth. The future outlook is exceptional, and the company is positioned for high revenue/earnings growth. This is a high-signal, high-upside business for investors.
Hesai Group (HSAI) Q2 2026: Robotics Lidar Shipments Surge 193%, SGI Revenue Guidance Doubled
Hesai is showing strong evidence of a long reinvestment runway, disruptive business model, and accelerating growth. There are clear signs of improving unit economics, compounding business model advantages, increasing customer value, exceptional future outlook, and rapid revenue/EPS growth. The company is transitioning into a platform with multiple high-growth, high-margin opportunities, making it a compelling growth business with substantial valuation upside.
Dell Technologies (DELL) Q2 2027: AI Server Orders Hit $60.9B, Driving 89% ISG Revenue Growth
Dell is exhibiting an unusually strong growth inflection, with a long reinvestment runway in AI infrastructure, rapidly expanding backlog and orders, and accelerating revenue and earnings growth well above 40%. Unit economics are improving, the business model is self-reinforcing, and customer value is increasing. The business is disruptive, cash flow is accelerating, and the company is transitioning from a legacy to a high-growth profile. All signals point to exceptional business momentum and upside.
Liquidia (LQDA) Q2 2026: $170M YUTREPIA Sales Fuel 31% Quarter-over-Quarter Growth and Pipeline Expansion
Liquidia demonstrates a long reinvestment runway, exceptional growth (31% QoQ, tripling sales over three quarters), improving unit economics, a disruptive business model, and clear evidence of compounding advantages and self-funded expansion. The business is accelerating in both revenue and cash flow, with a robust pipeline and category leadership, signaling high strategic and valuation upside.
Figma (FIG) Q1 2026: AI Credit Monetization Lifts Net Dollar Retention to 139%, Driving Guidance Raise
Figma is exhibiting multiple hallmarks of a high-signal, high-upside business: accelerating growth, strong unit economics, a disruptive and self-reinforcing business model, and clear evidence of long runway with high returns on capital. The transition to AI credit monetization is a major inflection, and all key signal questions are met at the highest standard.
VersaBank (VBNK) Q3 2026: US SRP Portfolio Surges to $793M, Setting Stage for $3B Growth in 2027
VersaBank demonstrates a long reinvestment runway, disruptive business model, and accelerating growth. The SRP portfolio's rapid expansion, AI-driven efficiencies, and strong backlog signal exceptional future prospects. Unit economics and customer value are improving, and the business is transitioning into a high-growth phase with clear lateral opportunities and accelerating cash flow.
Applied Optoelectronics (AAOI) Q2 2026: 800G Revenue Surges 10x, Capacity Ramp Drives Data Center Tailwind
AAOI shows a rare combination of long reinvestment runway, explosive growth, improving unit economics, and disruptive business model characteristics. The business is transitioning to a capacity-constrained, high-growth phase with strong backlog and clear levers for margin expansion, all supported by transcript-based evidence.
iRhythm (IRTC) Q2 2026: Margin Surges 1000bps as Vital Connect Deal Targets $500M MCT Upside
iRhythm is demonstrating a rare combination of durable 20%+ growth, margin inflection, and a strategic acquisition that opens a $500M+ incremental market. Operating leverage is clear, unit economics are improving, and the business model is compounding with AI-driven cost advantages and multi-channel expansion. The company is transitioning from a single-product to a platform play, with evidence of accelerating profitability and clear avenues for further reinvestment at high returns. All signal criteria are fully met.
Ciena (CIEN) Q3 2026: Backlog Surges to $10B, Cementing Multi-Year AI-Driven Growth Trajectory
Ciena demonstrates a long reinvestment runway, exceptional growth (backlog surge, revenue growth >30%), improving margins, and disruptive business model. The business is transitioning to a cash flow machine, with accelerating guidance and clear evidence of durable, compounding advantages.
Novation Bio (NUVB) Q2 2026: First-Line Ibtrozi Uptake Hits 85%, Cementing Chronic Oncology Model
The business is demonstrating a long reinvestment runway with a chronic therapy model, a significant inflection with first-line uptake, improving unit economics, and a self-reinforcing business model with durable, repeat prescribing. Customer value is compounding, future guidance is strong, and the business is highly growth-oriented and disruptive in oncology. All signal criteria are clearly met at the highest level.
Reddit (RDDT) Q3 2025: Advertiser Count Up 75%, Automation and App Focus Drive Margin Surge
Reddit is showing rare hypergrowth (68% revenue, 74% ad growth), massive advertiser expansion (75%), clear margin acceleration, and a disruptive, self-reinforcing business model with significant international optionality. Unit economics and ARPU are improving, and management is guiding to further growth and margin expansion. The business is not mature or capped, and the inflection is both recent and material, with upside remaining.
Unity (U) Q2 2026: Vector Growth Accelerates 23%, Propelling AI Flywheel and Margin Expansion
Unity exhibits all hallmarks of a high-signal, high-upside business: long reinvestment runway, disruptive and self-reinforcing model, strong unit economics, accelerating growth (with >40% YoY and >20% sequential growth), and a clear transition from turnaround to growth. The AI-driven flywheel, compounding data advantages, and margin expansion signal exceptional business evolution and future potential.
Fluence Energy (FLNC) Q3 2026: $6.4B Backlog Surges 30% as Data Center Wins Reshape Growth Trajectory
Fluence Energy demonstrates a long reinvestment runway, disruptive growth from data center demand, rapidly expanding backlog, and improving unit economics as scale increases. The business model is evolving with self-reinforcing elements (software, modular platforms), and recent developments (30% backlog growth, hyperscaler wins) signal a step-change in growth. Cash flow and margin recovery are in focus, and the company is clearly transitioning to a high-growth, high-visibility model.
Ethos Technologies (LIFE) Q1 2026: Direct Channel Rockets 136%, Powering Platform Scale and Product Expansion
Ethos demonstrates a long reinvestment runway, disruptive business model, rapid growth (well above 40%), and improving unit economics at scale. Backlog, product launches, and partnerships support future growth. The business model is self-reinforcing and cash flow is accelerating, with clear evidence of a growth company.
Insmed (INSM) Q2 2026: Peak Sales Outlook Jumps 75% as Brensupra Demand Surges
Insmed is demonstrating a long reinvestment runway, exceptional recent growth, and improving unit economics. The business model is self-reinforcing with a synergistic portfolio, and customer value is increasing. Guidance and backlog are exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth exceed 40% and the business is clearly in a growth phase.
GitLab (GTLB) Q2 2027: Net ARR Surges 42% Amid Flex Model Launch and AI-Driven Growth
GitLab demonstrates a long reinvestment runway, a disruptive model shift, and exceptional growth metrics (42% Net ARR, 150%+ large deal growth). Unit economics are improving, customers are becoming more valuable, and the business is transitioning to a flexible, AI-driven model with accelerating cash flow and broadening opportunity. All signal criteria for high-growth, high-potential businesses are met.
IonQ (IONQ) Q2 2026: Organic Revenue Surges 132% as Quantum Platform Accelerates Global Adoption
IonQ demonstrates exceptional signal: explosive revenue growth, a long reinvestment runway, improving unit economics, and a disruptive, self-reinforcing business model with high growth and margin potential. Backlog and guidance revisions are exceptional, and the business is clearly transitioning from R&D to scalable commercialization with strong cash flow potential.
CleanSpark (CLSK) Q3 2026: $6.6B Sandersville Lease Secures 20-Year Cash Flow Visibility
CleanSpark is undergoing a structural pivot to a high-margin, long-duration digital infrastructure platform, with a $6.6B/20-year lease and runway to $11.6B. The business model is self-reinforcing, customers are becoming more valuable, and future growth is exceptional based on contracted backlog and demand. The company is positioned for outsized revenue and EPS growth, with strong optionality and capital discipline.
Gilad Satellite Networks (GILT) Q2 2026: Defense Segment Set for 40% H2 Growth Surge
Gilad is at a major inflection point with a long reinvestment runway, accelerating growth (notably a 40% H2 defense ramp), improving margins, and disruptive business model features. The article substantiates these signals with concrete backlog, order, and margin data, indicating a high-growth, high-ROIC trajectory.
Intellia (NTLA) Q2 2026: 87% HAE Attack Reduction Sets Stage for First In Vivo Gene Editing Launch
Intellia is positioned as a first-mover in in vivo gene editing with a long reinvestment runway and disruptive business model. The company has demonstrated significant clinical progress (87% attack reduction, 90% TTR knockdown), a major inflection point in its business, and is transitioning to commercial launch with accelerating cash flow potential. Unit economics and customer value are improving, and the business is set for high growth and margin expansion. The model is self-reinforcing with strong barriers (precision medicine, HLA genotyping), and recent developments (trial results, regulatory progress) set up a period of exceptional growth and valuation upside.
Q2 Holdings (QTWO) Q3 2025: Backlog Jumps $485M as Tier 1 Wins and AI Strategy Drive Momentum
Q2 Holdings demonstrates a long reinvestment runway, disruptive model, accelerating backlog and revenue, improving margins, deepening customer value, and clear growth inflection. The business is not mature or capped, and the article supports the signal with concrete numbers and developments.
KLIC Q3 2026: Sequential Revenue Jumps 36% as Data Center and AI Packaging Demand Accelerates
KLIC demonstrates a rare combination of rapid revenue acceleration, high and rising utilization, expanding advanced segment, and multi-quarter order visibility. The business model is self-reinforcing with high switching costs and deepening customer relationships. Unit economics and cash flow are improving. The growth rate is exceptional, with management signaling further acceleration. The company is not a legacy business; it is at the center of a disruptive industry inflection with a long reinvestment runway. All major signal criteria are met at the highest level.
Snowflake (SNOW) Q2 2027: Product Revenue Growth Accelerates to 37% Amid AI-Driven Platform Expansion
Snowflake demonstrates a long reinvestment runway, accelerating revenue growth, improving unit economics, and self-reinforcing platform effects. The business model is disruptive with strong AI-driven expansion, significant backlog, and clear evidence of both revenue and margin acceleration. Customer value is deepening and forward guidance is exceptional, supporting the highest signal score.
Figma (FIG) Q2 2026: AI Credit Monetization Powers 48% Revenue Surge, Expands TAM
Figma demonstrates a long reinvestment runway, a disruptive business model, and accelerating growth (48% YoY). AI monetization and new product launches are expanding TAM and driving both revenue and margin inflection. Unit economics, customer value, and cash flow are all improving. The business is firmly in growth mode and well-positioned for further upside.
PAM Q2 2026: $2.7B Urea Project Signals Multi-Year CapEx Surge and Vertical Expansion
Pampa Energía is entering a new high-return business (fertilizer) with a long reinvestment runway, major step-change in growth, improving unit economics, and a self-reinforcing vertically integrated model. Backlog and guidance are exceptional, the business is disruptive for its market, and cash flow/earnings growth are set to accelerate. This is a clear growth business with high signal for investors.
Credo Technology Group (CRDO) Q1 2027: Optical Business Accelerates to $600M, Driving 115% Revenue Growth
Credo demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and future guidance is exceptional with accelerating growth. The business is disruptive, with accelerating cash flow and expected revenue/EPS growth well above 40%. The company is a clear growth business, not a legacy or stalling operation.
Shopify (SHOP) Q2 2026: AI Channels Triple, 75% of Agentic Orders Flow from Long-Tail Merchants
Shopify demonstrates a long reinvestment runway, exceptional growth, improving unit economics, a self-reinforcing business model, deepening customer value, and accelerating cash flow. Recent results show significant business evolution, with AI and international expansion driving growth well above 30% and clear disruptive potential. The business is firmly in a high-growth, compounding phase with multiple levers for continued outperformance.
Block (SQ) Q2 2026: Neighborhoods GPV Surges 220%, Unlocking Ecosystem Scale
Block demonstrates a long reinvestment runway, explosive growth in critical new segments (Neighborhoods GPV up 220%), improving unit economics, deepening network effects, and strong customer engagement. The business model is disruptive, with accelerating cash flow and robust guidance. The company is clearly in a high-growth, compounding phase with exceptional forward prospects.
TerraWulf (WULF) Q2 2026: $19B Anthropic Lease Secures 401MW, Scaling Long-Term Revenue Visibility
The article details a business with a long reinvestment runway, disruptive business model, and accelerating growth, evidenced by the $19B Anthropic lease, margin normalization, and capital discipline. All signal questions are met at the highest level, with clear evidence of exceptional backlog growth, improving unit economics, and strong future prospects.
GlobalFoundries (GFS) Q2 2026: Data Center and Comms Revenue Surges 62% as Optical Demand Accelerates
GlobalFoundries demonstrates a long reinvestment runway, exceptional recent growth (62% YoY in a key segment), improving unit economics, and a disruptive, self-reinforcing business model. Customers are becoming more valuable, guidance is accelerating, and the business is transitioning to a higher-margin, cash-generative profile. The growth and margin reset are both exceptional and likely to be durable.
Strata Critical Medical (SRTA) Q3 2025: 80% EBITDA Growth Signals Medical Platform Inflection
SRTA demonstrates a long reinvestment runway with high returns on capital, a transformative business evolution, improving unit economics, and a self-reinforcing, disruptive platform model. Growth rates, margin expansion, and cash flow inflection are exceptional, with strong evidence of a structural inflection and significant upside.
Western Digital (WDC) Q4 2026: Cloud Revenue Hits 89% of Sales, AI Storage Tailwind Accelerates
WDC is positioned as a high-growth, high-margin business with a long reinvestment runway, driven by secular AI/cloud tailwinds. The article details significant recent growth, improving unit economics, self-reinforcing business model, rising customer value, and exceptional forward guidance. It is clear the business is transitioning into a cash flow machine with a disruptive model and strong growth outlook.
Joby Aviation (JOBY) Q2 2026: Blade Revenue Jumps $14M, Driving Guidance Raise and Commercial Momentum
Joby demonstrates a long reinvestment runway, major revenue uptick, improving unit economics, and disruptive business model. Partnerships, certification progress, and guidance raise all signal exceptional future prospects and compounding business value. The article presents clear evidence of growth, cash flow acceleration, and industry leadership.
SoundHound (SOUN) Q2 2026: Revenue Jumps 45% as Oasis AI Platform Drives Multi-Vertical Expansion
SoundHound is showing a long reinvestment runway with high returns, significant recent growth (45% YoY), improving unit economics, and a disruptive, self-reinforcing business model. Customer value is rising, guidance is raised, and the business is transitioning into a high-growth, cash-generating phase. All major signal criteria are met or exceeded.
Everest Construction Group (ECG) Q2 2026: Backlog Surges 53% as Modular Expansion Drives New Growth
Everest Construction Group is demonstrating a long reinvestment runway, with clear evidence of high returns on capital and a 53% surge in backlog. Unit economics are improving with scale, and the business model is self-reinforcing through modular construction and operational playbooks. Customer value is rising, guidance is raised, and the business is positioned as a growth platform with accelerating cash flow. The company is not legacy or stalling, but rather in a rapid expansion phase with high signal for future growth and upside.
Waterdrop Inc. (WDH) Q2 2026: Insurance Revenue Surges 80.5% Fueling AI-Driven Growth and Shareholder Returns
Waterdrop demonstrates a long reinvestment runway, disruptive AI-driven business model, accelerating revenue and profit growth, exceptional guidance, and compounding unit economics. Customer value is increasing, and the business is transitioning into a high-growth, cash-generative platform. Signal is extremely high for investors seeking upside.
CorePay (CPAY) Q2 2026: Corporate Payments Sales Surge 40%, Fuels Guidance Raise and Portfolio Shift
CorePay demonstrates a long reinvestment runway at high returns, with a disruptive, technology-led business model and significant recent growth (40% in corporate payments). Unit economics are improving, margins are expanding, and customers are becoming more valuable. The business model is self-reinforcing, and future guidance and backlog signal continued, exceptional growth. The company is positioned as a growth leader rather than a legacy or transitioning business.
Energy Vault (NRGV) Q2 2026: Backlog Surges 107% to $2B, Cementing AI Infrastructure Growth
Energy Vault demonstrates a long reinvestment runway, disruptive business model, and accelerating growth, with a doubling of backlog and improving margins. The business is scaling rapidly, with high-value recurring revenue and clear evidence of compounding advantages and customer value. Guidance and backlog suggest exceptional future growth, and the business is positioned as a growth leader in a structurally attractive market.
Angel Studios (ANGX) Q2 2026: Guild Membership Surges 99%, Unlocking Platform Operating Leverage
Angel Studios demonstrates a long reinvestment runway, disruptive business model, clear network effects, and accelerating growth/operating leverage. Key metrics (Guild membership, revenue mix, operating efficiency) show exceptional momentum, with platform economics and customer value deepening. Guidance and backlog signal continued high growth, and the business is clearly transitioning into a growth platform with strong optionality.
Eli Lilly (LLY) Q2 2026: Obesity Portfolio Adds $6.8B, Fueling 48% Revenue Surge and Global Expansion
LLY demonstrates a long reinvestment runway, exceptional growth (48% revenue increase), improving unit economics, self-reinforcing business model, deepening customer value, and an exceptional future outlook. The business model is disruptive with broad optionality, cash flow is accelerating, and growth rates are well above 40%. The company is clearly in a hypergrowth phase, not legacy or stalling.
Compass Pathways (CMPS) Q2 2026: 8,000 Site Network Poised for Comp360 Launch as NDA Filing Nears Completion
Compass Pathways demonstrates a rare combination of long reinvestment runway, disruptive business model, accelerating growth, and improving unit economics, all supported by clear evidence from the call. The transition from clinical to commercial stage, large site network, and strong prescriber demand signal exceptional upside and relevance for investors seeking high-growth, high-ROIC opportunities in healthcare.
HUT 8 (HUT) Q2 2026: $26.6B Contracted Data Center Leases Signal Platform Compounding
The business demonstrates a long reinvestment runway, disruptive platform model, and a massive uptick in contracted revenue. Unit economics are improving, backlog and pipeline are expanding rapidly, and the model is self-reinforcing with strong customer validation. The transition to contracted, high-margin cash flows and project-level financing signals compounding growth potential, making this highly actionable for investors.
Klarna (KLAR) Q3 2025: Fair Financing Merchants Double, Fueling 139% Product Surge
Klarna demonstrates a long reinvestment runway, disruptive business model, and clear compounding effects from network and product expansion. There is strong evidence of exceptional growth, improving unit economics, and a transition to a higher-margin, multi-product fintech platform. The company is not a legacy business and is showing accelerating revenue, margin, and cash flow potential.
Figma (FIG) Q3 2025: Paid Teams Surge by 90,000 as AI-Native Platform Drives 38% Growth
Figma demonstrates a rare combination of rapid growth, expanding TAM, strong unit economics, and a disruptive, self-reinforcing business model. All key signals—runway, product adoption, customer value, margin trajectory, and market positioning—are exceptional and well-supported by the earnings call.
Innodata (INOD) Q1 2025: Revenue Soars 120% as Generative AI Pipeline Expands Across Big Tech
Innodata demonstrates a long reinvestment runway, disruptive business model, and exceptional growth rates (120% YoY). Margins are expanding, recurring revenue is growing rapidly, and the business is transitioning toward platformization with high-value, sticky customers. The company is not mature or capped, and the business model is compounding with scale and customer value deepening. The signal for future growth and valuation upside is very high.
Tower Semiconductor (TSEM) Q2 2026: Silicon Photonics Revenue Up 270%, Unlocking $1.3B Booked Pipeline
Tower Semiconductor demonstrates a long reinvestment runway, a disruptive business model in silicon photonics, and exceptional growth signals: 270% YoY segment growth, massive booked pipeline, improving margins, and accelerating cash flow. The business model is compounding with network effects, and customer value is increasing. Guidance and backlog point to continued, outsized growth, making this a high-signal, thesis-changing quarter.
PGEN Q2 2026: Pepsimius Revenue Surges 145% as Broad Label Drives Early Standard of Care Adoption
PGEN demonstrates a long reinvestment runway, disruptive business model, and exceptional growth (145% YoY, rapid profitability). Unit economics, customer value, and business model self-reinforcement are all strong. The business is transitioning from launch to scale with clear optionality and accelerating cash flow, making it highly relevant for investors seeking growth and platform leverage.
Zeta (ZETA) Q2 2026: Athena AI Drives 500% Usage Surge, Expanding Platform Adoption
Zeta demonstrates a long reinvestment runway with high returns, major recent developments (500% usage surge, partnerships), improving unit economics, a self-reinforcing AI-driven platform, deepening customer value, exceptional forward guidance, and a disruptive business model. Cash flow and growth rates are accelerating, with the company firmly positioned as a growth business. All signal questions are strongly supported by the call commentary and data.
Gloo Holdings (GLOO) Q2 2026: Revenue Soars 188% Amid Expanding AI Integration and Strategic Acquisitions
Gloo demonstrates a long reinvestment runway, exceptional growth (188% YoY revenue), improving unit economics, and a self-reinforcing platform with cross-selling and AI integration. Customer value is deepening, future guidance is robust, the business model is disruptive with lateral opportunities, and cash flow is improving. Revenue and EPS growth exceed 40%, and the company is clearly in a high-growth phase rather than legacy or transition.
TSMC (TSM) Q2 2026: 36% Revenue Growth Fueled by Leading-Edge Tech Amid $64B CapEx Surge
TSMC demonstrates a long reinvestment runway at high returns, with significant recent growth and backlog acceleration. Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Guidance and backlog signal exceptional growth, and the business is highly disruptive with accelerating cash flow and revenue/EPS growth well above 40%. TSMC is a growth leader, not a legacy or transitioning business.
Sterling Infrastructure (STRL) Q2 2026: Backlog Surges 150% as E-Infrastructure Drives Multi-Year Visibility
Sterling’s business is experiencing a step-function increase in backlog (150% YoY), with clear multi-year revenue visibility, accelerating growth, and a disruptive pivot to e-infrastructure. Unit economics, customer value, and cash flow are all improving. The business model is self-reinforcing with long runway, and the company is transitioning into a high-growth, high-return profile with exceptional near-term and long-term prospects.
TG Therapeutics (TGTX) Q2 2026: U.S. Breonvi Revenue Surges 64%, Franchise Eyes $1B Run Rate
TG Therapeutics demonstrates a long reinvestment runway, exceptional recent growth (64% YoY), improving unit economics, a self-reinforcing model, and increasing customer value. Guidance and backlog signal accelerating growth, and the business model is disruptive with clear lateral opportunities (multi-indication pipeline, SubQ platform). Cash flow is accelerating, and the company is transitioning to a high-growth, multi-product innovator.
Sanmina (SANM) Q3 2026: Core Revenue Up 17%, AI and Cloud Demand Accelerate Next Leg
Sanmina is demonstrating a long reinvestment runway, disruptive business model pivot, and exceptional growth (nearly 70% YoY, $16B+ target). Unit economics and customer value are improving. Cash flow and margin dynamics are strong. The business is now a scale growth platform in a secularly advantaged sector.
Ecolab (ECL) Q2 2026: Global High Tech Surges 29% as Portfolio Shifts Toward High-Margin Engines
Ecolab is demonstrating a strong inflection with high-growth, high-margin segments (global high tech, digital, life sciences) now central to its business. There is clear evidence of a long reinvestment runway, disruptive model, accelerating growth, improving unit economics, and exceptional future guidance. The business is not mature or capped and shows all hallmarks of a high-signal, compounding opportunity.
Celestica (CLS) Q2 2026: CCS Revenue Soars 84% as AI Infrastructure Demand Drives Record Margins
Celestica is demonstrating a long reinvestment runway with high ROIC, exceptional growth rates, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, the business is in a structural acceleration, and there are clear disruptive dynamics with strong future guidance. All signal criteria for a high-growth, high-upside business are met.
Applied Aerospace & Defense (AADX) Q2 2026: Revenue Surges 47%, Backlog Tops $1.1B, IPO Fuels Strategic Expansion
AADX demonstrates a long reinvestment runway, with high returns on capital and a clear path for redeployment post-IPO. The company posted a 47% revenue surge and backlog up over $1.1B, signaling major business evolution. Unit economics are improving, with adjusted EBITDA up and margins expected to expand. The vertically integrated, IP-driven model is self-reinforcing and compounding. Customer value is increasing with multi-segment growth. Guidance and backlog conversion suggest exceptional future growth. The business model is disruptive within aerospace and defense, with significant lateral opportunities. Cash flow is set to accelerate in H2, and the company is transitioning rapidly into a high-growth phase, with revenue and EPS growth well above 20%. All signal criteria are strongly met.
Digi Power X (DGXX) Q2 2026: $1.1B Contracted AI Revenue Marks AI Infrastructure Pivot
DGXX is at a major inflection with a large contracted backlog, clear reinvestment runway, accelerating revenue, improving unit economics, and disruptive business model in a high-growth sector. All signals point to exceptional growth, compounding advantages, and high investor relevance.
Ondas (ONDS) Q2 2026: Revenue Soars 13-Fold Amid $757M Backlog and Accelerated Growth Trajectory
Ondas demonstrates a long reinvestment runway, exponential revenue growth, improving unit economics, and a self-reinforcing, disruptive business model. Customer value is increasing, backlog and guidance are exceptional, and the business is transitioning into high-growth, cash-generative territory. The article provides clear evidence of a rare, high-signal inflection.
HeartFlow (HTFL) Q2 2026: Revenue Growth Accelerates 48% Amid Plaque and FFRCT Momentum
HeartFlow demonstrates a long reinvestment runway, disruptive AI-driven business model, accelerating revenue and margin growth, and expanding addressable market via clinical trials. Backlog and revenue growth are exceptional, unit economics are improving, and customer value is deepening. The business is clearly a high-growth, high-upside opportunity, with all major signal criteria strongly met.
Beeline Holdings (BLNE) Q2 2026: Revenue Growth Accelerates 57% Amid Strategic Shift Toward Higher-Margin Products
Beeline demonstrates a long reinvestment runway, disruptive business model with digital assets, and exceptional recent growth (57% YoY revenue, 40%+ margin/backlog improvement). Unit economics and cash flow are improving, the business is evolving rapidly, and the model is self-reinforcing with high customer value and strong future prospects. The article substantiates this with clear evidence.
dLocal (DLO) Q2 2026: TPV Surges 92% with Operating Leverage Gains Signaling Durable Growth
dLocal demonstrates a long reinvestment runway, disruptive business model, and accelerating growth with improving unit economics and operating leverage. Significant recent growth in TPV and profitability, combined with AI-driven efficiencies and product expansion, highlight exceptional business evolution and future prospects. The company is positioned as a growth business with substantial upside, meeting all signal criteria at the highest level.
Prenetics (PRE) Q2 2026: IM8 Revenue Surges 359% YoY, Achieving Positive Adjusted Free Cash Flow
Prenetics demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, a self-reinforcing business model, deepening customer value, and disruptive potential. The business is transitioning from rapid growth to profitability with strong guidance and clear evidence of future upside.
Pony AI (PONY) Q2 2026: Robotaxi Revenues Surge 691% Fueling Global Fleet Expansion
Pony AI demonstrates a long reinvestment runway with strong growth, disruptive business model, rapidly improving unit economics, and expanding global footprint. Revenue and EPS are growing at an exceptional rate, with clear evidence of operational leverage, customer value expansion, and accelerating cash flow potential. The business is positioned as a high-growth, industry-leading player with substantial valuation upside.
STAA (STAAR Surgical) Q2 2026: 111% Revenue Surge Fueled by China EVO+ Adoption and Operational Leverage
STAAR Surgical is demonstrating exceptional growth (111% YoY), clear evidence of a long reinvestment runway, improving unit economics, and a disruptive business model with global optionality. The business is compounding, customers are becoming more valuable, and the innovation pipeline suggests more upside. Guidance and backlog signal ongoing acceleration, and the company is transitioning to a platform business with strong cash flow and high growth potential.
IQIYI (IQ) Q2 2026: AI-Driven Decentralization Boosts Content Supply and International Membership Growth
IQIYI demonstrates a long reinvestment runway with high returns driven by AI and international expansion. There are significant recent developments—content distribution up 90%, international membership up 40%+, and short-form market share doubling. Unit economics are improving with AI-driven cost reductions. The business model is self-reinforcing with creator flywheel effects. Customers (members) are becoming more valuable, especially internationally. Growth guidance is strong, and the business is transitioning to a disruptive, scalable model. Cash flow and profitability are improving rapidly, with guidance for further acceleration. Revenue and EPS growth are likely to exceed 20%+ annually, and the company is clearly in a growth phase.
Tesla (TSLA) Q2 2026: CapEx Surges 100% as FSD and Robotaxi Drive New Backlog Records
Tesla is executing on a rare, high-velocity inflection with long reinvestment runway, disruptive business model, accelerating growth, and substantial backlog/guidance revision. The business model is self-reinforcing, customer value is deepening, and the future outlook is exceptional with clear, thesis-relevant signals throughout.
Datavault AI (DVLT) Q2 2026: Revenue Surges 287% Amid Strategic Acquisitions and Tokenization Ecosystem Buildout
Datavault AI demonstrates an exceptional growth trajectory (287% YoY revenue, $2.5B contract backlog), a disruptive and self-reinforcing model, improving unit economics, and a long reinvestment runway. The business is transitioning from development to commercialization with inflection in revenue and cash flow expected, supported by unique IP and regulatory positioning.
Fabrinet (FN) Q4 2026: 45% Revenue Surge Fuels Capacity Expansion and Market Diversification
Fabrinet demonstrates a long reinvestment runway at high returns, with a disruptive and self-reinforcing business model. The company is showing exceptional growth (45% YoY revenue, projected 43% next quarter), improving unit economics, and broadening customer and market exposure. Backlog and guidance suggest continued acceleration, and the business is transitioning into a high-growth, cash-generative phase.
Axe Compute (AGPU) Q2 2026: Signed Contract Value Surges Past $3 Billion, Setting Stage for $696M ARR
Axe Compute is showing a rare, high-signal ramp: massive signed contract backlog, clear and accelerating growth, long reinvestment runway, and a disruptive, capital-efficient model. Unit economics and customer value are improving, the business is transitioning from contract win to execution, and guidance/outlook is exceptional. All signal criteria are met or exceeded.
Sharon AI (SHAZ) Q2 2026: Secured AI Capacity Surges 60% as $8.8B Contracted Book Reshapes Growth Trajectory
Sharon AI demonstrates an exceptional growth inflection with a long reinvestment runway, disruptive business model, and a massive, visible backlog. The business is transitioning from pre-revenue to hypergrowth, with all key signal criteria—unit economics, customer value, capital access, and industry read-through—scoring at the highest level.
TE Connectivity (TEL) Q3 2026: Record $5.7B Orders Signal AI-Driven Backlog Surge Into FY27
TE Connectivity is exhibiting all the hallmarks of a high-signal, compounding business: long reinvestment runway, record-breaking order growth (27% YoY overall, 36% in industrial, 70% YTD in DDN), clear margin expansion, and a business model reinforced by secular AI, electrification, and grid modernization trends. Unit economics are improving, backlog is swelling, and the business is transitioning into a higher-growth, cash-generative phase. The model is self-reinforcing with content growth and strategic M&A, and guidance signals continued acceleration.
Natera (NTRA) Q2 2026: Signatera Clinical MRD Units Jump 56%, Unlocking Multi-Segment Momentum
Natera demonstrates a long reinvestment runway (expanding indications, global launches), exceptional growth (56% MRD volume jump, 31% revenue guide), improving unit economics and margins, and a disruptive, evidence-driven business model. Backlog and guidance signal accelerating future growth. The model is self-reinforcing with regulatory, reimbursement, and clinical trial compounding. The business is clearly in high-growth mode with strong optionality and no signs of stalling.
Alphabet (GOOG) Q2 2026: Cloud Revenue Soars 82% as AI Drives Record $514B Backlog
Alphabet’s results and positioning clearly indicate a long reinvestment runway, disruptive business model, accelerating growth, and exceptional backlog visibility. All signal criteria are met at the highest level, with evidence of compounding economics, deepening customer value, and a transformative growth profile.
LIDR Q2 2026: Revenue Surges 9x as Defense and Sports Analytics Expand Addressable Market
LIDR demonstrates a long reinvestment runway, massive recent growth, improving unit economics, and a disruptive business model with multiple avenues for expansion. The company is transitioning from pipeline to commercial conversion, with accelerating revenue and cash flow, and is positioned as a growth business with exceptional future prospects.
MTSI Q3 2026: Data Center Revenue Set to Jump 74%, Powering Margin Expansion
MTSI is showing a clear inflection with a long reinvestment runway, disruptive business model, rapidly improving margins, and accelerating growth. The article demonstrates exceptional future prospects, with strong backlog, double-digit revenue and EPS growth, and a transition to a high-value, high-margin business.
BlackSky (BKSY) Q2 2026: Gen 3 Unlocks 50% Revenue Growth, Propelling Recurring Intelligence Expansion
BlackSky demonstrates a rare combination of long reinvestment runway, disruptive business model, and accelerating growth. The shift to recurring revenue, rapid backlog growth, improving unit economics, and expanding international TAM are all clearly signaled and supported by management commentary and financials. The business is firmly in a high-growth, high-visibility phase with strong investor relevance.
Evergy (EVRG) Q2 2026: Data Center Load Drives 7-8% Retail Growth, $1B Capex Upside
Evergy is demonstrating a rare step-change in regulated utility growth, with a long reinvestment runway, double-digit rate base and load growth, and multi-decade contracts anchoring demand. Unit economics are improving with scale, the business model is self-reinforcing due to long-term ESAs and regulatory recovery, and customer value is increasing. Backlog and guidance revisions support an exceptional future outlook, and the business is transitioning into a high-growth, cash-generative model. The article surfaces all of these signals clearly.
Red Cat (RCAT) Q2 2026: Revenue Soars 520% as All-Domain Autonomy Drives Defense Demand
Red Cat demonstrates a long reinvestment runway, transformative growth (520% revenue increase), improving unit economics, a self-reinforcing platform, increasing customer value, and a disruptive, high-growth business model. The company is positioned for further acceleration, with clear catalysts and exceptional future prospects. All signal criteria are strongly met.
Digital Realty (DLR) Q2 2026: Backlog Hits $1.9B, Securing Multi-Year Double-Digit Growth Path
Digital Realty demonstrates a long reinvestment runway, accelerating backlog, improving unit economics, and disruptive business model characteristics. The business is growing rapidly with high visibility into future earnings and margin expansion, supported by a robust pipeline and strategic capital initiatives.
Freeport-McMoRan (FCX) Q2 2026: U.S. Mine Operating Income Surges 2.4x, Accelerating Copper Growth Pipeline
Freeport-McMoRan is showing a long reinvestment runway, major growth inflections (2.4x US operating income, 65% net income growth), improving unit economics, self-reinforcing model with brownfield/technology, rising customer value, exceptional guidance, disruptive leach innovation, accelerating cash flows, >20% growth, and clear growth trajectory.
ATI (ATI) Q2 2026: AA&S Margin Soars to 23.7% as Portfolio Shift Drives Durable Upside
ATI demonstrates a long reinvestment runway with high ROIC, significant recent growth in backlog and margins, improving unit economics, and a business model that is increasingly self-reinforcing through differentiation and customer reliance. Customer value is rising, growth guidance is exceptional, and the business is clearly in a high-growth, cash-generative phase with disruptive elements (specialty materials, sole-source status). The article captures these signals with precision.
Innodata (INOD) Q2 2026: Gross Margin Jumps 9 Points on Research-Driven Mix Shift
Innodata demonstrates a long reinvestment runway with high returns via proprietary datasets and recurring revenue. There is a material business evolution, with margin and revenue growth exceeding 40%. Unit economics are improving, and the business model is self-reinforcing with IP leverage. Customers are becoming more valuable, and guidance points to exceptional future growth. The model is disruptive, cash flow is accelerating, and revenue/EPS are set to grow over 40% annually. This is a clear growth business, not legacy or stalling.
Aurora (AUR) Q2 2026: Gen 2 Hardware Cuts Costs by 50%, Accelerates Path to Profitability
Aurora demonstrates a long reinvestment runway with high returns as it transitions to a scalable, asset-light business model. There are significant recent developments (hardware cost halving, rapid fleet expansion, 400%+ revenue growth guidance). Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Guidance and backlog are exceptional. The business is disruptive with clear lateral opportunities, accelerating cash flow, and projected high growth rates. Aurora is clearly a growth business entering industrial scale.
Circle (CRCL) Q2 2026: USDC On-Chain Volume Surges 151% as ARK and CPN Scale
Circle demonstrates an exceptional growth runway, compounding network effects, disruptive model, and accelerating financials. The business is transitioning into a high-margin, multi-segment platform with regulatory and distribution moats, and recent results show clear inflection and upside.
IREN (IRNF) Q4 2026: $4 Billion ARR Contracted Highlights Structural Compute Shortage and Capital Efficiency
IREN demonstrates a long reinvestment runway, exceptional growth, improving unit economics, and a disruptive, self-reinforcing business model. The backlog and ARR growth are outstanding, and the business is transitioning into a cash flow machine with high growth prospects, making the signal extremely high.
Revolution Medicines (RVMD) Q2 2026: R&D Spend Jumps 76% as Pancreatic and Lung Cancer Launch Readiness Accelerates
Revolution Medicines is at a critical inflection with a long reinvestment runway, massive recent uptick in spend and pipeline breadth, improving unit economics as it scales, and a disruptive, self-reinforcing model in oncology. The business is poised for high growth with accelerating cash burn aimed at capturing first-mover advantage, and guidance/operational signals point to exceptional future growth if execution succeeds.
Prague Holdings (PRG) Q2 2026: Consolidated GMV Surges 60% as Ecosystem Model Unlocks Margin Expansion
PRG demonstrates a long reinvestment runway, exceptional recent growth (GMV +60%), improving unit economics, and a self-reinforcing model driven by ecosystem and AI. Customers are becoming more valuable, guidance is raised, and all segments are compounding. The business is disruptive in consumer finance, cash flow is accelerating, and revenue/EPS growth outlook is well above 20%. This is a clear growth business with high signal for investors.
Arrowhead Pharmaceuticals (ARWR) Q3 2026: Redemplo Prescriptions Double, SHTG Data Unlocks $3B+ Opportunity
Arrowhead demonstrates a long reinvestment runway, major recent developments (prescription doubling, SHTG data), improving unit economics, and a self-reinforcing, disruptive business model. Customers are becoming more valuable, guidance is exceptional, and the business is positioned for high growth and cash flow acceleration. The pipeline and partnerships further reinforce its growth profile.
Ethos Technologies (LIFE) Q2 2026: Third-Party Channel Jumps 90%, Reshaping Margin Mix and Market Reach
Ethos demonstrates a long reinvestment runway, disruptive business model, and outstanding growth metrics (triple-digit revenue growth, 90%+ channel expansion, raised guidance). Unit economics and customer value are improving, and the business is a clear growth story with accelerating cash flow and strong capital allocation discipline. The signal is very high for investors seeking compounding, high-ROIC platforms.
Lucid Diagnostics (PAVM) Q2 2025: Revenue Climbs 40% as Medicare Milestone Nears
Lucid Diagnostics is at a genuine inflection point, with a long reinvestment runway, disruptive business model, and accelerating growth potential pending Medicare coverage. The 40% sequential revenue jump, margin structure, and backlog dynamics provide high signal. The business is transitioning from pre-coverage to potential high-growth, high-margin scaling, offering exceptional upside if reimbursement milestones are met.
Arista Networks (ANET) Q2 2026: Purchase Commitments Soar to $9.7B as AI Demand Drives Supply Chain Expansion
Arista demonstrates a long reinvestment runway with clear, high-ROIC opportunities, exceptional growth, and robust backlog increases. Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Guidance and backlog suggest exceptional future growth. The business is highly disruptive, cash flow is accelerating, and revenue/EPS growth is above 40%. This is a clear growth business with strong strategic signal.
SanDisk (SNDK) Q4 2026: $93.9B NBM Backlog Transforms Visibility and Margin Structure
SanDisk demonstrates a long reinvestment runway (NBM model, data center pivot), recent significant growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, guidance and backlog are exceptional, and the business model is disruptive. Cash flow is accelerating, growth is well above 40%, and the company is a clear growth business.
BridgeBio Pharma (BBIO) Q2 2026: Attruby U.S. Revenue Surges $150M as Pipeline Advances to FDA Review
BridgeBio demonstrates a long reinvestment runway, significant recent developments (tripling of Attruby revenue, three NDAs in priority review), improving unit economics, and a self-reinforcing business model with increasing customer value. The outlook is exceptional, with multiple late-stage launches, robust cash flow potential, and clear disruptive potential in rare disease markets. Growth rates and pipeline momentum indicate a high-growth, non-legacy business with substantial valuation upside.
MNTN Q2 2026: Active PTV Customers Jump 40% as SMB Adoption Accelerates
MNTN demonstrates a long reinvestment runway, disruptive business model, and accelerating growth. Customer count and engagement are rising rapidly, margins are expanding, and the business is transitioning from early adoption to mainstream. All signal questions are supported by transcript evidence and financial data.
Lattice Semiconductor (LSCC) Q2 2026: AMI Acquisition Doubles TAM, Propels 62% Top-Line Growth
Lattice exhibits a long reinvestment runway, a step-change in TAM and growth from the AMI acquisition, rapidly improving unit economics and margins, self-reinforcing platform dynamics, expanding customer value, and accelerating growth rates. The business is positioned for structural EPS expansion with high growth visibility, making the signal exceptionally strong.
Enlight Renewable Energy (ENLT) Q2 2026: Portfolio Grows 4.6% as European Storage Returns Hit 17%
Enlight demonstrates a long reinvestment runway with strong ROIC, recent significant growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance is accelerating, and the business model is disruptive with a high cash flow trajectory. The company is a clear growth story with multiple valuation levers.
Voyager Technologies (VOYG) Q2 2026: Backlog Surges 62% to $336M, Golden Dome and Lunar Wins Extend Growth Visibility
Voyager demonstrates a rare combination of long reinvestment runway, disruptive business model, accelerating growth, and expanding backlog. The business is transitioning into a high-growth, high-margin phase with multiple secular tailwinds, and the article substantiates each signal criterion with transcript-based evidence.
Ceribell (CBLL) Q2 2026: 33% Revenue Growth Accelerates Clinical Adoption and Expands Market Reach
Ceribell demonstrates a long reinvestment runway with high gross margins and clear avenues for redeployment. There is a recent significant uptick in growth (33% YoY). Unit economics are improving, with gross margin expansion and increased utilization. The business model is self-reinforcing, with product stickiness and expanding clinical evidence. Customers are becoming more valuable, and guidance/outlook is exceptional. The business is disruptive, with AI-driven diagnostics and hardware-software integration. Cash flow is improving, and revenue/earnings growth is well above 20%. Ceribell is a growth business, not legacy or stalling.
Ultragenyx (RARE) Q2 2026: Gene Therapy Launches Target 6,000-Patient Population, Setting Up 2027 Profitability Path
Ultragenyx is entering a high-growth, high-upside phase with significant catalysts (gene therapy launches, large addressable populations, and a clear path to profitability). The business model is disruptive, self-reinforcing, and shows improving unit economics, with accelerating cash flow and growth rates exceeding 20% annually. All signal criteria are met or exceeded.
NICE (NICE) Q2 2026: AI Backlog Jumps 72% as Platform Strategy Drives Enterprise Wins
NICE demonstrates a long reinvestment runway with high returns, exceptional recent growth (AI backlog up 72%), improving unit economics, a self-reinforcing platform model, deepening customer value, and robust guidance. The business is disruptive, cash flow is accelerating, and growth rates are well above 20%. The company is clearly in a growth phase with significant upside.
AMD (AMD) Q2 2026: Data Center Revenue Soars 107% as AI Demand Reshapes Segment Mix
AMD demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and accelerating growth in high-value segments. The business is transitioning to a structurally higher growth profile, with exceptional backlog and guidance revisions, making it highly relevant for investors seeking upside.
Apollo (APO) Q2 2026: ACS Fees Jump 50% as Origination Pipeline Redefines Private Markets
Apollo demonstrates a long reinvestment runway with high ROIC, exceptional growth in origination and fee streams, improving unit economics, and a self-reinforcing, integrated platform. Customer value is increasing, backlog and guidance signal accelerating growth, and the business model is disruptive with strong cash flow trends. Revenue and EPS are set to grow well above 20% annually, and the company is firmly in growth mode. Signal is exceptionally high for investors.
Astera Labs (ALAB) Q2 2026: PCIe 6 Surges to 50% of Revenue as Scorpio X Volume Ramps
Astera Labs demonstrates every hallmark of a high-signal, high-upside business: a long reinvestment runway, disruptive model, accelerating growth (over 100% YoY, 40% sequential guidance), expanding margins, and deepening customer value. Recent developments (Scorpio X ramp, PCIe 6 dominance) represent inflections with major valuation implications, and the business is clearly transitioning to a dominant AI infrastructure player with significant optionality.
Hinge Health (HNGE) Q2 2026: Operating Margin Jumps 1000bps as Platform Expansion Accelerates
Hinge Health demonstrates a long reinvestment runway, exceptional growth (over 40%), improving unit economics, and a self-reinforcing business model with platform effects. Customers are becoming more valuable, backlog/guidance is exceptional, and the business is both disruptive and a cash flow machine. Revenue and EPS growth are high, and the business is clearly in a growth phase with substantial optionality.
DigitalOcean (DOCN) Q2 2026: Inference Services Surge 800% as AI-Native Flywheel Accelerates
DigitalOcean demonstrates a long reinvestment runway, exceptional growth in AI-native workloads, rapidly improving unit economics, and a disruptive business model. Backlog, guidance, and customer mix all point to accelerating growth, high operating leverage, and a self-reinforcing platform, making this highly actionable for investors.
LifeCore (LFCR) Q2 2026: 200% Demand Surge Locked for 2028, Pipeline Momentum Reshapes Revenue Mix
LifeCore is at a well-documented inflection point: a doubling of demand is contractually locked, pipeline momentum is high, margins are expanding, and the business is transitioning from development-heavy to recurring commercial revenue. The runway is long, unit economics are improving, and the business model is strengthening with scale. The article presents clear evidence of a high-growth, high-ROIC opportunity with sector tailwinds and significant upside.
VIAVI Solutions (VIAV) Q4 2026: Data Center Drives 70% NSE Growth, Accelerating Optical Cycle
VIAVI is undergoing a structural transformation with a long reinvestment runway, clear double-digit growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, the outlook is exceptional, and the business model is disruptive. Cash flow is accelerating, and the company is positioned as a high-growth, non-legacy business. All signal indicators are strongly positive.
SITM Q2 2026: CED Revenue Soars 181% as AI Timing Demand Redefines Growth Trajectory
SciTime demonstrates a long reinvestment runway with high ROIC, massive growth in CED (181%) and total revenue (127%), and improving unit economics. The business model benefits from network effects and deepening customer relationships, with future growth visibility underpinned by multi-year commitments and a robust design funnel. Guidance and backlog signal exceptional future growth, and the company is transitioning into a cash flow machine. The business is clearly a growth company with disruptive potential, strong lateral opportunities, and accelerating revenue and EPS growth.
BillionToOne (BLLN) Q2 2026: Oncology Revenue Jumps 176% as Platform Expansion Accelerates
BLLN demonstrates exceptional growth, disruptive potential, and a long reinvestment runway. There are clear signals of accelerating revenue, margin expansion, and operational leverage, with strong evidence of self-reinforcing business dynamics and high future growth potential.
Axon (AXON) Q2 2026: Platform Solutions Revenue Surges 123% as Ecosystem Expansion Accelerates
Axon is demonstrating a long reinvestment runway with high returns, exceptional growth (123% in platform solutions, 39% ARR, 40% bookings), improving unit economics, and a self-reinforcing ecosystem business model. Customer value is deepening, guidance is raised, and the business is disruptive with accelerating cash flow. Revenue and EPS growth are well above 40%, and the company is in a clear high-growth phase.
Elemental Royalty (ELE) Q4 2025: Pro Forma Revenue Jumps to $87M as Merger Leverage Unlocks Cash Flow
Elemental Royalty demonstrates a long reinvestment runway, major structural growth (merger, Tether investment), improving unit economics, and a self-reinforcing business model. Customer value and cash flow are accelerating, with multi-year growth visibility and disruptive digital payout innovation. The business is firmly in a high-growth phase with substantial upside.
ALX Oncology (ALXO) Q1 2026: 100% Response in CD47-High HER2+ Breast Cancer Underscores Biomarker Strategy
ALXO is demonstrating a potentially disruptive, biomarker-driven oncology platform with high response rates, long durability, and major clinical inflection. The business is in a high-growth, high-optional, early-stage phase with accelerating data catalysts, strong unit economics (if validated), and a long reinvestment runway. The article clearly signals a business with significant valuation upside if execution continues.
Genius Group (GNS) Q1 2026: Pro Forma Revenue Jumps 80% as Premium Model Drives 10x Student Monetization
Genius Group demonstrates a long reinvestment runway, disruptive model, and clear acceleration in both revenue and profitability. Unit economics, customer value, and business model self-reinforcement are all improving rapidly, with exceptional growth guidance and strategic inflection clearly evidenced in the transcript and commentary.
Jabil (JBL) Q3 2026: AI-Driven Infrastructure Surges 50% as Third Hyperscaler Win Expands Growth Base
Jabil is demonstrating a clear long runway with high returns, substantial AI-driven growth, margin expansion, and strong cash generation. The business model is increasingly self-reinforcing with new hyperscaler wins and global capacity ramps, and guidance signals sustained high growth on a larger base. The article provides strong evidence for each signal criterion, supporting a top score.
ERock (EROC) Q2 2026: Backlog Surges 10x to $1.7B, Locking Production Through 2028
ERock demonstrates a long reinvestment runway with substantial backlog growth, disruptive business model, improving unit economics, and a clear transition to growth. Backlog and revenue guidance signal exceptional future growth, with accelerating cash flow and deepening customer value. The business model is self-reinforcing with high returns, and all signal factors are strongly positive.
Mostec (MTZ) Q2 2026: Backlog Surges $5B as Mission Critical Pipeline Expands
Mostec demonstrates a long reinvestment runway, disruptive business model evolution, and rapidly accelerating growth as evidenced by record backlog and margin expansion. The article details exceptional recent developments (backlog surge), improving unit economics, self-reinforcing business model, and deepening customer value. Guidance and backlog conversion point to durable high growth, and the company is positioned as a secular winner in infrastructure, supporting a top signal score.
Velo3D (VELO) Q2 2026: Revenue Surges 52% Amid Capacity Expansion and Operational Scaling
Velo3D shows a long reinvestment runway with high ROIC potential, a massive backlog increase, improving unit economics, and a self-reinforcing business model. Customer value is deepening, growth is exceptional as evidenced by revenue and backlog, and the business model is disruptive. Cash flow is on track to accelerate, and revenue/EPS growth is well above 40%. The company is clearly transitioning into a high-growth phase.
Kyivstar (KYIV) Q1 2026: Digital Revenue Jumps 257%, Multiplay Penetration Hits 40% of Mobile Base
Kyivstar demonstrates a long reinvestment runway, major digital revenue inflection, improving unit economics, a self-reinforcing multiplay model, deepening customer value, and exceptional near-term growth. The business is disruptive, cash flow is accelerating, and growth rates are well above 40%. The business is clearly in the high-growth category, with thesis-relevant signal throughout.
Better Home & Finance (BETR) Q3 2025: Tin Man AI Platform Drives 64% QoQ Margin Expansion as Partnerships Scale
The business demonstrates a long reinvestment runway, disruptive platform model, rapidly improving unit economics, accelerating growth, and strong customer value expansion. Backlog and guidance are exceptional, the business is transitioning to a high-growth, SaaS-like margin profile, and the AI platform model is both self-reinforcing and cash generative. The signal is unusually high and relevant for investors.
Amazon (AMZN) Q4 2025: AWS Backlog Jumps 40%, Securing Multi-Year AI Growth Visibility
Amazon demonstrates a long reinvestment runway with high ROIC, a massive and accelerating AWS backlog, and clear improvements in unit economics and business model self-reinforcement. Customer value is deepening, future growth is exceptional (with 40%+ backlog growth), and the business is disruptive with accelerating cash flow. The company is positioned as a growth leader rather than a mature or transitioning business.
Firefly Aerospace (FLY) Q2 2026: Backlog Soars to $1.5B, Signaling Accelerated Lunar and Launch Expansion
Firefly demonstrates a very long reinvestment runway with high returns, a massive and accelerating backlog, improving unit economics, and self-reinforcing business model through vertical integration and AI. Customer value is deepening, growth is exceptional, and the business is disruptive with accelerating cash flow potential. Revenue/EPS growth is well above 40%, and the company is clearly in a high-growth phase. Signal is extremely high and relevant for investors seeking upside.
Lumentum (LITE) Q4 2026: Revenue Surges 109% as AI Demand Accelerates Optical Connectivity Shift
Lumentum is demonstrating a long reinvestment runway at high returns, with significant recent growth, improving unit economics, a self-reinforcing business model, deepening customer value, exceptional forward guidance, a disruptive business model, accelerating cash flow, high revenue/earnings growth, and is clearly a growth business. All criteria for signal are strongly met.
So-Young International (SY) Q2 2026: Aesthetic Treatment Revenues Surge 130%, Driving Margin Expansion and Operational Efficiency
So-Young demonstrates a long reinvestment runway with high returns as it aggressively scales its clinic network. The business has delivered multiple quarters of triple-digit growth, with gross margin and unit economics improving. The business model is becoming self-reinforcing due to AI integration, network effects, and upstream partnerships. Customers are becoming more valuable, and cash flow is rapidly improving. Revenue and EPS growth are well above 40%, and the company is at a major inflection point towards profitability, making it a high-signal, high-upside opportunity.
Alphabet (GOOG) Q4 2025: Cloud Backlog Jumps 55% QoQ, AI Demand Drives $240B Pipeline
Alphabet demonstrates an exceptional growth profile with a massive and accelerating cloud backlog, strong reinvestment at scale, clear improvements in unit economics, disruptive business model, and accelerating cash flow. The business is not mature or capped, and all signal criteria are met or exceeded based on the call.
Firefly Aerospace (FLY) Q1 2026: Spacecraft Revenue Hits $67.6M on Artemis and Defense Tailwinds
Firefly Aerospace demonstrates a rare combination of long reinvestment runway, step-function growth (revenue and backlog), improving unit economics, and a self-reinforcing business model (AI/data/software + vertical integration). Customer value is deepening, guidance is exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth prospects are well above 40% annually, and the business is clearly in a growth phase with significant upside.
BTDR (Bitdeer) Q2 2026: $4.7B AI Co-Location Lease Anchors Strategic Pivot
Bitdeer demonstrates a long reinvestment runway with high returns, major business evolution with the $4.7B lease, improving unit economics, and a self-reinforcing, vertically integrated model. Customer value is increasing, guidance is strong, and the business model is highly disruptive. Cash flow is accelerating, growth rates are exceptional, and the company is clearly a growth business with significant upside.
ICHR Q2 2026: Capacity Expansion Targets $3B Run Rate as Gross Margin Surges 130bps
Ichor demonstrates a long reinvestment runway, clear inflection in growth (capacity expansion, margin gains, demand visibility), and improving unit economics. The business is transitioning from cyclical to structural growth, with a disruptive internalization model and strong customer order visibility into 2027. Guidance and backlog indicate exceptional forward growth, and the business is positioned as a high-growth, high-ROIC opportunity.
CoreWeave (CRWV) Q2 2026: Active Power Jumps 500 MW, Signaling Accelerated AI Cloud Expansion
CoreWeave demonstrates an exceptional growth runway with massive capacity expansion, surging backlog, improving unit economics, and disruptive business model attributes. The business is transitioning to scale, with accelerating cash flow, high double-digit (even triple-digit) growth, and clear evidence of compounding advantages and increasing customer value. The signal is very high and thesis-relevant.
Better Home & Finance (BETR) Q4 2025: Tin Man AI Platform Hits 44% of Volume, Driving Structural Shift
The business demonstrates a long reinvestment runway, disruptive model, accelerating growth, improving unit economics, and compounding data advantages. Recent developments (Tin Man AI at 44% of volume, 77% YoY revenue growth, guidance for 70%+ YoY loan growth) signal a major business evolution with strong forward momentum and significant upside potential.
EquipmentShare (EQPT) Q1 2026: Rental Revenue Jumps 37% as T3 Platform Drives Share Gains
EquipmentShare demonstrates a long reinvestment runway, disruptive technology, accelerating growth, and improving margins. The business model is self-reinforcing, with strong customer economics and capital efficiency. Guidance and backlog signal exceptional future growth, and the company is positioned as a high-growth, technology-enabled disruptor in a legacy industry.
Velo3D (VELO) Q1 2026: RPS Drives 48% Revenue Surge, Defense Backlog Hits $30M
Velo3D is transitioning to a recurring revenue model with strong backlog growth, margin expansion, and large defense contracts. The business shows a long reinvestment runway, improving unit economics, disruptive model, and accelerating cash flow, with clear evidence of growth and transition from pilot to scale.
Firefly Aerospace (FLY) Q4 2025: Backlog Climbs 22% as SciTech Integration Accelerates Defense Upside
Firefly demonstrates a long runway with high returns (backlog, national security tailwinds), recent step-change in growth (163% revenue, 22% backlog increase), improving unit economics, and a compounding business model through integration and recurring revenue. Customer value is increasing, guidance is exceptional, and the business is highly disruptive with accelerating cash flow potential and strong growth outlook.
SMCI (Super Micro Computer) Q4 2026: Backlog Surges to $60B Driving 78% Revenue Growth and Margin Expansion
SMCI demonstrates a long reinvestment runway, exceptional growth (backlog, revenue, and customer base all surging), improving unit economics, and a self-reinforcing, vertically integrated business model. The business is disruptive, with accelerating cash flow and guidance for 20%+ annual growth. The signal is extremely high for investors seeking upside.
Solve Energy (MWH) Q1 2026: Backlog Jumps 82%, Locking in Multi-Year Revenue Visibility
Solve Energy demonstrates a long reinvestment runway, disruptive business model evolution, and accelerating growth with exceptional backlog expansion. Unit economics, recurring revenue, and margin profile are improving, with evidence of compounding advantages and strong future outlook. The business is clearly a growth story with high investor relevance.
SPCX Q2 2026: Starlink Subscriber Growth and AI Compute Surge Drive 92% Revenue Jump
SpaceX demonstrates a long reinvestment runway, disruptive business model, and accelerating growth across all segments. There are clear signs of improving unit economics, expanding customer value, and compounding self-reinforcing advantages. Revenue and backlog growth are exceptional, with the business transitioning from high growth to a dominant, multi-segment leader.
WeRide (WRD) Q2 2026: Overseas Revenue Surges 164%, Driving Asset-Light Global Expansion
WeRide demonstrates a long reinvestment runway, rapid growth (82% YoY, 164% overseas, 2,593% in L2++/L3), and improving unit economics. The business model is self-reinforcing with strong network/data effects, and customers are becoming more valuable. Backlog and guidance are exceptional. The business is highly disruptive, with accelerating cash flow and revenue growth well above 40%. The company is a clear growth business with substantial optionality.
Nebius (NBIS) Q2 2026: AI Cloud Revenue Soars 514% with $5 Billion Capacity Target Raised
Nebius demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, self-reinforcing business model, deepening customer value, and a disruptive, high-growth profile. The company’s financial and operational data point to a business at a transformative inflection, highly relevant for investors seeking upside.
Forgent Power Solutions (FPS) Q3 2026: Bookings Surge 308% as Backlog Hits $2B, Margin Expansion in Sight
FPS is experiencing a business inflection with triple-digit bookings growth, a swelling backlog, accelerating margin expansion, and a clear shift to cash generation. The business model is disruptive, self-reinforcing, and shows improving unit economics and customer value. Revenue and EPS are set to grow at exceptional rates, and the company is transitioning into a high-growth, high-cash-flow phase with a long reinvestment runway. The signal is extremely high for investors seeking upside.
Figure (FIGR) Q1 2026: Consumer Loan Marketplace Volume Doubles, Unlocking Rule of 140 Margin Leverage
Figure demonstrates a long reinvestment runway, disruptive business model, and accelerating growth with clear improvements in unit economics and operational leverage. The business is rapidly onboarding partners, expanding into large new markets, and showing exceptional growth rates in both revenue and margins. The model is self-reinforcing with strong customer value expansion and clear signals of future outperformance.
Coherent (COHR) Q4 2026: Data Center and Comms Revenue Jumps 59% as Capacity Ramp Accelerates
Coherent demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a disruptive, self-reinforcing business model. Revenue and EPS are growing at exceptional rates, backlog is surging, and the business is positioned as a leader in a structurally attractive industry. All signal criteria are met at the highest level.
Solve Energy (MWH) Q4 2025: Backlog Soars 87% to $8B, Locking in Multi-Year Demand Visibility
Solve Energy is demonstrating a structural inflection with an 87% backlog increase, high recurring revenue, improving unit economics, and a disruptive integrated model. Guidance and backlog signal exceptional forward growth (over 50% YoY), with expanding addressable market and cash flow. The business is positioned as a growth compounder with high barriers and strategic optionality.
Klarna (KLAR) Q1 2026: Transaction Margin Surges 44% as Fair Financing Scales
Klarna is showing all hallmarks of a high-signal, high-upside business: long reinvestment runway, accelerating growth (44%+), improving unit economics, clear network effects, deepening customer value, and disruptive business model. Guidance and backlog imply further acceleration. The business is not mature or capped, and the narrative is supported by both financials and qualitative commentary. This is a rare, exceptional signal profile.
White Fiber (WYFI) Q1 2026: Data Center Revenue Jumps 200% as Retrofit Model Accelerates AI Demand Capture
White Fiber exhibits a long reinvestment runway with high ROIC, a step-change in growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance and backlog signal exceptional future growth, and the model is both disruptive and cash generative. Revenue and EPS growth rates are well above 40%, and the business is clearly in growth mode with substantial pipeline optionality.
NTHI Q2 2026: Median Survival Quadruples to 26.1 Months, Validating Intranasal Brain Cancer Therapy
NTHI demonstrates a long reinvestment runway, a disruptive business model, and a step-change in clinical outcomes with strong regulatory momentum. The growth trajectory is exceptional, with double-digit upticks, improving unit economics, and a platform with broad application. The company is at a pivotal inflection, and the article captures the high signal for investors.
Infleqtion (INFQ) Q2 2026: Revenue Doubles on Quantum Commercialization, $100M Government Funding Signal
Infleqtion displays a long reinvestment runway at high returns, very strong growth (116% YoY), improving unit economics, a self-reinforcing business model, increasing customer value, and exceptional future prospects with guidance and backlog. The business is disruptive, cash flow is accelerating, and it is likely to maintain high revenue/EPS growth. It is clearly a growth business at an inflection point.
Cerebras Systems (CBRS) Q2 2026: Core Revenue Doubles Amid 600 MW Data Center Capacity Expansion
Cerebras is demonstrating a long reinvestment runway with high returns, exceptional recent growth, improving unit economics, and a disruptive business model. The company is transitioning to a scalable, high-growth phase with accelerating cloud revenue, strong backlog, and expanding customer base. Guidance and backlog signal further acceleration, and the business model is self-reinforcing with deepening partnerships and technological differentiation.
CuriosityStream (CURI) Q2 2026: Licensing Revenue Surges 48%, Driving Record Profitability
CuriosityStream demonstrates a long reinvestment runway with high returns via licensing and AI training data, a major recent inflection with 48% licensing growth, improving unit economics, a self-reinforcing business model, increasing customer value, and exceptional future prospects based on backlog and guidance. The business is disruptive, cash flow is accelerating, and revenue/EPS growth is well above 40%. It is positioned as a high-growth business.
Viant Technologies (DSP) Q1 2026: CTV Contribution Surges 40% as Advertiser Shift Accelerates
Viant demonstrates a long reinvestment runway with strong ROIC, a disruptive business model, and accelerating growth in CTV and proprietary data. Exceptional financial and operational metrics (e.g., 40%+ CTV growth, margin expansion, and record pipeline) indicate a high-growth, self-reinforcing platform with clear investor upside. All signal criteria are strongly met.
Marvell Technology (MRVL) Q2 2027: Data Center Growth Accelerates 46%, Custom Business Set to Double in FY28
Marvell is demonstrating exceptional growth, with a long reinvestment runway, accelerating data center and custom silicon business, improving unit economics, and clear evidence of a self-reinforcing, disruptive business model. Revenue and EPS are set to grow well above 40% annually, and the business is positioned as a high-growth leader in a structurally expanding market.
AXTI Q1 2026: Indium Phosphide Backlog Surges Past $100M, Triggering Aggressive Capacity Doubling
AXTI demonstrates a long reinvestment runway (multiple years of capacity doubling), a backlog surge over $100M, improving unit economics, and a vertically integrated, self-reinforcing model. Customer value and ARPU are rising, the business is positioned for exceptional growth, and the model is disruptive within the substrate supply chain. Cash flow and profitability are inflecting, and the business is transitioning from recovery to high-growth mode, with revenue and EPS likely to grow above 40% annually. All signals indicate a high-growth, high-ROIC business at a key inflection.
XNCR Q1 2026: XF819 Dose Expansion Sets Up Multiple Late-Stage Oncology Catalysts
Zencore is at a pivotal inflection with multiple late-stage catalysts, a broad pipeline, and clear optionality for high returns on capital. Clinical data and backlog are set to accelerate, with disruptive platform potential and rapidly improving unit economics. The business is positioned for exceptional growth, with a runway for commercial and partnership expansion.
Similarweb (SMWB) Q2 2026: $60M in Multi-Year Contracts Signal Enterprise and AI Expansion
Similarweb demonstrates a rare combination of accelerating growth, expanding enterprise contracts, improving unit economics, and a disruptive shift to data consumption models driven by AI. All signal questions are fully met or exceeded, with clear evidence from the call and guidance. The business is positioned for significant upside and is not a well-worn story.
EOS Energy (EOSE) Q1 2026: Backlog Jumps with 2 GWh Frontier Deal, Unlocking Project Finance Flywheel
EOS Energy is demonstrating a long reinvestment runway with high returns, evidenced by a transformative project finance platform, significant backlog expansion, and accelerating manufacturing scale. Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Growth rates are exceptional, the business is disruptive, and cash flow inflection is imminent. The company is at a critical inflection point, and the signal for future value creation is very high.
Red Cat (RCAT) Q4 2025: Cash Surges to $168M as USV and Drone Output Scales for Global Demand
Red Cat is at an inflection point, with a long reinvestment runway, disruptive business model, and clear operational and financial signals of accelerating growth. The article details a transformative increase in cash, rapid manufacturing scale, and substantial contract pipeline, with evidence of improving unit economics and a self-reinforcing business model. The company is positioned for significant revenue and EPS growth, and the strategic context supports a high signal score.
Roblox (RBLX) Q3 2025: Bookings Surge 70% as DAUs Top 151 Million, Margin Compression Ahead
Roblox demonstrates a long reinvestment runway, exceptional growth rates, improving unit economics, and a self-reinforcing business model with strong network effects. Customer value is deepening, and future guidance signals continued acceleration. The business is disruptive, cash flow is accelerating, and both revenue and EPS are likely to grow over 40% annually. Roblox is firmly positioned as a high-growth business with significant valuation upside.
Tiendas 3B (TBBB) Q2 2026: 39% Revenue Growth Accelerates Expansion and Operational Efficiency
Tiendas 3B demonstrates a long reinvestment runway, exceptional growth (39% revenue, 20% same-store sales), improving unit economics, and a self-reinforcing model. Customer value is rising, backlog and guidance are strong, and the business is disruptive with accelerating cash flow. Revenue and EPS growth exceed 40%, and the company is firmly in growth mode.
Innovative Aerosystems (ISSC) Q3 2026: 40% Organic Growth Drives Margin Expansion and Strategic Momentum
ISSC demonstrates a rare combination of 40%+ organic growth, expanding margins, accelerating free cash flow, and entry into a disruptive eVTOL market with a large backlog. The business model is self-reinforcing, customers are becoming more valuable, and the company is transitioning from legacy to high-growth markets. All signals point to a long runway and high investor relevance.
Elmet Group (ELMT) Q2 2026: 55% Backlog Surge Highlights Defense Demand Acceleration
Elmet exhibits a long reinvestment runway, a disruptive and strategically positioned business model, and is experiencing a massive backlog surge with accelerating growth in high-value defense markets. Unit economics and margins are improving, supported by vertical integration and strong demand visibility. The business is clearly in a high-growth phase, with supporting evidence throughout the article.
ALXO Q2 2025: CD47 Biomarker Drives 65% ORR in HER2+ Gastric, Reshaping Breast Cancer Strategy
ALXO demonstrates a long reinvestment runway, a major inflection in clinical data (65% ORR in biomarker-selected patients), improving unit economics via focused pipeline, a self-reinforcing biomarker-driven model, increasing customer value, exceptional future growth potential, a disruptive approach in IO, accelerating cash flow runway, very high growth prospects, and is positioned as a growth business. All signal criteria are met at the highest level.
EOS Energy (EOSE) Q3 2025: Commercial Pipeline Jumps 21% as Data Center Demand Drives 22% of Volume
EOS shows a long reinvestment runway, significant acceleration in pipeline and backlog, improving unit economics, a self-reinforcing business model through automation and strategic partnerships, increasing customer value (data center and long-duration focus), exceptional future outlook with accelerating growth, disruptive business model in a rapidly scaling market, accelerating cash flow trajectory, revenue and EPS growth likely to exceed 40%, and is a clear growth business. All answers are strongly evidenced by the call data.
Boost Run Inc. (BRUN) Q2 2026: $1.9B Contracted Revenue Fuels Aggressive AI Infrastructure Expansion
Boost Run exhibits an unusually strong growth profile with a long reinvestment runway, massive recent backlog uptick, improving unit economics, and a disruptive model. The business is clearly in hypergrowth, with strong customer value deepening, accelerating cash flow, and a business model that is both self-reinforcing and highly scalable.
Hyperion DeFi (HYPD) Q1 2026: DeFi Monetization Surges 140% as Triple-Dip Strategy Scales
Hyperion DeFi demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, a self-reinforcing model, and deepening customer value. The business model is disruptive, cash flow is accelerating, and the company is clearly transitioning into a high-growth operator with significant upside potential, as evidenced by financials, backlog, and strategic positioning.
QuickLogic (QUIK) Q1 2026: New Product Revenue Jumps 51% as RadPro and Intel 18A Initiatives Accelerate
QuickLogic demonstrates a long reinvestment runway (RadPro, Intel 18A, chiplet model), with significant recent growth (new product revenue up 51% sequentially). Unit economics are improving, the business model is becoming self-reinforcing, and customer value is increasing. Guidance and backlog point to exceptional future growth, and the company is transitioning toward a disruptive, high-growth model with accelerating cash flow. The business is likely to grow revenue and EPS well above 40%, and is positioned as a growth business with strong optionality.
BlackSky (BKSY) Q1 2026: Gen 3 Contracts Drive $160M Backlog Surge, International Mix Expands
BlackSky is at a clear inflection: contract wins, backlog surge, and raised guidance all reflect a transition to high-growth, high-margin SaaS-like economics with international expansion. The business model is disruptive with a long reinvestment runway, compounding advantages, and accelerating cash flow. All signal criteria for upside and investor relevance are met or exceeded.
NextBoat Inc. (NXB) Q2 2026: Transaction Volume Surges 138%, Validating Scalable Marine Marketplace Model
The business demonstrates a long reinvestment runway with high returns, as evidenced by rapid transaction and revenue growth, improving unit economics, and a disruptive, scalable model. Recent acquisitions and product launches have driven significant inflections in backlog and growth, with clear evidence of self-reinforcing network effects and increasing customer value. The model is transitioning to higher-margin finance and warranty products, supporting accelerating cash flow and strong growth prospects. The business is clearly in a growth phase with exceptional future potential.
Figure Technology Solutions (FIGR) Q2 2026: Consumer Loan Volume Surges 132%, Accelerating Capital-Light Growth
Figure Technology Solutions demonstrates a long reinvestment runway with high returns, a disruptive business model, and accelerating growth metrics. The business is compounding with network effects, improving unit economics, and showing exceptional guidance and backlog growth. The company is transitioning into a cash flow machine, and the growth rates and margin expansion are exceptional and well above industry norms. The business is clearly in a high-growth phase, with significant optionality and competitive advantages deepening over time.
Baidu (BIDU) Q1 2026: AI Cloud Infra Jumps 79% as GPU Mix Lifts Margin Trajectory
Baidu demonstrates a long reinvestment runway, with exceptional growth in AI Cloud Infra (79%) and GPU cloud (184%), improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, cash flow is accelerating, and the business is clearly in a high-growth phase with global expansion, making it highly relevant for investors seeking upside.
ASM (ASM) Q2 2026: Logic Foundry Drives 24% Growth as 1.4nm, DRAM, and China Tailwinds Build
ASM demonstrates a long reinvestment runway at high returns, recent significant growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, backlog and guidance are strong, and the business is highly disruptive with accelerating cash flow. Revenue and EPS growth are well above 20%, and ASM is positioned as a growth business.
Roivant (ROIV) Q3 2025: Brepo 45mg Delivers 100% Response in CS, Unlocking Orphan Inflammatory Expansion
Roivant demonstrates a long reinvestment runway with high returns, transformative clinical results, improving unit economics, a self-reinforcing business model, and deepening customer value. The future outlook is exceptional, with accelerating growth, disruptive potential, and strong cash flow prospects. All signal questions are met at the highest level based on the evidence presented.
Nu Holdings (NU) Q2 2026: Record $1B Net Income Highlights AI-Driven Credit Expansion and Market Deepening
Nu Holdings demonstrates a long reinvestment runway, substantial recent growth, improving unit economics, and a self-reinforcing business model via AI and customer data. Customer value is increasing, guidance is strong, and the business is highly disruptive with accelerating cash flow and growth rates above 40%. The company is a clear growth business with significant optionality.
Keysight Technologies (KEYS) Q3 2026: Orders Surge 56% Fueling Broad-Based Growth and Margin Expansion
Keysight demonstrates a long reinvestment runway, exceptional recent growth (orders up 56%), improving unit economics with margin expansion, a self-reinforcing business model, increasing customer value, and exceptional future guidance. The business is disruptive with strong cash flow acceleration, is growing revenue and EPS over 20% annually, and is positioned as a growth business.
Axiom Therapeutics (AXSM) Q2 2026: 46% Revenue Growth Driven by Alzheimer's Agitation Launch and Neuroscience Pipeline Progress
Axiom Therapeutics is demonstrating an exceptional growth trajectory with a long reinvestment runway, disruptive model, and clear evidence of accelerating revenue, prescription growth, and pipeline advancement. Unit economics are improving, the business is self-reinforcing through payer access and clinical progress, and customers (patients/providers) are becoming more valuable. The future outlook is for exceptional growth with multiple catalysts, and the business is not mature or capped.
MARTI Technologies (MRT) Q2 2026: Revenue More Than Doubles with Adjusted EBITDA Turning Positive at $2.9 Million
MARTI demonstrates a long reinvestment runway, exceptional revenue growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, backlog/guidance is exceptional, and the business model is disruptive with lateral opportunities. Cash flow is accelerating, and top-line/earnings growth is well above 40%. The company is clearly in a high-growth phase, not a legacy or stalling business.
Kingsoft Cloud (KC) Q2 2026: AI Cloud Revenue Surges 82%, Driving First Positive Operating Margin
Kingsoft Cloud displays a long reinvestment runway with high returns, an exceptional growth inflection (82% YoY AI cloud surge), improving unit economics, a self-reinforcing business model, and deepening customer value. The business is disruptive, with accelerating cash flow and growth rates exceeding 40%. The transition to AI cloud marks it as a high-growth, non-legacy business with significant upside potential.
Hyperfine (HYPR) Q3 2025: Gross Margin Jumps 450bps as Next-Gen MRI Launches Drive Pipeline Expansion
Hyperfine demonstrates a long reinvestment runway, clear business model evolution, improving unit economics, and a disruptive approach to medical imaging. The business is transitioning to high growth with accelerating revenue and margin expansion, supported by robust backlog, a multi-vertical pipeline, and significant guidance revisions. All signal questions are fully met with strong evidence.
Hyperion DeFi (HYPD) Q3 2025: Validator Stake Surges 60% as DeFi Monetization Flywheel Accelerates
Hyperion DeFi demonstrates a long reinvestment runway, disruptive and compounding business model, rapidly accelerating validator growth (+60% MoM), expanding recurring revenue, and strong guidance for further growth. Unit economics are improving, customer value is deepening, and the business is transitioning into a high-growth, cash-generative model. All signal questions are met at the highest standard.
Alibaba Group (BABA) Q1 2027: AI Cloud Revenue Surges 45%, Driving Strategic Capital Investment
Alibaba demonstrates a long reinvestment runway with high returns on capital, driven by a disruptive, vertically integrated AI cloud business model. The company reports a 45% surge in AI Cloud revenue, triple-digit AI product growth, and improving unit economics and margins. The business is clearly in a high-growth, transformative phase with exceptional future prospects, supported by proprietary technology and strong capital allocation discipline. All signal criteria are met at the highest level.
Red Cat (RCAT) Q1 2026: Revenue Surges 849% as Black Widow Pipeline Hits $700M
Red Cat demonstrates a unique inflection: massive revenue growth, a $700M+ pipeline, improving margins, and operational leverage. The business is disruptive, has a long reinvestment runway, and is transitioning into a high-growth, cash-generating model with accelerating guidance and sector tailwinds. All signal factors are strongly supported.
Enlight Renewable Energy (ENLT) Q1 2026: U.S. Revenue Share Hits 37% as Portfolio Surges Past 41GW
Enlight demonstrates a long reinvestment runway, clear inflections in U.S. and storage growth, improving unit economics, and self-reinforcing advantages. Customer value is rising, future guidance is exceptional, and the business model is disruptive with accelerating cash flow. The company is transitioning into a high-growth, high-return platform with strong optionality and industry leadership.
AST SpaceMobile (ASTS) Q2 2025: CapEx Jumps to $323M as Satellite Manufacturing Scales for Direct-to-Device Launch
ASTS demonstrates a long reinvestment runway, a disruptive and self-reinforcing business model, and is at a major inflection with significant operational and financial developments. Unit economics and customer value are set to improve with scale, the business is transitioning to a growth phase, and the outlook is for rapid expansion. The article captures these signals directly from the call and management commentary, justifying a top score.
XEO (XEO) Q3 2025: Managed Premium Surges 140% to $1.2B, Margin Expansion Drives IPO Momentum
XEO demonstrates a long reinvestment runway, a disruptive insurance-as-a-service business model, exceptional recent growth (140% managed premium, 90% revenue), expanding margins, deepening customer value, accelerating cash flow, and a strong forward outlook. The business is at an inflection point with high signal for investors.
Beta Technologies (BETA) Q4 2025: Backlog Surges by $2B as Regulatory Tailwinds Accelerate Commercialization
Beta Technologies displays a long reinvestment runway, disruptive business model, rapidly expanding backlog, improving unit economics, and accelerating defense and commercial opportunities. The business is moving from validation to commercialization, with clear signals of high growth, margin potential, and durable competitive advantages.
Enlight Renewable Energy (ENLT) Q3 2025: Storage Portfolio Soars 6x in Three Years, Powering $2B Revenue Runway
Enlight demonstrates a long reinvestment runway at high returns, a massive recent uptick in storage-driven growth, improving unit economics, and a self-reinforcing business model. Customers (utilities) are becoming more valuable with storage/renewables integration, and guidance is revised upward with strong backlog. The business is highly disruptive, cash flow is accelerating, and revenue/EPS growth is robust. This is a top-tier, high-signal growth story with sector leadership potential.
InVivid (IVVD) Q3 2025: $87M Capital Infusion Powers Pivotal Antibody Launch Path
InVivid demonstrates a long reinvestment runway, a disruptive business model, and clear evidence of accelerating growth (41% YoY revenue, major capital infusion, pivotal trial catalyst). The business is transitioning from niche to broad market, with improving unit economics, robust commercial expansion, and high-value pipeline optionality. The risk/reward is highly asymmetric given the clinical and regulatory inflection ahead.
Xpeng Inc (XPEV) Q2 2026: $900M Humanoid Robotics Financing Signals Strategic Pivot and Growth Acceleration
Xpeng demonstrates a long reinvestment runway in both EVs and robotics, with a disruptive business model and accelerating growth. The $900M Dogotix funding, 65% QoQ delivery growth, and clear unit economics improvement signal exceptional future prospects. Backlog and guidance are strong, and the company is transitioning into a high-growth, multi-domain AI leader. All signal criteria are clearly met at the highest level.
Golar LNG (GLNG) Q2 2026: Fourth FLNG Order Boosts Fleet Capacity 41 Percent, Positioning for 50 Percent Earnings Growth
Golar LNG demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing business model. The business is disruptive, with accelerating cash flow, strong guidance, and is positioned as a growth company. The scale of backlog and earnings potential is exceptional and well-supported by evidence.
CrowdStrike (CRWD) Q2 2027: Net New ARR Surges 51% Fueling Record Falcon Flex Adoption
CrowdStrike demonstrates a long reinvestment runway at high returns, with significant recent growth in net new ARR and rapid product adoption. Unit economics are improving, the business model is self-reinforcing, and customer value is increasing. Guidance and backlog indicate exceptional future growth. The business is disruptive, cash flow is accelerating, and revenue/EPS growth is well above 40%. This is a high-growth, high-signal business with substantial upside.
NVIDIA (NVDA) Q2 2027: Data Center Revenue Surges 117% Year-Over-Year Amid Supply Constraints
NVIDIA demonstrates an exceptional growth runway, with clear evidence of reinvestment at high returns, disruptive business model, compounding advantages, and accelerating cash flow. The article details significant recent developments, backlog growth, and a business model that is both self-reinforcing and expanding. The signal for valuation upside is extremely high and well-supported.
Cerebras (CBRS) Q1 2026: Core Revenue Doubles as Wafer-Scale AI Demand Accelerates
Cerebras demonstrates a long reinvestment runway, disruptive business model, and rapidly accelerating growth (core revenue up 92%, cloud/services up 167%). Backlog and guidance signal exceptional future growth. Unit economics and margins are improving with scale, despite temporary rental headwinds. Major partnerships (OpenAI, AWS) validate product-market fit and reinforce the self-reinforcing business model. The company is clearly in the high-growth, high-ROIC phase with strong cash flow prospects as scale is achieved.
Hippo (HIPO) Q2 2026: Casualty Premiums Jump 61% as Diversification Accelerates Beyond Homeowners
Hippo demonstrates a long reinvestment runway, disruptive business model evolution, and accelerating growth across multiple lines. Unit economics and margins are improving, customers are becoming more valuable, and the business is transitioning from a legacy homeowners focus to a diversified, technology-driven platform. Guidance revisions and backlog/partner expansion suggest exceptional future prospects.
Cloudflare (NET) Q2 2026: Large Customer Base Grows 27% as Agentic Internet Drives Platform Adoption
Cloudflare demonstrates a long reinvestment runway with strong growth in large customers and developers, improving unit economics, and a self-reinforcing platform model. The business model is disruptive, cash flow is accelerating, and guidance points to continued rapid growth. The article makes clear that Cloudflare is at a strategic inflection point, offering substantial upside and investor-relevant signal.
MaxLinear (MXL) Q2 2026: Infrastructure Revenue Jumps 145% as Optical Demand Rewrites Growth Trajectory
MaxLinear is undergoing a major business model transformation with a long reinvestment runway, significant growth inflection in optical infrastructure, improving unit economics, and expanding margins. The business model is self-reinforcing with increasing customer value, backlog visibility, and disruptive potential in data center connectivity. Guidance and reported results support exceptional growth, and the business qualifies as a high-growth, thesis-relevant opportunity.
Sensient Technologies (SXT) Q2 2026: Natural Color Conversion Revenue Hits $25M, Signaling Acceleration Toward $1B Goal
Sensient is in the midst of a major secular shift with a long reinvestment runway, clear regulatory and consumer tailwinds, and double-digit growth. Unit economics are improving, the business model is self-reinforcing, and customer value is increasing. Backlog and guidance are exceptional, the model is disruptive, and cash flow is ramping. Revenue and EPS growth are high, and the business is firmly in a growth phase.
Applied Materials (AMAT) Q3 2026: Semiconductor Systems Revenue Surges 27% Year-Over-Year Amid AI-Driven Demand Expansion
Applied Materials demonstrates an exceptional growth profile: long reinvestment runway, disruptive business model, accelerating revenue and margin expansion, and clear evidence of compounding advantages in a rapidly expanding AI-driven market. The business is not mature or capped, guidance revisions are substantial, and the business model is highly self-reinforcing. All signal criteria are met at the highest level.
Applied Digital (APLD) Q4 2026: Contracted Lease Value Doubles to $36B, Unlocking Multi-Gigawatt Expansion
The business demonstrates a long reinvestment runway, massive recent growth in contracted value, improving and scalable unit economics, a self-reinforcing business model, deepening customer value, and accelerating growth outlook. The transition to a platform operator with direct hyperscaler commitments and a power pipeline is highly disruptive and signals exceptional future prospects.
Cadence (CDNS) Q2 2026: $8.1B Backlog and Agentic AI Adoption Propel 19% Growth Outlook
Cadence demonstrates a long reinvestment runway, disruptive AI-driven business model, and accelerating growth across all segments. Backlog, recurring revenue, and customer value are all rising materially. The company is showing exceptional growth and guidance revision, with clear evidence of self-reinforcing economics and a multi-year growth trajectory.
Semtech (SMTC) Q2 2027: Data Center Revenue Surges 91%, Backlog Fuels 160% Growth Outlook
Semtech is demonstrating long reinvestment runway, disruptive business model expansion, and exceptional growth (160% YoY data center, 58% YoY LoRa). Backlog and guidance indicate accelerating growth, margins are structurally improving, and the business is transitioning into a high-growth, high-margin profile with strong cash flow. All key signal criteria are met or exceeded.
Baker Hughes (BKR) Q2 2026: IET Orders Double to $7.1B, Unlocking Multi-Year Power Systems Ramp
Baker Hughes exhibits a long reinvestment runway (multi-year power systems ramp), recent step-change in growth (IET orders doubled), improving unit economics and margins, and a self-reinforcing business model with growing recurring revenue. Customers are becoming more valuable (higher ARPU, recurring services), and backlog/guidance is exceptional. The business model is disruptive within energy infrastructure, cash flow is accelerating, and growth rates are robust, with the company clearly in a growth phase.
Bloom Energy (BE) Q2 2026: Brookfield Financing Grows 5x to $25B, Locking In AI Power Demand Surge
Bloom Energy is at a major inflection: institutional capital, accelerating AI/data center demand, margin and cash flow inflection, and a disruptive business model with a long runway. Backlog and revenue growth are exceptional, and the company is positioned as a growth compounder with strong investor signal.
Core Scientific (CORZ) Q2 2026: $14B AMD Deal Locks In 530MW, Shifts Model to Long-Term AI Infrastructure
Core Scientific demonstrates a long reinvestment runway with a disruptive business model shift, exceptional backlog growth, and clear evidence of improving unit economics and customer value. The AMD deal and execution cadence underpin accelerating revenue and cash flow, with the business positioned as a growth platform in a supply-constrained, high-demand sector. All signal criteria for upside and business evolution are satisfied.
OKLO (OKLAH) Q2 2026: $3B Cash Fuels Accelerated Nuclear Platform Buildout and Record Reactor Execution
Oklo demonstrates a rare combination of long reinvestment runway, disruptive business model, rapid execution, and accelerating capital deployment. The Groves milestone, multi-pathway fuel strategy, and strong backlog/guidance signal exceptional future growth and cash flow potential. The business is positioned as a platform with deepening competitive advantages and high investor relevance.
Connexa Pharmaceuticals (KNSA) Q2 2026: ARCLIS Revenue Jumps 55% as Penetration Hits 21%
Connexa demonstrates a long reinvestment runway with only 21% market penetration and clear avenues for redeployment at high returns. There is a significant uptick in growth (55% YoY revenue gain), improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable over time, and the future outlook is exceptional with raised guidance. The business is disruptive in rare disease pharma, cash flow is accelerating, and revenue/EPS growth is well above 40% annually. This is a high-growth, innovative business with strong signal for investors.
Corning (GLW) Q2 2026: Optical Sales Jump 32% as AI and Data Center Demand Accelerates
Corning shows a long reinvestment runway with high returns, major double-digit growth in optical and solar, improving unit economics and margins, and a self-reinforcing business model through long-term agreements. Customer value is deepening, backlog and guidance are exceptional, and the business is shifting to a disruptive, platform-led model. Cash flow is accelerating, and revenue/EPS growth is expected to be well above 20%. This is a clear growth business, not a legacy or transitioning story.
Bandwidth (BAND) Q2 2026: Five $1M+ AI-Driven Wins Signal 22% Growth Inflection
Bandwidth is showing a clear inflection with accelerating growth, strong unit economics, and a disruptive, usage-based AI business model. Guidance and backlog support high growth, margins are expanding, and the business is not mature or capped. The article evidences all major signal criteria.
Onto Innovation (ONTO) Q2 2026: Backlog Surges to $1.1B as Dragonfly G5 Powers 80% Advanced Packaging Growth
ONTO demonstrates a long reinvestment runway, exceptional growth (80% in advanced packaging), expanding margins, and self-reinforcing business model. Backlog visibility, product innovation, and operational leverage provide clear upside. The business is transitioning to secular growth, with accelerating cash flow, and is likely to deliver >40% growth. All signal criteria for a high-growth, high-upside business are met.
NXP Semiconductors (NXPI) Q2 2026: Physical AI Pipeline Expands to $1.5B, Accelerating Edge Growth
NXPI is demonstrating a long reinvestment runway with high ROIC, double-digit and accelerating growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, backlog and guidance are exceptional, and the business is both disruptive and a cash flow machine. Revenue and EPS growth are robust, and the business is firmly in growth mode.
LAM Research (LRCX) Q4 2026: NAND Revenue Doubles, Driving 20% Sequential Growth Outlook
LAM Research is demonstrating exceptional growth and business model evolution: doubling NAND revenue, record service growth, expanding margins, and a clear multi-year runway driven by AI and memory transitions. All signal questions are strongly evidenced by the call, supporting a top score.
L3Harris (LHX) Q2 2026: Missile Solutions Revenue Jumps 14% as Backlog Hits $42B
L3Harris demonstrates a long reinvestment runway with high ROIC, exceptional recent growth (Missile Solutions up 14%, international up 20%+), and a record $42B backlog. Unit economics and margins are improving with automation and scale, and the business model is self-reinforcing with high switching costs and network effects in defense contracting. Customer value is rising (international mix, recurring revenue), and the future outlook is exceptional based on backlog and guidance. The business is highly disruptive in defense, cash flow is accelerating, and revenue/EPS growth is above 20%. This is a clear growth business with substantial optionality and valuation upside.
Teradyne (TER) Q2 2026: AI Drives 100%+ Revenue Surge as Wafer-to-Data Center Strategy Accelerates
Teradyne is exhibiting exceptional growth, business model leverage, and strategic positioning in a secularly expanding market. The article details a 100%+ revenue surge, accelerating AI-driven mix, margin expansion, and clear evidence of a long reinvestment runway, all supported by management commentary and guidance.
Genius Sports (GENI) Q2 2026: Media Revenue Jumps 193% as Legend Synergies Outpace Timeline
Genius Sports demonstrates a rare combination of accelerating growth, margin expansion, and compounding platform effects. The Legend integration is already delivering outsized synergies, media revenue is surging, and prediction markets present new, high-growth revenue streams. The business model is self-reinforcing, with owned audience and official data creating a durable moat. The outlook and guidance revisions support exceptional future growth.
FormFactor (FORM) Q2 2026: Gross Margin Surges to 53.3% as Advanced Packaging Demand Accelerates
FormFactor demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance is exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth are strong and sustained, and the business is clearly in growth mode.
Micron (MU) Q3 2026: $22B Customer Deposits Signal Durable AI Memory Demand
Micron demonstrates a long reinvestment runway, exceptional backlog and growth acceleration, improving unit economics, and a self-reinforcing business model. Customer value is increasing, guidance and backlog are exceptional, and the business is transitioning to a disruptive, high-growth, cash-generative model. All signal criteria for a thesis-grade, high-upside investment are met.
Amphenol (APH) Q2 2026: IT Datacom Surges 89% as AI Demand Drives Record Bookings
Amphenol is experiencing explosive growth (IT Datacom up 89%, bookings up 94%), with clear evidence of a long reinvestment runway, improving unit economics, and a self-reinforcing business model. The business is highly cash generative, guidance is accelerating, and the company is positioned at the center of a secular AI/datacenter buildout. All signal criteria are strongly met.
China Yuchai (CYD) Q2 2026: High-Horsepower Engine Sales Surge 42%, Expanding Data Center Exposure
CYD demonstrates a long reinvestment runway with high returns, recent significant growth (notably 42% in high-horsepower engines), improving unit economics, and a self-reinforcing business model. Customer value is rising, backlog and guidance are strong, and the business model is disruptive with lateral opportunities. Cash flow is accelerating, and the company is in a high-growth phase, as evidenced by revenue and EPS growth rates.
AmpliTech Group (AMPG) Q1 2026: Gross Margin Jumps 1500bps as 5G Orders Drive Backlog Above $20M
AmpliTech presents clear evidence of a long reinvestment runway, disruptive business model, accelerating growth, and improving unit economics. The backlog surge, margin expansion, and guidance all point to a business at a major inflection with high investor signal.
Expand Energy (EXE) Q2 2026: Twin Eagle Deal Adds $200M EBITDA, Unlocks Integrated Gas Platform
EXE is pivoting to an integrated gas platform with a long reinvestment runway, clear disruptive business model, accelerating cash flow, and strong growth signals (e.g., Twin Eagle EBITDA, raised FCF guidance, and expanding customer base). The business is compounding, with improving unit economics and growing customer value. The strategic shift and sector implications provide high signal for investors.
AVEX (AVEX) Q2 2026: Acquisition of Black Sea Technologies Expands Multi-Domain Autonomous Systems Leadership
AVEX demonstrates a long reinvestment runway, disruptive model, and clear business acceleration. The acquisition, backlog growth, margin expansion, and pipeline all point to exceptional future prospects. Unit economics are improving, the business is not mature, and customer value is deepening. The outlook and guide upgrades support a high signal score.
Flex (FLEX) Q1 2027: Cloud & Power Infrastructure Surges 35% as Spin-Off Nears
Flex demonstrates a long reinvestment runway (AI infrastructure), recent significant segment growth (35%+), improving unit economics, a self-reinforcing business model (integration with hyperscalers), increasing customer value, exceptional guidance, disruptive positioning, accelerating cash flow, and strong growth prospects. The business is clearly in a high-growth, transformative phase with substantial upside.
Integrity (ASIC) Q2 2026: Brokerage Channel Mix Lifts Premiums 23%, Drives Margin Outperformance
Integrity demonstrates a long reinvestment runway, disruptive technology integration, and accelerating growth metrics. Premiums, margins, and cash flow are all improving at high rates, and the business model is clearly self-reinforcing. The outlook, guidance, and risk factors are all well supported by transcript evidence.
META (META) Q2 2026: AI-Driven Ads Push 27% Revenue Growth, CapEx Commitment Signals Multi-Year Compute Bet
Meta demonstrates a long reinvestment runway, clear disruptive business model, and accelerating growth in both core and emerging segments. There are significant recent developments (AI-driven ad growth, enterprise monetization), improving unit economics, and a self-reinforcing model with network effects. The future outlook is exceptional, with CapEx signaling a multi-year growth and infrastructure bet. All signal questions are strongly supported by transcript evidence.
Ouster (OUST) Q2 2026: 56% Revenue Surge Accelerates Physical AI Platform Adoption
Ouster demonstrates a long reinvestment runway with high returns, a disruptive platform business model, and accelerating growth across all major metrics—revenue, unit shipments, and software mix. Recent product launches and capital raises position the company for further outperformance. The business is clearly in a high-growth phase with expanding unit economics, increasing customer value, and a self-reinforcing platform, making the signal exceptionally strong.
Monolithic Power Systems (MPWR) Q2 2026: Enterprise Data Surges 45%, Capacity Expansion Targets $6B+
MPWR demonstrates a long reinvestment runway with high returns, exceptional recent growth (45%+ in enterprise data), improving unit economics, a self-reinforcing business model, increasing customer value, and exceptional forward growth guidance. The business is disruptive, cash flow is accelerating, and the company is clearly a growth business with revenue and EPS likely to grow over 40% annually. The signal is very high for investors.
Allegro MicroSystems (ALGM) Q1 2027: Data Center Revenue Jumps 32%, Accelerating High-Margin Mix Shift
Allegro MicroSystems demonstrates a long reinvestment runway, disruptive business model, and accelerating growth in high-value verticals. All signal questions are strongly supported by earnings data: gross margin expansion, content growth, and robust backlog/bookings trends. The business is clearly in a high-growth phase with multiple secular tailwinds and visible catalysts.
VIA (VIA) Q2 2026: Pipeline Doubles, Network Deals Set Stage for 27% Revenue Growth Trajectory
VIA demonstrates a long reinvestment runway with high returns, a doubling pipeline, improving unit economics, and a disruptive, AI-driven business model. The company is transitioning into a high-growth, diversified platform with strong revenue and margin expansion signals, making it highly relevant for investors seeking upside.
CAMT Q2 2026: Advanced Packaging Orders Surge Past $600M, Driving 30% H2 Growth Outlook
Camtech demonstrates a long reinvestment runway at high returns, exceptional order growth, improving unit economics, and a self-reinforcing, disruptive business model. Backlog and guidance revisions point to accelerating growth, with strong cash flow prospects and clear evidence of a high-growth, non-legacy business. All signal criteria are met at the highest level.
Silicon Motion (SIMO) Q2 2026: Farai and Boot Drive Solutions Reach 30% of Revenue, Diversification Accelerates
SIMO demonstrates a very strong signal profile: a long reinvestment runway, dramatic revenue mix shift, improving unit economics, self-reinforcing model (NAND access and solutions), deepening customer value, and accelerating growth outlook. The business is clearly transitioning into a high-growth, less cyclical model with disruptive elements and strong cash flow trajectory. All criteria are met at the highest level.
OmniAb (OABI) Q2 2026: Milestone Revenue Jumps 244% as Clinical Pipeline Advances
OmniAb demonstrates a long reinvestment runway, major recent growth inflection, improving unit economics, deepening network effects, and a clear shift to royalty-based recurring revenue. The business model is disruptive within life sciences, cash flow is set to accelerate, and the company is transitioning rapidly into a growth phase with high-quality partners and expanding ecosystem leverage.
Madison Air (MAIR) Q2 2026: Backlog Surges 133% as Data Center and Commercial Demand Drive Visibility
Madison Air demonstrates a rare combination of rapid growth (133% backlog increase, 45% order growth), improving unit economics, expanding recurring revenue, and a multi-year runway across secular growth markets. The business model is self-reinforcing, margins are expanding, and the company is positioned as a growth compounder with significant upside. All major signal criteria are met at a high level.
Amazon (AMZN) Q2 2026: AWS Revenue Jumps 37% as AI Demand Drives $169B Run Rate
Amazon demonstrates a long reinvestment runway, rapid growth, improving unit economics, and strong self-reinforcing business dynamics. Backlog and guidance signal exceptional future growth, cash flow is accelerating, and the business is disruptive with significant lateral opportunities. The article evidences all these points with specific numbers and management commentary.
Definium Therapeutics (DFTX) Q2 2026: $805M Capital Raise Fuels DT120 Launch Readiness Amid Pivotal Data Wave
Definium demonstrates a long reinvestment runway, disruptive business model, and is at a major inflection with pivotal data. The business is transitioning from clinical stage to high-growth commercial, with a massive capital raise, accelerating commercial ramp, and a potentially category-defining asset. Growth rates, optionality, and business evolution all point to exceptional signal for investors.
MKS Instruments (MKSI) Q2 2026: Semiconductor Revenue Jumps 28% as AI Cycle Drives Multi-Year Visibility
MKS Instruments is demonstrating a rare multi-segment upcycle with long reinvestment runway, high returns on capital, and accelerating growth driven by secular AI demand. There is clear evidence of improving unit economics, self-reinforcing business model, increasing customer value, and exceptional future outlook based on backlog and guidance. The business is clearly disruptive with a cash flow acceleration and exceptional growth profile, making it highly relevant for investors seeking valuation upside.
BioMarin (BMRN) Q2 2026: Amicus Integration Unlocks $220M Synergy Path, Reshapes Rare Disease Platform
BioMarin’s combination of rapid synergy realization, portfolio diversification, clear growth levers, and pipeline productivity signals an exceptional inflection. The business model is self-reinforcing, with accelerating cash flow, high growth, and clear disruption potential in rare disease. The article demonstrates all the hallmarks of high-signal thesis evolution.
Tempus AI (TEM) Q2 2026: FDA Approvals Set Stage for $400M Revenue Uplift by 2028
Tempus AI demonstrates a long reinvestment runway, major FDA-driven inflections, accelerating unit economics, and a self-reinforcing data/diagnostics flywheel. Customer value is deepening, guidance and backlog signal exceptional future growth, and the business model is disruptive with expanding cash flow. Revenue and EPS growth are well above 20%, and the business is firmly in a high-growth phase.
Rocket Lab (RKLB) Q2 2026: Backlog Surges 137% to $2.36B as Neutron Progresses Toward Launch
Rocket Lab displays a long reinvestment runway, exceptional backlog growth (137%), improving unit economics, and a disruptive, vertically integrated business model. The future outlook is exceptional, with accelerating revenue and backlog, and the business is clearly in a high-growth phase with strong cash flow potential. The article supports each point with relevant data and context from the earnings call.
Grid Dynamics (GDYN) Q2 2026: AI Revenue Jumps 55% as GAIN Platform Anchors Enterprise Adoption
Grid Dynamics is demonstrating a long reinvestment runway, disruptive business model, and clear inflection in AI-led growth and margin expansion. Unit economics are improving, customer value is deepening, and guidance/backlog signals are strong. The business is transitioning into a high-growth, cash-generative model with multiple optionality vectors.
PureCycle (PCT) Q2 2026: Regulatory Deadlines Drive 37-Program Ramp as Ironton Breakeven Nears
PureCycle demonstrates a long reinvestment runway with regulatory-driven demand and a disruptive business model. The company is experiencing significant growth in its pipeline and backlog, improving unit economics, and self-reinforcing business advantages through vertical integration and sticky customer relationships. Guidance and backlog suggest an exceptional growth trajectory, with accelerating cash flow and clear transition from a development-stage to a growth-stage business. The article provides strong evidence for each signal criterion, justifying a high score.
BKV (BKV) Q2 2026: Power CapEx Jumps $128M as Jack County Acceleration Signals Platform Doubling
BKV is at a strategic inflection with a long reinvestment runway, clear business model advantages, accelerating growth, exceptional financial performance, and strong forward outlook. The article details significant developments, improving unit economics, disruptive business model, and the company's transition into a high-growth phase, all supported by transcript evidence.
Profound Medical (PROF) Q2 2026: $70M Sales Pipeline Signals Inflection Despite Revenue Timing Shift
Profound Medical is at a major inflection, with a disruptive model, accelerating pipeline, expanding reimbursement, and high-margin profile. The business is transitioning to mainstream adoption with clear signals of rapid growth, improved economics, and a long reinvestment runway. The article highlights all critical signals for investors.
TTMI Q2 2026: Data Center Sales Surge 91%, Powering Margin Expansion and Guidance Lift
TTMI is demonstrating a step-function in growth, margin, and backlog, with clear evidence of long runway, disruptive technology, and accelerating financials. The business is not mature or capped, and the data supports a very high signal for future value creation.
RadNet (RDNT) Q2 2026: 25% Revenue Growth Driven by Advanced Imaging and Digital Health Expansion
RadNet demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, rapidly improving unit economics, exceptional growth rates, and accelerating cash flow. The company is transitioning into a high-growth, high-margin digital health and imaging platform with clear valuation upside.
Satellogic (SATL) Q2 2026: Revenue Soars 259% as Persistent Monitoring Shifts Business Model
Satellogic demonstrates a long reinvestment runway, structural inflection, and disruptive business model with accelerating recurring revenue and operating leverage. Backlog growth, margin expansion, and rapid contract conversion signal exceptional business evolution. The business is clearly in a growth phase with high optionality and sector tailwinds, making the signal extremely strong.
ON (ON) Q2 2026: AI Data Center Revenue Surges 100%+, Driving Margin Expansion and Capacity Tightness
ON demonstrates a long reinvestment runway with high returns, a disruptive and self-reinforcing business model, and accelerating growth in AI data center and EV segments. Unit economics, backlog, and margins are all improving, with clear evidence of pricing power and demand visibility extending multiple years. The business is positioned as a growth engine with exceptional future prospects, supported by both financial and strategic developments.
Magnite (MGNI) Q2 2026: CTV XTAC Up 36% as SpringServe and AI Orchestration Expand Platform Edge
Magnite is demonstrating a long reinvestment runway, disruptive business model, accelerating growth and margins, clear customer value expansion, and exceptional future outlook based on guidance and backlog. The business is not mature or capped, and the article supports all points with evidence from the call.
CUNITY (Q) Q2 2026: ICS Growth Surges 28% on AI and Advanced Packaging Momentum
CUNITY demonstrates clear evidence of a long reinvestment runway, high returns on capital, and disruptive business model evolution. The business is experiencing significant double-digit growth in key segments, with backlog and guidance upgrades confirming exceptional future prospects. Unit economics and customer value are both improving, supported by self-reinforcing business dynamics (content gains, integration, switching costs). Cash flow is accelerating, and the business is firmly in the high-growth category, with all major signal criteria strongly met.
Oscar Health (OSCR) Q2 2026: Membership Surges 46%, AI-Driven Margin Leverage Accelerates
Oscar Health demonstrates a long reinvestment runway with high returns, clear disruptive business model, and accelerating growth (46% membership, 70% revenue). Unit economics and operating leverage are improving materially. The business is compounding, with customers becoming more valuable over time. While future guidance is raised, growth acceleration is strong but not quite at the 'exceptional' (30%+) level for the future, hence a 1 for question 6. The company is moving to a cash flow machine with accelerating cash flow. Revenue and EPS growth are well above 40%, and the business is firmly in the growth category. The signal is very high, but not quite a perfect 20 due to the future acceleration guidance being strong but not exceptional.
ARIES Technologies (AERT) Q1 2027: Revenue Jumps 43% as AI Transformation Expands Client Engagement
ARIES Technologies demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and accelerating cash flow. Revenue growth is over 40%, margins are expanding, and the business is transitioning successfully to AI transformation services. The only area not fully exceptional is the future guidance, which is strong but not accelerating above 30%.
ASUR Q2 2026: Recurring Revenue Rises 19% as AI and Cross-Sell Drive Margin Expansion
ASUR demonstrates a long reinvestment runway with high returns, clear inflection in recurring revenue and margins, improving unit economics, and a self-reinforcing business model with AI and cross-sell. Customer value is deepening, and the business is in clear growth mode. The only slight deduction is on the revenue/EPS growth rate, which is strong but not definitively above 40% annually.
BWXT (BWXT) Q2 2026: Backlog Jumps 40% as Commercial Nuclear Pipeline Accelerates
BWXT demonstrates a long reinvestment runway, disruptive business model, and accelerating growth with a 40% backlog surge. Unit economics are improving, and the business is positioned for a multi-decade cycle. Revenue growth is high but not consistently above 40%, so a 1 is awarded for that metric. Overall, the signal is very strong and highly relevant for investors seeking growth and strategic inflection.
Happen (HAPN) Q2 2026: Loan Originations Surge 29% as Brand Transition and AI Drive Margin Highs
Happen demonstrates a long reinvestment runway with strong ROIC, double-digit growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, the business is disruptive, and cash flow is accelerating. Guidance and backlog signal exceptional future growth, though annualized revenue/EPS growth is just below the 40% threshold for maximum scoring. The business is clearly in a high-growth phase.
Venture Global (VG) Q2 2026: 48% Revenue Growth and 91% Contracted Capacity Signal Robust LNG Expansion
Venture Global demonstrates a long reinvestment runway (expansion pipeline), strong recent growth (48% revenue, 42% volume), improving unit economics (EBITDA margin stable at scale), and a self-reinforcing model (contracting, operational resilience). Customer value is deepening with high contract coverage, future growth is exceptional (guidance raised), and cash flow is accelerating. The business is not highly disruptive in the tech sense (score 1 for Q7), but otherwise scores high on all signal metrics.
CLEAR (YOU) Q2 2026: EBITDA Margin Surges to 36.4% as eGates Drive Labor Efficiency
CLEAR demonstrates a long reinvestment runway (automation, B2B, international), significant recent growth (margin, bookings, FCF), and improving unit economics. The business model is self-reinforcing (network effects, pricing power, ecosystem), with customers becoming more valuable (ARPU, retention). Guidance and backlog signal accelerating growth. The business is disruptive with multiple levers, and cash flow is rapidly improving. Revenue growth is over 20% but under 40%, so question 9 is scored conservatively. CLEAR is a growth business with clear upside.
Madrigal Pharmaceuticals (MDGL) Q2 2026: ResDifera Patient Base Doubles, Underpinning $1.3B Trailing Sales Run-Rate
Madrigal demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is disruptive with accelerating cash flow and strong growth. The only slight deduction is for future guidance not being 'exceptional' (over 30% acceleration) but still robust. Overall, this is a high-signal, high-upside specialty pharma story.
FRMI Q2 2026: $6.5B Anchor Deal and 2.6GW Strategic Alliance Accelerate AI Power Delivery
Fermi America demonstrates a long reinvestment runway, a major commercial development, improving unit economics, and a self-reinforcing business model with disruptive characteristics. Customer value is deepening and the future outlook is exceptional, though cash flow is not yet accelerating due to the pre-revenue stage. Revenue and EPS growth prospects are strong, and the business is clearly in a high-growth phase.
Hagerty (HGTY) Q2 2026: Written Premium Surges 19% as State Farm Conversions Accelerate Growth
Hagerty demonstrates a long reinvestment runway, exceptional recent growth (written premium up 19%, earned premium up 42%), improving unit economics, and a self-reinforcing business model with expanding partnerships and flywheel effects. Customers are becoming more valuable, and the business is transitioning to a high-margin, cash-generative model. The only deduction is for revenue/EPS growth, which, while strong, is guided at mid-to-high teens rather than over 40%.
Allegiance (LGN) Q4 2025: Backlog Surges 49%, Locking in Multi-Year Data Center Demand
Allegiance demonstrates a long reinvestment runway, a 49% backlog surge, improving unit economics, self-reinforcing labor/capabilities, and growing customer value. The business is transitioning to growth with accelerating cash flow, revenue, and EPS, with clear evidence of compounding scale. The only deduction is for business model disruption, as it is semi-disruptive rather than fully disruptive.
Pharming (PHAR) Q2 2026: Joenja Grows 40% as Pipeline Readouts Set Up Multi-Billion Opportunity
Pharming demonstrates a long reinvestment runway, significant recent developments (Joenja up 40%), improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and future growth is exceptional with major pipeline catalysts. The business is disruptive within rare disease, cash flow is accelerating, and it is a clear growth business. Revenue/EPS growth is likely to be in the 20-40% range, justifying a 1 for question 9. Overall, signal is very high.
Equinix (EQIX) Q2 2026: CapEx Plan Surges to $7B as AI Demand Drives 23% Bookings Growth
Equinix demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing business model. The AI-driven demand surge, record bookings, and robust backlog signal exceptional forward prospects. Only revenue/EPS growth is slightly below the 40%+ threshold, otherwise the business is a clear compounder with high signal for investors.
Synopsys (SNPS) Q3 2026: EDA Growth Accelerates to Double Digits, Lifting Full-Year Outlook
Synopsys demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and accelerating growth in core segments. The integration of ANSYS and emergence of AI workflows provide additional optionality, though some forward-looking elements (e.g., agentic AI monetization) are still early-stage, warranting a slight reduction from perfect signal.
Gold.com (GOLD) Q3 2026: Revenue Surges 244% as Volatility and M&A Unlock Record Scale
Gold.com shows a long reinvestment runway, major business evolution, improving unit economics, and a self-reinforcing model with strong customer value trends. Current growth is exceptional, with digital and international expansion providing further optionality, though the business model is only semi-disruptive versus legacy finance. Cash flow and earnings are accelerating, and the business is clearly in a high-growth phase.
Bilibili (BILI) Q2 2025: Games Revenue Jumps 60% as AI-Driven Ads Expand Margin Path
Bilibili demonstrates a long reinvestment runway, strong recent growth in games (60%) and advertising (20%), improving unit economics, and a self-reinforcing business model via community and AI. Customer value is deepening, and guidance is for further margin and profit expansion. The business model is disruptive and cash flow is accelerating. However, revenue/EPS growth is likely just below the 40% threshold, so question 9 is scored down. Overall, this is a high-signal, growth business at an inflection point.
Toast (TOST) Q2 2026: Toast IQ Grow Hits $10M ARR Run-Rate, Unlocking New AI Revenue Streams
Toast is demonstrating a long reinvestment runway, rapid new product adoption (AI/Toast IQ Grow), improving unit economics, and a self-reinforcing platform model. Customer value is increasing with ARPU expansion, and guidance/outlook signal robust growth and margin improvement. The only deduction is for revenue/EPS growth not explicitly exceeding 40% YoY, but all other signal criteria are strongly met.
Paladine AI (PDYN) Q2 2026: Backlog Jumps 43% as Defense Pipeline Expands
Paladine AI demonstrates a long reinvestment runway, disruptive business model, accelerating revenue growth, and strong backlog expansion (43%). Unit economics are improving as scale increases, and there is clear evidence of compounding business model advantages. The only slight deduction is on cash flow, as the business is not yet a cash flow machine but is trending positively.
Enlight Renewable Energy (ENLT) Q2 2025: Guidance Raised 6% as U.S. Safe Harbor Hits 6GW Milestone
Enlight demonstrates a long reinvestment runway, strong recent growth, improving unit economics, self-reinforcing business model, deepening customer value, and is executing on a disruptive, scaling business model. The only slight deduction is on revenue/EPS growth, which is high but not explicitly over 40% annually in the forward guidance.
Littlefuse (LFUS) Q2 2026: Industrial Segment Jumps 52% as Bookings Hit Record High
Littlefuse demonstrates a long reinvestment runway with accelerating growth, record bookings, and expanding margins. The business is not fully disruptive but is transitioning toward higher-value, high-growth segments. Backlog, design win momentum, and segment growth rates signal exceptional near-term and long-term prospects. Unit economics, customer value, and cash flow are all improving, but the model is not entirely disruptive, warranting a slightly conservative signal score.
Alnylam (ALNY) Q4 2025: TTR Franchise Soars 151%, Anchoring 2030 Growth Ambitions
Alnylam is showing a long reinvestment runway, disruptive RNAi modality, and a massive TTR growth inflection, with strong unit economics and margin expansion potential. The only deduction is for future guidance not being exceptional (>30% acceleration) beyond the current year, but otherwise the business is high-signal and thesis-relevant for investors seeking scalable, compounding biotech models.
Carlsmed (CARL) Q2 2026: Surgeon User Base Expands 60%, Fueling Platform Adoption
Carlsmed demonstrates a long reinvestment runway, disruptive business model, rapidly expanding user base, and high gross margins. The business is growing revenue and EPS at high rates, with clear evidence of operational leverage and future catalysts. The only minor deduction is for future guidance not yet reaching exceptional acceleration, but overall, the signal is extremely strong.
Unusual Machines (UMAC) Q2 2026: Enterprise Revenue Jumps 687% as Supply Chain Strain Tests Scaling Ambitions
UMAC demonstrates a long reinvestment runway, disruptive business model, and exceptional recent growth (>40% YoY, >2x sequential). Unit economics and customer value are improving, with strong network effects from defense contracts. The business is transitioning into a high-growth phase, but cash flow is not yet accelerating, so one point is deducted there. Overall, the signal is extremely high and actionable for investors seeking growth and inflection opportunities.
Target Hospitality (TH) Q2 2026: WHS Segment Revenue Soars 142%, Driving Record Pipeline Growth
Target Hospitality demonstrates a long reinvestment runway, very strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, guidance is exceptional, and cash flow is accelerating. The business is growth-oriented with high visibility, though the model is not fully disruptive, hence a 1 for question 7.
Porch Group (PRCH) Q2 2026: Insurance Services Margin Hits 48% as Policy Growth Accelerates
Porch Group displays a long reinvestment runway with high returns on capital, exceptional margin expansion, and clear evidence of business model scalability. Recent growth is robust (but not quite 40%+ at consolidated level), and the business is self-reinforcing with data/AI advantages and distribution expansion. Unit economics and customer value are improving, with accelerating cash flow and a clear transition to a high-growth, high-margin model. The only minor deduction is for revenue/EPS growth not exceeding 40% at the consolidated level.
CACI (CACI) Q4 2026: Funded Backlog Jumps 29% as Tech-Driven Mix Expands Margins
CACI demonstrates a long reinvestment runway, disruptive business model, margin and cash flow expansion, and a significant backlog surge. The mix shift to tech/AI/space, high contract duration, and continued organic growth support strong signal. The only deduction is on the annualized growth rate, which, while strong, is not consistently above 40%.
OpenLANE (OPLN) Q2 2026: U.S. Dealer Volume Jumps 31% as Digital Share Gains Accelerate
OpenLANE demonstrates a long reinvestment runway, clear disruptive business model, improving unit economics, and accelerating digital penetration, all supported by strong transcript evidence. The only deduction is for future growth guidance, which, while raised, does not reach the threshold for 'exceptional' acceleration. Otherwise, the business is high-growth, scalable, and positioned for continued outperformance.
Frontline (FRO) Q1 2026: Spot Rates Double to $181K, Unprecedented Tanker Tightness Drives Cash Surge
Frontline is experiencing an exceptional inflection with spot rates at record highs, cash flow surging, and visible backlog. The business model is not disruptive in a tech sense, but the current market structure and operational leverage make this a rare, high-signal setup for investors.
Kratos (KTOS) Q2 2026: Engine Orders Jump to 3,000 as Hypersonics and Drone Demand Accelerate
Kratos demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing scale advantages. The article details a major inflection in engine and hypersonic demand, with double-digit organic growth, rapid backlog expansion, and future guidance supporting sustained acceleration. Margins are improving, customer value is deepening, and the business is transitioning to high-volume production. The only deduction is on the revenue/EPS growth question, as annualized growth is strong but not definitively above 40%.
D-Wave (QBTS) Q2 2026: Bookings Surge 1,120% as Commercial Quantum Adoption Accelerates
D-Wave demonstrates a rare combination of surging bookings/backlog, enterprise adoption, and technical/strategic differentiation. While cash flow is not yet accelerating (hence one point off), all other signal attributes are present at a high level, making this a highly actionable growth inflection.
Johnson Controls (JCI) Q3 2026: Backlog Surges 32% to $21B, Anchoring AI-Driven Growth Trajectory
JCI demonstrates a long reinvestment runway (AI/data center infrastructure), record backlog growth, improving unit economics, self-reinforcing business model, and deepening customer value. The business is transitioning into a high-growth, margin-expanding, cash-generative model with clear disruptive potential. Guidance and backlog suggest exceptional outlook, though growth rates are just under the 40% threshold for a perfect signal score.
Chime (CHYM) Q2 2026: Prime Tier Lifts RPAM 2x, Expands Higher-Income Penetration
Chime demonstrates a long reinvestment runway with high returns, major strategic developments (Prime tier, lending, enterprise channel), and improving unit economics. The business is self-reinforcing with deepening customer value and high engagement. Guidance and backlog support growth, and the business model is disruptive. Cash flow and margin expansion are visible, though revenue growth is strong but just under the 40% threshold for a top score. Overall, signal is extremely high for investors.
Comfort Systems USA (FIX) Q2 2026: Backlog Soars 73% to $14.1B, Modular Capacity Expansion Accelerates
FIX demonstrates a rare combination of long reinvestment runway (modular/tech buildout), massive backlog growth, improving unit economics, and a disruptive, compounding business model. The only deduction is for future growth rates moderating somewhat per management, but the overall signal is very high and actionable.
Bit Digital (BTBT) Q2 2026: 42% Cloud Services Revenue Surge Highlights Strategic Asset Shift
Bit Digital demonstrates a long runway for high-return reinvestment, a clear strategic pivot to high-growth infrastructure, and improving unit economics. The business model is self-reinforcing with recurring revenue and a large backlog. Customer value is increasing, and the outlook is for accelerating cash flow and growth. However, revenue growth guidance is robust but does not clearly exceed 40% for all metrics, so question 9 is scored conservatively.
Steel Dynamics (STLD) Q2 2026: Aluminum Shipments Jump 135%, Setting Up Second-Half Ramp
STLD is showing a major step-change in growth with the aluminum platform ramping rapidly, backlog surging, and clear margin/cash flow inflection. The business model is not fully disruptive (score 1 for Q7), but otherwise, the signals are strong: high reinvestment runway, accelerating growth, improving unit economics, and clear multi-year visibility. This is a high-signal, thesis-rich quarter.
NVEC Q1 2027: 81% Revenue Surge Signals Robotics and Medical Sensor Tailwind
NVE demonstrates a long reinvestment runway, disruptive business model, and clear improvements in unit economics and margins. The 81% revenue growth is a major inflection, supported by product innovation and diversified customer growth. While guidance is not explicit, management's optimism and the operational setup suggest ongoing growth, though the lack of formal targets and customer concentration risk slightly temper the score.
Blackstone (BX) Q2 2026: AI-Driven Data Center Platform Surges 42%, Unlocking New Fee Engines
Blackstone is showing a rare combination of secular growth drivers, business model transformation, and embedded realization upside. The AI/data center platform surge, fee engine diversification, and perpetual capital expansion signal a long reinvestment runway and self-reinforcing model. The only deduction is on annualized growth, which while strong, is not consistently above 40% across all metrics.
Nvent Electric (NVT) Q2 2026: Infrastructure Share Hits 60% as Data Center Orders Drive Capacity Expansion
Nvent demonstrates a very strong signal profile: long reinvestment runway, massive growth in infrastructure/data centers (with >40% growth), improving margins, strong backlog, and accelerating cash flow. The business is not fully disruptive (hence a 1 on question 7), but otherwise meets or exceeds all signal criteria for a high-growth, high-visibility industrial platform with clear secular tailwinds.
Liquidity Services (LQDT) Q3 2026: Retail GMV Jumps 19% as Consignment Mix Drives Margin Expansion
Liquidity Services is showing clear evidence of a long reinvestment runway (cash, no debt, expanding verticals), significant recent business evolution (retail GMV up 19%, ARR up 26%+), improving unit economics, self-reinforcing model, deepening customer value, and a disruptive, tech-enabled business model. The only deduction is on the revenue/EPS growth rate, which is strong but not consistently over 40%.
Intuitive Machines (LUNR) Q2 2026: Backlog Surges to $1.8B, Cementing Multi-Sector Space Prime Expansion
The business demonstrates a long reinvestment runway, disruptive model, and accelerating growth with a massive backlog increase and clear multi-sector expansion. Unit economics and customer value are improving, and the transition to recurring revenue is underway. The only slight deduction is on cash flow acceleration, which is forecasted but not yet fully realized.
Nexxen (NEXN) Q2 2026: CTV Revenue Surges 33%, Driving Raised Full-Year Growth Guidance
Nexxen demonstrates a long reinvestment runway, accelerating CTV and data product growth, and strong cash flow. AI-driven platform differentiation, increasing enterprise adoption, and new CTV initiatives support a disruptive, growth-oriented business model. The only deduction is for growth rate (Q9), which is strong but not above 40% overall.
Strong Signals (16-18)
Articles with valuable investment signals that merit attention
Hubbell (HUBB) Q2 2026: Data Center Sales Surge 65%, Driving Guidance Raise and Multi-Year Outlook
Hubbell demonstrates a long reinvestment runway (capacity, secular growth), significant recent developments (65% data center sales growth, raised guidance), improving unit economics, self-reinforcing model (installed base, pricing power), and deepening customer value. The business is not disruptive in a platform sense (hence 1 for Q7), and while revenue growth is strong (16-18%), it is not over 40% (Q9). The business is firmly in growth mode with multi-year backlog visibility.
IOVA Q2 2026: Margin Soars to 56% as Ampagni Demand Drives Record Scale
Iovance demonstrates a long reinvestment runway with high returns on capital, clear operational leverage, and a disruptive business model in TIL therapies. There is significant growth, margin expansion, and expanding commercial reach. The business is not yet growing revenue/EPS at 40%+ annually but is above 20%. Pipeline and global expansion are strong signals, though future guidance is not yet exceptional (hence a 1 for question 6). Overall, the business provides strong, actionable signal for investors.
JFrog (FROG) Q2 2026: Cloud Revenue Jumps 53% as Security Drives Multi-Year Commitments
JFrog demonstrates a long reinvestment runway, disruptive business model, accelerating cloud and security growth, and improving unit economics. There is clear evidence of high customer value expansion and self-reinforcing platform effects. However, the forward guidance for overall growth is in the low 20% range, not the highest possible, and backlog/guidance is strong but not at the exceptional acceleration threshold. The business remains a growth story with high signal for investors, but not at the most extreme end of the spectrum.
WaterBridge (WBI) Q2 2026: Waste Management Capacity Doubles, Unlocking 40-Year Growth Platform
WaterBridge demonstrates a long runway for reinvestment at high returns, major recent developments (doubling capacity, acquisitions), improving unit economics, self-reinforcing business model, and increasing customer value. The outlook is strong but not yet at exceptional acceleration (>30% growth), and while the model is disruptive with cash flow ramping, annual growth is guided in the 20-40% range.
Five9 (FIVN) Q2 2026: AI Revenue Jumps 78%, Accelerating Platform Shift in Regulated Enterprise CX
Five9 demonstrates a long reinvestment runway, disruptive model, and accelerating AI-driven growth, with clear improvements in attach rates and customer value. Backlog-driven guidance and high-profile enterprise wins point to strong future prospects. However, cash flow is not yet clearly accelerating and guidance, while strong, does not suggest >40% growth, so those items are scored conservatively.
SentinelOne (S) Q2 2027: 22% ARR Growth Signals Robust AI Security Platform Expansion
SentinelOne demonstrates a long reinvestment runway, disruptive AI-native model, and improving unit economics. While growth is strong and the business is transitioning to higher-margin segments, annual growth rates are just at the 20% threshold, so not all signal questions reach the highest mark. Still, the platform's expansion, upmarket wins, and cash flow trajectory are highly compelling.
Paymentus (PAY) Q2 2026: Enterprise Backlog Surges, Driving 28.8% Top-Line Expansion
Paymentus shows clear evidence of a long reinvestment runway, self-reinforcing business model, improving unit economics, and deepening customer value. The backlog and bookings surge, AI-driven product innovation, and platform evolution support a durable, high-growth outlook. While guidance for the next quarter is below 20% growth, the full-year and strategic positioning indicate strong signal. Risks and uncertainties are well-articulated. The business is disruptive and positioned for continued compounding growth, though near-term growth rates temper a perfect score.
Affirm Holdings (AFRM) Q4 2026: 41% Pay-in-X Growth Highlights Expanding Product Mix and Network Effects
Affirm demonstrates a long reinvestment runway, network effects, improving unit economics, and disruptive potential. The business is growing rapidly (Pay-in-X up 41%), but overall company growth is strong rather than hyper-growth. The future outlook is positive, though not exceptional (>30% acceleration), so some scores are rounded down. Still, the signal is high for investors seeking scalable fintech opportunities.
Rubrik (RBRK) Q2 2027: Subscription ARR Growth Accelerates 33% Amid Agentic Cyber Resilience Momentum
Rubrik demonstrates a long reinvestment runway with high returns on capital, accelerating growth, and improving unit economics. The business model is self-reinforcing with network effects, and customers are becoming more valuable. Guidance is strong but not exceptional (hence a 1 for question 6). The business is disruptive with a platform approach and shows accelerating cash flow. Revenue and EPS growth are over 20% but under 40%, and the company is a growth business. The only deductions are for slightly less-than-exceptional future guidance and growth rate.
ServiceNow (NOW) Q2 2026: AI ACV Surpasses $1B as Agentic Adoption Drives 9x Uptick
ServiceNow demonstrates a long reinvestment runway, compounding AI/cyber adoption, improving unit economics, and a disruptive, self-reinforcing model. Growth is strong but not hyperbolic; guidance is prudent. The business is clearly in a high-growth phase with strong fundamentals, though not all indicators point to an exceptional (40%+) acceleration.
XoZymes (EXOZ) Q2 2026: 10x Productivity Leap Positions NCT for Commercial Launch
XoZymes demonstrates a long reinvestment runway, disruptive business model, and clear productivity breakthroughs that materially de-risk commercialization. Unit economics are improving, customers are likely to become more valuable, and the business is transitioning to growth. However, as the company is still pre-revenue and cash flow is not yet accelerating, a perfect signal score is not warranted.
Neptune Insurance (NP) Q2 2026: AI-Driven Productivity Lifts Revenue Per Employee to $3M, Margin Expands 165bps
Neptune demonstrates a long reinvestment runway with high returns, strong recent growth, improving unit economics, a self-reinforcing model, and increasing customer value. While the business is disruptive and cash flow is accelerating, the forward guidance suggests strong but not hyper-growth, and regulatory upside is not yet realized, slightly tempering the signal score.
DraftKings (DKNG) Q2 2026: 75% Customer Acquisition Surge Drives $1B Adjusted EBITDA Core Outlook
DraftKings demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and exceptional customer acquisition growth. While growth is strong, not all guidance suggests >40% acceleration, warranting a conservative approach on a few metrics. Still, the signal is very high and the business is at an inflection point.
Harmonic (HLIT) Q2 2026: Broadband Backlog Jumps 71% as Pure-Play Focus Drives Visibility
Harmonic demonstrates a long reinvestment runway, a significant 71% backlog surge, improving unit economics, and a self-reinforcing platform model. Customer value is deepening, and guidance is raised on accelerating growth. The business is not fully disruptive (score 1), and expected annual growth is strong but not consistently above 40%. Otherwise, the business is clearly in a growth phase with high future optionality and cash flow acceleration.
ACM Research (ACMR) Q2 2026: 36% Revenue Growth Driven by Advanced Packaging and ECP Expansion
ACM Research demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. There is strong evidence of business evolution and growth, though guidance is robust but not accelerating at an exceptional (30%+) rate. Revenue growth exceeds 20% but not 40%. The business is clearly growth-oriented and not mature or legacy.
Omada Health (OMDA) Q2 2026: Gross Margin Jumps 700bps as Multi-Condition Expansion Accelerates
Omada exhibits nearly all the hallmarks of a high-signal, platform-scale business: long reinvestment runway, disruptive multi-condition model, accelerating margin and cash flow, and deepening customer value. Growth is robust but just below the 40%+ mark for the forward period, and guidance implies continued but slightly moderated acceleration. The business is not entirely unknown, but the combination of margin inflection, AI leverage, and channel expansion creates strong valuation upside.
Genco Shipping (GNK) Q2 2026: Dividend Jumps 433% as Spot TCE Surges and Fleet Leverage Expands
Genco Shipping demonstrates a strong reinvestment runway, clear recent business inflection, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the outlook is exceptional with accelerating cash flow. However, while the business is semi-disruptive, it is not fully disruptive, and projected growth is strong but not consistently above 40% annually, warranting a slightly conservative signal score.
B1 Medicines (ONC) Q2 2026: Brukinza Drives 31% Growth, Pipeline Readouts Accelerate Inflection
B1 Medicines displays strong growth, durable franchise value, and a disruptive, diversified pipeline with global scale. The business is not scoring a perfect 20 as the forward growth, while robust, is not at a hyper-growth (40%+) pace, and some pipeline execution risk remains.
ARGX Q2 2026: VivGuard Drives 60% Revenue Surge as Seronegative GMG Approval Expands Market
ARGX demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value. The business is not showing >40% revenue/eps growth but is still delivering double-digit growth with exceptional pipeline optionality. The risk is that while the current growth is robust, the future hinges on pipeline readouts, so not all signal scores reach the maximum.
EquipmentShare (EQPT) Q4 2025: 34% Rental Revenue Growth Unlocks Margin Expansion as T3 Tech Drives Share Gains
EQPT exhibits a long reinvestment runway, clear disruptive tech platform, improving unit economics, and a rapidly scaling business model. Growth is strong but not hyperbolic (guidance implies ~27-34%), so not all scores are maxed. The business is clearly in a high-growth phase with multiple self-reinforcing elements, but not every metric is at the absolute top decile.
PicPay (PICS) Q2 2026: 67% Revenue Growth Highlights Operating Leverage and Strategic Diversification
PicPay demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing ecosystem. While growth is strong and diversified, the forward guidance does not suggest >40% growth for the next period, and some metrics (like net income) are normalizing. The business is still in a high-growth phase with clear optionality, but not all signals are at the maximum level.
Legion (LGN) Q1 2026: Backlog Doubles to $5.4B as Data Center Demand Drives Expansion
Legion demonstrates a long reinvestment runway, massive backlog growth, improving unit economics, and strong customer value expansion. The business is transitioning to a higher-margin, higher-throughput model with accelerating cash flow and robust growth. While network effects are not fully self-reinforcing, the business is disruptive within its sector. The only slight deduction is for the business model not being a classic platform or network, but otherwise signal is very high.
PureCycle (PCT) Q2 2025: $300M Capital Raise Accelerates Global Expansion to 1B Pound Capacity
PureCycle demonstrates a long reinvestment runway, strong recent business evolution, improving unit economics, and a self-reinforcing model with disruptive characteristics. Customer value is increasing, and guidance points to accelerating growth and margin improvement. While not all metrics are at the highest possible level (e.g., cash flow acceleration and revenue/eps growth are strong but not yet over 40%+), the business is clearly in a high-growth, inflecting phase with substantial upside optionality.
Sea Limited (SE) Q2 2026: Shopee’s 28% GMV Growth and $1B Adjusted EBITDA Target Signal Strong Execution
Sea Limited demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. Recent growth is substantial but not quite at the exceptional acceleration threshold for some metrics. The business is clearly a growth business with expanding moats, but guidance and future growth, while strong, are not at the highest possible signal level.
Elemental Royalty (ELE) Q1 2026: Revenue Soars 83% as Portfolio Scale and Optionality Drive Record Cash Flow
Elemental Royalty demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers (mine operators) are becoming more valuable as the portfolio matures. While growth is strong and guidance is ahead of plan, it is not yet at an exceptional acceleration (>30%+), and revenue/eps growth is likely in the 20-40% range, not >40%. The business is clearly disruptive and transitioning into a scaled, cash-generative model.
Cipher Digital (CIFR) Q2 2026: Data Center Pipeline Expands to 5.3 GW, Securing Multi-Year Growth Visibility
Cipher Digital demonstrates a long reinvestment runway with high returns, recent pipeline expansion, improving unit economics, and a self-reinforcing business model. Customers (hyperscalers) are becoming more valuable, and the business is transitioning to a high-quality, contracted revenue model. The growth profile is strong, though not all signals point to 40%+ revenue/eps growth yet. The model is disruptive with cash flow acceleration, but the pipeline conversion risk and Texas regulatory uncertainty temper the score slightly.
VEON (VEON) Q2 2026: Digital Revenue Jumps 54%, Outpacing Core Telecom and Fueling Guidance Hike
VEON demonstrates a long digital reinvestment runway, disruptive model, and accelerating digital economics. There are clear inflections in digital revenue/margin mix, capital return, and ecosystem scaling. While growth is strong and guidance is raised, the business is not yet at hypergrowth (over 40%), so scores are capped accordingly. The signal is very high for an emerging market telco transitioning into a digital platform.
Grail (GRAL) Q2 2026: Gallery Test Volumes Jump 35% as FDA Approval Becomes Market Catalyst
Grail demonstrates a long reinvestment runway, disruptive business model, rapid volume growth (35%), margin expansion, and significant upcoming regulatory inflection. However, cash flow is not yet accelerating and growth, while strong, is not over 40% annually. The business is clearly in a high-growth, high-optional upside phase, but not yet at full escape velocity.
PURR Q1 2026: Hype Token Holdings Surge 46%, New Validator Deepens Ecosystem Leverage
PURR demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing advantages. There is a significant uptick in token holdings and value, but future growth rates are not clearly above 40% and guidance is not exceptional. The business is transitioning from pure treasury to ecosystem operator, with strong cash flow growth and multiple avenues for expansion, though some risks and dependencies remain.
Estrana Health (ASTH) Q2 2026: G&A Falls 210bps as AI Platform Drives Margin Expansion
Estrana Health demonstrates a long reinvestment runway, disruptive self-reinforcing model, improving unit economics, and strong customer value growth. While growth is robust, it is not accelerating above 40%, and guidance upgrades are strong but not exceptional. The business is a growth platform with significant optionality and cash flow.
XZO (XZO) Q1 2026: Non-ACI Premiums Reach $105M, Validating Platform Diversification
XZO demonstrates a long reinvestment runway with high returns, significant business evolution via external premium growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is disruptive with accelerating cash flow. Revenue growth is strong but not above 40%, and the business is firmly in growth mode. However, guidance does not signal exceptional (30%+) future growth, warranting a slightly lower score for questions 6 and 9.
Pattern (PTRN) Q2 2026: Net Revenue Retention Hits 129% as International Revenue Surges 87%
Pattern demonstrates a long reinvestment runway, exceptional revenue and EBITDA growth, improving unit economics, and a self-reinforcing data/AI flywheel. Customer value and NRR are rising, and the business model is disruptive with a clear path to further international and channel expansion. While future growth rates are expected to moderate, the company remains a high-growth, high-ROIC business, with only slight deductions for forward guidance moderation.
Commerce (CMRC) Q1 2026: GMV Accelerates 14% as B2B and Agentic Commerce Drive Platform Differentiation
Commerce demonstrates multiple high-signal characteristics: long reinvestment runway, accelerating GMV, improving unit economics, self-reinforcing platform, and increasing customer value. The business model is disruptive and cash flow is accelerating. Growth is strong but not consistently above 40%, and while guidance is strong, it is not exceptional. The piece captures a growth business with significant optionality.
Rubrik (RBRK) Q3 2026: Identity Resilience Push Lifts Security Expansion Above 40%
Rubrik demonstrates a long reinvestment runway, disruptive platform shift, and high expansion rates, with security add-ons and AI modules driving growth. The business is not yet at hypergrowth (>40% revenue/eps), and monetization of AI is nascent, so a couple points are held back. Still, the signal is very high due to the business model evolution and strong performance indicators.
BETA Technologies (BETA) Q2 2026: Backlog Nears $4B as Hybrid and Defense Platforms Accelerate Commercialization
BETA Technologies demonstrates a long reinvestment runway, exceptional backlog growth, improving unit economics, a self-reinforcing business model, and increasing customer value. The business is disruptive with dual-use opportunities and accelerating commercialization. However, cash flow is not yet accelerating, and near-term revenue growth, while strong, is not yet at the highest tier, warranting conservative scoring on those axes.
PATRON (PTRN) Q1 2026: Net Revenue Retention Hits 127% as Non-Amazon Channels Surge 119%
PATRON demonstrates a long reinvestment runway, disruptive model, and strong unit economics with high NRR and diversified growth. Recent growth is substantial but not quite at the highest acceleration threshold for every metric. Cash flow and margin expansion are evident, and the business is in clear growth mode with multiple avenues for continued value creation.
Jacobs (J) Q3 2026: AI Build-Out Lifts Backlog 27% as Margin Expansion Accelerates
Jacobs demonstrates a long reinvestment runway with high ROIC opportunities in AI and advanced manufacturing. Backlog growth is exceptional, and unit economics/margins are improving. The business model is increasingly self-reinforcing, with deepening customer relationships and strong cash flow growth. While not disruptive in the classic sense, the pivot to AI infrastructure is significant. Growth rates are robust, though not consistently above 40%, and the company is firmly in growth mode.
Red Violet (RDVT) Q2 2026: Record 447 New IDI Customers Signal Accelerating Identity Intelligence Demand
Red Violet demonstrates a long reinvestment runway, record customer growth, and expanding margins, with a disruptive AI-native platform and network effects. Unit economics are improving, customer value is rising, and the business is clearly in a high-growth phase. While there is strong growth and cash flow acceleration, the guidance for future quarters is positive but not explicitly exceptional, and revenue growth, though robust, is just below the highest threshold, warranting a slightly conservative scoring.
Eaton (ETN) Q2 2026: Electrical Americas Margins Jump 190bps, Backlog Visibility Extends to 15 Years
Eaton demonstrates a long reinvestment runway, exceptional backlog growth, and improving unit economics. The business model is self-reinforcing and customers are becoming more valuable. The future is strong, but not quite at the extreme 'exceptional' level for every metric (e.g., revenue/EPS growth is not consistently over 40%). The model is semi-disruptive given industry context, but not fully disruptive.
Redwire (RDW) Q1 2026: Backlog Soars 71% as Book-to-Bill Hits 1.92, Fueling Quality Growth Strategy
Redwire demonstrates a long reinvestment runway with high ROIC potential, a massive backlog uptick, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the future outlook is strong with accelerating growth. The business model is disruptive with lateral opportunities. Cash flow is improving but not yet accelerating, and while growth is strong, revenue/EPS growth is just below the highest tier. Overall, the business is in a clear growth phase with significant upside signals.
AIP Q2 2026: ACV Plus Royalties Surge 44% as Data Center and Automotive Demand Diversify Revenue Base
Arteris demonstrates a long reinvestment runway, disruptive business model, and accelerating growth in ACV/royalties (44% YoY). There is clear evidence of improving unit economics, compounding business model, and deepening customer value. Royalty growth is robust but not yet at a giant scale, and revenue/EPS growth is strong but not consistently over 40%. The business is clearly in a high-growth phase and not legacy or stalling.
QuinStreet (QNST) Q3 2026: Home Services Soars 63%, AI Integration Drives Margin Expansion
QuinStreet exhibits a long reinvestment runway with high returns, significant recent growth (notably in home services), and improving unit economics. The business model shows self-reinforcing characteristics via AI and data leverage. Customer value is increasing, and guidance signals strong growth and margin expansion. The business is semi-disruptive due to AI integration, with accelerating cash flow. Revenue/EBITDA growth is strong but not consistently above 40%, and the company is a clear growth business, not a legacy or stalling one.
Sharon AI (SHAZ) Q1 2026: Contracted TCV Surges to $2.2B as Data Center Capacity Expands to 100MW
Sharon AI demonstrates a long reinvestment runway with high returns, major recent contract wins, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is disruptive with accelerating cash flow. While growth is strong, it is not yet at the 40%+ level for revenue/EPS, and backlog/guidance is good but not exceptional, warranting slight conservatism in the signal score.
XPO (XPO) Q2 2026: LTL Margin Hits 79.9% as AI Productivity and Market Share Drive 300bp Gain
XPO demonstrates a long reinvestment runway, major recent margin and productivity inflections, and improving unit economics. The business model is self-reinforcing, customer value is increasing, and cash flow is accelerating. While the model is not fully disruptive, it is semi-disruptive within LTL. The growth outlook is strong but not quite at the extreme upper end for revenue/EPS acceleration, justifying a slightly lower score on those dimensions.
WESCO (WCC) Q2 2026: Backlog Surges 60% as Data Center Momentum Drives Record Visibility
WESCO demonstrates a strong reinvestment runway, record backlog growth, and margin expansion, with clear secular tailwinds. The business model is not fully disruptive but is evolving, and growth is robust but not quite at the highest tier for all metrics. Still, the signal for investors is very high with strong future prospects.
Madison Air (MAIR) Q1 2026: Backlog Doubles to $2.5B, Powering Commercial Momentum
Madison Air demonstrates a long reinvestment runway, a doubling of backlog, clear unit economics improvement, self-reinforcing model, and deepening customer value. Guidance is raised and backlog visibility is strong, but the business model, while innovative, is not fully disruptive (score 1 for question 7). Growth is above 20% but not clearly above 40% (score 1 for question 9). The business is solidly in growth mode with accelerating cash flow and margin expansion.
RBC Bearings (RBC) Q4 2026: Aerospace & Defense Surges 41%, Backlog Hits $2.3B as Submarine and Missile Ramps Accelerate
RBC Bearings is exhibiting clear growth signals: a long reinvestment runway, surging backlog, improving unit economics, and self-reinforcing business model with defense/space content expansion. Customer value is rising, and the business is positioned for further growth, though cash flow acceleration and near-term revenue/EPS growth are strong but not yet at hypergrowth levels. The business is not a legacy stall but a full-fledged growth platform.
MP Materials (MP) Q2 2026: NDPR Sales Jump 127% as Magnetics Ramp and Heavy Rare Earth Strategy Advance
MP Materials demonstrates a long reinvestment runway with high returns, significant recent growth in NDPR sales, improving unit economics, and a self-reinforcing, vertically integrated model. Customer value is increasing, and the business is transitioning to higher-margin downstream products. While growth is robust and the business model is disruptive, the guidance for future growth is solid but not at the very high end (over 40%), slightly limiting the score on questions 6 and 9. Overall, the business signals strong strategic and financial momentum with clear upside potential.
Einride (ENRD) H1 2026: Tesla Partnership Triples Fleet, Accelerating Revenue Growth and Autonomous Expansion
Einride demonstrates a long reinvestment runway with high ROIC potential, a transformational fleet expansion, improving unit economics, and a disruptive business model. The business is showing accelerating growth and strong customer adoption, though cash flow generation is not yet accelerating, and forward revenue/EPS growth is likely below the 40%+ threshold in the near term. The overall signal is very high due to the scale of the Tesla partnership and autonomous expansion, but some uncertainty remains around execution and immediate profitability.
Better Home and Finance (BETR) Q2 2025: Tinman AI Platform Lifts Contribution Margin to 40%, Unlocking B2B Scale
BETR demonstrates a long reinvestment runway, disruptive AI-driven business model, and improving unit economics. Major inflection in B2B margin and volume, but not quite at exceptional (30%+) growth rates for future guidance. The business is transitioning to a high-margin, recurring revenue model with strong optionality and platform effects, though some macro and execution risks remain.
Neptune Insurance (NP) Q1 2026: AI-Driven Premium in Force Surges 32%, Margin Floor Holds Despite Seasonality
Neptune demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing, disruptive business model. Customers are becoming more valuable, and the company is transitioning into a cash flow machine. While growth is strong, it is not consistently above 40% annually, and guidance, while raised, is not exceptional. The business is a clear growth story with high strategic signal.
D-Wave (QBTS) Q1 2026: Bookings Soar 1,994% as Dual-Platform Quantum Bet Accelerates
D-Wave demonstrates a long reinvestment runway with high ROIC potential, and the bookings/backlog surge is a clear inflection. Unit economics and customer value are improving, and the business model is increasingly self-reinforcing. The dual-platform approach is disruptive with significant lateral opportunities. The business is transitioning to recurring, scalable growth, but cash flow is not yet accelerating, and revenue/eps growth is likely in the 20-40% range rather than over 40%. The business is not yet a cash flow machine, but all other signals are strong and point to high strategic upside.
Roblox (RBLX) Q4 2025: 69% DAU Growth Fuels Platform Expansion, Margin Leverage in Focus
Roblox demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. The business is in a high-growth phase with exceptional international expansion and platform leverage. While bookings growth is projected to moderate, the underlying business model remains disruptive with strong cash flow prospects and a clear margin improvement path. The only deduction is for the forward guidance, which, while strong, is not at the highest acceleration.
Galaxy Digital (GLXY) Q2 2026: Data Center Pipeline Surges Past 5.7GW, Anchoring Dual-Segment Expansion
Galaxy Digital demonstrates a long reinvestment runway, disruptive dual-segment model, improving unit economics, and high returns on capital, with strong backlog growth in data centers. The business is transitioning to recurring, infrastructure-driven revenue, but some guidance is good rather than exceptional, and revenue growth is likely below the highest tier. Still, the signal is high given the inflection and optionality.
Establishment Labs (ESTA) Q2 2026: U.S. Revenue Jumps 141% as Minimally Invasive Platform Nears 15% of Sales
Establishment Labs demonstrates a long reinvestment runway, disruptive business model, premiumization, and rapidly improving unit economics. The minimally invasive platform is expanding TAM and pricing power, and the business is transitioning to a high-margin, cash-generative model. While top-line growth is strong, it is not above 40% annually, and future guidance, while raised, is not exceptional. Risks remain around pipeline execution and regulatory timelines, but the overall signal is very high.
Figure (FIGR) Q3 2025: Marketplace Volume Nearly Doubles as Blockchain Origination Hits 250 Partners
Figure demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding network effects. There is significant partner and volume growth, and the transition to a capital-light, fee-based platform is driving margin expansion. While growth is strong, it is not consistently above 40% in all metrics, and future guidance is positive but not exceptional. Overall, the signal is very high for a business at an important inflection.
Liftoff Mobile (LFTO) Q2 2026: 35% Revenue Growth Highlights AI-Driven Platform Expansion
Liftoff demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with strong operating leverage. Significant recent growth (35% YoY), high margins, and durable AI-driven advantages are evident. The business is still growing at a high rate but guidance for next quarter is for a lower (21-24%) growth rate, so not all signal questions can be maximized.
HIVE Digital Technologies (HIVE) Q1 2027: GPU Cloud ARR Surges to $180M, Cementing AI Gigafactory Growth
HIVE demonstrates a long reinvestment runway, material recent growth in ARR, improving unit economics, and a disruptive dual-engine model. The business model is self-reinforcing, customers are becoming more valuable, and the company is transitioning into a growth business. Guidance is strong but not yet exceptional (not >30% acceleration), and projected annual revenue growth is above 20% but not consistently over 40%.
Robinhood (HOOD) Q2 2026: Net Deposits Surge $22B as Product Ecosystem Drives Record Engagement
Robinhood demonstrates a long reinvestment runway, multiple disruptive business lines, and improving unit economics. There are significant recent developments (record net deposits, new products, international expansion), and the business model is self-reinforcing. Customer value is deepening, and cash flow is accelerating. The growth outlook is strong but not quite exceptional on all fronts, thus a slightly conservative score for growth rate and future guidance.
Eton Pharmaceuticals (ETON) Q2 2026: 99% Revenue Surge Driven by Hemangiol Relaunch and ASN-001 Acquisition
Eton demonstrates a long reinvestment runway, recent significant growth, improving unit economics, and strong customer value expansion. The business model is semi-disruptive with some self-reinforcement, and the outlook is for exceptional growth. Cash flow and earnings are accelerating, and the business is firmly in growth mode. The only slight deduction is for business model compounding and disruptive potential, which are present but not dominant compared to network-effect businesses.
Red Violet (RDVT) Q1 2026: EBITDA Margin Hits 41% as AI-Driven Identity Graph Scales
Red Violet demonstrates a long reinvestment runway, high margins, and a disruptive, scalable business model with compounding effects from AI. Customer onboarding, expanding verticals, and margin expansion signal durable growth. However, revenue growth is strong but not consistently above 40%, and guidance is not formally provided, so some uncertainty remains.
EME Q2 2026: RPOs Surge 44% to $17.1B, Locking in Multi-Year Demand Visibility
The business demonstrates a long reinvestment runway, accelerating backlog, improving margins, and clear customer value deepening. However, the model is not fully disruptive (score of 1 for Q7), and while growth is substantial, it is not consistently above 40% (Q9). The signal remains very high, with strong forward visibility and compounding advantages.
Cardinal Infrastructure Group (CDNL) Q1 2026: Backlog Climbs 60%, Vertical Integration Drives Margin Expansion
Cardinal demonstrates a long reinvestment runway, significant recent growth (backlog up 60%, organic growth 64%), improving unit economics, and a self-reinforcing model via vertical integration and labor force. Customer value is deepening (80% recurring), and guidance/backlog signals exceptional future growth. The business is not fully disruptive but is semi-disruptive for its sector. Cash flow is accelerating, but YoY revenue/eps growth is high but not consistently >40%. The company is a clear growth business.
CECO Environmental (CECO) Q2 2026: Orders Surge 191%, Backlog Hits $1.8B, Raising Full-Year Outlook
CECO demonstrates a long reinvestment runway, exceptional recent growth (orders up 191%, backlog up 164%), improving unit economics, and compounding business model advantages post-acquisition. Customer value is increasing, and the future outlook is strong but not at hypergrowth levels. The model is not deeply disruptive but shows some innovation. Cash flow is accelerating, and the business is firmly in growth mode. Revenue/EPS growth is strong but not consistently above 40%.
Dave (DAVE) Q2 2026: Fee Cap Removal Unlocks Majority of Advances, Accelerating Monetization Path
Dave demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing dynamics with AI underwriting and capital-light funding. While growth is strong and the business is transitioning into higher profitability, the guidance and backlog do not quite reach the 'exceptional' (30%+ acceleration) threshold for all signal questions, and revenue/EPS growth is strong but not consistently above 40%. Still, the overall signal is very high given the inflection in monetization and scale.
NPO Q2 2026: AST Sales Jump 21.8% as Semiconductor Tailwinds Drive Guidance Raise
NPO demonstrates a long reinvestment runway, clear inflection in semiconductor growth, improving unit economics, and compounding business model advantages. Customer value and margin expansion are evident, and guidance revisions are material. While the business is not purely disruptive, the signal for multi-year growth and valuation upside is strong, though not at the absolute highest level for a lesser-known or truly unique business.
Karis Life Sciences (CAI) Q2 2026: Molecular Profiling Revenue Jumps 55% as Commercial Expansion Accelerates
Karis Life Sciences demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. There is a major inflection in revenue and volume growth, and the business is generating accelerating cash flow. The only slight deduction is for future growth rates and backlog: while growth is strong (27-28% guided), it is not above 40%, and guidance does not yet include new product launches, so the future is very promising but not fully exceptional on every dimension.
Dynatrace (DT) Q1 2027: Net New ARR Jumps 41% Organically, AI Observability Drives Platform Expansion
Dynatrace demonstrates a long reinvestment runway, clear business model advantages, improving unit economics, and strong customer value expansion. There are recent significant developments (net new ARR up 41% organically, log management doubling), but forward guidance implies growth acceleration is moderate rather than exceptional. The business is disruptive, cash flow is accelerating, and it is positioned as a growth leader. However, the annual revenue/EPS growth outlook is just under the highest threshold, and guidance for back-half acceleration is strong but not yet at a 40%+ pace.
Symbotic (SYM) Q3 2026: Operational Systems Up to 56, Software Revenue Jumps 57% as Platform Expands
Symbotic shows a long reinvestment runway, disruptive business model, improving unit economics, and a major inflection ahead with the Walmart ramp and software transition. Recurring revenue and margin expansion are accelerating, but near-term growth rates are strong rather than explosive, and the business is entering a pivotal transition rather than already compounding at the highest rates.
DFINIUM Therapeutics (DFTX) Q1 2026: R&D Spend Jumps 77% as Three Phase III Readouts Approach
DFINIUM is on the cusp of a major inflection with three Phase III readouts, a disruptive single-dose psychiatric therapeutic, and a robust cash runway. The business model is highly disruptive with a long reinvestment runway and potential for compounding value. However, growth is not yet proven at the 40%+ level, and cash flow is not yet accelerating, which slightly tempers the signal score.
Life360 (LIF) Q2 2026: Record 185K Paying Circles Drive 38% Revenue Growth Amid AI Transition
Life360 demonstrates a long reinvestment runway, strong growth in core metrics, improving unit economics, and a self-reinforcing business model with expanding customer value. The business is transitioning to an AI-native model and rapidly scaling its advertising platform, indicating disruption and future upside. However, while growth is strong, some guidance and margin expansion are moderate rather than exceptional, warranting a slightly conservative signal score.
Remitly (RELY) Q2 2026: Active Users Top 10 Million as AI-Driven Margin Expansion Accelerates
Remitly demonstrates a long reinvestment runway, clear business evolution, improving unit economics, and a compounding, defensible model with network effects and switching costs. Customers are becoming more valuable, and the business is disruptive with accelerating cash flow. Growth is strong, though not quite at the exceptional level for all metrics, and guidance signals continued expansion. The only slight deduction is for growth rates just below the highest threshold and guidance not reflecting an 'exceptional' acceleration.
Fractyl Health (GUTS) Q2 2026: 80% Weight Loss Maintenance Signals Strong Path to FDA Submission
Fractyl presents a long reinvestment runway, a disruptive model, and a clear path to high-value inflection with strong clinical data and regulatory milestones. The business model is self-reinforcing, and customer value is deepening. While not yet a cash flow machine and revenue growth is prospective, the strategic positioning and momentum signal high potential for valuation upside, justifying a high signal score.
Pagaya (PGY) Q2 2026: Auto Volume Up 33% as Platform Leverage Drives Profit Acceleration
Pagaya demonstrates a long reinvestment runway, disruptive embedded model, improving unit economics, and deepening customer value. There is clear operational leverage and network effect, with accelerating profitability and a strong growth profile. The only slight markdown is on near-term growth guidance (not quite >40%) and backlog exceptionalism, but overall the signal is very high for investors.
Datadog (DDOG) Q2 2026: Non-AI Customer Growth Accelerates to High 20s as Platform Expansion Deepens
Datadog demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing platform model. Customer value is deepening, and the business is disruptive with strong cash generation. While future guidance is strong, it is not exceptional (under 30% acceleration), and revenue growth is just below the 40% threshold for the highest score. Overall, the business signals are robust and highly relevant for investors.
AXTI (AXTI) Q3 2025: Indium Phosphide Backlog Surges to $49M as AI Data Center Demand Accelerates
AXTI is at a structural inflection with a long reinvestment runway, exceptional backlog growth, improving unit economics, and a self-reinforcing business model. Customer value, business model disruption, and growth signals are all strong. The only moderation is in cash flow and annualized growth (not clearly >40%)—otherwise, signal is high and relevant for investors seeking upside.
AppLovin (APP) Q2 2026: Consumer Spend Jumps 28% Above Peak, Model Upgrades Drive Q3 Reacceleration
AppLovin demonstrates a long reinvestment runway, disruptive model, and strong compounding dynamics (model/data flywheel, expanding verticals, increasing ARPU). Growth is robust but not consistently >40% for all metrics. Unit economics and cash flow are improving, and the business is transitioning from gaming-centric to multi-vertical. The main caveat is that while growth is very strong, it is not yet at an 'exceptional' acceleration in all dimensions, and some bottlenecks (creative tooling, onboarding) remain.
Sezzle (SEZL) Q2 2026: Subscribers Jump 76%, Pushing Platform Engagement and Product Expansion
Sezzle demonstrates a long reinvestment runway, disruptive model, and strong unit economics, with clear evidence of compounding engagement and margin expansion. While growth is strong, the outlook for >40% revenue/eps growth is not fully clear for the next year, and some risks around credit and new product adoption temper the signal. Still, the business is firmly in high-growth territory with significant strategic upside.
Agibank (AGBK) Q4 2025: Active Clients Surge 73% as Hybrid Model Scales, AI Drives Efficiency
Agibank demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and clear operational leverage. Growth is strong but not yet at the highest acceleration (hence 1 on Q6 and Q9). The business is clearly in growth mode with exceptional future prospects, but not all metrics are at the maximum possible signal.
TON Strategy (TONX) Q2 2026: Staking Yield Accelerates to 17%, Driving $15M Revenue Amid Legacy Wind-Down
TON Strategy demonstrates a long reinvestment runway with high returns via staking, a disruptive and capital-light business model, and a substantial recent acceleration in revenue and asset growth. The business model is self-reinforcing, and customer/economics are improving. While growth is strong, the future guidance is conservative and not yet exceptional, and annualized growth is high but not confirmed at >40%. The business is now a focused growth model, not legacy or merely transitioning.
White Fiber (WYFI) Q3 2025: NC1 Contract Demand Doubles, Anchoring $400M+ Development Path
White Fiber demonstrates a long reinvestment runway, major recent business evolution (NC1 contract), improving unit economics, and self-reinforcing business model. Customer value is deepening and future growth is strong, though not quite at the most exceptional level for all metrics. The business model is disruptive, with cash flow set to accelerate as projects ramp, and the company is clearly in a growth phase. Revenue and EPS growth are likely high but not in the extreme 40%+ category for the next year, and cash flow acceleration is moderate until ramp occurs.
WYFI Q2 2026: NC1 Active Deployment Boosts Contracted Revenue to $865M, Scaling Cloud Services
White Fiber demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing dynamics through contracted revenue and capital-efficient growth. While revenue growth and backlog are strong, they do not quite reach the threshold for the highest acceleration. The business is clearly transitioning into a high-growth phase, but some elements (such as future guidance) are good but not yet exceptional.
Neptune Insurance (NP) Q3 2025: Written Premium Jumps 33% as Distribution Expansion Drives Record Policy Growth
Neptune Insurance demonstrates a long reinvestment runway, disruptive asset-light model, and strong operating leverage. Premium growth and retention are robust, and margins are exceptional. While not all metrics point to hypergrowth (revenue growth is high but not over 40%), the business is clearly transitioning into a high-quality, compounding, and scalable platform with significant optionality.
HeartFlow (HTFL) Q4 2025: Gross Margin Climbs 400bps as AI-Powered Plaque Revenue Accelerates
HeartFlow demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong self-reinforcing data/AI moat. Revenue growth is over 20% but not consistently over 40% going forward, and while backlog/guidance is strong, it is not 'exceptional' (30%+ acceleration). The business is clearly growth-oriented and non-legacy. Signal is very high, but not the absolute maximum due to the pace of plaque ramp and Q1 guidance.
ALX Oncology (ALXO) Q3 2025: CD47-High Response Rate Hits 65%, Redefining Biomarker-Driven Oncology
ALXO demonstrates a long reinvestment runway, disruptive biomarker-driven strategy, and strong recent clinical advances with high response rates and robust pipeline. While cash flow is not yet accelerating and revenue growth is not imminent, the business is positioned as a high-growth, high-optional business with clear valuation upside if execution continues.
Coincheck (CNCK) Q2 2026: Marketplace Volume Surges 72% as Staking Revenue Doubles
Coincheck demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. The business is showing operating leverage and moving into high-growth verticals like staking and institutional services. While growth is strong, the outlook does not quite reach exceptional acceleration (>30%) for all metrics, but the signal for continued expansion and optionality is very high.
Rubrik (RBRK) Q4 2026: Net New Subscription ARR Hits $115M as Identity and AI Drive Platform Expansion
Rubrik demonstrates a long reinvestment runway with high returns on capital, clear disruptive potential in cyber resilience and AI operations, and strong unit economics. There is substantial evidence of platform expansion, customer value deepening, and legacy displacement runway. However, while growth is robust, not all guidance points to 40%+ acceleration, and AI contributions are not yet material to near-term financials, warranting a conservative deduction.
Navan (NAVN) Q4 2026: New Bookings Up 50% as AI Drives Legacy Displacement
Navan demonstrates a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and increasing customer value. There is clear margin expansion, strong bookings growth, and robust retention. While growth is strong (24-30% YoY), it is not consistently above 40%, and guidance is solid but not exceptional. The business is positioned as a growth leader rather than a legacy or transitioning player.
Inter & Co (INTR) Q1 2026: Loan Portfolio Surges 33% as AI Banking Push Drives Margin Expansion
The company is showing strong growth, with a long reinvestment runway, disruptive AI-driven model, and improving unit economics. There is a significant shift in business model and margin expansion, though growth is not yet over 40% QoQ and some risks remain in asset quality and fee income diversification.
Elowit (ELWT) Q1 2026: Contracted Backlog Climbs 143% as Recurring Revenue Base Expands
Elowit demonstrates a long reinvestment runway, disruptive recurring revenue models, and a 143% YoY backlog surge—clear markers of a business at an inflection point. Unit economics and customer value are improving, and the business model is self-reinforcing. While cash flow is not yet accelerating and annual growth is likely under 40%, the business is firmly in growth mode with exceptional future prospects.
COHU (COHU) Q2 2026: HPC Pipeline Expands to $850M, Doubling Capacity to Meet AI Test Demand
COHU is at a major inflection, with a long reinvestment runway (HPC/AI pipeline), accelerating bookings, improving unit economics, and a disruptive recurring revenue model. Customer value is rising, and the business is transitioning into a growth phase. However, while growth is strong, it is not at the extreme (40%+) level for all metrics, and cash flow is improving but not yet a clear 'machine.' The business model is disruptive and self-reinforcing, but supply chain and input cost risks temper the signal slightly.
Reddit (RDDT) Q1 2026: Ad Revenue Soars 74% as Performance Automation Scales
Reddit demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and exceptional cash generation. Recent growth is strong but not quite at the 40%+ threshold for future quarters, and guidance suggests continued but slightly moderating acceleration. The business is clearly in a high-growth phase, with multiple avenues for value creation, though some future assumptions (e.g., data licensing scale) are not yet fully realized.
Solstrategy (STKE) Q2 2026: HoudiniSwap Acquisition Adds $12M Revenue Run-Rate, Accelerating Infrastructure Expansion
Solstrategy is undergoing a significant business model evolution, adding a large new revenue stream and expanding into higher-margin, disruptive infrastructure. The business model is self-reinforcing, with improving unit economics and increasing customer value. While cash flow is not yet accelerating and growth is not projected above 40%, the strategic runway and optionality are very strong, supporting a high signal score.
Bullish (BLSH) Q3 2025: SSNO Revenue Jumps 300% as Tokenization Drives Platform Expansion
Bullish demonstrates a long reinvestment runway, disruptive business model, and clear inflection in its SSNO/tokenization platform. The business is transitioning to recurring revenue and shows strong operating leverage, but near-term growth is somewhat muted by event seasonality and crypto price declines, preventing a perfect score. Still, the signals for future growth and competitive advantage are strong.
Pattern (PTRN) Q3 2025: Non-Amazon Revenue Soars 81% as Platform Diversification Accelerates
Pattern demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding customer value. The business is transitioning rapidly to high-growth channels and geographies, but full exceptional acceleration (>30% growth) is not yet fully sustained in all metrics (e.g., next quarter guidance is below 40% growth). Signal is high but not at the absolute maximum due to some moderation in forward growth rates.
AVEX (AVEX) Q1 2026: Tactical Systems Revenue Surges 548% on Deep Strike Ramp, Margin Expansion Signals Durable Demand
AVEX exhibits a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. Recent results show a massive surge in growth and margin expansion, though future growth is somewhat dependent on pipeline conversion, justifying a slightly conservative score on future guidance and growth rate. The business is not yet at a recurring 40%+ annual growth pace, but it is a clear growth story with significant optionality and upside.
Navan (NAVN) Q2 2026: New Signed GBV Surges 60%, Driving Raised Full-Year Outlook
Navan demonstrates a long reinvestment runway, disruptive business model, and clear operating leverage, with strong evidence of compounding unit economics and customer value. The 60% surge in new signed GBV and margin expansion are highly material. Guidance is strong but not quite at the 'exceptional' acceleration threshold. Revenue growth is robust but just below the highest band. The business is clearly transitioning into a growth phase with significant optionality.
Prologis (PLD) Q2 2026: Data Center Starts Surge Past $2.1B, Unlocking Multi-Year Growth Runway
Prologis demonstrates a long reinvestment runway, significant growth in data centers, and improving unit economics. The business model is self-reinforcing, customer value is deepening, and guidance is accelerating. While not fully disruptive, the scale and adjacency moves are strategic. Revenue/EPS growth is strong but not above 40%, and the business is clearly in growth mode.
EXLS Q2 2026: Data and AI Revenue Surges 30%, iMerit Acquisition Expands AI Model Reach
EXL demonstrates a long reinvestment runway, disruptive AI-led business model, and clear compounding effects via recurring revenue and proprietary IP. The iMerit acquisition and rapid AI revenue growth (30%+) are significant developments. Some caution on cash flow acceleration and growth rate (not 40%+), but overall, the signal is very strong for investors seeking growth and transformation in IT services.
Arm (ARM) Q1 2027: AGI CPU Demand Pipeline Surges Past $2B, Cloud AI Royalties Offset Smartphone Drag
Arm displays a long reinvestment runway, disruptive business model, and accelerating cloud AI/AGI CPU growth, but near-term growth is not above the 40% threshold and some risks around supply chain remain. The business is not entirely unknown, but the shift to AI infrastructure and royalty model deepening provides real signal.
Belden (BDC) Q2 2026: Ruckus Acquisition Lifts Solutions Mix Above 20%, Reshaping Margin Profile
Belden is at a structural inflection point with a long reinvestment runway, high-margin mix shift, and strong growth in AI/data center verticals. While not a classic disruptive model (hence a 1 on question 7), the business shows accelerating backlog, improving unit economics, and a clear shift toward higher-value, recurring revenue. The outlook and performance signal above-average upside for investors.
Unity (UNIT) Q2 2026: Fiber Bookings Jump 30% as AI Demand Drives Record Lease-Up
Unity demonstrates a long reinvestment runway, record bookings, improving unit economics, and a disruptive business model. The business is transitioning rapidly to high-growth fiber with strong lease-up, but near-term ARPU softness and legacy drag temper the signal slightly. Overall, the signal is very high and relevant for investors.
NextPower (NXT) Q1 2027: Backlog Climbs to $5.5B as Platform Expansion Accelerates
NextPower demonstrates a long reinvestment runway, disruptive platform expansion, and improving unit economics with a strong backlog and cash flow. However, the guidance revision is positive but not yet at an 'exceptional' acceleration, and revenue growth guidance is strong but not projected to be over 40%. The business is clearly in growth mode with significant strategic upside.
Amoresco (AMRC) Q2 2026: Data Center Awards Drive 65% Surge in Project Backlog, Reshaping Growth Profile
Amoresco demonstrates a long reinvestment runway, significant business evolution (backlog up 65%), improving unit economics, and a self-reinforcing business model with expanding recurring revenue. Customers are becoming more valuable over time, and backlog/guidance revisions are exceptional. The business model is disruptive, and revenue/earnings growth is strong but not consistently above 40%. Cash flow is improving but not yet accelerating. The business is clearly in a growth phase.
Palantir (PLTR) Q2 2026: U.S. Commercial Bookings Surge 153%, Sovereign AI Drives Record Demand
Palantir demonstrates a long reinvestment runway with high returns, a disruptive business model with compounding advantages, and accelerating cash flow. The quarter showed a massive uptick in bookings and revenue growth, particularly in the U.S. commercial segment. Unit economics are improving, and customer value is deepening. While international growth lags, the business is clearly in a high-growth phase. Guidance is strong but not at the exceptional acceleration threshold for a perfect score.
Flywire (FLYW) Q2 2026: Transaction Volume Jumps 43% as Software-Led Moat Expands
Flywire demonstrates a long reinvestment runway, disruptive software-driven business model, improving unit economics, and deepening customer value. There is a significant recent uptick in transaction volume and ongoing margin leverage, though near-term growth guidance is strong but not extreme. The business is clearly in a growth phase with accelerating cash flow, but annualized growth rates are below the >40% threshold for the highest marks in some categories.
Xometry (XMTR) Q2 2026: Marketplace Revenue Surges 45% on AI-Driven Buyer Expansion
Xometry demonstrates a long reinvestment runway with high returns, a disruptive AI-native business model, and clear network effects. Marketplace revenue and buyer growth are accelerating, and unit economics are improving. However, while guidance is raised and margin expansion is ongoing, the absolute growth rate for the next quarter is slightly below the highest threshold, and international profitability is still emerging. The outlook is very strong, but not at the most extreme level of inflection.
AMETEK (AME) Q2 2026: Orders Surge 28% as Backlog Hits $4.1B, Locking in Multi-Year Growth Visibility
AMETEK demonstrates a long reinvestment runway with high returns, a major backlog and order inflection, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and guidance is strong. The business is semi-disruptive rather than fully disruptive, and while growth is robust, it is not consistently above 40%. The business is clearly a growth story with accelerating cash flow.
Uber (UBER) Q2 2026: Delivery Hero Deal Doubles Platform Reach to 100 Markets
Uber demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with evidence of operational leverage and expanding platform scale. The Delivery Hero deal and AV commercialization are significant, but some growth rates (e.g., guidance) are strong but not at the highest acceleration, and while outlook is robust, it is not universally exceptional. Signal is very high, but not at the absolute maximum due to some maturing aspects and the scale of execution risk.
MELI Q2 2026: Credit Portfolio Expands 75% as Ecosystem Flywheel Drives User Profitability
MercadoLibre demonstrates a long reinvestment runway, disruptive ecosystem, improving unit economics, and compounding customer value. The 75% credit portfolio growth, stable asset quality, and accelerating cross-platform engagement are highly significant. While not all metrics are above 40% growth, the business is clearly in a high-growth, self-reinforcing phase with strong cash flow and strategic optionality.
Flowtech (FTK) Q2 2026: Data Analytics Surges 223% as Backlog Tops $500M, Powering Recurring Revenue Shift
Flowtech demonstrates a long reinvestment runway, disruptive model shift, and rapidly improving unit economics, with a major backlog and recurring revenue inflection. However, near-term guidance is strong but not yet at exceptional acceleration (>30%), and revenue growth, while high, is not consistently above 40%. Overall, the business is clearly transitioning to a high-signal, high-growth profile.
Arcus Biosciences (RCUS) Q2 2026: Castatafan Targets $5–10B Opportunity as Frontline RCC Competition Clears
Arcus is at a major inflection point: it has a long reinvestment runway, a disruptive pipeline, and is transitioning to a product-driven model with major upside. The loss of competition in RCC, robust capital position, and clear upcoming catalysts provide strong signal. Some uncertainty remains on near-term cash flow acceleration and whether revenue/earnings will exceed 40% growth, but the overall signal is very high.
Materion (MTRN) Q2 2026: Backlog Surges 30% as Defense and Space Orders Fuel Multi-Segment Margin Expansion
Materion demonstrates a long reinvestment runway, record backlog growth, and margin expansion across all segments. Unit economics are improving, the business model is self-reinforcing in several segments, and customer value is increasing. Guidance and backlog suggest accelerating growth, though not all metrics are at the highest possible threshold (e.g., revenue/EPS growth is strong but not above 40%). The model is not fully disruptive but shows strong optionality and lateral opportunities.
Regenxbio (RGNX) Q2 2026: $310M Cash Infusion Extends Runway, Accelerates RGX202 Launch Path
Regenxbio demonstrates a long reinvestment runway, recent major developments (milestone payments, rapid enrollment), improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, and the business is transitioning to a growth phase, though forward guidance is good but not exceptional (hence a 1 for Q6 and Q9). The opportunity is high signal, but not the most explosive growth scenario.
KRMN Q2 2026: Backlog Surges 65% to $1.3B, Locking in Multi-Year Demand Visibility
KRMN demonstrates a long reinvestment runway, record backlog growth, improving unit economics, and a self-reinforcing integration model. Customer value is increasing, and forward guidance signals exceptional growth. While the business model is not fully disruptive, it is highly strategic within its sector. Cash flow is improving but not yet accelerating at maximum pace, and the company is firmly in high-growth mode with annual revenue/eps growth above 40%.
Grindr (GRND) Q2 2026: AI Terraforming Yields 2.5x Engineering Output, Unlocks Margin Upside
Grindr demonstrates a long reinvestment runway, disruptive AI-driven transformation, and improving unit economics. There is clear evidence of margin expansion and a strong growth profile, but revenue growth is not consistently above 40%, and guidance, while raised, is not exceptional. Still, the business is positioned as a growth platform with compounding advantages.
PubMatic (PUBM) Q2 2026: Emerging Revenue Doubles as AI Platform Drives 15% of Business
PubMatic demonstrates a long reinvestment runway, disruptive model, clear improvements in unit economics, and compounding data advantages. Revenue mix shift, margin expansion, and new verticals support high signal, though near-term growth is not above 20%+ for all metrics, and some guidance is mid-teens rather than hypergrowth. Still, the model is evolving rapidly with strong evidence of inflection.
Palo Alto Networks (PANW) Q4 2026: Nearly $1B Net New Next-Gen Security ARR Highlights Platformization Surge
PANW demonstrates a long reinvestment runway, disruptive platformization, and accelerating ARR growth, with improving unit economics and strong cash flow trends. The business model is self-reinforcing and customers are becoming more valuable. However, while guidance is strong, the future outlook is very good but not quite at the 'exceptional' acceleration threshold for a perfect score. Revenue growth is high but just below the 40% mark for some metrics.
Amber International (AMBR) Q2 2026: 39% Sequential Revenue Growth Validates AI Agent Pivot
Amber International demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing dynamics with improving unit economics and margin expansion. The company is in a clear growth phase, with a major pivot validated by strong sequential revenue growth and profitability. However, future growth guidance is withdrawn (limiting visibility), and while growth is strong, it does not yet exceed 40% YoY, moderating the score slightly. Overall, the signal is very high given the early inflection and business model transformation.
Yuanbao Inc. (YB) Q2 2026: 30% Revenue Growth Accelerates AI-Driven Insurance Innovation
Yuanbao demonstrates a strong reinvestment runway with high ROIC, disruptive AI-driven business model, and clear evidence of improving unit economics and customer value. Revenue growth is robust (30%), but not over 40%. Backlog/guidance is positive but not exceptional. Cash flow is accelerating, and the company is a growth business with emerging new revenue streams. The business model is self-reinforcing and shows signs of compounding advantages.
Alkermes (ALKS) Q2 2026: Proprietary Product Sales Jump 34% as Orexin Pipeline Expands
Alkermes demonstrates a long reinvestment runway, clear business model evolution, and improving unit economics. The orexin platform is disruptive with multi-indication potential, and the business is transitioning to growth. However, not all future guidance is exceptional, and cash flow acceleration is moderate. Revenue growth is strong but not consistently above 40%, warranting a conservative approach.
Waystar (WAY) Q2 2026: 40% of Bookings AI-Driven as Platform Consolidation Accelerates
Waystar demonstrates a long reinvestment runway, strong recurring revenue growth, improving unit economics, and high customer retention. AI monetization is now embedded and driving bookings, but while growth is strong (18% YoY, 10% normalized organic), it does not cross the 20%+ threshold for some signal questions. The business is not fully disruptive but is showing semi-disruptive traits, and future guidance is positive but not exceptional. The signal is high but not at the absolute maximum.
MediaAlpha (MAX) Q2 2026: Open Marketplace Revenue Surges 26% as Carrier Spend Broadens
MediaAlpha demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. The business is clearly in a secular growth phase, with expanding carrier participation and AI-driven differentiation. While growth is strong, it is not accelerating at 40%+ rates, and cash flow is increasing but not yet at an exceptional pace. The outlook is for continued high growth, but not at the most extreme levels.
ELF (ELF) Q1 2027: RODE Drives $160M Sales Surge, Fueling 36% Top-Line Expansion
ELF demonstrates a long reinvestment runway, disruptive multi-brand model, improving unit economics, and strong customer value metrics. There are significant developments (RODE's growth, international expansion) and accelerating cash flow. However, guidance does not indicate 30%+ acceleration, and while growth is robust, it is not at the most extreme levels. The business is a clear compounder, but not every signal is maxed out.
Frequency Electronics (FEIM) Q1 2027: Revenue Surges 70 Percent Driven by Space and Defense Backlog Expansion
FEIM demonstrates a long reinvestment runway, record backlog growth, improving unit economics, and accelerating cash flow. The business model is not fully self-reinforcing or disruptive, but there are elements of both. Customer value is improving, but not consistently deepening yet. Growth is strong, with revenue and EPS likely to exceed 40% annually in the near term, and the business is transitioning into a high-growth phase. Risks around scalability and execution remain, tempering the maximum signal score.
Butterfly Network (BFLY) Q3 2025: IQ3 Drives 85% Probe Volume, AI and Chip Roadmap Signal Multi-Year Leverage
Butterfly Network demonstrates a long reinvestment runway, disruptive business model, and strong product/AI platform momentum. The IQ3 shift, chip roadmap, and AI flywheel are all high-signal, while enterprise deal timing and software churn temper near-term growth acceleration. The business is clearly in a growth phase with potential for further upside if execution continues.
Milrose Properties (MRP) Q2 2026: $1B Capital Recycled, Platform Diversifies Beyond Foundational Builder
Milrose demonstrates a long reinvestment runway, recent significant business developments (multifamily entry, capital recycling), and improving unit economics. The business model is self-reinforcing with increasing customer value, but future growth, while strong, is not at an exceptional acceleration rate. The business is semi-disruptive, and cash flow is accelerating. Revenue and EPS growth is strong but not at hypergrowth levels. This is a clear growth business, but not at the highest possible signal tier.
LFS Q4 2025: Social Business Revenue Jumps 33% as Policy Reform Unlocks Expansion
LFS demonstrates a long growth runway, clear operating leverage, and a disruptive model, with policy-driven demand and strong competitive moats. However, while growth is robust, it does not consistently exceed 40% across all metrics, and global expansion is still in early stages, warranting a slightly lower score for exceptional forward growth.
PodcastOne (PODC) Q4 2026: Programmatic Ad Revenue Doubles, AI Monetization Levers Accelerate
PodcastOne exhibits strong signals of a scalable, tech-driven business with a long reinvestment runway and disruptive potential. Programmatic ad revenue growth, improving unit economics, and a unique equity-based talent model are clear positives. However, while growth is robust, it is not yet at the 'exceptional' level for all metrics (e.g., growth is high but not consistently 40%+), and cash flow, while improving, is not yet accelerating at maximum velocity. Still, the company is positioned as a growth business with considerable upside.
Upstart (UPST) Q2 2026: Secured Product Margin Improves 61 Points, Accelerating Path to Profitability
Upstart demonstrates a long reinvestment runway, disruptive AI-driven business model, and clear signs of margin and unit economic improvement. There is a notable inflection in secured product margin, strong customer value trends, and robust funding resilience. While growth is strong, it is not at hyper-growth levels across all metrics, and some cash flow and future guidance signals are promising but not exceptional. The business is clearly in growth mode but not yet at the highest possible signal.
WIX (WIX) Q2 2026: Base44 Margin Jumps to 60% as Proprietary AI Drives Cost Efficiency
WIX demonstrates a long reinvestment runway, disruptive business model, and clear margin inflection via proprietary AI. There is evidence of improving unit economics, customer value, and business model self-reinforcement. However, while growth is strong, guidance points to low-to-mid teens growth rather than exceptional acceleration, and some risks remain around retention and cohort durability. The signal is very high, but not at the absolute peak due to these uncertainties.
HeartFlow (HTFL) Q3 2025: 41% Revenue Growth Signals Durable AI-Driven CAD Adoption
HeartFlow demonstrates a long reinvestment runway, disruptive model, and strong unit economics with accelerating adoption and margin leverage. While the current growth is robust and the business is positioned for future outperformance, the delayed impact of next-gen products and cash flow ramp moderate the near-term signal. The business is clearly a growth story, but not yet at the highest acceleration tier for all metrics.
Turning Point Brands (TPB) Q2 2026: Modern Oral Surges 128%, Now 48% of Revenue
TPB demonstrates a long reinvestment runway in a high-growth category with clear optionality. Modern Oral's growth is exceptional and reshaping the business. Unit economics and customer value are improving, though margin leverage is pending. The business model is highly disruptive, but the self-reinforcing loop is still developing. Cash flow is moderate due to investment phase. Revenue and EPS growth are above 40%, and the business is in a strong growth phase.
Microsoft (MSFT) Q4 2026: Azure Surges 41% as AI Demand Outpaces Supply
Microsoft demonstrates a long reinvestment runway, exceptional cloud growth, and improving unit economics with a disruptive, self-reinforcing business model. However, as a mega-cap and well-followed company, some upside is capped, and growth, while strong, is not at the hyper-growth level for all segments. The signal is very high but not at the absolute maximum due to scale and maturity.
Real Brokerage (REAX) Q3 2025: Agent Base Surges 39% as Automation Drives 13% Cost Efficiency Gain
Real Brokerage demonstrates a long reinvestment runway with high returns, disruptive business model, and strong network effects. Agent and transaction growth are rapid, automation is improving economics, and ancillary attach rates are rising. However, while growth is strong, margin headwinds and lack of formal guidance temper the outlook, and the business is not yet at the very highest level of acceleration (e.g., >40% revenue/EPS growth or truly exceptional future guidance).
Yum China (YUMC) Q2 2026: 1,200 Net New Stores Signal Brand Acceleration and Margin Expansion
Yum China displays a long reinvestment runway (store expansion, franchise growth), improving unit economics, and self-reinforcing business model elements (brand ownership, modular innovation). Customers are becoming more valuable, and cash flow is accelerating. However, growth guidance is high-single-digit to double-digit rather than hypergrowth, and while the business is clearly growth-oriented, the signal is not at the absolute highest tier for disruption or >40% growth.
Virtuix Holdings (VTIX) Q1 2027: OmniOne Orders Surge 150% Post Meta Collaboration, Defense Expansion Accelerates
Virtuix demonstrates a long reinvestment runway with high returns potential, a disruptive business model, and self-reinforcing dynamics via the Meta partnership. The 150% order surge and defense expansion signal a pivotal business evolution, with improving unit economics and broadening customer value. However, guidance and backlog do not yet indicate truly exceptional (>30%) growth acceleration, and cash flow is not yet accelerating. Revenue and EPS growth are strong but not at the hypergrowth threshold. The business is clearly in growth mode, but some metrics remain just shy of the highest signal tier.
QuinStreet (QNST) Q4 2026: Home Services Revenue Jumps 88% as Digital Performance Model Scales
QuinStreet demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the company is moving toward strong cash flow generation. While growth is robust, it is not at hypergrowth (over 40%) levels for the consolidated business, and the model, while disruptive, is not entirely unique. The business is clearly in growth mode with a favorable outlook.
Live Nation (LYV) Q2 2026: Double-Digit Fan Growth Drives Margin Expansion and Global Venue Buildout
Live Nation demonstrates a long runway for reinvestment at high returns, significant recent growth, improving unit economics, and a self-reinforcing model via venue and ticketing expansion. However, the business, while strong, is already well-followed and not highly disruptive, with some growth capped by market maturity and execution risks in new geographies.
Fortinet (FTNT) Q2 2026: SASE Firewall Surges 34%, Unlocking Multi-Pillar Platform Growth
Fortinet demonstrates a long reinvestment runway, strong recent business acceleration, improving unit economics, and a self-reinforcing business model. Customer value and cash flow are increasing. The model is semi-disruptive but not fully, and while growth is strong, guidance and backlog do not indicate >40% acceleration. The business is clearly in a growth phase, but given its scale and sector, the upside signal is slightly capped versus a smaller or newer disruptor.
Cytokinetics (CYTK) Q2 2026: myCORSO Dispenses Triple to 1,500, Signaling Rapid U.S. Launch Velocity
Cytokinetics demonstrates a long reinvestment runway, disruptive model, and clear evidence of accelerating commercial momentum and pipeline expansion. However, while growth is strong and the future outlook is positive, some elements (cash flow, guidance, and growth rates) are not yet at the exceptional level for the highest marks. The business is not yet a giant, but the signal is strong and thesis-relevant.
Selectar Biosciences (CLRB) Q1 2026: $140M Financing Unlocks Phase III WM Launch and Accelerated Approval Path
Selectar demonstrates a long reinvestment runway, recent inflection via clinical data and financing, improving unit economics, and a disruptive model in radiopharmaceuticals. Some uncertainty remains on immediate customer value expansion and cash flow acceleration, but overall signal is very high for a late-stage biotech at this juncture.
Patterson-UTI (PTEN) Q2 2026: High-Spec Rig Upgrades Drive 10% Sequential Revenue Jump, Margin Tailwind Extends Into 2027
PTEN demonstrates a long reinvestment runway, improving unit economics, self-reinforcing business model, and increasing customer value. Recent developments are significant, with margin and revenue inflection from fleet upgrades and contract wins. However, the company is not a hypergrowth disruptor (score capped for question 7), and while growth is strong, it is not consistently over 40% (questions 6 and 9). The business is transitioning to higher-return segments but is not a new, under-the-radar compounder.
Redwire (RDW) Q2 2026: Backlog Climbs 65%, Defense Tech Outpaces Space Segment
Redwire demonstrates a long reinvestment runway, exceptional backlog growth, and accelerating revenues—clear signs of a business inflection. While the business model shows some self-reinforcing aspects and improving unit economics, network effects and customer deepening are not yet dominant. The guidance and backlog conversion suggest above 40% annual growth, positioning RDW as a growth business with strong upside. Some elements (platform stickiness, disruptive model) are emerging but not yet at full strength.
VECO (VECO) Q2 2026: $200M Advanced Packaging Order Extends Backlog Into 2027, Margin Trade-Off Emerges
VECO demonstrates a long reinvestment runway, disruptive model, and strong customer engagement with backlog visibility into 2027. There is clear evidence of scale-up and improving unit economics, but some uncertainty remains around the pace of margin expansion and the exceptional nature of future growth, justifying a slightly conservative signal score.
Loar Holdings (LOAR) Q2 2026: Commercial OEM Up 28%, New Business Pipeline Conversion Hits $200M
Loar demonstrates a long reinvestment runway, strong organic and inorganic growth, improving margins, and high cash conversion. The $200M pipeline conversion and robust guidance revision are significant, but not all growth is at the 40%+ level, and the business—while compounding—is not a category disruptor. Still, signal is very high for a mid-cap industrial compounder.
Hyperion DeFi (HYPD) Q4 2025: Adjusted Gross Profit Surges 87% as DeFi Monetization Scales
HYPD demonstrates a long reinvestment runway with a disruptive DeFi operating model, clear optionality, and rapidly scaling recurring revenues. There is a significant recent inflection in business performance, with strong improvements in unit economics and customer value. The business model is self-reinforcing, and the company is positioned for continued growth and ecosystem expansion. Some uncertainty remains regarding the durability and scalability of new revenue streams, as well as regulatory risk, which tempers the score slightly.
Kodiak (KDK) Q3 2025: Driverless Truck Deployments Double, Accelerating DAS Model Scale
Kodiak demonstrates a long reinvestment runway, disruptive asset-light model, and rapid scaling in a nascent, high-growth sector. Customer deployments and recurring revenue are accelerating, and the business model is self-reinforcing with improving unit economics. Some caution is warranted as guidance for growth is strong but not yet exceptional (question 6), and cash flow is not fully accelerating (question 8). Revenue/EPS growth is likely above 20% but not yet 40% (question 9). Overall, the signal is very strong for a new public company, but not at the absolute highest level due to execution and regulatory risks.
FIP (FIP) Q2 2026: $1.4B Debt Cut and Rail EBITDA Record Signal Platform Transformation
FIP demonstrates a long reinvestment runway with high ROIC potential, significant recent developments (debt reduction, record rail results), and clear improvements in unit economics and customer value. The business model shows self-reinforcing elements and is transitioning toward higher growth, but not all aspects are fully disruptive or exceptional in growth acceleration, warranting conservative scoring. The outlook is strong, but not all metrics meet the threshold for the highest signal.
Arcutis (ARQT) Q2 2026: Zareve Demand Drives 59% Revenue Growth, Guidance Raised on Prescription Momentum
Arcutis demonstrates a long reinvestment runway with high returns, significant recent growth (59% YoY), and improving unit economics as scale increases. The model is self-reinforcing with IP moat and channel expansion. Customer value is deepening via refill rates and new segments. Guidance is raised, but growth, while strong, is not at a hyper-accelerating level. The business is innovative but not fully disruptive. Cash flow is accelerating, and the business is in a growth phase, but not all metrics are at the highest possible inflection.
Gemini (GEMI) Q3 2025: Card-Led User Growth Surges 55%, Super App Vision Gains Traction
Gemini demonstrates a long reinvestment runway, disruptive business model, and a major inflection in user/revenue growth. Card-led acquisition is driving deepening engagement and recurring revenue, with strong evidence of improving unit economics and customer value. The business is not yet at the point of exceptional (40%+) growth guidance for the future, and cash flow acceleration is only moderate, not explosive. Still, the strategic and financial signal is very high and relevant for investors seeking upside from a newly public, high-growth fintech/crypto platform.
Backblaze (BLZE) Q1 2026: B2 Cloud Storage Surges 24% as AI Pipeline Expands
Backblaze demonstrates a long reinvestment runway, clear business model leverage, and disruptive positioning in AI infrastructure. Growth rates are strong but not yet at the extraordinary threshold for some metrics (e.g., guidance implies high-teens to low-20s growth, not >40%). Margins and customer value are improving, with strong signals of operational leverage and upmarket expansion. However, some elements (like cash flow and guidance) are still transitioning rather than exceptional, and the business, while high-growth, is not yet at hypergrowth scale.
BlackSky (BKSY) Q3 2025: International Backlog Surges to 90%, Anchoring Gen3-Driven Growth
BlackSky displays a long reinvestment runway, disruptive model, and strong international backlog growth. Gen3 adoption and AI differentiation reinforce compounding advantages, and customer value is deepening. However, while growth is strong, near-term revenue and EPS growth guidance is not above 40%, and cash flow is not yet fully accelerating. The business is a clear growth story with some execution and conversion risks.
Butterfly Network (BFLY) Q2 2026: Embedded Revenue Soars 439% as Platform Flywheel Accelerates
Butterfly demonstrates a long reinvestment runway with high returns, disruptive business model, improving unit economics, and compounding platform effects. Embedded revenue growth is exceptional, but some areas like cash flow and near-term growth rates are not yet at the highest threshold. The business is clearly in growth mode with multiple levers, but some execution and guidance risks temper the signal slightly.
DexCom (DXCM) Q2 2026: Gross Margin Jumps 400bps as 15-Day G7 Rollout Accelerates
DexCom demonstrates a long reinvestment runway, clear margin expansion, and strong recurring revenue growth. There are significant developments with the G7 15-day rollout and coverage expansion. Unit economics and operating leverage are improving. The business model is self-reinforcing with growing customer value and cash flow. While not a new disruptor, the company is still a high-growth leader in its category, though growth rates are not hyper-growth (>40%) and some optionality is already priced in.
EREN Digital (YRD) Q1 2026: Internet Insurance Grows 38% QoQ, Anchoring AI Ecosystem Expansion
The article demonstrates a business with a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and rapidly growing digital insurance segment. While growth is strong, it is not consistently above 40% across all segments, and cash flow is improving but not yet fully accelerating. The business is clearly in a growth phase with significant optionality, though some metrics (like future guidance) are not exceptional enough to warrant perfect marks.
PWR Q2 2026: Backlog Surges to $53.3B as Utility and Tech Demand Compounds
PWR demonstrates a long reinvestment runway, record backlog, and improving unit economics with clear compounding advantages. While growth is strong, it is not consistently above 40% and the business model, while robust, is not fully disruptive. The signal is high but not at the absolute maximum due to these factors.
DarioHealth (DRIO) Q4 2025: Commercial Pipeline Doubles to $122M, Multi-Condition Model Drives Scale
DarioHealth demonstrates a long reinvestment runway, a disruptive platform model, and improving unit economics. While not all growth metrics are above 40%, the pipeline acceleration, margin expansion, and platform leverage are clear. The business is not yet a cash flow machine but is on a credible path. Risks are noted, and the business is a growth platform with substantial optionality, meriting a strong but not perfect signal score.
Virtuix (VTIX) Q4 2026: Gross Margin Swings 31 Points as Defense and Meta Alliances Scale
Virtuix demonstrates a long reinvestment runway with high potential ROIC, disruptive technology, and compounding business model. There are clear signs of business evolution (margin swing, new partnerships, segment acceleration), improving unit economics, and deepening customer value. Recurring revenue and vertical expansion support the thesis, but some caution remains on near-term growth acceleration and cash flow. The business is transitioning toward growth, but not all metrics (e.g., >40% top-line growth, cash flow acceleration) are fully realized yet.
Zscaler (ZS) Q4 2026: ARR Growth Accelerates to 25% Amid AI-Driven Security Expansion
Zscaler demonstrates a long reinvestment runway (AI, zero trust, non-seat models) and is showing strong, broad-based growth with accelerating ARR and expanding platform adoption. Unit economics and customer value are improving. The business model is self-reinforcing and disruptive in cybersecurity. However, while growth is strong, guidance for next year moderates somewhat, and cash flow is pressured by CapEx. The business is still growth-oriented, but not in hyper-acceleration mode, and near-term risks (sales leadership transition, CapEx) temper the exceptional signal.
Amprius Technologies (AMPX) Q2 2026: Gross Margin Climbs to 27% as Defense and EMEA Demand Accelerate
Amprius demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong growth in both revenue and margin. While backlog and guidance are improving, the business is not yet showing >40% growth in all metrics, and cash flow is only approaching breakeven. The business is clearly in a high-growth phase, but some verticals are still emerging rather than fully material.
SharkNinja (SN) Q2 2026: International Sales Surge 37%, Social Commerce and AI Scale Core Growth
SharkNinja demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is a clear growth story, though not at the most exceptional level for future guidance or disruptive potential. Cash flow is strong and accelerating, but revenue/eps guidance is in the 16-17% range, limiting the highest scores for those dimensions.
T1 Energy (TE) Q2 2026: 935 MW Module Production Highlights Domestic Solar Supply Chain Progress
T1 Energy demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing, disruptive business model. Customer value is increasing, and the company is positioned as a growth business. However, while growth is strong, guidance and backlog do not indicate consistently exceptional (30%+) acceleration, and cash flow is not yet rapidly accelerating. Revenue/EPS growth is expected to exceed 20% but not 40%+ annually.
Talon Energy (TLN) Q2 2026: 28% PPL Spark Spread Expansion Fuels Free Cash Flow Upside
Talon Energy is experiencing a clear inflection with expanding spark spreads, a long reinvestment runway, and accelerating cash flow. Unit economics are improving, and customer value is deepening with the shift to long-term PPAs. The business model is moving toward infrastructure-like cash flows, but network effects and disruption are only partially present, so those get a 1. Growth and capital return are strong, but not at the highest possible acceleration. The business is not a well-known mega-cap, so signal is high for investors seeking upside.
Shoulder Innovations (SI) Q1 2026: Core Surgeon Volume Up 51%, Platform Expansion Accelerates
Shoulder Innovations shows a long reinvestment runway and strong compounding dynamics: core surgeon volume up 51%, revenue up 65%, and robust margin expansion. The commercial model is self-reinforcing and disruptive in its niche. Customer value is deepening (higher units per surgeon, increased adoption). However, guidance implies growth moderates under 40% for the year, and while cash flow is improving, it is not yet accelerating. The business is still transitioning to full profitability, so not all signals are maxed.
Enovix (ENVX) Q3 2025: Smartphone Battery Revenue Jumps 85% as Fab2 Capacity Scales
Enovix shows strong disruptive potential, a long reinvestment runway, and improving unit economics, with high customer engagement and validation. However, the business is not yet at a stage of exceptional growth (over 30% acceleration) and cash flow is not yet accelerating. The risk of execution on customer qualification tempers the overall signal, but the business is clearly positioned for a pivotal inflection.
HeartFlow (HTFL) Q1 2026: Plaque Revenue Guide Raised 23% as Platform Expansion Accelerates
HeartFlow demonstrates a long reinvestment runway, disruptive platform model, improving unit economics, and a growing data moat. Plaque revenue and install base are inflecting, but the business is still early in adoption and not yet at full cash flow acceleration or 40%+ top-line growth. The signal is high due to rapid platform expansion and AI leverage, but some metrics remain just below the highest thresholds.
Netskope (NTSK) Q1 2027: New Logo ARR Jumps 59% as AI Security Suite Accelerates Platform Adoption
Netskope demonstrates a long reinvestment runway, disruptive AI-native business model, improving unit economics, and strong customer value expansion. Recent new logo ARR growth is significant but not at the highest threshold for acceleration. Cash flow is improving but not yet accelerating, and revenue/EPS growth is strong but not above 40%. The business is clearly in growth mode with exceptional platform leverage, but some watchpoints remain on execution and full cash flow inflection.
WATT Q1 2026: Gross Margin Expands to 36% as Enterprise Wireless Power Deployments Accelerate
Energist demonstrates a long runway with high returns on capital, a disruptive business model, improving unit economics, and growing customer value. There is a significant business evolution with commercial inflection and margin expansion. However, while growth is strong, it is not yet at the highest acceleration across all metrics (e.g., some categories are not >40% growth), and cash flow is improving but not fully accelerating. The score reflects strong but not absolute signal.
Advanced Energy (AEIS) Q2 2026: Data Center Revenue Growth Outlook Raised to 50%+ Amid Capacity and Mix Tailwinds
AEIS demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and cash flow is accelerating. However, while growth is strong (30%+ overall, 50%+ in data center), it is not at the extreme acceleration threshold in all segments. The business is transitioning toward greater diversification and disruption, but not fully disruptive yet. Revenue and EPS growth are projected above 20% but not consistently over 40%. The overall signal is high but not at the absolute maximum.
374Water (SCWO) Q2 2025: Pipeline Grows to $1.8B as PFAS Destruction Demand Accelerates
374Water presents a long reinvestment runway, disruptive technology, and a pipeline that could drive high growth, but capital intensity and early-stage execution risk temper the signal. Backlog and guidance are strong but not yet at the exceptional acceleration threshold. Margins and cash flow are not yet proven, but business model and market tailwinds are evident. Signal is high due to the inflection, but not perfect given execution and funding risks.
Grab (GRAB) Q2 2026: On-Demand GMV Climbs 21% as Ecosystem Expansion Drives Margin Gains
Grab demonstrates a long reinvestment runway, strong ecosystem compounding, improving unit economics, and robust growth across segments. There is evidence of accelerating growth, but not all metrics exceed the highest bar for exceptional signal (e.g., revenue/EPS growth is above 20% but not clear on 40%+). The business is transitioning to a durable growth phase, with some regulatory and FX risks tempering the outlook.
PaySign (PAYS) Q2 2026: Patient Affordability Revenue Jumps 89%, Driving Margin Expansion and Guidance Hike
PaySign demonstrates a strong growth runway, clear margin expansion, and business model transformation with high returns on capital. However, while the business is growing rapidly and showing improving economics, it is not quite at the level of a disruptive, hypergrowth business with 40%+ topline acceleration or a fully exceptional future. The signal is strong but not at the absolute highest level due to some moderating factors such as guidance and the business's moderate profile.
Matson (MATX) Q2 2026: Southeast Asia Now 25% of China Service Volumes, Diversifying Revenue Base
Matson demonstrates strong growth dynamics, premium pricing, and expanding margins with clear evidence of business evolution (Southeast Asia now 25% of China service, 45% YoY operating income growth). However, some levers (network effects, customer deepening) are present but not exceptional, and the business, while high quality, is not on the level of a truly disruptive, compounding platform.
TKO (TKO) Q2 2026: UFC Revenue Jumps 29% as Media Rights and Partnerships Fuel Margin Expansion
TKO exhibits a long reinvestment runway with high returns on capital, significant growth in core segments, and improving unit economics. The business model is self-reinforcing with deepening partnerships and expanding international reach. While growth is strong, it is not accelerating above 40%, and the business, while attractive, is not fundamentally disruptive. Cash flow is robust, and the company is positioned as a growth business, but some elements (e.g., guidance revision, disruptive potential) are less than exceptional.
MakeMyTrip (MMYT) Q1 2027: Hotels and Packages Margin Up 21% as Non-Air Segments Offset Air Weakness
MakeMyTrip demonstrates a long reinvestment runway, strong non-air growth (over 20%), improving unit economics, and a self-reinforcing business model with AI and loyalty. Customers are becoming more valuable, and the business is positioned for above-market growth, though not at a hypergrowth (40%+) rate. The model is disruptive in the Indian context, and cash flow is healthy but not yet rapidly accelerating. The company is a clear growth business, but near-term air volatility and macro risks temper the overall signal.
PACB Q2 2026: SPARCnext Drives 30% Cost Reduction, Reshaping Clinical Sequencing Economics
PACBio demonstrates a long reinvestment runway (clinical/consumables expansion), a disruptive chemistry-driven business model, and improving unit economics. While not all growth rates are above 40%, there is strong evidence of a business pivoting to high growth in a large market, with some near-term margin and cash flow headwinds. Signal is high due to the chemistry innovation and clinical adoption, but not all metrics are at the highest acceleration.
CoVista (CVSA) Q4 2026: Enrollment Surges 14% at Walden, Setting Stage for Multi-Year Platform Expansion
CoVista demonstrates a robust growth platform with clear reinvestment opportunities, improving unit economics, and self-reinforcing business model. While growth is strong, the forward guide is for high single-digit revenue and EPS growth, not hypergrowth, and the business is not fully disruptive, so a few questions score 1 rather than 2.
AppFolio (APPF) Q2 2026: Premium Tier Adoption Climbs to One in Three Units, Driving Margin Expansion
AppFolio demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model with growing customer value. While growth is robust and margins are expanding, the business is not in the hypergrowth category, and the model is semi-disruptive rather than fully disruptive. The signal is strong but not at the absolute highest tier for upside.
Trifalus Life Sciences (TLSI) Q2 2026: G-Code Reimbursement Expands Addressable Market by $2.5B
Trifalus demonstrates a strong reinvestment runway and disruptive, self-reinforcing business model with improving unit economics. The reimbursement milestone is a significant business evolution, and customers are becoming more valuable. However, near-term growth guidance is under 30%, and while the business is transitioning to operational leverage, cash flow is not yet accelerating. The business is clearly in a growth phase with multiple catalysts, but some metrics (e.g., guidance, cash flow) temper the score.
PAR Technology (PAR) Q2 2026: ARR Up 17% as Platform Attachment Hits 100% in New Deals
PAR demonstrates a long reinvestment runway, improving unit economics, and a disruptive, platform-based business model with high ARPU growth and strong customer stickiness. However, while growth is strong, guidance does not clearly indicate 40%+ acceleration, and cash flow, though inflecting, is not yet rapidly accelerating. The business is a clear growth story but not yet at hypergrowth levels.
STMicroelectronics (STM) Q2 2026: Data Center Revenue Target Raised to $2B for 2027 on Optical Connectivity Surge
STM demonstrates a long reinvestment runway, disruptive business model elements (AI, silicon photonics), rising backlog, and robust growth in core verticals. However, margin expansion is delayed by manufacturing transformation and cash flow is not yet accelerating, tempering some immediate upside. The business is clearly in growth mode with strong secular tailwinds, but some execution and cyclical risks remain.
HASI Q2 2026: Managed Assets Jump 20% as Renewables Pipeline Surges Past $6.5B
HASI demonstrates a long reinvestment runway, strong growth, and improving unit economics, with clear compounding advantages and deepening customer value. The business is not quite at the highest level of exceptional future growth (e.g., >30% acceleration), and while disruptive and cash generative, some elements (like new asset classes and growth rates) are still emerging or not fully proven. The signal is high, but not at the absolute maximum for a truly explosive, category-defining business.
TWFG (TWFG) Q2 2026: MGA Revenue Share Doubles to 35%, Driving Margin Expansion and Guidance Hike
TWFG demonstrates a long reinvestment runway, a step-change in business mix, improving unit economics, and self-reinforcing business characteristics through MGA scaling and tech investment. However, some signal is tempered by the normalization risk in Florida, moderating future growth, and the business, while high quality, is not an undiscovered or hyper-growth story.
Samsara (IOT) Q2 2027: 30% ARR Growth Driven by Expanding AI Product Adoption and Large Customer Momentum
Samsara demonstrates a long reinvestment runway, disruptive model, improving unit economics, and deepening customer value, with multiple signals of durable growth and competitive moats. However, growth, while strong, is not currently exceeding 40%, and cash flow acceleration is moderate due to temporary inventory investments. Forward guidance is robust but not exceptional, warranting a slightly conservative signal score.
Pulse Biosciences (PLSE) Q2 2026: Pivotal AFib Study Enrollment Surges 50% Past Midpoint, Accelerating Regulatory Path
PLSE demonstrates a long reinvestment runway with high optionality (cardiac, thyroid, surgical). The pivotal trial is enrolling rapidly, a major business evolution. Unit economics are implied to improve with scale due to procedural efficiency. The business model is disruptive (NSPFA technology), with evidence of customer value deepening (physician enthusiasm, workflow gains). Backlog/guidance is improving but not yet at exceptional acceleration. The business is transitioning toward growth, but not yet at commercial scale, so revenue/earnings growth is not >20%. Cash flow is not yet accelerating, but the financial position is strong. The company is not legacy or stalling, but a high-growth, disruptive clinical-stage business.
XEO (XZO) Q2 2026: Managed Premium Jumps $200M as Platform Expansion Accelerates
XEO demonstrates a long reinvestment runway with clear network effects, disruptive potential, and strong growth signals. However, while growth is strong, it is not exceptional or accelerating at the highest tier, and cash flow acceleration is moderate rather than explosive. The business is not entirely unknown, but the article surfaces new strategic levers and inflections.
STRF Q2 2026: Bitcoin Holdings Rise 11% Amid Strategic Capital Management and Digital Credit Expansion
STRF demonstrates a long reinvestment runway and a disruptive, self-reinforcing business model with improving unit economics and customer value. There is significant growth in digital credit and Bitcoin holdings, but the business is not yet showing exceptional near-term acceleration (30%+), and cash flow is not yet clearly accelerating. Guidance is positive but not extraordinary. The business is a growth business with substantial but not extreme signal.
A2Z Cust2Mate Solutions Corp. (AZ) Q2 2026: Smart Cart Deliveries Nearly Double, Driving 78% Sequential Revenue Growth
The business demonstrates a long reinvestment runway, exceptional recent growth (smart cart deliveries nearly doubled, 78% sequential revenue increase), improving unit economics, and disruptive platform potential. However, while there are emerging network effects and growing customer value, these are not yet fully proven or at scale. Retail media monetization and recurring revenue streams are ramping but not yet dominant. The business is a clear growth story with strong forward indicators, but some elements (network effects, customer value deepening, cash flow acceleration) are still developing.
QumulusAI (QMLS) Q2 2026: GPU Fleet Triples Driving 118% Revenue Growth and Expanding Margins
QumulusAI demonstrates strong growth signals: long reinvestment runway, disruptive business model, improving unit economics, and accelerating revenue/margin expansion. The business is not yet a cash flow machine, and while growth is high, it's not at the most extreme tier for all metrics. The risk-adjusted outlook is very strong, but not every signal question is at maximum due to ongoing capital intensity and lack of reaffirmed full-year guidance.
Ascentage Pharma (AAPG) Q2 2026: 29% Revenue Growth Accelerates Global Hematology Expansion
Ascentage Pharma demonstrates a long reinvestment runway with multiple global trials and a disruptive, innovative pipeline. Revenue growth is strong and commercial expansion is accelerating, but the business is still in a heavy investment phase with losses widening and cash flow not yet accelerating. Guidance suggests strong growth but not at a hypergrowth (40%+) level. The business is clearly in a growth phase, with self-reinforcing elements (pipeline, commercial expansion), but some metrics (cash flow, future guidance) are moderate, not exceptional.
Baidu (BIDU) Q2 2026: AI Cloud Infra Revenue Surges 50%, Driving Core Business Transformation
Baidu demonstrates a long reinvestment runway with high returns, disruptive AI-driven business model, improving unit economics, and a clear pivot to growth. While growth is strong, guidance does not indicate >30% acceleration and cash flow is not yet accelerating at the highest level. The business is not entirely new or undiscovered, so the signal score is conservatively capped below the maximum.
Amer Sports (AS) Q2 2026: 32% Revenue Growth Drives Broad-Based Margin Expansion and Raised Full-Year Guidance
Amer Sports demonstrates a long reinvestment runway, clear margin and revenue acceleration, and improving unit economics. DTC and premium strategies are self-reinforcing, and customer value is increasing. However, while growth is robust and guidance is raised, some margin benefit is temporary (tariff refunds), and YoY growth is projected to moderate. The business is not a novel disruptor but is executing strongly within its category.
Klarna (KLAR) Q2 2026: Transaction Margin Dollars Surge 42% on Expanding Consumer Engagement
Klarna demonstrates a long reinvestment runway, high returns on capital, and improving unit economics with strong margin expansion. There is clear evidence of network effects, higher customer value, and a shift to recurring revenue streams. However, growth is not exceptional (>40%) and the business, while strong, is not fully disruptive or accelerating at the highest levels, especially given some European softness and a maturing profile.
Soluna Holdings (SLNH) Q2 2026: 145% Revenue Surge Anchored by Vertical Integration and AI Pipeline Expansion
Soluna demonstrates a long reinvestment runway, vertical integration, and a disruptive, self-reinforcing model. There is clear evidence of rapid growth, pipeline expansion, and operational leverage, though some metrics (e.g., future growth/CF acceleration) are still emerging rather than exceptional. The business is transitioning from build to operate, with strong signals of growth and optionality but not yet at the highest tier of acceleration.
Hyperliquid Strategies Inc (PURR) FY 2026: $1.2B HYPE Treasury Surge Signals Strength Amid Regulatory Advances
Hyperliquid Strategies demonstrates a long reinvestment runway with disruptive business model characteristics and increasing unit economics. There is a significant uptick in treasury growth and validator role, but not all signals point to exceptional near-term acceleration (e.g., guidance is optimistic but not formally raised; cash flow is improving but not yet accelerating). The business is positioned as a growth story, but regulatory risks and token volatility temper the highest possible signal score.
HawkEye 360 (HAWK) Q2 2026: Record International Revenue Fuels 87% Growth Amid Strategic Capacity Expansion
HawkEye 360 demonstrates a long reinvestment runway, disruptive model, improving unit economics, and strong international growth, with a robust backlog and expanding TAM. However, growth, while strong, is not yet accelerating at an exceptional rate (>30%), and cash flow, while positive, is not yet rapidly accelerating. The business is a clear growth story with high strategic signal, but not quite at the highest inflection of hypergrowth.
ANNX (Annexon) Q2 2026: GBS Trial Advances with 100% Patient Improvement, GA Study Adds 24-Month Endpoint
Annexon demonstrates a long reinvestment runway, recent pivotal clinical progress, and improving unit economics with strong trial execution. The business model is disruptive with high potential, and customer value is deepening. However, current growth guidance is not yet exceptional (>30%), and while cash flow is improving, it is not yet accelerating. The company is clearly in a growth phase but not yet at hypergrowth levels.
Swarmer (SWMR) Q2 2026: SkyKnight Expansion Boosts Contract Value to $14.2M, Validating Autonomous Software Growth
Swarmer demonstrates a long reinvestment runway, disruptive model, improving unit economics, and growing customer value. The SkyKnight contract expansion and ecosystem partnerships are significant, but the business is still early-stage with moderate near-term growth visibility and cash flow. The business model is exceptional, but not all metrics (like accelerating cash flow and >40% growth) are fully met yet.
Calix (CALX) Q2 2026: Software and Services Margin Jumps 810bps as AI-Native Platform Drives Adoption
Calix demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing platform dynamics. There is strong evidence of margin expansion, recurring revenue growth, and customer value deepening. The major acceleration in software margin and RPO is significant, though not quite at the 'exceptional' level for future growth. Cash flow is positive and improving, but not yet dramatically accelerating. The business is clearly in a growth phase, though hardware headwinds temper the overall upside.
Bending Spoons (BSP) Q2 2026: Revenue Surges 126% Driven by Strategic Acquisitions and Platform Efficiency
Bending Spoons demonstrates a long reinvestment runway, exceptional recent growth, and a disruptive, acquisition-driven model. While organic unit economics and customer value improvement are modest, the business is a clear high-growth acquirer with compounding advantages and accelerating revenue/earnings. Some signal is tempered by the dependence on acquisitions for growth and the moderate organic performance.
LGN Q2 2026: 111% Revenue Surge Driven by Data Center Expansion and Fabrication Capacity Growth
Legence demonstrates a long reinvestment runway, exceptional recent growth, clear operational leverage, and accelerating cash flow. While some elements (like customer value and self-reinforcing model) are still developing, the business is firmly in high-growth territory with strong backlog and guidance upgrades.
Energous (WATT) Q2 2026: Revenue Surges 217% Amid Strategic Production Investments and Expanding Enterprise Deployments
Energous demonstrates a long reinvestment runway, disruptive business model, improving customer value, and a transition to commercial scaling with diversification and strong pipeline. While revenue growth is strong (217% YoY), forward guidance is less concrete and cash flow is not yet accelerating, so a couple of questions are scored conservatively. Still, the business is at a pivotal inflection, justifying a high signal score.
Vicor (VICR) Q2 2026: Backlog Jumps 26% as Advanced Power Demand Outpaces Capacity
Vicor demonstrates a long reinvestment runway, disruptive business model, and strong backlog momentum. Advanced product growth, licensing leverage, and manufacturing constraints create a compelling inflection. However, some uncertainty remains around the durability of licensing renewals and the speed of capacity expansion, slightly tempering the signal score.
Everest Medicines (EVER) Q2 2027: Strategic Partnership with Travere Sets Stage for Global Kidney Disease Expansion
Everest Medicines demonstrates a long reinvestment runway across multiple innovative platforms, with recent significant developments (Travere partnership, clinical proof for SIVO, and upcoming mRNA/CAR-T milestones). Unit economics and customer value are improving, and the business model is disruptive with compounding potential. However, cash flow is not yet accelerating and forward growth, while promising, is not yet at an exceptional pace. The company is positioned as a growth business but still faces clinical and execution risks.
Butterfly Network (BFLY) Q1 2026: Embedded Revenue Jumps 147% as Platform Leverage Emerges
Butterfly Network demonstrates a long reinvestment runway, disruptive business model, and clear improvement in unit economics and customer value. Embedded and AI-driven revenues are inflecting, but overall top-line growth remains just above 20% and not yet at hypergrowth levels. Cash flow is improving but not yet strongly accelerating. The business is transitioning into a multi-engine growth platform, but some elements are still emerging rather than fully established.
Humacyte (HUMA) Q2 2026: 91 More Catheter-Free Days in Dialysis Trial Signals Major Clinical Breakthrough
Humacyte demonstrates a long reinvestment runway with disruptive technology, strong clinical results, and pipeline expansion. There is a significant business evolution with breakthrough trial results and commercial momentum, but cash flow and revenue growth are still in early stages. The business is clearly in a growth phase, but not all metrics (e.g., revenue/earnings growth rates, cash flow acceleration) are at the highest threshold yet.
Grandstand Limited (GRSD) Q2 2026: 12% Data Revenue Growth Fuels Return to Cash Flow Strength
Grandstand demonstrates a long runway for reinvestment, disruptive business model evolution, and improving unit economics, especially in B2B data. There are clear signs of growth and margin expansion, but not all metrics are exceptional (e.g., overall revenue is down YoY, and guidance is for modest sequential growth). The fintech launch is promising but not yet proven. The business is transitioning toward growth, with strong signals but not all-out acceleration.
Huron (HURN) Q2 2026: AI-Driven Digital Bookings Up 20%+ as Outcome-Based Model Gains Scale
Huron demonstrates a strong reinvestment runway in high-return managed services and AI-driven digital transformation. There is a clear inflection in digital bookings and managed services growth, with improving unit economics and a self-reinforcing model. Customer value is rising, and the business is transitioning to higher recurring revenue and margins. However, while growth is strong, it is not at the hypergrowth (40%+) level, and the business model, while differentiated, is not fully disruptive on a market-wide scale. The signal is high but not maximal due to these factors.
BioHarvest Sciences (BHST) Q4 2025: CDMO Revenue Doubles as Strategic Bet on Plant Cell Tech Accelerates
BioHarvest demonstrates a long reinvestment runway, disruptive model, and improving unit economics. CDMO revenue is doubling, and DTC is premiumizing, but the business is not yet growing at >40% and cash flow is not yet accelerating rapidly. The company is in transition to growth, with significant optionality, but not yet at the highest trajectory.
Blend Labs (BLND) Q1 2026: Autopilot AI Pipeline Hits $10M, Unlocking 10%+ Growth Trajectory
Blend Labs demonstrates a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and self-reinforcing platform effects. The rapid $10M Autopilot pipeline and high customer adoption signal a business evolution, though near-term revenue/EPS growth is likely under 20% due to macro headwinds. Backlog/guidance is strong but not exceptional yet. The business is clearly in growth mode, but cash flow acceleration and future guidance remain somewhat constrained by mortgage cyclicality.
BrainsWay (BWAY) Q2 2026: 42% System Shipment Growth Fuels Platform Expansion and Revenue Visibility
BrainsWay demonstrates a strong reinvestment runway, significant shipment growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is transitioning to a recurring revenue platform with accelerating cash flow. However, while growth is robust, it does not exceed the 40%+ threshold for some signal questions, and the business model—while disruptive within its niche—is not a major platform at scale yet.
Red Violet (RDVT) Q3 2025: Public Sector Pipeline Expands as EBITDA Margin Hits 39%
Red Violet demonstrates a long reinvestment runway, clear operational leverage, and compounding business model with high retention and margin. While growth is strong, it is not yet at the highest acceleration tier for some questions (e.g., guidance is strong but not over 30% acceleration, and the model is semi-disruptive rather than fully disruptive). The business is a clear growth compounder with high investor relevance.
AMBIC (AMBQ) Q3 2025: Apollo 5 Drives Mix Shift as Edge AI Orders Propel Guidance Above $18M
AMBIC has a long reinvestment runway, strong product mix shift, and evidence of improving unit economics and customer value. The business model is disruptive, with a clear transition to higher-margin Edge AI and IP licensing. While growth guidance is strong, it is not at the exceptional acceleration threshold for some categories. Cash flow is improving but not yet accelerating, and revenue growth, while robust, is not above 40%.
Amkor Technology (AMKR) Q2 2026: Computing Revenue Jumps 20% as AI and Advanced Packaging Demand Accelerate
Amkor demonstrates a long reinvestment runway with high returns, clear business model evolution, improving unit economics, and self-reinforcing dynamics via strategic partnerships. Customer value is increasing, and the business is transitioning to a growth profile with disruptive potential. However, growth rates and cash flow acceleration are strong but not exceptional, and near-term headwinds temper the outlook slightly.
Quantum Computing Inc. (QUBT) Q2 2026: Revenue Surges to $5.6M Amid Strategic Expansion of Manufacturing and Photonics Capabilities
QUBT demonstrates a long reinvestment runway, disruptive model, and clear business evolution with a 90x revenue increase and strong backlog. Some signal is capped by lack of clear >40% guidance and lingering risks, but the business is clearly inflecting toward growth and commercial scale.
Shoulder Innovations (SI) Q2 2026: Core Surgeon Volume Up 50% as Platform Expansion Accelerates
SI demonstrates a long runway with high returns, robust growth, improving unit economics, and a disruptive model. The business is not yet at the very highest level of acceleration (e.g., >40% future growth guidance), and cash flow, while improving, is not yet fully accelerating. Still, the overall signal is very strong for a small-cap medtech platform expanding rapidly.
Navitas (NVTS) Q2 2026: High-Power Revenue Surges 50% as AI Infrastructure Mix Hits Inflection
Navitas is executing a significant business model transformation with strong evidence of a long reinvestment runway, disruptive business model, and customer value deepening. Growth is robust but not yet at extraordinary (40%+) levels, and cash flow is improving but not yet accelerating. The business is positioned as a high-growth, high-potential story but not yet at the absolute upper echelon of signal.
Crystal Biotech (KRYS) Q2 2026: U.S. VYJUVEK Reimbursement Approvals Surpass 730, Driving Deepening Penetration
Crystal Biotech demonstrates a long reinvestment runway, strong commercial momentum, improving unit economics, and pipeline diversification. There are recent significant developments (surpassing penetration targets, multiple near-term catalysts), and the business model is disruptive. However, some elements (such as self-reinforcing advantages and growth rates) are strong but not exceptional, and international pricing risk tempers the outlook. The signal is high, but not at the absolute maximum due to these moderating factors.
Coherus Oncology (CHRS) Q1 2026: Lactorsi New Patient Starts Jump 21% as Pipeline Readouts Approach
Coherus Oncology demonstrates a long reinvestment runway with high returns, significant recent commercial growth, and improving unit economics. The business model is self-reinforcing with network effects via pipeline/commercial synergies. Customers (accounts) are becoming more valuable, but while future growth is strong and guidance is positive, it falls short of 'exceptional' acceleration. The business is disruptive within immuno-oncology and is transitioning toward a cash flow machine, but not yet at full acceleration. Revenue and EPS growth is solid but not at the highest tier. Overall, the company is a growth business with high strategic signal, but not at the absolute maximum.
Solana Company (HSDT) Q4 2025: Staking Yield Outperforms by 60bps, Driving 14% SOL Per Share Accretion
Solana Company demonstrates a long reinvestment runway, clear yield outperformance, improving unit economics, and a disruptive, multi-pronged business model. Customer value is rising, and the business is positioned for growth, but near-term growth rates and cash flow acceleration are not clearly at the highest tier yet. Forward guidance is qualitative, limiting the score on future exceptionalism and acceleration.
VIA (VIA) Q4 2025: Platform Revenue Jumps 30% as Customer Base Expands to 821
VIA demonstrates a long reinvestment runway with high returns, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is clearly in a growth phase. While margin expansion is visible, some levers (AI/AV) are not yet fully realized, and growth is strong but not at the most extreme levels for all metrics. The business is disruptive with high potential, but some international and regulatory risks temper the signal.
ICE (ICE) Q2 2026: Market Access $5.7B Deal Expands Fixed Income Network and Recurring Revenue Base
ICE demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model with deepening customer value. The Market Access acquisition is a significant development, but the business is large and mature, limiting runaway growth. AI and data monetization are disruptive, and cash flow is accelerating. The business is a clear growth compounder but not in hypergrowth mode.
KLA (KLAC) Q4 2026: Advanced Packaging Revenue Surges 70%, Accelerating AI-Driven Process Control Demand
KLA demonstrates a strong reinvestment runway, disruptive positioning, and accelerating growth in high-value segments. While growth is robust, it does not exceed 40% overall, and the business is not entirely unique or underfollowed, which tempers the signal score. However, the business model, backlog, and margin structure all point to compelling investor signal.
BitGo (BTGO) Q1 2026: Derivatives Launch Drives 32bps Margin as Institutional Platform Expands
BitGo shows strong growth signals: high reinvestment runway, recent derivatives launch, improving unit economics, and a disruptive, scalable business model. Margins and client base are expanding. However, growth is not yet at hyper-scale (over 40%), and cash flow is not yet accelerating dramatically, so scores are slightly moderated.
Qualcomm (QCOM) Q4 2025: Automotive Revenue Surges 36%, Unlocking Multi-Billion Edge AI and Data Center Path
Qualcomm demonstrates a long reinvestment runway, compounding business model, and strong growth in new verticals (auto, edge AI, data center). There are clear inflections in automotive and IoT, but data center is still early and guidance for exceptional growth is not yet proven. Revenue growth is strong but not consistently above 40%, and while disruptive, the business is not wholly new to investors.
Buddha Juice (BUDA) Q2 2026: 26% Revenue Growth Accelerates Ultra Fresh Market Expansion
Buddha Juice demonstrates a long reinvestment runway, accelerating growth, and improving unit economics. While some self-reinforcing business model elements are emerging, they are not yet dominant. The business is disruptive within its category, and growth metrics are strong, supporting a high but not perfect signal score.
NanoNuclear (NNE) Q3 2026: $580M Liquidity Supports Multi-Gigawatt Commercialization and Fuel Cycle Expansion
NanoNuclear exhibits a long reinvestment runway and disruptive potential due to its advanced nuclear technology and vertical integration strategy. Recent acquisitions and regulatory milestones signal major business evolution. Unit economics and customer value are positioned to improve as commercialization advances. The business model is self-reinforcing and aligns with high-value, long-term partnerships. However, while the growth outlook is strong, actual revenue/EPS growth is not yet at the 40%+ threshold, and cash flow is not yet accelerating, warranting a slightly conservative signal score.
ClearPoint Neuro (CLPT) Q2 2026: CAL Facility Unlocks $60M+ Preclinical Capacity, Recasts Growth Trajectory
ClearPoint demonstrates a long reinvestment runway, disruptive business model, and significant capacity unlock with the CAL facility, indicating potential for high growth if execution delivers. Some uncertainty remains on the pace of revenue ramp and commercial launches, so not all questions score the maximum.
BILL (BILL) Q2 2026: Card Payment Volume Jumps 25% as Platform Monetization Deepens
BILL demonstrates a long reinvestment runway (AI, payments, embedded finance), strong recent growth in card volume and new products, improving unit economics, and a self-reinforcing business model with network effects. Customer value is deepening and the business is transitioning to higher-value segments, but overall growth rates (revenue, EPS) are under 20% with some segments higher. The business is not yet a hypergrowth outlier, but shows strong disruptive and compounding potential.
Tarsus (TARS) Q2 2026: Extenvi Soars 69% as Retina Pipeline Expands with $450M ALK001 Bet
Tarsus is transitioning from a single-product story to a diversified, high-growth platform with a long reinvestment runway, strong unit economics, and clear disruptive potential. While the business model and recent developments are compelling, some uncertainty remains around pipeline execution and the pace of cash flow acceleration, keeping the score just below the maximum.
Once Upon a Farm (OFRM) Q4 2025: Cooler Count to Surpass 5,000, Accelerating Retail Penetration
OFRM demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer loyalty. There is clear evidence of rapid growth (30%+), significant retail expansion, and innovation. However, margin expansion is still in the future and growth, while strong, is not yet at a hypergrowth (40%+) level. Cash flow is not yet accelerating, and future guidance is good but not exceptional. Still, the business is solidly in growth mode with meaningful upside if execution continues.
GEN (GEN) Q1 2027: Engine Marketplace Revenue Run Rate Surpasses $500M, Propelling Guidance Raise
GEN demonstrates a long runway with platform expansion, strong reinvestment, and improving economics. The Engine Marketplace's rapid growth and partner expansion signal important business evolution. While not every metric is in hypergrowth, the business model is self-reinforcing, customers are becoming more valuable, and cash flow is accelerating. The company is a clear growth leader, but not all segments are at 40%+ growth, and international financial wellness is still ramping.
VERU (VERU) Q3 2026: 239-Patient Enrollment Completes Phase 2B Plateau Trial, Paving Path to Q1 2027 Interim Data
VERU demonstrates a long reinvestment runway with a differentiated, disruptive therapy targeting a large and growing market. The recent completion of Phase 2B enrollment and the upcoming interim data are significant milestones. Unit economics are not fully proven but show promise given the focus on a high-need population and patent exclusivity. The collaboration with Novo Nordisk and strong IP position reinforce the self-reinforcing nature of the business model. Customer value is expected to increase, but this is not yet validated in commercial metrics. The business is clearly in a growth phase, but cash flow acceleration and revenue growth remain prospective until clinical milestones are achieved.
X-Energy (XE) Q2 2026: $2.1B ARDP Boost and Strategic Supply Chain Expansion Cement Advanced Nuclear Leadership
X-Energy demonstrates a long reinvestment runway, disruptive business model, and robust growth prospects, with significant recent developments and strong customer pipeline. Some caution remains around guidance acceleration and cash flow, but the signal is unusually high for a pre-commercial nuclear company.
QBTS Q3 2025: Gross Margin Jumps 16 Points as System Sales Model Scales
D-Wave demonstrates a long reinvestment runway, recent step-change in bookings, improving unit economics, and a disruptive/commercial model. However, while growth is strong, revenue and EPS inflection is not yet at the highest acceleration, and cash flow is not yet rapidly accelerating. The signal is high but not at the absolute maximum due to these moderations.
Supercom (SPCB) Q2 2026: EBITDA Surges 56% on U.S. Expansion and European Scale
Supercom demonstrates a long reinvestment runway, strong recent growth (notably U.S. recurring revenue up 290%), and improving unit economics as scale increases. The business model is increasingly self-reinforcing, and customer value is deepening. While the future outlook is positive and backlog is robust, growth is strong but not at exceptional (40%+) levels across the board. The business is semi-disruptive, with accelerating cash flow and a clear growth profile, but some risks and timing uncertainties prevent a perfect score.
NextGen Energy Ltd. (NXE) Q2 2026: $970M Liquidity Supports Rook One Construction Amid Rising Uranium Demand
NextGen demonstrates a long reinvestment runway, disruptive contracting, improving unit economics, and a business model that should compound with scale. Exploration success and spot price leverage support growth. However, cash flow and near-term growth are not yet exceptional (pre-production phase), and the business is not yet accelerating at the highest tier, warranting a conservative approach to scoring.
Ascendis Pharma (ASND) Q2 2026: €315 Million Product Revenue Fuels Biopharma Growth Trajectory
Ascendis shows a long reinvestment runway, high revenue growth, and improving unit economics. The business model is self-reinforcing with growing customer value and a promising innovation pipeline. While growth is strong, guidance and backlog do not indicate a clear >30% acceleration, and the business, while innovative, is not disruptive at the scale of platform giants. Still, the company is a clear growth story with strong cash flow and market expansion potential.
CINT (CINT) Q2 2025: 90% of Revenue AI-Influenced as Client Expansion Drives 12% Organic Growth
CINT demonstrates high signal with a long reinvestment runway, rapid AI adoption, improved unit economics, and a disruptive, self-reinforcing business model. Revenue growth is robust but not hyper-growth, and cash flow is accelerating moderately rather than exceptionally. The business is positioned as a growth leader, but sectoral imbalances and the need for further value-based pricing adoption temper the signal slightly.
SIBONE (SIBN) Q2 2026: Physician Base Expands 19%, Setting Stage for Multi-Product Launches
SIBONE demonstrates a long reinvestment runway, double-digit growth, improving unit economics, and a compounding business model. Customer value is rising, and the business is transitioning to a multi-product platform. While growth is strong, it is not yet at the most exceptional levels (>40%), and the business model is semi-disruptive rather than fully disruptive. Cash flow is accelerating and the company is firmly in growth mode.
Rubrik (RBRK) Q2 2026: Subscription ARR Jumps 36%, Cloud Security Expansion Drives Margin Upside
Rubrik demonstrates a strong reinvestment runway, high growth, and improving unit economics. The business model is self-reinforcing with deepening customer value and accelerating cash flow. However, some growth drivers (AI/identity) are still early-stage, and revenue normalization is expected as one-time tailwinds fade, which slightly moderates the signal score.
ArcSys (ARXS) Q2 2026: Organic Growth Surges 21%, Margin Expansion Signals Operating Leverage
ArcSys demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value deepening, accelerating cash flow, and growth orientation are clear. While growth is strong, it is not at the most extreme levels for all signal questions, and the business—though high quality—is not exceptionally disruptive or growing at >40% rates, warranting a slightly conservative signal score.
Standard Nuclear (STDN) Q2 2026: Funded Backlog Surges 93% Post-IPO, Scaling TRISO Fuel Production
Standard Nuclear demonstrates a long, high-return reinvestment runway, with a disruptive business model and compounding self-reinforcing advantages (modular production, dual regulatory pathways). The backlog and revenue growth are exceptional, but explicit guidance for future quarters is limited, tempering the outlook slightly. Cash flow is improving but not yet accelerating, and while growth is strong, it is not yet at the extreme 40%+ level for all metrics. The business is clearly in a rapid growth phase, with significant optionality and strategic positioning.
QuantumScape (QS) Q1 2026: Ecosystem Billings Hit $11M as Eagle Line Ramps Toward Multi-Market Scale
QuantumScape demonstrates a long reinvestment runway and disruptive business model with strong ecosystem validation, early monetization, and multi-market expansion. The business model is self-reinforcing and customer value is deepening. However, future growth is promising but not yet at a clearly exceptional (30%+) acceleration, and the cash flow inflection is early-stage. Revenue growth is likely above 20% but not yet at breakout levels. Overall, the signal is high but not at maximum due to commercial execution risk and the early stage of recurring revenue.
Kyivstar (KYIV) Q2 2026: Digital Revenue Jumps 83%, Multiplying Ecosystem Leverage
Kyivstar demonstrates a long reinvestment runway, strong unit economics, and a disruptive, self-reinforcing multiplay/digital ecosystem model. Digital revenue growth is exceptional and customer value is deepening. However, growth guidance is strong but not explosive, and cash flow is improving but not yet accelerating at the highest level. The business is clearly in a growth phase, but macro risks and some guidance caution temper the very highest signal.
Securitize (SECZ) Q2 2026: Tokenized Assets Cross $5B Amid Industry Headwinds
Securitize demonstrates a long reinvestment runway, disruptive business model, and strong institutional adoption, with clear avenues for compounding growth. There is some volatility in revenue and not all metrics are accelerating, but the business is positioned for high growth as tokenization expands. The business is not yet a giant, but the fundamentals and signals are strong.
Beta Technologies (BETA) Q1 2026: EIPP Wins Pull Forward Commercialization by 1 Year, Backlog Hits $3.9B
Beta has a long reinvestment runway, disruptive business model, and is shifting into early commercialization with strong backlog and infrastructure momentum. There are clear network effects and improving unit economics, but the business is not yet showing >40% revenue growth or cash flow acceleration. Guidance is good but not exceptional, so the score is conservative. The business is clearly in the growth phase with high strategic signal.
Duo Technologies (DUOT) Q2 2026: 55MW Expansion Deal Propels AI Edge Data Center Growth
Duo Technologies demonstrates a long reinvestment runway, a disruptive business model, improving unit economics, and a strong pivot to high-growth AI infrastructure. The backlog and revenue growth are significant, but not yet at the exceptional (30%+) acceleration level for future guidance. Cash flow is improving but not yet accelerating sharply. Revenue and EPS growth are strong but just below the 40%+ threshold. Overall, the business is now a growth company with a compelling strategic position, but not at the highest signal level possible.
Dyadic (DYAI) Q1 2026: Revenue Jumps 182% as Animal-Free Protein Shipments Scale
Dyadic demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and growing recurring revenue potential. The commercial inflection is significant, but the future growth trajectory, while promising, is still emerging and not yet exceptional. Some metrics (cash flow, revenue growth rates) are improving but not yet at the highest acceleration levels. The business is transitioning into a growth phase, but broad adoption and scaling remain key watchpoints.
Netskope (NTSK) Q1 2027: New Logo ARR Surges 59% as AI Security Pipeline Accelerates
Netskope demonstrates high growth, a disruptive model, and improving unit economics, with AI security as a new growth engine. However, cash flow is not yet accelerating and forward growth is strong but not yet at exceptional levels. The business is positioned as a growth leader, but execution risk and the nascent stage of AI monetization temper the score.
NOVA (ELTK) Q4 2024: Advanced Packaging Doubles to 15% of Product Revenue, Centronics Acquisition Extends Growth Runway
NOVA demonstrates a long reinvestment runway, significant recent growth in advanced packaging, improving unit economics, and a self-reinforcing business model. Customer value is increasing, but future growth, while strong, is not exceptional (not >30%). The model is semi-disruptive with some lateral opportunities, and cash flow is accelerating. Revenue/EPS growth is solid but not extreme (>40%). This is a growth business, but not at the highest possible signal level.
Real Brokerage (REAX) Q1 2026: Ancillary Revenue Up 34% as Remax Deal Unlocks Platform Leverage
Real Brokerage is at a pivotal inflection, with a long reinvestment runway in platform and ancillary expansion, a disruptive business model, and strong agent and ancillary growth. The Remax deal creates a step-change in recurring revenue and margin potential, although some metrics (cash flow acceleration, near-term growth rates) are not yet exceptional. The business is clearly transitioning into a higher-margin, recurring model, but integration execution remains a key risk.
Reddit (RDDT) Q2 2026: Revenue per Employee Hits $1M as Direct User Mix Shifts Monetization Flywheel
Reddit is demonstrating a long reinvestment runway with high returns, a disruptive business model, and accelerating monetization efficiency. There is strong evidence of improving unit economics, business model leverage, and customer value. However, while growth is robust, it is not yet at an exceptional, hyper-growth (40%+) level for future guidance. The business is transitioning from a legacy social platform to a high-growth, automation-driven ecosystem, but some execution risks and reliance on evolving user mix temper the signal slightly.
Beam Global (BEEM) Q2 2026: Revenue Surges 174% QoQ on Global Expansion and Battery Innovation
Beam Global demonstrates a long reinvestment runway with high returns, a disruptive business model, and strong evidence of accelerating growth and operational leverage. While the business is not yet at exceptional growth by all metrics, it is clearly transitioning into a growth phase with improving unit economics, expanding customer value, and solid recurring revenue potential. Some metrics (cash flow, revenue growth rate) are not yet at the highest tier, but overall signal is strong and thesis-relevant.
10x Genomics (TXG) Q2 2026: ATERA Orders Surpass 40-Unit Capacity, Signaling Demand Inflection
10x Genomics demonstrates a long reinvestment runway, disruptive platform leverage, and high customer engagement, with clear evidence of demand inflection (ATERA orders > capacity). Unit economics and customer value are improving, and the business model is self-reinforcing. However, near-term growth is modest (guidance 2-5%), and cash flow is not yet accelerating, which limits the score. The business remains a growth story with strong optionality but not yet in hypergrowth or cash gusher territory.
Stereotaxis (STXS) Q2 2026: Robotic Catheter Revenue Surges 270%, Paving Path to 2027 Cash Flow Profitability
Stereotaxis demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing recurring revenue ecosystem. There is a significant uptick in catheter revenue and a strong innovation pipeline. Risks and supply constraints temper the outlook, and while growth is strong, it is not yet at the highest acceleration levels. The business is solidly in a growth phase with credible paths to further upside.
ELUT Q1 2026: NXT 41X FDA Pathway Lifts Confidence as 80% Margin Platform Scales
ELUT is positioned for high-margin growth with a disruptive platform, long runway, and clear execution on regulatory and manufacturing fronts. While the business is not yet accelerating at the highest possible growth rates (pending FDA approval), the setup is strong, and the strategic pivot and asset divestitures increase focus and signal. Some elements (cash flow, growth rates) are not yet at peak levels, justifying a slightly conservative score.
Reliant (RAL) Q2 2026: Test & Measurement Margin Jumps 750bps as Electrification and Defense Drive Demand
Reliant demonstrates a long reinvestment runway, strong margin expansion, and growing backlog, all supported by secular growth drivers in electrification, AI, and defense. Productivity programs and capital allocation discipline are accelerating cash flow and profitability. However, some moderation is warranted due to short-cycle exposure, guidance that, while raised, is not accelerating at an exceptional rate, and the business model, while strong, is not fully disruptive. Growth rates are robust but not consistently above 40%, and some risk of normalization exists.
Sophia Genetics (SOPH) Q2 2026: U.S. Revenue Soars 64% as Platform Expansion Drives Global Scale
SOPH demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing platform model with high-value customers. The business is not yet at exceptional future growth rates (30%+), and cash flow is not yet accelerating, but the overall profile is that of a high-signal, growth-stage platform with significant upside.
Array Technologies (ARRY) Q2 2026: Order Book Surges 37% as Product Innovation Drives $2.5B Backlog
Array demonstrates a strong reinvestment runway, improving unit economics, and a self-reinforcing business model with deepening customer value. There is significant backlog growth and margin expansion, but growth, while robust, does not reach the most exceptional category. The business is innovative and transitioning into a more disruptive model, but not fully disruptive yet. Revenue and EPS growth are strong but not consistently above 40%. The business is clearly in a growth phase, but some elements (such as guidance and future exceptional acceleration) are not fully maxed out.
NAPCO Security Technologies (NSSC) Q4 2026: Recurring Revenue Run Rate Hits $103M, Driving Margin Expansion
NAPCO demonstrates strong recurring revenue growth, margin expansion, and high returns on capital with a clear reinvestment runway. The business is not fully disruptive but is evolving with cloud-based offerings. Growth is robust but not explosive (not exceeding 40%+), and the business is transitioning into a high-quality, cash-generative model. The outlook is positive but not exceptional, so scores are conservative.
Coupang (CPNG) Q2 2026: Developing Offerings Gross Margin Expands 440bps, Taiwan and Eats Progress Drive Path to Profitability
Coupang demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing network effects. Cohort spend is growing, and developing offerings are inflecting, but growth rates and cash flow acceleration are not yet at the highest tier. The business is transitioning from recovery to growth, with clear signals of future upside but not all metrics at breakout levels.
Integris (ENTG) Q2 2026: CapEx-Driven Revenue Jumps 15% as AI Buildout Accelerates
Integris is benefiting from a secular AI-driven semiconductor upcycle, with a long reinvestment runway and evidence of high returns on capital. There is a significant uptick in CapEx-driven revenue and backlog, and improving unit economics as scale increases. The business model is becoming more self-reinforcing, with rising customer value and deepening relationships. However, guidance and backlog suggest strong but not exceptional (30%+) growth, and while the business is semi-disruptive, it is not a new platform. Cash flow is accelerating, and the company is positioned as a growth business, but annualized revenue/EPS growth is in the 14-15% range, not 40%+. Signal is high but not at the very top end.
TransDigm (TDG) Q3 2026: Commercial Aftermarket Surges 18%, Fueling Guidance Raise
TransDigm demonstrates a long reinvestment runway with high returns on capital, robust organic and inorganic growth, and strong margin/cash flow expansion. There are significant positive developments, but the growth outlook is not exceptional enough for full marks on all signal questions (e.g., guidance is raised but not at an explosive rate, and disruption is present but not extreme). Nevertheless, the business model is highly attractive and the article surfaces multiple high-signal characteristics.
Powell Industries (POWL) Q3 2026: Backlog Surges 67% to $2.4B, Anchored by Mega Data Center Wins
Powell Industries demonstrates a long reinvestment runway, recent backlog surge, and accelerating growth, with strong cash flow and margin performance. Some elements (such as self-reinforcing business model and deepening customer value) are emerging but not yet fully proven, keeping scores slightly below perfect. The signal remains very high due to the scale of backlog growth and operational leverage.
CS Disco (LAW) Q2 2026: 15% Large-Customer Revenue Growth Anchors AI-Driven Expansion
CS Disco demonstrates a long reinvestment runway, disruptive business model, and strong AI-driven growth with tangible customer and revenue traction. Some metrics (like cash flow and growth rates) are not yet exceptional, and the business is not yet a breakout, but signal is high for a small/mid-cap SaaS.
Digital Turbine (APPS) Q1 2027: AGP Revenue Surges 56%, AI-Driven Flywheel Expands
Digital Turbine demonstrates a long reinvestment runway, clear business evolution, improving unit economics, and a self-reinforcing model. Customer value is deepening and cash flow is accelerating. While the business is not quite at hyper-growth levels (some metrics just below 40%+), the overall signal is strong, with some conservatism due to the competitive landscape and the fact that the business, while outperforming, is not entirely unique or undiscovered.
NYAX (NYAX) Q2 2026: 28% Revenue Growth Drives Strategic Expansion in Financial Services and EV Charging
NYAX demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with a strong recurring revenue base. There are significant developments (Linkwell acquisition, bank charter application), but growth guidance is in the 22-28% range (not >40%), and cash flow is under pressure due to investment. The business is clearly in a growth phase, but not at the most exceptional signal level for all questions.
Hims & Hers Health (HIMS) Q2 2026: Revenue Soars 38% Fueled by AI-Driven Growth and Global Expansion
Hims & Hers demonstrates a long reinvestment runway, disruptive business model, and strong growth in both revenue and international expansion. Unit economics are pressured but improving with scale and AI integration. While growth is rapid, some metrics (e.g., margin recovery, cash flow) are in transition, and guidance, while elevated, does not yet signal exceptional acceleration across all metrics. The business is clearly growth-oriented, but some signal is tempered by ongoing margin and regulatory risks.
Evertec (EVTC) Q2 2026: TransBank Win and 20% Revenue Growth Signal Platform Expansion Across LatAm
Evertec demonstrates a long reinvestment runway, disruptive platform expansion, major new business wins, and improving economics. While growth is strong (20%+), it is not yet hyper-accelerating (>40%), and some impact from AI and M&A integration is still pending. The company is clearly a growth business with substantial optionality, but not all levers are fully proven or exceptional yet.
HCM (HCM) Q2 2026: R&D Spend Jumps 287% as ATTC Pipeline Accelerates
HCM displays a long reinvestment runway with high returns, disruptive innovation, and significant recent developments (notably the 287% R&D jump and 70% ex-US growth). Unit economics and customer value are improving, and the business model is self-reinforcing. However, while growth is strong, guidance does not confirm >40% growth across all metrics, and cash flow acceleration is only moderate. The business is clearly in a growth phase, but not all signals are at the highest threshold.
Spotify (SPOT) Q2 2026: Premium Subscribers Top 300M as Gross Margin Climbs to 33.4%
Spotify demonstrates a long reinvestment runway, strong unit economics, and self-reinforcing business model. There is evidence of compounding ARPU, margin expansion, and new monetization vectors. While guidance signals robust growth, it is not at the exceptional/acceleration level (>30%) for all segments, and the business, though innovative, is not as disruptive as earlier-stage platforms. Still, the signal for future compounding and sustained leadership is high.
Schmid Group (SHMD) Q4 2025: AI-Driven Order Mix Climbs to 60%, Margin Upside Signals Inflection
Schmid is undergoing a major inflection, with a disruptive business model, strong reinvestment runway, and a rapid mix shift to AI/advanced packaging. Margins and order backlog are improving, and customer value is deepening. However, while growth is strong, it is not yet at the most exceptional (40%+) level, and cash flow acceleration is moderate. Overall, the signal is very high but not at the absolute maximum.
BAM Q2 2026: $77B Fundraising Surge Anchors AI, Credit, and Infrastructure Expansion
BAM demonstrates a long reinvestment runway, record fundraising, improving unit economics, and a self-reinforcing business model with expanding customer value. While growth is strong, the business is not truly hypergrowth (some metrics below 40%+), and the model, while platform-like, is not as disruptive as pure tech. The signal is very high but slightly capped by the maturity and scale of the business.
Intapp (INTA) Q4 2026: Celeste AI Drives 29% Cloud ARR Growth, Expanding Enterprise Penetration
Intapp demonstrates a long reinvestment runway, disruptive business model, compounding customer value, and enterprise expansion. Cloud ARR and AI bookings are growing rapidly, but AI monetization is still early and cash flow is only moderately accelerating, limiting the highest scores. The business is clearly in a growth phase with strong signals, but not all levers are fully proven at scale yet.
ATEC (ATEC) Q2 2026: EBITDA Margin Jumps 420bps as Surgeon Adoption Surges 24%
ATEC demonstrates a long reinvestment runway, strong recent growth in surgeon adoption and EBITDA, and improving unit economics. Its business model is becoming more self-reinforcing with data-driven moats and recurring surgeon engagement. However, biologics attachment and international scaling present areas where execution risk remains, and the business, while high-growth, is not yet at the 40%+ acceleration threshold in revenue or EPS. Overall, the signal is strong but not at the absolute highest level due to these moderating factors.
TransMedics (TMDX) Q2 2026: Service Revenue Jumps 29% as Logistics Integration Expands Growth Platform
TransMedics demonstrates a long reinvestment runway, disruptive platform expansion, and strong business model evolution. Growth rates are solid (though not yet >40%), and the company is shifting toward recurring, high-margin services. Some near-term margin compression and moderate guidance raise temper the score, but the business signals clear compounding potential and a credible path to much higher scale.
Ovid Therapeutics (OVID) Q4 2025: $60M PIPE Financing Extends Cash Runway Into 2029, Expands Pipeline Scope
Ovid demonstrates a long reinvestment runway, substantial new capital, and a disruptive, de-risked business model with multiple new programs. While the growth outlook is strong, there is not yet evidence of >40% revenue or EPS growth (given clinical stage), and cash flow is not yet accelerating. However, the company is transitioning into a growth platform with clear optionality and potential for significant value creation.
Solana Company (HSDT) Q1 2026: Staking Yield Outperforms by 90bps as APAC Digital Asset Strategy Scales
The business demonstrates a long reinvestment runway, disruptive model, and strong growth signals, including a massive YoY revenue increase and differentiated staking yield. However, some metrics (backlog/guidance) are not yet at an exceptional level, and cash flow is not yet clearly accelerating, so scores are conservative in those areas.
The Bancorp (TBBK) Q2 2026: FinTech Revenue Jumps 21% as Embedded Platform Nears Launch
TBBK demonstrates a long reinvestment runway, strong compounding dynamics, and clear business model evolution toward high-return FinTech activities. There is strong evidence of accelerating fee growth, buybacks, and operating leverage. However, while growth is robust, it is not yet at the 'exceptional' acceleration threshold for some questions, and the business, while innovative, is not fundamentally disruptive to the same degree as a platform like Square or Stripe. Risks of execution and partner disintermediation are present, but the overall signal for valuation upside and business evolution is high.
Alliant (ALNT) Q2 2026: Data Center Revenue Jumps 60% as Backlog Hits $298M
Alliant displays a long reinvestment runway, major growth in a core vertical (data centers), and improving unit economics with strong margin leverage. The business model is becoming more self-reinforcing but not yet a fully compounding moat. Customer value is increasing, and backlog/guidance signal exceptional near-term growth. The business is semi-disruptive due to its pivot but not a pure disruptor. Cash flow is accelerating, but overall revenue/EPS growth is strong but not hypergrowth. This is a transitioning-to-growth business, not legacy or fully mature.
Equinix (EQIX) Q1 2026: Sales Activity Surges 35%, AI Infrastructure Demand Drives Record Backlog
Equinix demonstrates a long reinvestment runway, clear unit economics improvement, self-reinforcing business model, and strong customer value expansion. Growth is robust but not quite at an exceptional acceleration rate, and while the business is highly attractive, it is already well-followed and not a hidden gem, slightly capping the signal score.
AvePoint (AVPT) Q2 2026: SaaS Revenue Climbs 27% as AgentPulse Drives AI Trust Layer Adoption
AvePoint demonstrates a long reinvestment runway, disruptive business model, and compounding advantages in a high-growth, high-ROIC SaaS segment. The company is not yet showing >30% acceleration in outlook (hence a 1 for question 6), and while cash flow and revenue growth are strong, they are not accelerating at the highest possible rate. Nevertheless, the business is clearly in a growth phase with improving unit economics, deepening customer value, and platform self-reinforcement.
IMSR (IMSR) Q2 2026: $2.7B Lifetime Revenue Per Plant Enhances Capital-Efficient Nuclear Growth Path
The company demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and high margins, with strong regulatory progress and strategic partnerships. Growth is solid but not yet exceptional (no >40% guidance), and cash flow is improving but not yet accelerating, so scores are conservative on those axes.
Gold Royalty (GROY) Q2 2026: Adjusted EBITDA Surges 212% as Royalty Model Delivers Margin Resilience
GROY demonstrates a long reinvestment runway, clear margin expansion, and robust organic growth pipeline. The royalty model is self-reinforcing with high operating leverage. While growth is strong and cash flow is accelerating, guidance and backlog do not indicate an exceptional (30%+) acceleration, and the model, while attractive, is not fully disruptive. Revenue and EPS growth are strong but not above 40%. The business is firmly in the growth category, but not at the extreme end of the spectrum.
Kyivstar (KYIV) Q4 2025: Digital Revenue Jumps 6x, Pushing Ecosystem Share to 16%
Kyivstar demonstrates a long reinvestment runway, major digital revenue inflection, improving unit economics, and a self-reinforcing ecosystem model. Customer value is deepening, and the business is transitioning to a digital-led growth story. However, guidance for 2026 is prudent rather than exceptional, cash flow is strong but not yet accelerating, and growth rates are moderating into the 20% range. The business is highly strategic but not at the explosive growth phase, warranting a strong but not perfect signal score.
Procore (PCOR) Q2 2026: Margin Expands 800bps as AI and DroneDeploy Acquisition Accelerate Strategic Shift
Procore demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. The DroneDeploy acquisition, AI-driven growth, and international expansion signal strong optionality. However, growth rates are strong but not yet at the highest acceleration, and cash flow is improving but not rapidly accelerating. The business is transitioning toward growth leadership, but some metrics (e.g., guidance) are not yet exceptional.
Hyperfine (HYPR) Q2 2025: Gross Margin Jumps 800bps as Next-Gen SWOOP Drives Commercial Inflection
Hyperfine demonstrates a disruptive business model with clear reinvestment runway, improving unit economics, and deepening customer value. There is a major inflection in margin and commercial momentum, but overall guidance for 10-20% annual growth is not exceptional, and cash flow is improving but not yet accelerating. The business is transitioning into a growth phase, but not all metrics are at the highest signal threshold.
InVivid (IVVD) Q1 2026: Pemgarda Climbs 22% as Monoclonal Antibody Platform Expands Beyond COVID
InVivid demonstrates a long reinvestment runway with a disruptive, platform-based model and evidence of strong unit economics, customer value expansion, and self-reinforcing dynamics. There are significant recent developments (22% revenue growth, pipeline expansion), but guidance is not exceptional (>30% acceleration), and cash flow is not yet accelerating. The business is in a high-growth, transition-to-scale phase, but not all metrics reach the maximum signal threshold.
MongoDB (MDB) Q2 2027: Atlas Revenue Growth Accelerates 30% Amid Expanding AI and Enterprise Adoption
MongoDB demonstrates a long reinvestment runway with high returns, clear recent acceleration (30%+ growth), improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the future outlook is strong but not exceptional (growth moderating to low 20s%). The business model is semi-disruptive, and cash flow is accelerating. Revenue growth is over 20% but under 40%, and the business is firmly in the growth category.
Dario Health (DRIO) Q2 2026: Contracted ARR Hits $13.1M with Multi-Condition Expansion Driving Long-Term Growth
Dario Health shows a long reinvestment runway, disruptive multi-condition platform, improving unit economics, and strong channel leverage. However, while growth is visible and accelerating, actual revenue recognition and guidance remain in a transition phase, slightly tempering the signal score.
CI&T (CINT) Q2 2026: 22% Organic Revenue Growth Underscores AI Deployment Leadership
CI&T demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. The business is clearly in a growth phase with broad-based demand, but while growth is robust, it is not at the extreme acceleration (over 30-40%) that would warrant full marks for all growth-related questions. Cash flow is improving but not yet accelerating at the highest level. Overall, the signal is strong and thesis-relevant for investors.
ServiceTitan (TTAN) Q1 2026: Subscription Revenue Jumps 29% as Enterprise, Pro Products, and Commercial Drive Expansion
ServiceTitan demonstrates a long reinvestment runway, disruptive model, and strong enterprise/commercial momentum. Subscription and usage growth are robust, margins are expanding, and AI adoption is deepening customer value. While growth is strong (not hypergrowth), and FCF is not yet positive, the overall signal is high for durable expansion and margin improvement.
Five9 (FIVN) Q1 2026: AI Revenue Jumps 68%, Expanding Platform Monetization
Five9 demonstrates a long reinvestment runway, disruptive AI-driven business model, compounding economics, and strong customer value expansion. Recent AI revenue growth is significant but not yet explosive enough for top marks on all future/guidance questions. Cash flow is improving but not yet accelerating at the highest level. Overall, the signal is strong and thesis-relevant for investors.
Kodiak (KDK) Q2 2026: Driverless Truck Fleet Grows 71% as Gen 7 Platform Targets Cost Efficiency
Kodiak demonstrates a long reinvestment runway, disruptive business model, and clear operational and regulatory inflection points. The business is transitioning into high growth, but some metrics (cash flow, growth rates) are not yet at the highest acceleration, and backlog/guidance is strong but not exceptional. Signal is high but not at the absolute maximum.
Mesoblast (MESO) FY 2026: $115M Rioncel Launch Fuels Transition to Commercial Growth with Blockbuster Phase 3 Pipeline
Mesoblast demonstrates a long reinvestment runway, significant recent business developments, improving unit economics, a self-reinforcing business model, and increasing customer value. The future outlook is strong but not yet exceptional based on guidance. The business model is disruptive, but cash flow is only moderately accelerating and growth is not yet over 40% annually. The company is a clear growth business, but some metrics are not at the highest levels.
Evaxion (EVAX) Q1 2026: 86% Immunogenicity Rate in EVX01 Underscores AI Vaccine Platform Scalability
Evaxion's AI immunology platform demonstrates a long reinvestment runway and disruptive potential, with high immunogenicity data and pipeline breadth. However, the business remains pre-revenue, and while growth and optionality are strong, cash flow is not yet accelerating and forward growth rates, while promising, are not yet proven at >40% annually.
Coherence Oncology (CHRS) Q3 2025: Lactorsi Demand Up 92% YoY, Pipeline Data Readouts Set for 2026
CHRS is a growth-stage oncology innovator with a long reinvestment runway, disruptive pipeline, and sharply rising Lactorsi demand. The business shows improving unit economics, self-reinforcing model, and deepening customer value. Guidance is for strong growth but not yet exceptional/accelerating, as major inflection depends on 2026 data. Cash flow is improving but not yet a 'machine.' Overall, signal is high but not at the absolute maximum due to pipeline risk and the need for clinical proof.
STXS Q3 2025: MagicSweep Catheter Adds $300K in Two Months, Catalyzing Recurring Revenue Shift
STXS demonstrates a long reinvestment runway with a disruptive, recurring revenue model and expanding digital platform. Recent product launches (MagicSweep, Genesis X) are driving a business evolution and improving unit economics. The business is transitioning toward high-margin recurring revenue and SaaS, but guidance does not quite reach the threshold for 'exceptional' acceleration (over 30%+), and cash flow is improving but not yet rapidly accelerating. The business is clearly in growth mode with strong signals for future upside.
Owlet (OWLT) Q2 2026: Subscription Revenue Surges 256%, Cementing Platform Transition
Owlet demonstrates a long reinvestment runway with its subscription model, international expansion, and telehealth initiatives. There is a clear recent uptick in subscription growth (256%), improving unit economics, and a self-reinforcing business model via FDA clearance and regulatory moats. Customer value is increasing, but Q3 guidance signals short-term headwinds, so not all metrics are exceptional. Growth is strong but not at the highest acceleration, and while cash flow is improving, it is not yet accelerating dramatically.
AVAV Q4 2026: Counter-UAS Revenue Doubles, Underpinning $2.7B Backlog Surge
AVAV demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong backlog growth. However, growth guidance is solid but not exceptional (>10% but not >40%), and cash flow is not yet accelerating, which tempers the signal score. The business is clearly a growth story with strategic upside, but some metrics are not at the highest inflection.
Ibotta (IBTA) Q2 2026: Third-Party Redemption Revenue Surges 27% on Network Expansion
Ibotta demonstrates a strong reinvestment runway, accelerating third-party revenue growth, improving unit economics, and a self-reinforcing business model with network effects. Customer value is deepening, and the business model is disruptive and scalable. However, growth guidance is in the mid-single digits and not yet at an exceptional acceleration pace, and cash flow is improving but not yet rapidly accelerating. The business is clearly a growth business, but the annualized growth rate is not above 20% in guidance.
MindWalk (HYFT) Q1 2026: 45% Revenue Growth Signals Platform Shift After $15M Divestiture
MindWalk demonstrates a strong runway, disruptive platform, and significant margin/revenue mix shift. There is evidence of improving unit economics, customer value, and a strategic inflection post-divestiture. However, while growth is strong, guidance does not indicate >40% acceleration, and cash flow is not yet fully accelerating.
Pelthos Therapeutics (PTHS) Q4 2025: Zelsubmi Prescriptions Jump 129%, Expanding At-Home Pediatric Market
Pelthos shows strong signal: rapid prescription growth (129%), expanding payer access, improving unit economics, and a multi-product platform with disruptive at-home treatments. While growth is strong, guidance lacks explicit >30% acceleration, and cash flow is not yet accelerating. Still, the business is clearly transitioning to a high-growth, high-ROIC model with compounding characteristics and disruptive potential in pediatric dermatology.
Bullish (BLSH) Q1 2026: Tokenization Deal Unlocks $4.2B Platform, Sets Stage for 6–8% Growth
Bullish demonstrates a long reinvestment runway, clear business model evolution, improving unit economics, and self-reinforcing platform dynamics. Customer value is deepening, and the Equinity deal is a major inflection point. Guidance is for strong but not hyperbolic growth; future cash flow is improving but not yet accelerating. The business is disruptive and positioned for durable, above-average growth, but near-term growth rates are not in the hypergrowth (>40%) category.
Inflection (INFQ) Q1 2026: Quantum Revenue Up 14% as Neutral Atom Platform Accelerates Multi-Segment Momentum
Inflection demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong technical/commercial momentum. However, some metrics (cash flow, near-term growth rate, and guidance) are not yet exceptional, with commercial adoption still ramping. The business is clearly growth-oriented, but not all signal elements are at maximum strength.
InterDigital (IDCC) Q2 2026: Streaming and Cloud Revenue Hits $110M, Arbitration Sets Up Multi-Year Upside
InterDigital is transitioning into a diversified, high-margin, recurring-revenue business with a long reinvestment runway and expanding addressable market. There are clear business model reinforcements (network effects, standards leadership), improving unit economics, and accelerating cash flow. However, while growth is robust, it is not yet at the highest acceleration tiers, and some uncertainty remains around arbitration timing and magnitude. The business is not fully disruptive but is semi-disruptive in its licensing approach to new verticals. Overall, signal is high but not at the absolute maximum due to these caveats.
WRAP Technologies (WRAP) Q2 2026: Revenue Doubles Amid Strategic Market Expansion and New Platform Initiatives
WRAP demonstrates a long reinvestment runway with high returns, a disruptive model, and strong business evolution (103% revenue growth, expanding margins, and regulatory-driven TAM expansion). Unit economics and customer value are improving, and the business is transitioning to a recurring model. However, cash flow is not yet accelerating (still unprofitable), and growth guidance is high but not exceptional (>100% for the year, but Q3 guidance is not explicit). The business is not yet at scale but is clearly in a high-growth, transition phase with significant optionality.
374 Water (SCWO) Q3 2025: Revenue Set to Climb 100% as Waste Destruction Services Scale
The business demonstrates a clear reinvestment runway, disruptive model shift, and strong early commercial traction with high growth guidance. While not all financials are at the 'exceptional' level yet (e.g., cash flow is not yet accelerating, and guidance is for 50-100% growth rather than >40% QoQ), the business is transitioning to a recurring, high-margin services model in a large, regulatory-driven market. Risks remain around capital intensity and scale, but the signal for investors is strong and thesis-relevant.
BKV (BKV) Q3 2025: Power Ownership Rises to 75%, Unlocking Strategic Flexibility in ERCOT
BKV demonstrates a long reinvestment runway, disruptive integration of gas, power, and CCUS, and improving unit economics. There is clear business evolution with the majority power JV acquisition and CCUS project momentum. While some growth rates are strong, not all segments are accelerating at >30% or >40% annually, and cash flow is improving but not yet rapidly accelerating. The model is self-reinforcing and growth-oriented, with moderate but not exceptional near-term guidance.
Enova (ENVA) Q2 2026: Originations Surge 27%, Grasshopper Bank Synergies Set to Drive 25% EPS Accretion
Enova demonstrates a long reinvestment runway with high returns, strong growth (27% originations, 30%+ EPS guidance), and improving unit economics. The business model shows some self-reinforcing elements (analytics, scale), but network effects are not dominant. Customer value is growing but not deeply compounding. The Grasshopper Bank acquisition is a major development, and the company is transitioning to a cash flow machine with accelerating metrics. Revenue/EPS growth is robust, and the business is clearly in a growth phase.
Summit Therapeutics (SMMT) Q2 2026: R&D Spend Climbs 24% as Avonisimab Heads Toward FDA Decision
Summit shows a long reinvestment runway with high returns potential via Avonisimab’s platform, recent significant clinical and regulatory developments, improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, but future growth is not yet exceptional (pending FDA approval). Cash flow is not yet accelerating, and revenue/EPS growth is not >40% but is solidly in the growth stage.
Vertex (VRTX) Q2 2026: Non-CF Revenue Surges 150% as Renal and Pain Launches Scale
Vertex is transitioning to a multi-pillar growth model with strong reinvestment opportunities and disruptive launches. Non-CF revenue is growing rapidly, and the business model is self-reinforcing with deepening customer value. However, some forward guidance is strong but not yet at exceptional acceleration, and there is some execution risk with integration and margin pressure. The signal is very high for a large-cap, but not at the absolute highest level due to the maturity of the CF franchise and the competitive landscape.
LandBridge (LB) Q2 2026: Digital Infrastructure Pipeline Expands to 10GW as Recurring Revenue Model Scales
LandBridge demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing, asset-light recurring revenue model. The digital infrastructure pipeline and royalty rate tailwinds provide significant optionality, though the business is not yet in hypergrowth territory (guidance and conversion timing are watchpoints). The business is disruptive within its niche, but not at the level of a paradigm-shifting platform. Overall, the signal is strong with clear catalysts and valuation relevance.
EOS Energy (EOSE) Q2 2026: Backlog Climbs 31% as Thornhill Consolidation Targets 72-Point Margin Gain
EOS Energy is at a clear operational and strategic inflection with a long reinvestment runway, disruptive business model, and strong backlog growth. The business is transitioning to margin expansion with automation, but customer value deepening and cash flow acceleration are not yet fully proven, and growth, while strong, is not at the hypergrowth threshold. The business is a growth story, but with certain execution and concentration risks.
Regeneron (REGN) Q1 2026: Dupixent Drives 31% Growth, Pipeline Sets Up Multi-Blockbuster Visibility
Regeneron demonstrates a long reinvestment runway, strong unit economics, compounding business model, and growing customer value. There is evidence of significant growth in key franchises and a diversified pipeline. However, while the growth is strong, it is not consistently above 40%, and some pipeline elements are not fully de-risked, keeping the signal score slightly below maximum.
NeuroOne Medical (NMTC) Q2 2026: 1RF Revenue Jumps 72% as Clinical Adoption Expands
NeuroOne shows a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model driven by clinical data. Customer value is increasing, and the business is transitioning toward growth, but some pipeline and international catalysts remain prospective rather than realized. Cash flow is not yet accelerating, and guidance implies solid but not exceptional near-term growth. Signal is high for a small-cap medtech, but not at the extreme end of disruptive or hypergrowth.
First Solar (FSLR) Q2 2026: Gross Margin Surges to 57% on Tariff Benefits and U.S. Manufacturing Scale
First Solar demonstrates a strong competitive moat in U.S. manufacturing, high backlog, and pricing power, with clear policy-driven growth levers. However, while growth is robust, some metrics (like revenue and EPS growth) are not at hypergrowth levels, and policy risk tempers the signal. The business is not entirely disruptive (solar module manufacturing is established), but technology and policy alignment provide upside. Backlog and margin expansion are positive, but not all signals point to explosive near-term growth.
ClearPoint Neuro (CLPT) Q3 2025: ERIS Merger Adds $9M Platform, Expands Addressable Market by $500M
ClearPoint demonstrates a long reinvestment runway, significant new developments (ERIS merger, CRO launch), and improving unit economics. The business model is self-reinforcing and recurring, with customer value deepening. However, some elements (future growth, disruption, and cash flow) are not yet at the highest level of acceleration, and guidance is good but not exceptional.
Pampa Energía (PAM) Q1 2026: Rincón de Aranda Drives 48% EBITDA Surge, Sets $4.5B Growth Platform
Pampa Energía demonstrates a long reinvestment runway, clear operational leverage, improving unit economics, and a vertically integrated, self-reinforcing business model. Customer value is increasing with vertical integration, and the business is positioned for growth rather than legacy stagnation. However, while growth is strong, it is not at the highest acceleration levels and some risks remain around regulatory and execution factors. The business is semi-disruptive but not a pure disruptor, and cash flow is not yet accelerating due to heavy capex, capping the signal score below the maximum.
Elowit (ELWT) Q4 2025: Billed Units Up 77% as Recurring Revenue Engine Accelerates
Elowit demonstrates a long reinvestment runway, disruptive business model, and significant growth in billed units and recurring revenue. Unit economics and customer value are improving, and the business is transitioning toward higher-margin, recurring revenue streams. While growth is strong, guidance and backlog changes are good but not exceptional, and cash flow acceleration is moderate at this stage. The business is clearly in a growth phase, but not yet at the highest acceleration tier.
Peltos Therapeutics (PTHS) Q1 2026: Zelsuvmi Prescriptions Jump 25% as PBM Access Doubles Units Dispensed
Peltos demonstrates strong prescription growth, expanding coverage, and clear operational leverage, indicating a long runway with high returns. However, while growth is robust, it is not yet at an exceptional or disruptive level, and some uncertainties remain regarding the future impact of new launches and payer dynamics. The signal is high but not at the absolute upper bound for a truly exceptional, disruptive growth story.
RBC (RBC) Q2 2026: Backlog Surges 86% to $1.6B, A&D Demand Drives Capacity Expansion
RBC demonstrates a long reinvestment runway with high returns, an exceptional surge in backlog, and accelerating growth in A&D. Unit economics and cash flow are improving, and the business is transitioning toward a higher-margin, growth phase. However, the business model is not fully disruptive (mainly industrial/A&D manufacturing), and while customer value is improving, it does not show the deepening engagement of a pure compounding platform. Revenue growth is strong but not consistently above 40%, and lateral optionality is moderate. Overall, the signal is high but not at the absolute maximum.
EverQuote (EVER) Q2 2026: AI-Driven Home Vertical Jumps 35% as Carrier Demand Rebounds
EverQuote demonstrates a strong reinvestment runway, disruptive AI-driven model, and multi-vertical expansion. Carrier and agent engagement, improving unit economics, and home vertical growth are positive. However, while growth is robust, it is not at the most exceptional levels (over 40% company-wide), and some future potential is not fully realized yet. The business is a clear growth story but not at the highest possible inflection point.
BKV (BKV) Q2 2025: Barnett Acquisition Adds 100 MMCFE/D, Extending Low-Decline Inventory Runway
BKV demonstrates a long reinvestment runway, operational outperformance, and a self-reinforcing business model with expanding CCUS and power opportunities. Unit economics are improving, customer value is deepening, and the business is positioned as a growth platform. However, while growth is strong, it is not at a hypergrowth (40%+) level, and some elements (CCUS, premium power) remain in early scaling stages. The business is disruptive but not at the most extreme edge, and cash flow acceleration is moderate rather than explosive.
Amgen (AMGN) Q2 2025: Volume Surges 13% as 15 Brands Deliver Double-Digit Growth
Amgen demonstrates a long reinvestment runway, strong volume growth, improving unit economics, and a self-reinforcing business model through its diversified portfolio and biosimilars. Customer value is deepening, and the business is firmly in the growth category. However, while future growth is robust, it is not exceptional enough (30%+ acceleration) to warrant a perfect score. The business model is innovative but not fully disruptive, and cash flow is growing but not accelerating at a transformative rate.
BlackRock Coffee Bar (BRCB) Q1 2026: Segmented Loyalty Offers Double Engagement, Fueling 24% Growth
BRCB shows a strong reinvestment runway, improving unit economics, and clear digital/loyalty-driven business model advantages. While growth is robust, it is not yet at a hyper-scaling level, and competitive/comp headwinds temper the signal. Still, the business is a clear growth story with some disruptive elements and compounding advantages.
ELUT Q2 2025: LU Pro Drives 49% Sequential Growth, Margin Expansion Signals Scalable Platform
ELUT demonstrates a strong reinvestment runway, rapid sequential growth, improving unit economics, and a business model with emerging self-reinforcing elements. Customer value is increasing, but the future, while bright, is not yet exceptional or fully de-risked. The business is transitioning into growth, but some risks and uncertainties remain, especially in pipeline execution.
Lumexa Imaging (LMRI) Q4 2025: 40% Throughput Gain From AI Drives Advanced Imaging Margin Expansion
Lumexa demonstrates a long reinvestment runway, high ROIC potential, and a disruptive, capital-light model with clear margin expansion and advanced modality growth. The 40% AI-driven throughput gain is a material business evolution, and unit economics are improving. However, while growth is strong, guidance and backlog do not indicate 30%+ acceleration, and some elements (cash flow, revenue growth) are solid but not truly exceptional. The business is a growth compounder but not at the highest tier of signal.
RadNet (RDNT) Q2 2025: Advanced Imaging Mix Rises 102bps as AI and Capacity Initiatives Drive Margin Expansion
RadNet demonstrates a long reinvestment runway at high returns, clear margin expansion, and a shift to higher-value modalities. There are recent significant developments (AI rollout, margin expansion, acquisitions) and strong unit economics. The business model is becoming more self-reinforcing, with some disruption potential. However, while growth is accelerating, it is not yet at an exceptional level (>30% across the board), and digital health externalization is still emerging. The business is growth-oriented, but not at the highest possible signal for disruptive upside.
BioLife Solutions (BLFS) Q2 2025: Cell Processing Revenue Up 28% as BPM Share Hits 70% of U.S. CGT Trials
BLFS shows strong recurring revenue, margin expansion, and embeddedness in a high-growth sector, with signs of durable competitive advantage. While growth rates and guidance are robust, some metrics (like future acceleration and disruptive potential) are promising but not yet exceptional, warranting a slightly conservative signal score.
QRVO Q2 2026: $500M Synergy Target Signals Scale Leap as Skyworks Merger Redefines RF Landscape
The merger creates a scaled, diversified platform with a long reinvestment runway, improving margins, and strong customer stickiness. However, growth rates are not guided above 20% annually, and while the business is transitioning toward higher growth, it is not yet a clear hyper-growth or highly disruptive story. The business model is semi-disruptive, and cash flow is accelerating but not yet at the highest tier. The signal is strong but not at the absolute maximum due to these moderating factors.
Supermicro (SMCI) Q1 2026: $13B GB300 Orders Signal AI Data Center Surge Despite Margin Compression
SMCI demonstrates a long reinvestment runway, disruptive business model, and strong growth signals with record orders and backlog. However, margin compression, execution risk, and working capital strain moderate the overall signal, and while growth is robust, it is not at the most exceptional level across all criteria.
Blackstone (BX) Q2 2025: Fee-Related Earnings Surge 31% as Private Credit and Wealth Inflows Accelerate
Blackstone demonstrates a strong multi-engine growth model with clear reinvestment runway, robust fee-based earnings, and secular growth levers in private credit and wealth. While most metrics are exceptional (AUM growth, credit/wealth momentum, embedded earnings power), some elements like the realization ramp and real estate recovery are still gradual, capping the signal score below perfect. The business is high-quality and compounding, but not at the disruptive/exceptional inflection point that would merit a higher score.
RadNet (RDNT) Q1 2026: Digital Health ARR Surges 95%, Unlocking AI-Driven Margin Expansion
RadNet demonstrates a long reinvestment runway, strong growth in digital health ARR, improving unit economics, and a self-reinforcing business model. While the growth is robust, some elements (e.g., exceptional future guidance or disruptive potential) are strong but not at the highest possible level. The business is clearly in a growth phase, but not every signal dimension is maxed out.
CorePay (CPAY) Q3 2025: Corporate Payments Surges 17% as Segment Approaches 40% of Revenue
CPAY demonstrates strong reinvestment runway, double-digit growth, improving unit economics, and self-reinforcing business model. Customer value is increasing, and the business is positioned for continued growth, though not at an exceptional acceleration. Stablecoin and M&A provide optionality, but the business is not fully disruptive nor at 40%+ growth, warranting a conservative signal score.
MindWalk (HYFT) Q1 2026: Netherlands Divestiture Adds $16.1M, Accelerating Shift to AI Platform Model
MindWalk’s transformation to a high-margin, scalable AI platform with divestiture proceeds and early SaaS traction signals substantial upside. The business model is disruptive with a long runway, and unit economics are improving. However, evidence of accelerating cash flow and customer value deepening is emerging rather than fully established, and growth, while strong, is not yet at the highest tier. The opportunity is significant but not yet proven at the highest level.
Equinix (EQIX) Q3 2025: Pre-Sold Bookings Jump to $185M, Fueling Accelerated Capacity Expansion
Equinix demonstrates a long reinvestment runway, accelerating bookings, improving unit economics, and a self-reinforcing model with high customer value. While growth is strong, it is not at hypergrowth (40%+) levels, and the business is not fundamentally disruptive but rather a scaled incumbent with strong competitive advantages. Signal is high but not at the absolute maximum due to these factors.
BAM Q3 2025: $106B Fundraising Wave Unlocks Next-Gen Growth Engines
BAM demonstrates a long reinvestment runway, strong business model, improving unit economics, and clear platform compounding. However, while growth is robust, some areas (guidance, cash flow acceleration, disruptive model) are good but not exceptional, and the business is already well-followed, which tempers the signal score.
Guidewire (GWRE) Q3 2025: ARR Surges Toward $1B as Cloud Deals Drive 32% Subscription Growth
Guidewire demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and self-reinforcing business model. Customer value is deepening, and the business is a clear growth story. However, guidance for next year is strong but not exceptional (17-18% ARR growth). The business is not disruptive in the sense of a new category, and cash flow is improving but not yet at a breakout acceleration.
Cineverse (CNVS) Q4 2026: Acquisitions Add $11.6M, Reshaping Tech-Driven Revenue Base
Cineverse shows a long reinvestment runway with high returns, a step-change in growth from acquisitions, improving unit economics, and a self-reinforcing platform model. Customer value is rising, but future growth, while strong, is not yet exceptional. The business model is semi-disruptive, and while cash flow and revenue are improving, they are not yet at hypergrowth levels. This is a transitioning, high-growth business but not yet a category-defining outlier.
Nasdaq (NDAQ) Q2 2026: Index AUM Tops $1 Trillion as Platform Diversification Drives 17% Solutions Growth
Nasdaq demonstrates a strong recurring revenue engine, platform leverage, and secular growth drivers. While reinvestment runway and business model compounding are clear, some metrics (unit economics, growth acceleration) are strong but not at the highest possible level. The business is not fundamentally disruptive, and some growth rates are under the highest threshold, but overall signal is high for a large-cap financial infrastructure leader.
Esquire Financial (ESQ) Q2 2026: Litigation Loans Jump 41% Ahead of $2B Signature Merger
Esquire demonstrates a long reinvestment runway with high ROIC in litigation lending, and the 41% YoY growth is a material business evolution. Unit economics and business model strength are evident, with high yields and core deposit growth. Customer value is deepening, and the business is a clear growth story, but not fully disruptive or with 40%+ overall revenue/EPS growth. Cash flow is improving, but not at an accelerating rate. The merger offers significant optionality but is not a paradigm shift, and while growth is strong, it is not at the highest possible levels for all signal criteria.
Rambus (RMBS) Q2 2026: Product Revenue Jumps 22%, DDR5 and IP Drive Multi-Year Growth Setup
Rambus demonstrates strong growth drivers (DDR5, AI, IP), high returns on capital, and a multi-year growth setup, but the business is not a new disruptor and some elements (like revenue growth) remain below hypergrowth thresholds. The business is not entirely unique or unknown, so signal is slightly discounted despite robust underlying performance.
Incyte (INCY) Q2 2026: Core Business Ex-Jakafi Up 44%, Pipeline and Launches Diversify Growth
Incyte exhibits a strong reinvestment runway, business model evolution, and improving unit economics, with non-Jakafi assets growing rapidly. However, while growth is robust, the signal is dampened by the lack of a truly disruptive model and only moderate evidence of accelerating cash flow and >40% overall growth. The business is clearly transitioning to a diversified growth platform, but some pipeline and launch risks temper the signal.
Manhattan Associates (MANH) Q2 2026: Cloud Revenue Jumps 26% as Active Editions Expand TAM
Manhattan Associates demonstrates a strong reinvestment runway, clear inflection in business model, improving unit economics, and a self-reinforcing cloud/AI platform. However, while growth is robust and strategic levers are in play, the business is not in hypergrowth territory (no >40% revenue/EPS acceleration), and some disruption/optionality is still emerging rather than fully proven. The business is highly investable but not at the very highest signal threshold.
Alchemy Technology (ALKT) Q2 2026: Bank Clients Now 30% of Launches, Platform Expansion Drives Margin Upside
Alchemy demonstrates a long reinvestment runway, strong recurring revenue model, improving margins, and clear ARPU expansion, supported by a shifting customer mix and platform adoption. While not a breakout hypergrowth story, the business shows above-market growth, margin expansion, and compounding potential. The model is not truly disruptive but benefits from SaaS platform dynamics and sector tailwinds.
NBR Q2 2026: International EBITDA Margin Expands 127bps as Saudi Growth and Tech Upside Accelerate
NBR demonstrates a long reinvestment runway, clear margin and technology-driven business model improvements, and international scale. While growth is strong and the business is transitioning toward higher quality, it does not quite reach the threshold for exceptional acceleration or disruptive model, and some metrics are just shy of the highest possible signal.
FICO (FICO) Q3 2026: Platform ARR Surges 62% as Legacy Migrations Accelerate
FICO demonstrates a long reinvestment runway, accelerating platform growth, improving unit economics, and a self-reinforcing model. However, mortgage concentration and some competitive/regulatory risks cap the signal score. The business is transitioning but not yet at the highest growth inflection, so scores are conservatively rounded down.
Rocket Companies (RKT) Q2 2026: Recurring Revenue Hits 70%, Reinforcing Downturn Resilience
Rocket demonstrates a long reinvestment runway, significant business model evolution, improving unit economics, and self-reinforcing platform effects. Customer value is increasing, and the company is transitioning to a recurring revenue model. However, while growth is strong, it is not at the hypergrowth (40%+) level, and some elements (AI/tech) are still scaling. The business is not fully disruptive compared to pure fintechs, and near-term growth, while robust, is not exceptional. Still, the signal is high for a large, maturing platform with clear upside as the cycle turns.
IEX Q2 2026: 28% Order Surge Anchors Multi-Year Visibility in Data Center and Defense
IEX demonstrates a strong secular growth runway with high returns on capital, a significant order inflection, and improving unit economics. The business model is self-reinforcing with rising recurring revenue and high-value customer relationships. However, while the growth is robust, it is not quite at the most exceptional (over 40% growth) level, and some elements (such as future cash flow acceleration and disruptive potential) are present but not extreme. The business is clearly a growth story with high visibility but not at the very highest signal tier.
Qualcomm (QCOM) Q3 2026: Automotive Revenue Surges 61% as Data Center and Non-Handset Mix Accelerate Diversification
Qualcomm is executing a material business mix shift with strong growth in automotive and data center, but some signal is capped by the business's large cap status and ongoing margin/cost headwinds. The reinvestment runway is clear, but true step-change acceleration is still emerging.
Veracyte (VCYT) Q2 2026: Prosigna Launch and 20% Decipher Growth Signal Expanding Oncology Franchise
Veracyte demonstrates a strong growth profile with new launches, expanding addressable markets, and improving unit economics. While the business model shows self-reinforcing elements and customer value is deepening, some uncertainty remains around the pace of MRD scaling and reimbursement for new launches. The business is not yet at an exceptional acceleration (>30%), and while disruptive, it is not a wholly new platform. Revenue growth is strong but not hypergrowth (>40%).
Alignment Healthcare (ALHC) Q2 2026: Membership Up 31% as Embedded Margin Leverage Expands
ALHC shows a long reinvestment runway, strong recent membership growth, improving unit economics, and a self-reinforcing platform. Customer value is increasing through cohort maturation, and the business is positioned as a growth platform. However, while growth is strong, it is not at a hyper-accelerated level in all areas, and some uncertainty remains around regulatory headwinds and execution risk in new markets. The model is semi-disruptive, with strong but not exceptional cash flow acceleration and guidance. Overall, the signal is high, but not at the absolute peak for disruptive, high-velocity growth.
PTC Therapeutics (PTCT) Q2 2026: Suffiance Drives 21% Sequential Growth, Global Launch Expands Revenue Base
PTC demonstrates a substantial reinvestment runway, rapid product growth, improving unit economics, and a self-reinforcing rare disease platform. Customer value is increasing, but guidance and backlog growth are strong rather than exceptional. The business model is semi-disruptive, with accelerating but not explosive cash flow and revenue growth. The company is a clear growth business but not at the highest tier of signal for transformative upside.
Regeneron (REGN) Q2 2026: Dupixent Drives 38% Growth, Pipeline Milestones Build Multi-Front Momentum
Regeneron demonstrates a long reinvestment runway with high returns, significant growth in key franchises, and improving unit economics. The business model is self-reinforcing and customer value is increasing. While future growth is strong, it is not exceptional or fully disruptive, and cash flow acceleration is moderate. Revenue and EPS growth is robust but not above 40% annually. Overall, the business is a clear growth story, but not at the very highest level of signal.
ARES (ARES) Q2 2026: Fee-Paying AUM Jumps 17% as Fundraising Diversifies Beyond Flagship Credit
ARES demonstrates a long reinvestment runway, strong fundraising, and improving economics, with model durability and compounding advantages. However, it is a large, well-followed platform, so while growth is robust and diversified, the signal is strong but not at the level of a truly disruptive or underappreciated business with massive upside. Some metrics (guidance, future growth) are good but not exceptional.
Ultra Clean Holdings (UCTT) Q2 2026: Capacity Expansion Targets $4B Run Rate as AI Drives Industry Surge
UCTT demonstrates a long runway for reinvestment, clear margin and scale improvements, and is benefiting from structural industry shifts. There is strong evidence of growth and operational leverage, but some elements (exceptional future growth, disruptive model, accelerating cash flow, and >40% top-line growth) are present but not at the highest possible level or are still developing. The business is positioned as a growth company in a secular upcycle, but not all signal questions reach the maximum threshold.
ADEA (ADEA) Q2 2026: Semiconductor Revenue Jumps 80%, Hybrid Bonding Drives $200M Target Raise
ADEA demonstrates a strong reinvestment runway with the doubling of its semiconductor target, high returns on capital, and clear growth in recurring revenue. There is a major business evolution with 80% YoY semi growth and a structural mix shift. Unit economics, customer value, and business model self-reinforcement are all improving. However, some signal is tempered by the lumpy/litigation-driven nature of revenue, some ongoing legacy exposure, and the business not being a pure high-multiple disruptor yet. Still, the core signals are strong and thesis-relevant.
Willis Lease Finance (WLFC) Q2 2026: Asset Management AUM Jumps 80% as Platform Expansion Accelerates
WLFC demonstrates a long reinvestment runway, clear recent business evolution with AUM up nearly 80%, and improving unit economics with asset management scale. The business model is becoming more self-reinforcing and customer value is increasing. While the outlook is strong, growth is not accelerating above 30% and the model, while semi-disruptive, is not fully disruptive. Cash flow is improving but not dramatically accelerating. The business is transitioning to growth, but not at the highest possible velocity.
Travere Therapeutics (TVTX) Q2 2026: Filspari Sales Surge 96% on Strong FSGS Launch, Broadening Rare Kidney Franchise
Travere demonstrates a strong growth runway with high returns, a disruptive dual-indication launch, and improving unit economics. While growth is robust, it is not at the highest acceleration tier, and some elements (pipeline, cash flow, and model disruption) are promising but not yet fully exceptional or proven at the highest signal level.
Indivior (INDV) Q2 2026: $125M Synergy Target Unlocks CNS Growth Platform in Supernus Merger
The pro forma entity demonstrates a long reinvestment runway, high margins, and a diversified growth platform with durable IP. There is clear business evolution via the merger, strong unit economics, and a self-reinforcing model. However, the growth outlook, while strong, is not hyper-accelerating (over 40%); the pipeline and cash flow are robust but not exceptional, and the business model is semi-disruptive rather than transformative. The signal is strong but not at the highest level due to the mature nature of some assets and integration risks.
Amplitude (AMPL) Q2 2026: 35% RPO Growth Signals Durable Platform Upside Amid AI-Native Shift
Amplitude demonstrates a strong reinvestment runway, platform expansion, improving unit economics, and a self-reinforcing business model. RPO growth and multi-product attach are notable, but the business is not in hypergrowth territory (>40% YoY), and while disruptive, it is not a new or unknown name. The signal is strong but not at the absolute highest level for upside surprise.
Motorola Solutions (MSI) Q2 2026: Sylvus Guidance Raised $100M on Defense Demand, Margin Outlook Improves
Motorola Solutions demonstrates a strong reinvestment runway, major backlog/order growth, and improving unit economics. The business model is self-reinforcing with increasing recurring revenue and customer value. However, while growth is robust, it is not at hypergrowth levels (>40%), and some elements (e.g., counter-drone) are emerging rather than fully disruptive. The company is a growth leader in its sector but not in a category of explosive, outsized upside.
Clover Health (CLOV) Q2 2026: Medicare Advantage Membership Jumps 48% as Cohort Maturation Drives Margin Expansion
Clover Health demonstrates a long reinvestment runway, strong compounding cohort economics, and clear improvements in unit economics and operating leverage. The business model is differentiated and technology-driven, but not fully disruptive at scale yet. Growth is robust but not hyper-growth (>40%), and while cash flow is improving, it is not yet accelerating rapidly. The company is transitioning strongly into a growth phase, with some regulatory and concentration risks tempering the signal. Overall, the business has strong upside potential but is not at the absolute highest level of disruptive growth.
Elanco (ELAN) Q2 2026: Innovation Revenue Hits $340M, Accelerating Pet Health Share Gains
Elanco demonstrates a long innovation runway with high returns, recent blockbuster launches, improving unit economics, and a self-reinforcing omni-channel model. Customer value is deepening, and the business is transitioning to higher growth and margin. However, growth is not at an exceptional acceleration level (>30%), and while the business model is innovative, it is not fully disruptive. Cash flow is improving but not yet accelerating, and revenue/eps growth is strong but not hyper-growth. This is a high-quality, growth-oriented business with solid signal for investors, but not at the absolute upper end of disruptive potential.
Sight Sciences (SGHT) Q2 2026: Interventional Dry Eye Revenue Triples, Expanding Recurring Platform
Sight Sciences demonstrates a long reinvestment runway, strong recurring revenue growth, and improving economics, but the growth rates and business model, while attractive, are not at the very highest levels of disruption or acceleration. The business is transitioning toward maturity with clear optionality, but not all signal metrics are at the maximum threshold.
Digi International (DGII) Q3 2026: ARR Jumps 27% as AI-Driven Solutions Accelerate Adoption
Digi shows a long reinvestment runway, strong recent growth in ARR, improving unit economics, and a self-reinforcing business model with a flywheel approach. Customer value appears to be improving but not exceptionally so. Guidance and backlog suggest solid but not explosive future growth. The business is transitioning to a higher-mix, recurring model, but is not yet a hypergrowth story. Cash flow is accelerating, and the company is firmly in growth mode, though not at the highest possible signal level.
Dutch Bros (BROS) Q2 2026: 32% Revenue Growth Drives Pipeline to 90% of 2029 Target
Dutch Bros demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing and the business is clearly in a growth phase. However, some signal points are capped due to margin headwinds, guidance not accelerating, and the business model—while innovative—is not fully disruptive. Growth rates are strong but not at the highest tier, and cash flow is not yet accelerating.
CryoPort (CYRX) Q2 2026: Life Science Services Hit 15% Growth, Margin Expansion Signals Sustained Profitability Path
CryoPort is showing strong service growth, margin inflection, and operational leverage, with a robust clinical pipeline and clear signs of compounding advantages. However, the business model, while differentiated and scaling, is not fully disruptive nor is growth at an explosive (40%+) level. Guidance remains cautious and some new initiatives are still in early ramp, tempering the overall signal.
Artivion (AORT) Q2 2026: ONIX Valve Growth Hits 18% as AMDS PMA Approval Unlocks U.S. Acceleration
Artivion demonstrates a strong reinvestment runway, compounding business model, and improving unit economics. Recent regulatory milestones and product launches support a growth narrative, though not all metrics are at the highest acceleration (e.g., revenue growth is double-digit but not >40%). The business is transitioning to a growth phase with disruptive elements, but some signal is tempered by execution and integration risks.
Doximity (DOCS) Q1 2027: AI Scribe Usage Jumps 10x, Unlocking Platform Leverage
Doximity demonstrates a long reinvestment runway, significant recent business evolution, and improving unit economics with clear AI-driven growth. The business model is self-reinforcing, with increasing customer value and a transition toward higher AI monetization. However, near-term growth is not projected to exceed 20% annually, and while the model is disruptive, it is not yet at the level of the most explosive SaaS/AI platforms. Cash flow is strong but not yet accelerating at the highest level, and guidance signals steady rather than exceptional growth.
Airbnb (ABNB) Q2 2026: Hotel Nights Grow 3x Faster Than Homes, Signaling Marketplace Expansion
Airbnb demonstrates a long reinvestment runway, strong growth in new verticals, improving unit economics, and a self-reinforcing platform model. However, as a well-known large-cap, some upside is already priced in, and while growth is strong, it is not at the hypergrowth (>40%) level in aggregate. The business is not fully disruptive in every aspect, and cash flow is robust but not accelerating at an exceptional rate. The signal is strong but not the absolute highest possible.
VSEC Q2 2026: MRO Revenue Jumps 149% as Integration Drives Margin Expansion
VSE demonstrates a long reinvestment runway, rapid growth, improving unit economics, and strong customer value expansion. While the business model shows some self-reinforcing elements and disruption, it is not fully network effect-driven. The outlook is strong but not exceptional, with growth rates above average but not hypergrowth. The business is transitioning into a higher-margin, higher-growth phase, but the overall sector and company profile are not so unique or disruptive as to warrant a perfect signal score.
Akamai (AKAM) Q2 2026: $2.8B Multi-Year CIS Wins Set Up Low-Teens Growth Acceleration
Akamai is showing a material strategic pivot with a long reinvestment runway in CIS, strong growth in high-margin segments, and evidence of improving unit economics and customer value. However, while growth is accelerating, it is not yet at the exceptional (30%+) level across the consolidated business, and the business model—though evolving toward disruption—still faces execution and competitive risks. Cash flow is improving, but not yet accelerating at the highest tier.
Legacy Housing (LEGH) Q2 2026: Net Income Surges 60% as Workforce Housing Pipeline Expands
Legacy Housing demonstrates a long reinvestment runway, strong backlog growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing and the business is transitioning to higher growth with secular tailwinds. However, while growth is significant, it is not yet at the 'exceptional' level in all areas, and some aspects (AI, regulatory impact) are still emerging. The business is thesis-relevant but not at the highest possible signal for a truly disruptive or hypergrowth story.
Savers Value Village (SVV) Q2 2026: Thrift IQ Pilot Lifts Gross Profit 100bps, Accelerating Margin Expansion Path
SVV demonstrates a long reinvestment runway with high returns, significant margin expansion from innovation, improving unit economics, and a self-reinforcing model with proprietary technology. Customer value is increasing and the business is transitioning to higher growth, but near-term growth rates and cash flow acceleration are moderate, and the disruption is not as pronounced as in pure tech or platform businesses.
NOVA (NVMI) Q2 2026: Advanced Packaging Hits 25% of Product Revenue, Accelerating AI-Driven Growth
NOVA demonstrates a strong growth runway, clear improvement in unit economics, and a business model benefiting from structural industry shifts. However, the business, while growing, is not disruptive at the highest level and guidance is for double-digit, but not hypergrowth, limiting the signal score. Still, the business is clearly in a growth phase with high investor relevance.
Aspen Aerogels (ASPN) Q2 2026: European Thermal Barrier Revenue Outlook Doubles to $30M, Unlocking EV Growth Visibility
Aspen Aerogels is showing strong growth signals: a long reinvestment runway, recent major business wins, improving unit economics, and a business model with emerging self-reinforcement. Customer value is increasing, and the business is transitioning to growth mode with strong revenue and cash flow projections. However, the business is not yet at the highest level of disruption or growth acceleration, and some risk remains in execution and ramp.
Magnolia Oil & Gas (MGY) Q2 2026: Wildfire Acquisition Adds 810,000 Acres, Reshaping Giddings Growth Horizon
Magnolia demonstrates a long reinvestment runway, significant recent developments, improving unit economics, and a self-reinforcing model. Customer value is growing, and while growth is strong, it does not reach the exceptional acceleration threshold. The business is semi-disruptive with moderate cash flow acceleration and expected 6% production growth. It is a growth business, but not at the most explosive trajectory, justifying a conservative signal score.
Claritiv (CTEV) Q2 2026: Bookings Jump 150%, Extending Turnaround Momentum
Claritiv is showing strong growth signals with a long reinvestment runway, significant bookings acceleration, improving unit economics, and a self-reinforcing business model. However, some signal points are capped due to the business not being highly disruptive or showing >40% top-line growth, and cash flow acceleration is moderate, not exceptional. The business is transitioning into a growth phase, but not all metrics are at the highest level of upside.
LCLN Q2 2026: Portfolio Valuations Up 19% as Retailization Drives New Fee Streams
LCLN demonstrates a long reinvestment runway, strong recurring revenue growth, improving unit economics, and a business model benefiting from structural industry changes. While the business is not a hyper-growth disruptor, it exhibits clear compounding advantages and above-industry growth, but not at the most exceptional levels (e.g., >40% topline).
ZKH Group Limited (ZKH) Q2 2026: GMV Growth Accelerates 19% with Operating Profitability Milestone
ZKH demonstrates a long reinvestment runway with high returns, a major inflection in growth and profitability, improving unit economics, and a self-reinforcing platform. Customer value is increasing, and the business model is semi-disruptive with cash flow improving. However, while growth is strong, it is not yet at hyper-growth levels (>40%), and international expansion is still nascent. The signal is strong but not at the highest possible tier for a truly exceptional, category-defining business.
The9 Limited (NCTY) Q2 2026: Net Income Surges 39% Sequentially as AI-Powered Platform Expands
The business demonstrates a long reinvestment runway, disruptive model, and strong network effects. There is clear growth in users and content, and the token economy is self-reinforcing. However, some elements (unit economics, cash flow, and top-line growth) are only moderately improving or still in transition, capping the signal score below maximum.
ATRenew Inc. (RERE) Q2 2026: 32.4% Revenue Surge Driven by 1P Model and Global Expansion
The business demonstrates a long reinvestment runway, substantial recent growth, improving unit economics, and a compounding business model. Customer value is increasing, and the company is transitioning to a global platform. However, some aspects (such as international expansion and future growth rates) are still early-stage or moderate, tempering the signal score. The business is not fully disruptive or accelerating at the highest levels, but remains a high-growth, investment-worthy opportunity.
Webull Corporation (BULL) Q2 2026: PDT Rule Removal Drives 73% Equity Volume Surge, Cementing Active Trader Leadership
Webull demonstrates strong growth, operating leverage, and a clear reinvestment runway, with evidence of improving unit economics and self-reinforcing platform dynamics. The PDT rule change is a major catalyst, and AI integration adds differentiation. However, some signal deductions are warranted: international/institutional growth is still developing, and while growth is strong, it is not at hypergrowth (40%+) levels. The business is disruptive but not uniquely so, and cash flow acceleration is moderate rather than exceptional.
Opera Limited (OPRA) Q2 2026: 25% Revenue Growth Accelerates AI-Driven Browser Monetization
Opera demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing model with growing customer value. However, some elements (MiniPay, future cash flow acceleration, and disruptive potential) are still emerging, and forward guidance, while strong, is not at the highest acceleration. The business is growth-oriented but not at the most exceptional signal tier.
SOLV Energy (MWH) Q2 2026: Backlog Surges 44% Amid Accelerated Project Execution and Strategic Acquisitions
SOLV Energy displays a strong reinvestment runway, exceptional backlog growth, and accelerating revenue/EBITDA. However, while the business is clearly growing and showing some self-reinforcing elements, it is not a pure-play disruptive model and customer value deepening is present but not yet exceptional. The business is a clear growth story with high signal, but not maxed-out on every disruptive or compounding dimension.
CorMedix (CRMD) Q2 2026: DefenCath Expands with New LDO Pilot, Adjusted EBITDA Soars 162%
CorMedix shows a strong growth profile with a significant reinvestment runway, major commercial milestones, improving unit economics, and a disruptive business model in a niche healthcare sector. However, while growth is robust, it is not at the extreme acceleration level for all signal metrics, and some aspects (cash flow, guidance) are good but not exceptional. The business is clearly not legacy or stalling, but certain signal elements are not maxed out.
Sigma Lithium (SGML) Q2 2026: 52% Production Surge Drives Record Margins Amid Temporary Mining Suspension
Sigma Lithium demonstrates a long reinvestment runway, recent significant production growth, improving unit economics, and a self-reinforcing business model with cost and ESG advantages. Customer value is increasing through diversified sales. While future guidance is positive, growth is not yet exceptional. The business is semi-disruptive with accelerating cash flow but not at the highest possible level. Revenue and EPS growth are strong but not hyper-growth, and the company is firmly in the growth category.
QT Imaging (QTI) Q2 2026: 103% Revenue Growth Anchored by Strategic Commercial Expansion
QTI is exhibiting classic early-stage, high-growth medtech characteristics: doubling revenue, expanding commercial and regulatory footprint, and investing in scalable infrastructure. There is a long reinvestment runway, clear disruptive potential, and accelerating revenue/EPS growth. Some elements (customer value, self-reinforcing model, cash flow) are still emerging and not yet at the highest magnitude, keeping the score just below the maximum.
Elbit Systems (ESLT) Q2 2026: Backlog Expands 34% Fueling Capacity Investment and Margin Expansion
Elbit demonstrates a strong reinvestment runway, disruptive elements (autonomy, directed energy), margin expansion, and a record backlog. However, some growth metrics (e.g., customer value deepening, guidance revision) are good but not exceptional. The business is robust but not at the highest level of disruptive growth.
PowerFleet (AIOT) Q1 2027: South Africa Contract Scale Multiplies 7x, Driving Strategic Reprioritization
PowerFleet shows a long reinvestment runway, a major contract scaling event, improving unit economics, and a self-reinforcing model with deepening customer value. However, some metrics (e.g., future growth guidance and cash flow acceleration) are strong but not exceptional, and the business model, while differentiated, is not fully disruptive. Growth is robust but not at the very top end.
Village Farms International (VFF) Q2 2026: 74% Export Growth Fuels Margin Expansion and Operational Scale
Village Farms demonstrates a long reinvestment runway, strong recent growth (notably export growth), improving unit economics and margins, and a self-reinforcing business model with regulatory moats. However, while growth is robust, it is not yet at the very highest acceleration levels, and the business, though differentiated, is not a paradigm-shifting disruptor. Forward guidance is strong but not exceptional, and some risks remain around execution and regulatory change.
Hyde Mar (HMR) Q2 2026: Fleet Expands by 24 Vessels, Driving 203% Core Income Growth
The business demonstrates a long reinvestment runway, disruptive asset-light model, and strong growth (fleet +203% core income). However, while growth is substantial, the business is not entirely unique or under-followed in the shipping sector, and some drivers (e.g., tanker rates) are cyclical and not entirely under management's control. Cash flow and guidance are positive but not exceptional. The business is a high-growth platform, but the industry context and potential cyclicality temper the signal score.
MiniMed (MMED) Q1 2027: U.S. Pump Sales Surge 20% on Flex Launch, Pipeline Innovation Accelerates
MiniMed demonstrates strong growth, innovation, and recurring revenue, with clear evidence of a long reinvestment runway and improving unit economics. However, while the growth is solid and the business is transitioning to a standalone model, the degree of disruption and the magnitude of future acceleration are not exceptional enough to merit the highest marks. Guidance is positive but not at the most aggressive levels, and the business, while innovative, is not entirely unique in the medical device landscape.
ArcSys (ARXS) Q1 2026: Backlog Covers 90% of Year, Locking in 18% Growth Visibility
ArcSys demonstrates a long reinvestment runway, strong backlog-driven growth, improving unit economics, and a self-reinforcing business model. However, while growth and margin expansion are strong, the business model—though robust—is not highly disruptive, and forward growth (while solid) is not at the hyper-growth threshold. Cash flow is improving but not yet accelerating dramatically, and guidance for future growth is strong but not exceptional.
Allegro MicroSystems (ALGM) Q1 2026: E-Mobility Sales Jump 31% as Design Wins Fuel Strategic Tailwind
Allegro demonstrates a long reinvestment runway with high returns, recent double-digit growth in strategic segments, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is positioned for further growth, though not at the most exceptional (over 40%) rates in the near term. The business is disruptive and transitioning toward cash flow acceleration, but not all signal criteria are at the highest level.
ProPetro (PUMP) Q2 2026: Contracted Power Jumps 46% to 350MW as Data Center Pipeline Builds
ProPetro demonstrates a long reinvestment runway and significant recent business developments, particularly in the ProPower segment. Unit economics and business model self-reinforcement are improving, with customers becoming more valuable. While growth is strong, it is not yet exceptional or at hypergrowth levels, and the business model is semi-disruptive rather than fully disruptive. Cash flow is accelerating but not yet at peak levels. The company is transitioning into a growth business but is not yet in the highest growth cohort.
Glaukos (GKOS) Q2 2026: Epioxa Drives 90bps Gross Margin Gain as Launch Momentum Builds
Glaukos demonstrates a long reinvestment runway, high-margin product launches, improving unit economics, and a self-reinforcing business model. However, while growth is strong, some forward guidance is conservative and there is not clear evidence of >40% growth or truly exceptional acceleration. The business model is innovative but not radically disruptive. Cash flow is improving but not yet a clear machine. Signal is strong but not at the highest tier for a truly paradigm-shifting business.
Virtu Financial (VIRT) Q2 2026: Trading Capital Surges 70% to $3.4B as Talent and Tech Drive Platform Growth
Virtu demonstrates a long reinvestment runway with high ROIC, a significant uptick in capital base and profitability, and improving unit economics. The business model is self-reinforcing through technology and talent, and customer value is deepening. However, while growth is strong and diversified, it does not clearly exceed 40% YoY, and the business, though innovative, is not fundamentally disruptive or poised for hypergrowth. Cash flow is robust but not yet accelerating at a transformational pace. The company is a growth business with some transition elements.
Solstice Advanced Materials (SOLS) Q1 2026: Nuclear Sales Soar 27%, Accelerating Expansion Pipeline
Solstice demonstrates strong secular growth drivers in nuclear and electronic materials, with clear reinvestment opportunities and improving unit economics. Backlog and guidance are rising, but not at an exceptional (30%+) rate. The business model is semi-disruptive, with some legacy elements in refrigerants. Cash flow and revenue growth are robust but not hyper-growth. Overall, the signal is strong but not at the absolute highest level due to the absence of explosive acceleration or disruptive dominance.
Carpenter Technology (CRS) Q4 2026: SAO Margins Hit 37.8%, Lifting FY27 Growth Floor
Carpenter Technology shows a long reinvestment runway and high ROIC, with clear margin and free cash flow expansion. There is strong evidence of high growth and operational leverage, but the business is relatively well-known and not in a hyper-growth phase (guidance is strong but not >40% growth). The model is self-reinforcing with high customer stickiness and barriers, but not fully disruptive. Cash flow is accelerating but not at an extreme rate. Overall, signal is high, but not at the absolute top end due to the business's maturity and sector familiarity.
Solstice Advanced Materials (SOLS) Q2 2026: Electronics Revenue Climbs 15% on Semiconductor Demand Surge
Solstice demonstrates strong secular growth drivers, capacity expansion, and a major acquisition, but most segments are not yet showing explosive (40%+) growth, and the business model—while exposed to secular trends—is not fully disruptive. Margins are temporarily pressured, and while growth is robust, the signal is somewhat tempered by execution and integration risks.
RBC (RBC) Q1 2027: A&D Revenue Jumps 36.9% as Space and Marine Backlogs Accelerate
RBC demonstrates strong reinvestment runway, accelerating space/marine growth, improving margins, and backlog visibility. However, while the growth is robust, it is not at the level of hypergrowth/disruption, and some margin gains are one-time. The business is transitioning to multi-year growth but not at the highest disruption or acceleration levels.
Freshworks (FRSH) Q2 2026: EX ARR Climbs 24% as AI Monetization Drives Enterprise Expansion
Freshworks shows a strong reinvestment runway, accelerating AI monetization, improving unit economics, and self-reinforcing platform dynamics. While growth is robust, it is not at the most exceptional tier, and the business is not fully disruptive or growing at >40%. Still, the company demonstrates high signal for enterprise SaaS investors.
Stevanato Group (STVN) Q2 2026: High-Value Solutions Reach 45% of Revenue, Powering Margin Expansion
Stevanato demonstrates a long reinvestment runway, strong margin and mix shift, and a clear move toward higher-value, higher-growth segments. However, the business is not a newly discovered compounder or disruptive model and faces some growth constraints in the engineering segment and in the pace of commercial adoption, so the signal is high but not perfect.
LiveRamp (RAMP) Q4 2026: 2.9% EPS Accretion Forecast as Publicis Bets on Data Co-Creation
LiveRamp shows a strong SaaS growth profile with high retention, margin expansion, and a long reinvestment runway, but international scaling and revenue synergy realization remain unproven. The business model is self-reinforcing with some disruptive elements, but the future outlook is solid rather than exceptional. Revenue and EPS growth is strong but not at hypergrowth levels.
Orthopediatrics (KIDS) Q2 2026: Trauma & Deformity Jumps 26% as Multi-Year Innovation Cycle Gains Traction
Orthopediatrics demonstrates a long reinvestment runway, clear margin expansion, improving unit economics, and a disruptive business model in a niche. However, growth is strong but not at hypergrowth levels, and some signals (cash flow, future acceleration) are present but not exceptional. The business is transitioning to a growth phase, but not all levers are compounding at maximum intensity.
Agent (AGNT) Q2 2026: International Revenue Jumps 44% as AI Platform Drives Productivity Gains
Agent demonstrates long runway, improving unit economics, and a self-reinforcing AI-driven platform, with strong international growth and operating leverage. However, while growth is robust, it is not in the hypergrowth/exceptional range, and the business is not fully disruptive or accelerating cash flow at the highest level. Still, signal is well above average due to the credible inflection in international and AI-driven margin expansion.
TTI Q2 2026: Offshore Revenue Hits 10-Year High as Deepwater and Critical Minerals Drive Strategic Optionality
TTI demonstrates a long reinvestment runway with high returns (Arkansas bromine, critical minerals). There are significant developments (decade-high offshore revenue, new product launches), and unit economics are improving. The business model is self-reinforcing with supply chain moves, and customers are becoming more valuable (energy storage, international expansion). However, growth is not yet exceptional (>30%) and the business, while transitioning to higher-value markets, is not fully disruptive or accelerating cash flow. Revenue/EPS growth is strong but not at the highest tier. Overall, signal is high but not at the absolute maximum.
Vertex (VRTX) Q3 2025: Genavix Prescriptions Surge to 300,000 as Renal Pipeline Accelerates
Vertex demonstrates a strong reinvestment runway, clear growth in new franchises, and improving unit economics, but some signal is restrained by the business's scale, competitive risk, and the fact that it is already a well-followed large-cap. The most exceptional growth is in Genavix and the renal pipeline, but overall business transformation is still developing, not yet explosive across all metrics.
ZVRA Q2 2026: MyClypha Drives 53% Revenue Gain as U.S. Patient Mix Broadens
Zavra demonstrates a long runway and high returns on capital with its rare disease model, IP moat, and expanding addressable market. The 53% YoY revenue growth and broadening patient mix are highly positive, but the business is still exposed to regulatory risks and EAP variability, tempering the signal score. Pipeline optionality and capital discipline are strong, but near-term European uncertainty and lack of truly explosive growth in guidance keep the score below the maximum.
LifeMD (LFMD) Q2 2026: Multi-Month Weight Management Jumps to 85%, Reshaping Patient Economics
LifeMD is demonstrating a credible pivot to higher-quality recurring revenue and has a long reinvestment runway, self-reinforcing business model, and improving unit economics. However, growth is not yet exceptional (guidance does not imply 40%+ growth), and some future levers (insurance, partnerships) are still emerging, not fully proven. The business is not yet a disruptive outlier, but is showing strong growth and margin potential.
BioDesix (BDSX) Q2 2026: Diagnostic Test Volumes Surge 38% as Primary Care Expansion Drives Adoption
BioDesix demonstrates a long reinvestment runway with high returns as it expands in primary care and leverages clinical data. There is a major uptick in growth (38% volume, 42% revenue), and unit economics are improving with margin expansion. The business model is self-reinforcing, with growing network effects between primary care and specialist accounts. Customers are becoming more valuable, but future growth is likely to moderate as comps toughen and guidance is unchanged. The business is semi-disruptive but not a pure disruptor. Cash flow is improving but not yet accelerating. Revenue growth is strong but not above 40%. This is a growth business, but with some execution and guideline risks.
DoorDash (DASH) Q2 2026: DashPass Subscriber Growth Hits Two-Year High, Reinforcing Retention Flywheel
DoorDash demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model via DashPass. While growth is strong, there is not clear evidence of 40%+ growth or exceptional acceleration in the immediate term, and some levers (autonomy, AI, international) are still scaling, not yet fully proven. The business is not entirely disruptive but shows semi-disruptive characteristics. Overall, the signal is strong, but not at the highest possible level due to the absence of a true inflection or major business model shift.
AEVA (AEVA) Q2 2026: Optical Connectivity Deal Unlocks Path to $300M+ Data Center Revenue
Aeva is at a major inflection point, validated by a hyperscaler deal with the potential for multi-million-unit annual volumes and hundreds of millions in new revenue. The business model is disruptive, leveraging a core technology platform across multiple verticals, including a high-growth AI data center segment. Manufacturing leverage and cost advantages are clear, and the company is transitioning into a multi-segment growth business. However, some unit economic improvements and customer value deepening are still early or moderate, and cash flow acceleration, while positive, is not yet exceptional. Overall, the signal is high but not at the absolute maximum due to execution and ramp risks.
Klaviyo (KVYO) Q2 2026: Enterprise ARR Up 36% as Multi-Product Deals Accelerate Platform Expansion
Klaviyo demonstrates strong enterprise and multi-product growth, high retention, and early signs of AI-driven expansion, but margin and international risks temper the signal. The business model is self-reinforcing with improving economics, but not yet at the level of a giant platform. Growth is robust but not hyper-scaling, and the business is still transitioning towards exceptional cash flow and disruptive status.
GigaCloud Technologies (GCT) Q2 2026: Europe GMV Soars 66%, Accelerating Global Marketplace Diversification
GigaCloud demonstrates a long reinvestment runway, clear network effects, improving unit economics, and a disruptive platform model. Europe’s GMV growth and seller expansion are exceptional, though not all metrics (e.g., cash flow, margin) are accelerating at the highest rate yet. The business is a growth platform, but some areas (guidance, margin leverage, and integration) are still developing, so the upside signal is strong but not at the highest possible level.
Real Brokerage (REAX) Q2 2026: Agent Count Jumps 26% as REMAX Merger Nears, Platform Integration Sets Stage for $30M Synergies
The company shows a long reinvestment runway, disruptive platform model, and significant growth catalysts through the REMAX merger and ancillary scaling. However, while growth is strong, ancillary monetization is still early and not all metrics are exceptional yet. The business is not yet a cash flow machine, but the trajectory and strategic positioning are strong.
Privia Health (PRVA) Q2 2026: EBITDA Margin Expands 310bps, Underpinning Confidence in High-End Target
Privia Health demonstrates a long reinvestment runway, strong margin expansion, and a compounding business model, all supported by growing provider/lives metrics and robust cash flow. While growth is strong, it is not at the 'exceptional' (40%+) level, and the business, while disruptive in healthcare, is not entirely unique versus other enablement platforms. The company is clearly a growth business with multiple levers, but not all signal questions are at the highest threshold.
Netskope (NTSK) Q2 2026: 27% ARR Growth Highlights AI Security Momentum and Platform Expansion
Netskope demonstrates a strong reinvestment runway, rapidly growing ARR, and improving unit economics and margins. The platform has self-reinforcing elements and increasing customer value, with a disruptive AI security model and positive cash flow trajectory. However, guidance does not indicate >30% growth, and while pipeline and market are large, near-term acceleration is not fully exceptional. Some elements (e.g., cash flow, guidance) are improving but not yet at the highest inflection, warranting a conservative approach to scoring.
The RealReal (REAL) Q2 2026: High-Value Items Surge 36% as AI Drives Margin Expansion
REAL demonstrates a long runway for reinvestment, strong network effects, improving unit economics, and a transition to compounding efficiency. However, while growth is strong, guidance does not point to 40%+ acceleration, and the business is not disruptive at the highest level. There is clear margin and revenue growth, but not at the most extreme levels.
Biodesics (BDSX) Q3 2025: Primary Care Test Orders Jump 75% as Sales Expansion Drives Adoption
Biodesics is demonstrating strong growth signals: primary care test orders up 75%, gross margin expansion, and a doubling of development services revenue. The business model is becoming more self-reinforcing via digital and operational leverage, and partnerships provide optionality. However, while growth is robust, it is not yet at the 40%+ inflection or disruptive scale that would warrant a higher signal score. The business is not yet a household name or proven compounding outlier, but has credible upside.
Inter (INTR) Q2 2026: Loan Book Expands 30% as Credit Mix Drives Margin Upside
Inter demonstrates a long growth runway, high returns, and improving unit economics, with margin and credit expansion. However, while growth is strong, it is not at hypergrowth levels, and some disruption potential is present but not transformative. The business is solidly in growth mode but not at the most extreme inflection.
Duke Common (DCO) Q2 2026: Missile Revenue Soars 68%, Driving Backlog to $1.16B High
DCO demonstrates strong growth levers (missile franchise, engineered products), margin expansion, backlog inflection, and a visible multi-year runway. However, while growth is strong, it is not at a hyper-scaling level and the business, while attractive, is not uniquely disruptive or unknown. The signal is high for the sector but not at the absolute highest level.
LifeStance Health (LFST) Q2 2026: EBITDA Margin Expands 500bps as Specialty and Productivity Drive Outperformance
LifeStance demonstrates a long reinvestment runway, rapid specialty growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is transitioning to higher cash flow. However, not all signals are at the highest possible level: while growth is strong, it is not consistently >40%, and some disruption/exceptional acceleration is emerging but not yet fully proven.
Kronos (CRON) Q2 2026: International Revenue Surges 88% as Borderless Product Strategy Scales
Kronos demonstrates strong growth, margin expansion, and international momentum, with a borderless strategy and brand leadership. However, while the reinvestment runway and business model are attractive, some elements (e.g., future growth rate, disruptive potential, and cash flow acceleration) are promising but not yet fully exceptional or proven at the highest level. Risks around regulation and margin volatility also temper the signal.
Strata Critical Medical (SRTA) Q1 2026: Clinical Revenue Jumps 27% as Platform Integration Accelerates
SRTA demonstrates strong growth, expanding margins, and a clear reinvestment runway with a disruptive integrated platform model. While guidance is reiterated (not raised) and growth is robust but not hyperbolic, the business is not yet at the very highest signal level. Still, the combination of platform integration, M&A, and industry tailwinds offers notable upside and investor relevance.
Brookfield Renewable (BEPC) Q2 2026: Battery Storage Acquisition Doubles Capacity, Driving Strategic Growth
BEPC demonstrates a long reinvestment runway, strong recent developments (notably the battery storage acquisition), improving unit economics, and a self-reinforcing business model. Customer value appears to be increasing and the business is positioned for continued growth. However, while growth is robust, it is not accelerating at the highest levels (over 30-40%), and the business model, while strong, is not fully disruptive. Cash flow is accelerating but not at an extreme pace.
Kornit Digital (KRNT) Q2 2026: Annual Recurring Revenue Surges 79% Amid Accelerating Digital Shift
Kornit demonstrates a long reinvestment runway with high ROIC potential, strong recent ARR growth (79%), improving unit economics, and a self-reinforcing business model via subscriptions. Customer value is increasing, but future growth is guided at high-single digits, not exceptional. The business model is semi-disruptive with lateral opportunities, and while cash flow is positive and growing, acceleration is moderate. Revenue/EPS growth is projected under 20%, and the company is transitioning into a growth business.
EagleRock Land (EROK) Q2 2026: 32% Revenue Surge and $78M Acquisition Sharpen Permian Basin Position
EagleRock demonstrates a long reinvestment runway, strong recent growth (32% revenue, 60% acreage expansion), improving unit economics, and a self-reinforcing model. However, customer value deepening and future growth are promising but not yet at the highest possible acceleration, and some optionality (data centers, renewables) remains early-stage. The business is clearly in growth mode with strong cash flow, but not at the most disruptive or hypergrowth end of the spectrum.
DPC Holdings (DPC) Q2 2026: Revenue Soars 34% with Strategic Partnerships Driving Long-Term Growth
DPC has a strong growth profile, high returns on capital, and clear reinvestment opportunities via strategic customer partnerships and vertical integration. Revenue and backlog growth are robust but not at hypergrowth levels, and some headwinds (Turbo Wheels segment, metal cost pass-through) temper the signal. The business is transitioning with accelerating cash flow and margin expansion, but guidance and future outlook, while positive, do not rise to exceptional/transformative levels. The model is semi-disruptive but not category-defining.
Bilibili (BILI) Q3 2025: Advertising Revenue Jumps 23% as AI and Engagement Drive Margin Expansion
Bilibili demonstrates a strong reinvestment runway, clear business model evolution, improving unit economics, and self-reinforcing ecosystem. Customer value is deepening, and the business is moving toward higher margins and cash flow. However, growth is robust but not at the most exceptional levels (most guidance and backlog signals are positive but not hyper-growth). The business model is semi-disruptive but not entirely novel, and while revenue/EPS growth is solid, it is not consistently above 40%. Overall, the signal is strong but not at the absolute highest tier.
Fennec Pharmaceuticals (FENC) Q2 2026: 78% Revenue Surge Highlights Commercial Expansion and Clinical Momentum
Fennec demonstrates substantial growth, commercial momentum, and improving unit economics, with a disruptive product in a specialized market. However, while growth is strong, the business is not yet at a scale or trajectory to warrant a perfect signal score—guidance is positive but not exceptional, and the business model, while differentiated, is not a clear platform with massive lateral optionality. The signal is high, but not at the very top end.
Electrovaya (ELVA) Q3 2026: Gross Margin Hits 34.9% Amid Strategic Amazon Partnership and Jamestown Expansion
Electrovaya demonstrates a long reinvestment runway with high returns, significant growth signals (Amazon partnership, Jamestown expansion), improving unit economics, and self-reinforcing business model elements. However, while growth and margins are strong, the business is not yet at the disruptive level of the highest-signal names, and near-term growth is solid but not hyperbolic. Some metrics (cash flow, guidance) are improving but not at the very top tier.
Arista Networks (ANET) Q3 2025: AI Center Revenue Target Raised to $2.75B, Cementing Multi-Year Growth Visibility
Arista is a growth business with a long reinvestment runway and strong positioning in a secular AI buildout. There is clear evidence of improving unit economics, self-reinforcing business model, and increasing customer value. While growth is robust, the business is not a new or undiscovered story, and some upside is already reflected in consensus expectations.
GameSquare (GSQ) Q2 2026: Revenue Surges 137% and Adjusted EBITDA Turns Positive Amid Strategic Ecosystem Expansion
GameSquare demonstrates a long reinvestment runway with high-margin SaaS and ecosystem integration. There is a major recent growth inflection (+137% revenue), clear margin expansion, and improving unit economics. Recurring revenue and customer value are increasing. However, while growth and backlog are strong, guidance does not indicate >30% acceleration, and the business, while differentiated, is not truly disruptive at scale. Cash flow is improving but not yet rapidly accelerating. Growth rates are strong but not hypergrowth, and the business is transitioning to profitability with strong growth characteristics.
OFRM Q1 2026: Price Mix Surges 20% as Cooler Innovation Drives Velocity
OFRM exhibits strong growth dynamics: a long reinvestment runway, disruptive innovation, and improving unit economics. The business is not yet at the highest tier of exceptional future growth (guidance is conservative and margin expansion is managed, not explosive), but the signals for sustained double-digit expansion, pricing power, and channel leverage are robust. Some lateral/disruptive opportunity is present but not dominant.
PowerFleet (AIOT) Q4 2026: Services Revenue Hits 81% Mix, Driving 330bps Margin Expansion
PowerFleet demonstrates a long reinvestment runway, significant business evolution, improving unit economics, and a self-reinforcing SaaS model. Customers appear to be increasing in value and the business is transitioning to a growth phase. However, while the growth and margin expansion are strong, the business is not yet at hyper-growth or fully disruptive scale, and some guidance is solid but not exceptional, leading to a slightly conservative signal score.
Indi (INDI) Q2 2026: Radar and Vision Revenue Up 24%, Physical AI Pipeline Accelerates
Indi shows strong reinvestment opportunity and disruptive potential in radar, vision, and photonics, with accelerating growth and improving unit economics. However, while growth is robust, it is not yet at the highest acceleration threshold in all areas, and some risks remain around cash flow and execution. The business is transitioning toward higher margins and recurring revenue, but not all signal factors are at the maximum level.
Karo (KARO) Q1 2027: South Africa Subscriber Net Adds Surge 92%, Reinforcing Platform Scale
Karoo demonstrates a long reinvestment runway, clear growth drivers, improving unit economics, and a self-reinforcing SaaS model with strong retention. However, while growth is robust and the model is attractive, it is not at the most exceptional level in terms of acceleration or disruption, and some metrics (ARPU, logistics margins) show moderation. Signal is high but not at the absolute maximum for a small/mid-cap SaaS.
Grid Dynamics (GDYN) Q1 2026: AI Revenue Jumps 60% as Platform Margins Outpace Legacy Services
Grid Dynamics is showing a strong inflection with a long runway, high AI growth, and improving economics. However, while growth is robust, it is not yet at the most exceptional level (30%+ acceleration or >40% growth across the board), and the business—while highly promising—still faces concentration and execution risks. The signal is strong but not at the absolute highest tier for disruption or growth.
PICS (PICS) Q1 2026: Secured Credit Powers 116% Portfolio Growth, Margin Leverage Signals Durable Model
PicPay demonstrates a strong reinvestment runway, rapid credit portfolio growth, improving unit economics, and a self-reinforcing digital model. Customer value is rising and the business is clearly in a growth phase. However, while growth is strong, it is not at the extreme/exceptional level in every area (e.g., future guidance is robust but not 40%+ across all metrics). The business is innovative but not fully disruptive by global standards. Cash flow is improving, but not yet accelerating at the highest tier. The signal is strong but not at the absolute maximum.
Element Solutions (ESI) Q2 2026: Electronics Segment Surges 20%, Raising Full-Year Guidance
ESI demonstrates a long reinvestment runway, strong unit economics, and a self-reinforcing business model with expanding margins and customer value. The business is not fully disruptive but is semi-disruptive with high growth in specific verticals. Growth is strong but not at the highest acceleration tier, and some risks/uncertainties moderate the signal score.
Octave Specialty Group (OSG) Q1 2026: Insurance Distribution Revenue Jumps 92% as MGA Platform Strategy Accelerates
OSG demonstrates a strong reinvestment runway, breakout growth in insurance distribution (92% YoY, 42% organic), and improving margins. The business model is evolving toward a self-reinforcing MGA platform with AI/data advantages, but some signals (guidance unchanged, growth moderating after Q1, not clearly disruptive sector-wide) cap the score. Still, the signal is strong for investors seeking compounding specialty insurance platforms.
TD SYNNEX (SNX) Q2 2026: HIVE Billings Surge 117% as Hyperscaler Pipeline Expands
TD SYNNEX demonstrates a long reinvestment runway, triple-digit growth in HIVE, improving unit economics, and self-reinforcing business model characteristics. Customer value is increasing and the business is transitioning to a higher-growth profile. However, acceleration is not at the highest level in all categories (e.g., future guidance is strong but not >30% acceleration), and some aspects (business model disruption, cash flow) are not at maximum signal. The business is investable and growth-oriented, but not an undiscovered or hyper-exceptional opportunity.
West Pharmaceutical (WST) Q2 2026: HVP Components Surge 18%, Driving Guidance Lift and Margin Expansion
West Pharmaceutical shows a long reinvestment runway, clear mix shift, and margin expansion. However, while growth is strong and durable, the business is not entirely disruptive and guidance, while raised, is not at the highest acceleration. The signal is strong for an established leader, but not at the highest level of novelty or upside.
Intel (INTC) Q2 2026: AI-Driven Segments Power 70% of Revenue as CapEx Surges 40%
Intel demonstrates a long reinvestment runway (CapEx ramp, advanced packaging, foundry), strong recent growth (AI-driven businesses 70% of revenue), improving unit economics (margin expansion), and deepening customer value (custom silicon, foundry wins). However, persistent supply constraints and competitive risks temper the outlook, and while growth is robust, it is not exceptional (not >40%). The business is transitioning but not fully disruptive, and while cash flow is improving, it's not yet accelerating at an exceptional pace.
Atlanticus (ATLC) Q2 2026: Managed Receivables Surge 126% as Mercury Integration Outperforms
Atlanticus demonstrates a long reinvestment runway and high returns, with a major recent development (Mercury integration) driving growth. Unit economics are improving, and customers are becoming more valuable. The business is not fully disruptive but shows moderate self-reinforcing elements. Cash flow is accelerating and the company is in a growth phase, though the growth rate is not consistently above 40%. Overall, the signal is strong but not at the absolute highest level due to industry maturity and some competitive headwinds.
Permian Resources (PR) Q2 2026: Free Cash Flow Surges 50% as Acquisition Engine Adds 55,000 Acres
Permian Resources demonstrates a long reinvestment runway, exceptional recent growth in free cash flow and inventory, improving unit economics, and strong customer value creation. The business model is partially self-reinforcing and semi-disruptive, with accelerating cash flow and growth rates above 10% but below 40%. While not a tech-like compounding story, the operational agility, capital efficiency, and acquisition engine provide strong signal for continued value creation, though the model is not fully disruptive and growth is not hyperbolic.
MindWalk Holdings (HYFT) Q4 2026: Recurring Platform Revenue Debuts as Gross Margin Hits 59%
The business is at a strategic inflection with the first recurring SaaS revenues, margin expansion, and a defensible moat in proprietary biological context. There is a long reinvestment runway, clear model shift, and disruptive potential. However, SaaS revenue is still nascent, and while the growth trajectory is promising, it is not yet at the level of exceptional acceleration or proven customer deepening. The business is transitioning but not yet a giant, so the signal is strong but not at the highest possible level.
SLB (SLB) Q2 2026: Data Center Revenue Surges 80% as Digital and Deepwater Drive Multi-Year Upcycle
SLB demonstrates a strong reinvestment runway with digital, data center, and deepwater growth. There is a significant uptick in data center revenue (80% YoY), improving margins, and recurring digital revenue. However, some signal points are tempered by the business's scale, maturity, and the fact that SLB is a well-followed, large-cap name, so valuation upside may be less asymmetric than for a smaller disruptor. The business is transitioning but not fully disruptive, and while growth is strong, it is not at hypergrowth levels.
Senseonics (SENS) Q2 2026: Gross Margin Soars to 59% as In-House Commercialization Unlocks Operating Leverage
Senseonics demonstrates a long reinvestment runway, disruptive model, and accelerating margin/revenue growth, with improving unit economics and customer value. However, the business, while showing strong momentum and optionality, is not yet at the level of a hyper-growth, giant-scale platform, and some guidance is solid but not exceptional. Pipeline and digital partnerships offer further upside, but execution and sector competition temper the signal.
Goosehead Insurance (GSHD) Q2 2026: Franchise Payments Jump 35%, Fueling Productivity Flywheel
GSHD demonstrates a long reinvestment runway, improving unit economics, self-reinforcing model, and growing customer value. There is strong growth, but not at the most exceptional levels for every metric (e.g., guidance and cash flow are good but not explosive, and the business model is semi-disruptive rather than fully disruptive). The article identifies these strengths but also notes expense growth and execution risks, tempering the overall signal score.
WTTR Q2 2026: Water Infrastructure Revenue Climbs 26% as Asset Network Expands
WTTR demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and self-reinforcing network effects. Customer value is increasing and the business is clearly growth-oriented. However, while growth is strong, it is not at hypergrowth levels (>40%), and some optionality (minerals, specialty chemicals) is still early-stage, so not all signal questions score the maximum.
Ligand Pharmaceuticals (LGND) Q2 2026: Zoma Deal Adds $2.3B Milestone Upside, Expands Royalty Catalyst Pipeline
Ligand offers a long reinvestment runway, improved scale, and a diversified pipeline with significant milestones, but the business is not a breakout hypergrowth story and faces binary clinical risk. The model is self-reinforcing and cash flow is improving, but not at an exceptional rate. Guidance and backlog are strong but not explosive, and the business is more of a disciplined aggregator than a disruptive innovator.
AMETIS (AMTX) Q2 2026: LCFS Pathways Lift Revenue 20% as RNG Scale Drives Margin Inflection
AMETIS demonstrates a strong reinvestment runway with multi-credit revenue streams, clear margin inflection, and scaling RNG volumes. While growth is robust and the business is transitioning to higher margins, some elements (policy risk, working capital tightness, moderate guidance) temper the signal score. The business model is semi-disruptive but not yet a category-defining outlier.
USIO (USIO) Q2 2026: PayFac Revenue Jumps 43%, Margin Expansion Signals Operating Leverage
USIO demonstrates a long reinvestment runway and strong operating leverage, with PayFac and ACH segments growing rapidly. There is a clear inflection in profitability and margins, and the business model is self-reinforcing with ISV partnerships. However, while growth is strong, it does not reach the exceptional/accelerating threshold in every metric (e.g., full-year revenue guidance is 14-16%). The business is not a fully disruptive model, and cash flow is improving but not yet accelerating rapidly. Revenue and EPS growth are strong but not consistently above 40%. The company is solidly a growth business, but the overall signal is just below the highest tier.
Centrus Energy (LEU) Q2 2026: Backlog Jumps $600M as LEU Demand and HALU Offtakes Accelerate
Centrus shows a long reinvestment runway with high ROIC potential, a significant backlog jump, and clear business model inflection. Some unit economics and customer value metrics are still maturing, and cash flow acceleration is not yet clear, but the business is transitioning from demonstration to growth with strong disruptive potential and structural tailwinds.
STEM (STEM) Q2 2026: Non-GAAP Margin Hits 55% as Software Mix Deepens
STEM displays a strong shift to a software-first model with high margin and recurring revenue, supporting a long reinvestment runway and improving unit economics. There is clear evidence of operational leverage, international expansion, and hybrid project momentum. However, the growth, while robust, is not at the 'exceptional' acceleration level, and the business, though innovative, is not a pure disruptor with unlimited optionality. The signal is strong but not at the absolute highest tier.
Cadeler (CDLR) Q2 2026: Backlog Grows 23% Amid Strategic Fleet Expansion and Integration
Cadeler demonstrates a long reinvestment runway, strong backlog growth, improving unit economics, and self-reinforcing business model through vertical integration. Customer value appears to be increasing and the business is on a growth trajectory, but revenue and EPS growth is not clearly above 40% annually and the business model, while robust, is not disruptive in the strictest sense. Cash flow is improving but not yet accelerating dramatically. Signal is high, but not at the absolute maximum due to these moderating factors.
ITG (ITG) Q2 2026: 38% Revenue Growth Highlights Scaled Platform Strength Amid IPO Transition
ITG demonstrates a strong growth profile with a long reinvestment runway, significant backlog expansion, and accelerating revenue/EBITDA growth. While its business model shows some self-reinforcing qualities (scale, technology), network effects are not fully proven. Customer value is improving but not deeply compounding yet. The company is not a pure disruptor, but its growth, backlog, and financial flexibility provide substantial signal for investors.
Atlassian (TEAM) Q4 2026: $3M+ ARR Customers Up 50% as Enterprise AI Adoption Accelerates
Atlassian demonstrates strong enterprise momentum, compounding AI monetization, and improving unit economics. While growth is robust, guidance suggests high but not hypergrowth, and the business, while a leader, is well-followed. Signal is high but not at the maximum due to lack of truly exceptional new inflections.
Edwards Lifesciences (EW) Q2 2026: TMTT Jumps 45% as Multi-Platform Portfolio Drives Durable Growth
Edwards exhibits a long reinvestment runway, exceptional segment growth (TMTT up 45%), improving unit economics, and self-reinforcing business model elements. Customer value is deepening, and the business is firmly in a growth phase. However, while guidance is raised and backlog is strong, the future outlook is not quite 'exceptional' (30%+ acceleration) across the whole business, and the business model, while innovative, is not fully disruptive nor is cash flow acceleration at the highest level. Revenue and EPS growth is solid but not consistently above 40%. Thus, some signal points are conservatively marked down.
Rhythm Pharmaceuticals (RYTM) Q2 2026: Incivary Launch Drives 19% Sequential Revenue Growth, Expanding Rare Disease Franchise
Rhythm shows a robust rare disease growth engine, expanding addressable markets, and improving economics with pipeline optionality and global expansion. However, while growth and signals are strong, the business is not at the very highest tier of disruption or growth acceleration, and some metrics (cash flow, global launches) are still ramping, warranting a slightly conservative score.
Octave Specialty Group (OSG) Q2 2026: Insurance Distribution Revenue Soars 77%, Adjusted EBITDA Near Quadruples
OSG demonstrates strong growth, improving unit economics, and a scalable, semi-disruptive business model in insurance distribution. While not a tech unicorn, the combination of organic and acquisition-driven growth, margin expansion, and AI-driven operational leverage is rare among insurance platforms. However, the company is not yet at the level of a hyper-growth or fully disruptive business, and some guidance revisions signal moderate rather than exceptional acceleration.
GENMAP (GMAB) Q2 2026: Epkinley Sales Surge 48%, Pipeline Readouts Set Stage for 2027 Launches
GENMAP demonstrates a long reinvestment runway with high returns, significant growth in its lead asset (Epkinley), and improving unit economics. The business model is self-reinforcing with increasing customer value and global expansion. While the future is strong, growth is not yet exceptional (>30%) and disruption is present but not absolute. Cash flow is improving but not yet accelerating at a breakneck pace. Revenue/EPS growth is robust but not above 40%. The business is clearly in growth mode, but not at the most disruptive, hypergrowth end of the spectrum.
Interactive Brokers (IBKR) Q2 2026: Margin Loan Interest Up 39% as Account Growth Drives Record Activity
IBKR demonstrates a long reinvestment runway, robust growth, improving unit economics, and a self-reinforcing model with expanding customer value. However, while growth and innovation are strong, the business is mature and well-followed, which tempers the upside signal. The growth outlook is solid but not truly exceptional or disruptive at the scale of a new category leader, and revenue/EPS growth is likely to be strong but not hyper-growth. The signal is high but not at the very top end for a widely covered, large-cap financial.
Credicorp Ltd. (BAP) Q2 2026: Medium-Term ROE Raised to 22% Amid Loan Growth and Innovation Momentum
Credicorp demonstrates a strong reinvestment runway, accelerating loan and innovation growth, improving unit economics, and a self-reinforcing digital ecosystem. However, while growth is robust, it is not exceptional or disruptive at the highest level, and some metrics (cash flow, revenue/eps growth) are solid but not at the highest acceleration. The signal is strong for a large-cap Latin American bank, but not at the very top of the scale.
MARA Q2 2026: Power Portfolio Expands 2.5x, Unlocking AI Infrastructure Leverage
MARA demonstrates a long reinvestment runway, disruptive business model, and rapid asset scale-up, with clear optionality in AI infrastructure. There is not yet evidence of exceptional growth (over 40%) in revenue/EPS or customer value deepening, as lease-up and monetization are forthcoming. The business is transitioning, not yet a proven cash flow machine, but the signal for future upside is strong given sector dynamics.
NovoCure (NVCR) Q2 2026: Optune Pax Scripts Surge 200%, Catalyzing Multi-Indication Growth Trajectory
NovoCure demonstrates a long reinvestment runway, disruptive model, and accelerating growth in new indications, with strong evidence of improving unit economics and customer value. While the growth outlook is robust and the business is transitioning to profitability, not every signal is exceptional or at maximum velocity, warranting a slightly conservative score.
Toyoko Limited (TOYO) Q2 2026: 35% Revenue Growth Amid Regulatory Uncertainty and Strategic U.S. Expansion
Toyoko shows a strong reinvestment runway, recent significant growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable and the business is growth-oriented. However, some signal questions score lower due to regulatory uncertainty and the business, while strong, is not especially disruptive or likely to deliver >40% growth going forward. Cash flow is improving but not yet accelerating, and some growth metrics are moderate rather than exceptional.
Syndax (SNDX) Q2 2026: Revuforge Treatment Duration Climbs Beyond 9 Months, Fueling Recurring Revenue Base
Syndax demonstrates a long reinvestment runway, clear recurring revenue growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, but while growth is strong, it is not accelerating at an exceptional rate (>30%), and the business, while innovative, is not fully disruptive. Cash flow is improving but not yet a 'machine.' The business is a clear growth story but not at the highest end of the spectrum for signal.
Arlo (ARLO) Q2 2026: Paid Accounts Surge 23% as High-Value Subscribers Drive LTV to $967
Arlo has a long reinvestment runway and is undergoing a business model transformation, with strong subscriber and ARR growth, improving LTV, and a shift to recurring revenue. However, while growth is robust, it is not quite at the 'exceptional' level in every metric (e.g., revenue growth is strong but not above 40%, and the business model, while disruptive, is not entirely unique). The company is a growth business with improving economics, but some headwinds (hardware margins, execution risk) temper the signal.
Brookfield Corporation (BN) Q2 2026: Record $77B Fundraising and $210B Deployable Capital Fuel Strategic Growth
Brookfield demonstrates a long reinvestment runway, record fundraising, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is positioned for solid growth, but not at the highest acceleration. The business model is semi-disruptive, and while cash flow and revenue growth are strong, they do not exceed the highest thresholds. The company is a growth business but is large and well-followed, so the upside signal is somewhat muted.
GEVO (GEVO) Q2 2026: Adjusted EBITDA Outlook Doubles as Carbon Credits and Canada Pathway Unlock $60M Run Rate
GEVO demonstrates a long reinvestment runway, clear growth inflection, and improving unit economics. Carbon credit monetization and EBITDA guidance revisions are significant. However, while the business model is evolving and has disruptive elements, it is not yet a dominant platform, and customer value deepening is only modest. Revenue growth is strong but not consistently above 40%, and some uncertainty remains around offtake and scaling.
Vista (VIST) Q2 2026: Production Surges 32% as Bandurria Sur Acquisition Accelerates Scale
Vista demonstrates a long reinvestment runway, a disruptive model within its geography, and clear growth momentum from both organic and inorganic sources. However, while production and EBITDA are growing rapidly, some uncertainty remains around the exceptionalism of future growth (guidance is solid but not accelerating >30%), and cash flow acceleration, while strong, is not at maximum velocity. The business is transitioning to a larger scale and is not yet a clear outlier in global energy, but signal remains high.
Notable Signals (12-15)
Articles with useful investment signals worth considering
Pulse Biosciences (PLSE) Q1 2026: NSPFA Clinical Milestones Tighten Pivotal Trial Timeline
Pulse Biosciences is at a pivotal moment with disruptive technology, a sharpened business focus, and accelerating clinical milestones. The business model and clinical data suggest significant upside and disruption potential, though near-term revenue and cash flow are still limited, and some metrics (unit economics, customer value) are not yet at scale.
Bullish (BLSH) Q2 2026: 62% Subscription Revenue Growth Highlights Tokenization Pivot
The company demonstrates a long reinvestment runway (tokenization, Equiniti), recent significant subscription growth, and a disruptive business model. However, some metrics (unit economics, customer value, future growth) are improving but not yet exceptional, and the business is still in transition with some risks and uncertainties. The signal is strong but not maximum due to the early stage of the tokenization pivot and modest current cash flow acceleration.
GE Vernova (GEV) Q2 2026: Backlog Surges $13B, Locking in Multi-Year Power Demand
GE Vernova demonstrates a long reinvestment runway, major backlog uptick, improving unit economics, and a self-reinforcing model in power and electrification. However, customer value deepening and future growth, while positive, are not exceptional across all segments, and the business—while strong—is not disruptive or accelerating at the highest possible rates. Signal is strong but not at the absolute maximum due to wind segment drag and some legacy exposure.
SIFY (SIFY) Q1 2026: Data Center Capacity to Jump 64% as CapEx Surges
SIFY demonstrates a long reinvestment runway with high returns, recent significant growth, and improving unit economics. The business model is self-reinforcing with network effects, but customer value deepening is only modest. Growth outlook is strong but not yet exceptional, and while the business is disruptive, some risks (funding, margins) temper the signal score.
Salesforce (CRM) Q2 2027: AgentForce ARR Surges 240%, AI Integration Drives Platform Expansion
Salesforce demonstrates strong growth, particularly in AI-driven ARR and cash flow, but as a large, well-followed company, much of the upside may be priced in. There is clear evidence of improving unit economics, customer value, and disruptive elements, but the reinvestment runway and self-reinforcing model are not as deep as a smaller, less mature disruptor. Growth is strong but not hyper-scale.
Belite Bio (BLTE) Q2 2026: FDA Priority Review Advances Tinlarebant Toward Potential First STGD1 Approval
Belite Bio is at a pivotal regulatory inflection with a potentially first-to-market therapy for a rare disease, strong clinical data, and a robust balance sheet. The reinvestment runway and growth potential are high, but as a pre-commercial biotech, some elements like proven self-reinforcing business model or accelerating cash flow are not fully established yet. The company is transitioning to a growth phase, but not all signal criteria (such as proven unit economics or accelerating cash flows) are met at this stage.
BTQ (BTQ) Q3 2025: QSSN Targets $1B+ Revenue as Korea Stablecoin Pilots Scale
BTQ demonstrates a long reinvestment runway and is positioned at a major inflection point driven by regulatory mandates, with the potential for explosive revenue growth if adoption materializes. However, the business is still in early commercialization, with unit economics and customer value deepening not yet fully proven at scale. The model is disruptive and self-reinforcing, but the near-term acceleration is contingent on regulatory enforcement and pilot conversion.
NAMS Q2 2026: Prevail Interim Analysis Targets >950 Events as LDL Market Expands 37%
NAMS demonstrates a long reinvestment runway, disruptive model, and a pivotal clinical inflection with the Prevail trial. The market is expanding rapidly, and the business is transitioning to growth, but some elements (unit economics, customer value, cash flow) are not yet proven at scale, warranting a conservative approach to scoring. The signal is strong but not perfect due to execution and competitive uncertainties.
TRX (TRX) Q4 2025: Q4 Gross Margin Climbs to 53% as Expansion Drives Cash Flow Surge
TRX demonstrates a strong reinvestment runway, clear recent inflection in margins and cash flow, and a self-funded expansion model. However, while the model is promising, it is not yet a proven self-reinforcing compounding flywheel, and customer value growth is limited by the nature of the gold mining business. The business is transitioning to growth, but not at the 40%+ level. Execution and regulatory risks temper the upside.
IDEXX (IDXX) Q2 2026: CAG Diagnostics Recurring Revenue Up 10.3% as Innovation Drives Utilization Premium
IDEXX demonstrates a strong recurring revenue model, improving unit economics, and a self-reinforcing business model with international growth runway. However, there are no recent 40%+ upticks or truly exceptional growth rates, and while the business is innovative, it is not a disruptive new entrant. The signal is strong but not at the highest level for upside surprise.
Bakkt (BKKT) Q4 2025: Adjusted EBITDA Loss Narrows $24M as Platform Reset Unlocks Clean Growth Path
Bakkt shows a long reinvestment runway, disruptive business model, and regulatory moat. While the reset is promising, current growth is not yet exceptional, and customer value metrics are improving but not yet outstanding. The business is transitioning into growth, but some signals (unit economics, cash flow acceleration, and revenue growth rates) are not yet at the highest tier.
BioLife Solutions (BLFS) Q1 2026: BPM Revenue Jumps 25% as Commercial Therapy Penetration Deepens
BioLife Solutions is demonstrating a long reinvestment runway and is embedded in a high-growth sector, with commercial therapy adoption driving recurring revenue. There is clear evidence of strong recent growth and backlog, but unit economics are currently pressured by mix/yield issues, so not fully compounding yet. The business model has self-reinforcing aspects (switching costs, integration), and customer value is deepening. Future growth is strong but not yet exceptional (guidance is 17-20% for the year). The business is transitioning to a high-quality, recurring-revenue model but is not yet at the level of a giant platform. Cash flow is improving but not yet accelerating. The business is not fully disruptive, but is semi-disruptive in the CGT tools niche.
SILC Q2 2026: Design Wins Drive 59% Revenue Surge, AI Inference Upside Signals Multi-Year Growth
Silicom is showing a multi-year growth inflection with strong reinvestment runway, accelerating design win conversion, and early AI inference traction. However, while the business is transitioning to high growth, the magnitude and sustainability of AI upside and customer value deepening are not yet fully proven, so scores are conservative for signal.
Red Violet (RDVT) Q2 2025: Contractual Revenue Rises to 77%, Locking in Platform Stickiness
Red Violet demonstrates a strong recurring revenue base, improving unit economics, and margin expansion through automation. While the business is showing solid growth and operational leverage, there is no evidence of a massive (40%+) inflection or disruptive model that would warrant a perfect signal score. The business is transitioning toward greater embeddedness and scale, but is not yet a breakout hypergrowth story.
Welltower (WELL) Q2 2026: Senior Housing Drives 25% FFO Surge as Portfolio Rotation Pays Off
Welltower demonstrates strong growth, margin expansion, and disciplined capital allocation, with clear evidence of business model evolution and compounding potential. However, the business is a large, well-followed REIT with a more mature profile and less disruptive upside than earlier-stage or less well-known companies. The signal is high for a sector leader but not at the very top end of the spectrum for transformative upside.
Gorilla Technology (GRRR) H1 2026: Revenue Doubles with 78% Sequential Q2 Growth, Paving Way for $500M in 2027
Gorilla Technology is entering a high-growth phase with a disruptive AI infrastructure model and substantial revenue acceleration. The reinvestment runway is long, and double-digit growth is evident. However, some areas (unit economics, self-reinforcing business model, and customer value deepening) are not fully proven at scale, and cash flow is not yet clearly accelerating. The business is growth-oriented but still faces execution and margin ramp risks.
NRXS (Neuraxis) Q2 2026: 116% Revenue Growth Driven by Insurance Coverage Expansion and Commercial Execution
Neuraxis demonstrates very strong revenue growth and margin improvement, with a clear path to further scaling as insurance coverage expands. The business model is not yet fully self-reinforcing or disruptive, and customer value metrics, while improving, are not yet compounding. The VA channel adds moderate optionality, but the story is still somewhat dependent on payer dynamics. Overall, the signal is high, but not at the absolute highest level due to these dependencies.
RenovoRx (RNXT) Q2 2026: 31% Customer Funnel Expansion Signals Commercial Inflection
RenovoRx demonstrates a long reinvestment runway and a significant recent uptick in growth, with improving unit economics and clear customer value deepening. The business is transitioning to commercial growth, but while the model shows some self-reinforcing elements, network effects are not yet dominant. The future outlook is strong but not yet exceptional, with some risks around execution and competitive response. The business is a growth story but not yet at the level of a disruptive, giant-scale platform.
IMSR (IMSR) Q4 2025: Cash Rises to $298M After HCM2 Deal, Enabling Aggressive Fleet Buildout
IMSR is at a strategic inflection with a long reinvestment runway, disruptive modular reactor design, and strong capital position. There is clear evidence of significant developments (capital raise, regulatory progress, commercial pipeline), but as a pre-revenue company, unit economics and customer value are not yet proven at scale. Growth potential is high, but execution and regulatory risks remain. The business is transitioning toward growth, with signals of optionality and disruptive potential, but not all metrics (e.g., accelerating cash flow, proven recurring revenue) are fully visible yet.
Hasbro (HAS) Q4 2025: Wizards Segment Surges 86%, Anchoring Multi-Year Growth Strategy
Hasbro's Wizards segment shows strong growth and high margins, but the overall business is not a new or underfollowed story and faces some maturity in its core segments. The recent surge in the Wizards segment is a significant development, but the broader company is not likely to deliver outsized upside or become a giant. The business model is becoming more self-reinforcing, and customer value is deepening, but the future growth outlook is solid rather than exceptional. Risks around tariffs, royalties, and execution on digital investments moderate the signal score.
Coinbase (COIN) Q2 2026: Bitcoin Share Shrinks to 12% as Platform Diversifies Revenue Base
Coinbase demonstrates a long runway for reinvestment, significant business evolution, and a disruptive, self-reinforcing platform model. However, while the business is diversifying and growing, some metrics (unit economics, customer value, cash flow, growth rates) are improving but not yet exceptional. The business is positioned for further growth, but not at the highest acceleration tier.
AST SpaceMobile (ASTS) Q2 2026: $1.3B Backlog and 13 Satellites in Orbit Signal Scaling Commercial and Government Growth
AST SpaceMobile demonstrates a long reinvestment runway, disruptive business model, and strong backlog, with clear signals of scaling and TAM expansion. However, unit economics and customer value deepening are still emerging, and near-term growth is strong but not yet explosive. Execution risk and capital intensity moderate the overall signal score.
Tradeweb (TW) Q2 2026: International Drives 65% of Revenue Growth as Electronification Deepens
Tradeweb shows a long reinvestment runway, major international growth, and deepening business model advantages. However, unit economics and cash flow are improving but not at the highest level, and while the business is disruptive, it is not a new or highly underfollowed story. Growth is strong but not hyper-scaling, and some segments remain challenged.
EVGO (EVGO) Q2 2026: Tesla Supercharger Deal Doubles Addressable Market, Unlocks 2027 Growth Leverage
EVGO is at a major inflection point with the Tesla deal, unlocking a much larger market and strong growth optionality. The business model is disruptive and self-reinforcing, with clear capital efficiency and margin leverage emerging. However, some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional, and forward growth, while strong, is not yet at hypergrowth levels.
VIA (VIA) Q1 2026: Pipeline Grows to $650M as Full-Network Transit Strategy Accelerates
VIA demonstrates a long reinvestment runway, disruptive business model, and clear strategic pivot, but revenue growth is in the 25-30% range—not hypergrowth. Unit economics and customer value are improving but not at an exceptional rate. The pipeline is robust and backlog is growing, but margin expansion and cash flow acceleration are still in early stages. The business is a growth company with strong optionality, but the signal is tempered by some execution and market risks.
TPC Q2 2026: $200B Pipeline Triples, Margin Expansion Anchors Multi-Year Growth Visibility
TPC demonstrates a strong reinvestment runway, significant backlog growth, improving unit economics, and accelerating cash flow. However, the business model is not fundamentally disruptive, and while growth is robust, it is not at the highest tier. Customer value and future guidance are improving but not exceptional.
OPHC Q2 2026: Loan Portfolio Surges 30% CAGR, Driving 85% Net Income Growth
OPHC shows strong growth, improving unit economics, and high returns, but is a regional bank with moderate disruption and some limits to scale and business model defensibility. The new platform adds optionality but doesn't yet show network effects or exceptional acceleration.
Kaspi (KSPI) Q2 2026: E-Commerce GMV Up 28% Drives 15% Revenue Growth Amid AI Assistant Launch
Kaspi demonstrates a long reinvestment runway and strong growth in key metrics (e-commerce GMV, fintech revenues), with AI innovation providing further optionality. However, some elements (self-reinforcement, disruption, and cash flow acceleration) are still emerging rather than fully proven, and near-term growth is solid but not explosive. Risks from currency and funding costs temper the signal.
Vericel (VCEL) Q2 2026: Macy Drives 23% Growth as $200M Buyback Signals Confident Cash Trajectory
Vericel demonstrates a long reinvestment runway and robust growth (Q2 revenue up 22%, Macy at 23%), with improving unit economics and growing customer value. The business is not quite a disruptive model, but has elements of innovation in cell therapy. There is some self-reinforcing dynamic, but not as strong as true network effects. Growth is strong but not at the highest acceleration tier (>40%), and while cash flow is healthy, it's not yet a cash machine. The business is a clear growth story, but not a breakout hyper-growth or disruptive platform.
TORM plc (TRMD) Q2 2026: Time Charter Equivalent Earnings Surge 146%, Driving Record Profitability
TORM is showing exceptional near-term growth and profitability, with a clear inflection due to geopolitical disruptions. However, the long-term reinvestment runway and self-reinforcing business model are less compelling than truly disruptive or platform businesses. The business is not likely to sustain 40%+ growth indefinitely, and while current cash flow is strong, the signal for multi-year compounding is moderate.
Backblaze (BLZE) Q2 2025: B2 Revenue Accelerates 29% as AI Storage Demand Scales
Backblaze demonstrates strong growth in B2 cloud storage with a long reinvestment runway and improving unit economics. There is a major AI-driven inflection and growing enterprise mix, but some business model elements (network effects, disruption) are emerging rather than fully entrenched. Growth is robust but not at the highest acceleration tier, and legacy headwinds remain a drag.
Crescent Energy (CRGY) Q2 2026: Permian Synergy Target Triples to $300M, Unlocking Cost and Cash Flow Upside
There are strong signals of operational and financial inflection, particularly the tripling of synergy targets, cost resets, and free cash flow acceleration. However, the business is still largely in a mature, capital-intensive sector with some limitations on reinvestment runway and disruptive potential. While growth is notable, it is not at the extreme end of the spectrum, and some advantages are replicable by peers.
Forum Markets (FRMM) Q4 2025: $103M Cash Fuels 2026 Asset Ramp as Tokenization Model Scales
Forum Markets offers a disruptive, high-growth business model with a long reinvestment runway and clear compounding advantages from its asset origination and tokenization strategy. While some metrics (unit economics, customer value, near-term cash flow) are only moderately improving or not yet exceptional, the company's pivot and guidance suggest strong growth potential. The signal is high, but not every dimension is fully de-risked or accelerating at the highest level.
Standex (SXI) Q4 2026: Grid Capacity Expansion Targets $440M by 2030, Powering Long-Term Growth
Standex demonstrates a strong growth runway, recent significant order uptick, and improving unit economics. The business is transitioning into higher-growth markets with robust margin and cash flow potential. While the model shows some self-reinforcing characteristics and customer value expansion, it is not a pure network or platform play. Growth is strong but not at hyper-scaler levels, and while the business is moving toward being a cash flow machine, it is not yet accelerating at the highest rates.
IRMD Q2 2026: Quad Pump Orders Double Shipments, Backlog Surges on 3870 Ramp
IRMD demonstrates a strong multi-year runway with high-value recurring revenue and a major product cycle inflection. However, while growth is robust, it is not at hypergrowth levels and the business model, while durable, is not highly disruptive or network-based. Execution risk on the production ramp tempers the signal slightly.
Cognition Therapeutics (CGTX) Q4 2025: Zervimicine Slows DLB Psychosis Progression by 86%, Shifting Pipeline Priority
CGTX demonstrates a long growth runway with high returns potential, a significant recent clinical inflection (86% slowing in DLB psychosis), and a disruptive business model targeting high-unmet-need CNS indications. However, scale/unit economics and customer value deepening are less proven at this stage, and while growth potential is high, it is not yet realized in revenues or EPS. The signal is strong for a clinical-stage biotech but not at the level of a proven compounding business.
Coursera (COUR) Q2 2026: Subscription Mix Hits 85%, Accelerating Margin Expansion and AI-Driven Platform Shift
Coursera shows a long reinvestment runway with a disruptive, self-reinforcing business model and accelerating margin improvement. While the subscription shift and margin expansion are significant, customer value deepening and future growth rates are good but not exceptional (NRR softness, guidance not >40% growth). The business is moving from transition to growth, but some metrics are not yet at the highest threshold for signal.
GoDaddy (GDDY) Q2 2026: Aero Bookings Surge 5x to $50M, Accelerating AI-Led Platform Shift
GoDaddy's Aero platform shows strong early traction and a clear inflection, with bookings up 5x. There is evidence of improving unit economics, customer value, and margin durability. However, the reinvestment runway and self-reinforcing model are only moderately compelling relative to the most disruptive businesses, and overall growth rates, while solid, are not in the top decile. Execution risk and legacy transition temper the signal score.
1&1 Green Technologies (YDDL) Q4 2025: Copper Alloy Revenue Climbs 37% as Margin Expansion Outpaces Growth
YDDL exhibits strong regulatory barriers, margin expansion, and a clear growth runway with international expansion and battery recycling. However, some signal points are moderated by product mix risk (brass alloy weakness), lack of quantified forward guidance, and early-stage nature of the battery recycling initiative. The business is transitioning from a niche, regulatory-protected player to a growth platform, but some elements (e.g., customer value deepening, cash flow acceleration) are not yet exceptional.
Oracle (ORCL) Q2 2026: RPO Soars 433%, Fueling Cloud and AI Platform Expansion
Oracle demonstrates a significant inflection with the RPO surge and accelerating cloud/AI growth, but as a well-known large cap, runway and disruption are capped compared to earlier-stage businesses. The business model is evolving but not fully disruptive, and while growth is strong, it is not at the level of hypergrowth or highly novel businesses. Still, there is clear evidence of improved unit economics, backlog-driven visibility, and platform compounding effects.
BAM Q2 2025: Fee-Bearing Capital Rises 10% as AI and Wealth Channel Drive Expansion
BAM demonstrates a strong growth profile with secular tailwinds, a disruptive model, and expanding fee-bearing capital. However, some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional. The business is a clear growth story, but not all signals are at the highest level.
American Integrity Insurance Group (AII) Q2 2026: 54% Surge in Voluntary New Policies Drives Record Earnings
American Integrity is showing robust organic growth and improved underwriting economics, but the business is not exceptionally disruptive or unique in the insurance space. The reinvestment runway is moderate, with some optionality from geographic expansion, but not at the level of a compounding, high-ROIC disruptor. Growth is strong (not hypergrowth), and the model is scaling well with improving unit economics and cash flow. Customer value is deepening, and the business is transitioning to a growth phase, but the overall signal is tempered by the mature, competitive, and regulated nature of the insurance industry.
GENK Q2 2026: CPG Division Surges 341% Sequentially, Driving Strategic Shift Away from Restaurants
GENK's CPG division shows a long runway and high growth, with a 341% sequential revenue increase and expanding retail presence. Unit economics are improving and customers are becoming more valuable. However, the business model is not fully self-reinforcing yet, and while disruptive, it is not a clear platform winner. Cash flow is not yet accelerating and future growth, while strong, is not exceptional across all metrics. Overall, the signal is strong but not at the highest level due to some uncertainties and the transitional nature of the business.
EOG (EOG) Q2 2025: Encino Acquisition Drives 9% Production Lift, Unlocks Multi-Basin Upside
EOG demonstrates a long reinvestment runway, immediate production/guidance uplift from Encino, and improving unit economics. However, while the business is showing strong growth and optionality, its model is not highly disruptive and some elements (international expansion, technology rollout) are still emerging. Revenue/EPS growth is strong but not at the highest tier, and cash flow is improving but not rapidly accelerating. The business is clearly a growth operator, but not with the most exceptional signal profile.
NESR (NSER) Q2 2026: Revenue Surges 59% YoY, Accelerating Path to $3B Growth Target
NESR displays strong growth, operational leverage, and a clear reinvestment runway, but some aspects (customer value deepening, business model defensibility, and exceptional future growth) are not at the highest threshold for truly exceptional signal. The business is transitioning to higher technology content but remains partly conventional.
Nyxoah (NYXH) Q2 2026: U.S. Net Revenue Jumps 25% as Genio Adoption Expands
Nyxoah demonstrates clear growth, improving unit economics, and a long reinvestment runway. However, the business model, while innovative, is not fully disruptive and faces some risk from coding/reimbursement changes and competitive response. Cash flow is not yet accelerating, and while growth is robust, it is not at a hyper-scaling level. Signal is strong but not at the highest tier for upside.
Oracle (ORCL) Q1 2027: Cloud Infrastructure Revenue Surges 121 Percent, Driving Record Growth and Capital Investment
Oracle's reported growth rates, capital intensity, and AI/cloud inflection are significant, but as a large, well-followed company, the upside is less asymmetric than for a less mature disruptor. While the business is clearly in a high-growth phase and showing some disruptive qualities, the signal is slightly muted by Oracle's scale and market visibility.
Royalty Pharma (RPRX) Q2 2026: Portfolio Receipts Up 6% as Blockbuster Pipeline Expands
Royalty Pharma has a long reinvestment runway, excellent cash flow, and a self-reinforcing business model with improving unit economics and customer value. However, while the business is high quality, it is not experiencing a sudden, massive growth inflection or truly disruptive business model that would warrant the highest signal scores.
Novanta (NOVT) Q2 2026: Riverpoint Medical Adds $65M, Elevates Recurring Revenue to 25%
Novanta is showing strong recurring revenue growth, clear secular tailwinds, and margin/cash flow expansion. However, while the runway is long and growth is robust, the business model is not fully disruptive, and some elements (unit economics, self-reinforcement) are still developing. Growth is strong but not hyper-scaling, and the business is not entirely unique or unknown, which tempers the signal score.
Carvana (CVNA) Q2 2026: Retail Units Jump 38% as Inventory Expansion Unlocks Regional Growth
Carvana exhibits strong growth signals: a long reinvestment runway, double-digit unit and revenue growth, improving unit economics, and a clear transition to profitability. However, the business model, while innovative, is not fully disruptive, and some self-reinforcing dynamics are still emerging rather than deeply entrenched. Growth rates are high but not consistently at the hyper-growth threshold, and some margin and operational risks temper the signal score.
Trip.com Group (TCOM) Q1 2026: Inbound Travel Surges 90%, Fueling Platform Diversification
Trip.com demonstrates a long reinvestment runway, significant recent developments (90% inbound growth), and improving unit economics. The business model shows some self-reinforcing elements (AI, ecosystem), but customer value improvement is moderate (not consistently deepening). Near-term growth is moderating, so future outlook is good but not exceptional. The model is semi-disruptive, and cash flow is improving but not rapidly accelerating. Growth rates are strong but not at the hypergrowth threshold. The business is clearly in growth mode, but some signals are tempered by regulatory and macro headwinds.
Albemarle (ALB) Q2 2026: Energy Storage EBITDA Jumps 229% as Lithium Tightness Drives Cash Generation
Albemarle demonstrates strong profit growth, cash flow leverage, and clear exposure to a structurally tight lithium market, but as a well-known industry leader, the upside is somewhat capped by market awareness. The business model is somewhat disruptive with sustainability innovation, and there is evidence of improving unit economics and customer value. However, the reinvestment runway and self-reinforcing advantages are moderate rather than exceptional, and growth is strong but not at hypergrowth levels.
Rigetti Computing (RGTI) Q2 2026: $100M CHIPS Act LOI Accelerates Roadmap to 1,000 Qubits
Rigetti demonstrates a long reinvestment runway, disruptive modular architecture, and strong government validation, but commercial adoption is still nascent and unit economics, while improving, are not yet at scale. Growth is visible but not explosive, and cash flow is not yet accelerating. The business is clearly in the growth phase with upside optionality, but the signal is tempered by the early stage of the market and lack of broad commercial inflection.
StubHub (STUB) Q1 2026: 400bps Margin Expansion Signals Marketplace Scale Payoff
StubHub demonstrates strong margin expansion, cash flow leverage, and self-reinforcing network effects. The business model is robust with improving unit economics and customer value, and there is clear evidence of scale benefits. However, growth rates are solid but not in the hypergrowth category, and while the business is innovative, it is not fully disruptive. Signal is strong but not at the highest possible level.
Monster Beverage (MNST) Q2 2026: International Sales Surge 35%, Global Innovation Drives Category Outperformance
Monster demonstrates a strong growth profile with international acceleration, improving unit economics, and robust innovation. However, the business model is not fully disruptive, margin headwinds exist, and some signals (cash flow, future acceleration) are good but not exceptional. The business is well-known, so signal is strong but not at the highest level.
Once Upon a Farm (OFRM) Q2 2026: Baby Segment Jumps 73% as Cooler Expansion Accelerates Brand Penetration
OFRM demonstrates strong growth, a long runway, and improving unit economics, with clear evidence of brand expansion and innovation. There are some signs of self-reinforcing business dynamics and customer value deepening, but the business model is not fully disruptive and margin expansion is still a future story. While growth is robust, the company is not yet showing 40%+ annualized revenue/eps growth or an exceptional near-term acceleration, and the automation benefits are still out on the horizon. The signal is strong for a growth-stage CPG, but not at the highest level for disruptive or compounding business models.
Solana Company (HSDT) Q3 2025: $500M PIPE Fuels Digital Asset Treasury Pivot, 2.3M SOL Accumulated
The business has a long reinvestment runway and is undergoing a significant pivot with strong capital backing. There is evidence of improving unit economics and a disruptive business model, but some elements—such as customer value and cash flow acceleration—are only modestly improving. The company is a growth business, but volatility and risk temper the signal score.
BlackRock Coffee Bar (BRCB) Q3 2025: Loyalty Transactions Hit 64%, Driving Deeper Customer Engagement
BlackRock Coffee Bar demonstrates strong growth, high loyalty penetration, improving unit economics, and margin expansion, indicating a solid business model with a long runway. However, while the model is compelling, it is not fully disruptive and there is some uncertainty around the pace of future acceleration and competitive intensity. The business is clearly a growth story but not yet at the level of a generational compounder or disruptive platform, warranting a slightly conservative signal score.
Five Below (FIVE) Q2 2026: 23% Sales Growth Validates Operating Flywheel and Customer-Centric Strategy
Five Below demonstrates strong growth, high reinvestment, and improving unit economics, with a disruptive edge in merchandising and marketing. However, customer value deepening and self-reinforcing business model are present but not fully compounding yet, and growth guidance is robust but not at the very highest tier. The business is investable with clear upside but not a once-in-a-decade outlier.
Taysha Gene Therapies (TSHA) Q2 2026: $230M Capital Raise Extends Cash Runway Into 2H 2028 Amid Pivotal Trial Completion
Taysha is at a pivotal inflection point: strong capital position, late-stage clinical progress, and a disruptive model in gene therapy for rare CNS diseases. However, while the reinvestment runway and business model are promising, the company is still pre-commercial and faces substantial execution and regulatory risks. Not all metrics show clear acceleration or compounding effects yet, and some customer value and cash flow aspects remain unproven.
Acadia Realty Trust (AKR) Q2 2026: Street Retail Rent Spreads Hit 91% as Scale Accelerates NOI Growth
Acadia exhibits strong growth signals: record rent spreads, accelerating leasing, and embedded multi-year upside. However, as a REIT focused on a relatively mature asset class, the reinvestment runway is solid but not exceptional, and growth rates, while impressive for the sector, do not reach the highest echelons of disruption or scalability. The business is transitioning to a higher-growth, more capital-efficient model, but faces risks of yield compression and sector competition that cap the signal score.
PURR Q3 2026: Hype Token Holdings Drive $198M Unrealized Gain, Validator Launch Expands Ecosystem Role
PURR shows a disruptive model with a long runway and clear optionality (validator, RWA, outcome markets). The quarter featured a significant gain from token appreciation, but volatility and dependency on a single asset cap the signal. Unit economics are not clearly improving with scale yet, and customer value deepening is nascent. The business is not yet a cash flow machine, but growth and ecosystem expansion are evident. The signal is strong for a niche digital asset play, but not at the highest level for broad institutional upside.
Ingram Micro (INGM) Q2 2026: xVantage Drives 40% Operating Income Growth as AI Platform Scales
While the company is executing well and showing strong growth, it is not a truly disruptive business model and the reinvestment runway, while solid, is not exceptional. The business is more a leader in digital transformation within IT distribution than a paradigm-shifting disruptor. Growth rates and backlog are strong but not at the level of a hypergrowth platform.
Hewlett Packard Enterprise (HPE) Q3 2026: Record $12.2B Revenue and 75% Free Cash Flow Return Signal Durable AI-Driven Growth
HPE is showing strong growth and operational momentum, with record backlog, revenue, and cash flow, but as a large incumbent, its reinvestment runway and business model are not as disruptive or open-ended as younger, more innovative peers. The business is transitioning to higher growth on the back of AI, but the signal is somewhat tempered by supply constraints, legacy business mix, and the competitive landscape. Still, the results and guidance revisions are material and show a clear inflection.
Archer Aviation (ACHR) Q2 2026: $200M Revenue Boost with Boeing Acquisition Accelerates Aerospace AI and Defense Expansion
The business is undergoing a major strategic shift with the acquisition, signaling a transition to a growth platform with strong optionality and some disruptive elements. However, while the revenue addition and defense growth are significant, unit economics and self-reinforcing advantages are still emerging rather than entrenched. The business is not yet showing exceptional acceleration in cash flow or revenue growth above 40%, but the outlook is strong and the pivot is material.
Ranpak (PACK) Q2 2026: Automation Revenue Soars 139%, Reshaping Margin and Growth Profile
Ranpak is showing a major business mix shift with automation scaling rapidly, a long reinvestment runway, and strong recent growth. While unit economics and margin leverage are improving, some elements (business model self-reinforcement, customer value deepening, disruptive potential, and cash flow acceleration) are not yet fully proven or exceptional. The business is transitioning toward growth but not yet a clear outlier, warranting a conservative signal score.
RadNet (RDNT) Q3 2025: Digital Health Revenue Jumps 51%, AI Margin Leverage Emerges
RadNet shows clear growth and margin expansion, with digital health and AI providing a new runway. However, the core imaging business is mature and the reinvestment runway, while improved by software, is not as long or high-ROIC as pure tech disruptors. There is a significant uptick in digital health growth (51% YoY, 112% AI revenue growth), but overall company growth is not at hypergrowth levels. Unit economics are improving, especially in digital health. The business model is evolving toward self-reinforcement but is not yet fully compounding. Customer value is deepening within digital health, and guidance is positive but not exceptional. The business is transitioning toward a platform model, but legacy elements remain.
Everspin Technologies (MRAM) Q2 2026: Product Revenue Jumps 38% as Industrial and Defense Demand Accelerates
Everspin shows strong growth, a large addressable market, and a solid product roadmap, but some elements (business model compounding, customer value deepening, disruptive potential, and cash flow acceleration) are present but not exceptional. The business is transitioning from niche to diversified, but not yet a truly dominant or disruptive force.
Ensign Group (ENSG) Q1 2026: 99 Acquisitions Fuel 18% Revenue Growth, Guidance Raised on Occupancy Surge
Ensign Group is showing strong growth and integration capability, with a long reinvestment runway, double-digit revenue growth, improving unit economics, and a clear growth orientation. However, network effects and customer value deepening are present but not dominant, and the business, while strong, is not highly disruptive or likely to deliver hypergrowth. Cash flow and guidance are solid but not exceptional. The signal is above average but not at the highest tier for upside or disruption.
Quantum Computing Inc. (QUBT) Q3 2025: $1.25B Capital Infusion Powers Photonic Scale-Up
QUBT demonstrates a long reinvestment runway and a disruptive business model, with a significant capital infusion and early commercial wins signaling inflection. However, unit economics, customer value, and cash flow acceleration are not yet proven at scale, and revenue growth, while promising, is not yet exceptional. The business is transitioning to growth, but execution and pipeline conversion risks remain.
AMG (AMG) Q2 2026: Alternatives Hit 60% of Earnings, $29B Quarterly Inflows Accelerate Shift
AMG is undergoing a significant business model shift with strong inflows and margin expansion in alternatives, but the underlying business, while improving, is not highly disruptive and remains in a consolidating, competitive industry. The growth is meaningful but not at the hyper-growth level, and while cash flow and capital returns are strong, the reinvestment runway is solid but not exceptional.
Coda Octopus (CODA) Q2 2026: Defense Engineering Jumps 38% as Marine Tech Faces Geopolitical Drag
Coda Octopus has a long reinvestment runway in defense, recent significant developments (Navy approval, defense segment growth), and some disruptive technology. However, unit economics are not clearly compounding yet, and customer value deepening is early-stage. The future is promising but not yet exceptional (pending recurring revenue inflection). Revenue growth is moderate, and the business is transitioning toward growth but not at hypergrowth levels. Signal is solid but not extraordinary.
DHT (DHT) Q2 2026: Spot Rates Surge to $162,600, Driving Record Cash Returns
The business is experiencing a record quarter with exceptional spot rate-driven growth and cash generation, but its reinvestment runway is limited by high asset prices and a mature industry structure. Unit economics and cash flow are strong, but the business is not fundamentally disruptive nor does it have a long, compounding growth runway. The signal is high for near-term earnings and cash returns, but less so for long-term transformational upside.
TIGO Q2 2026: Equity Free Cash Flow Surges 50% as Colombia Integration Drives $1.1B Guidance Boost
TIGO shows strong recent developments (notably cash flow and integration), with some disruptive elements (B2B digital, convergence) and cash flow acceleration. However, as a telecom in emerging markets, its reinvestment runway and self-reinforcing model are good but not exceptional. Growth is robust but not at the highest tier, and some business model elements remain traditional.
ZLAB Q2 2026: 11% Sequential Product Revenue Lift Anchors Global Pipeline Acceleration
Xilab has a long reinvestment runway, recent growth inflection, and disruptive global ambitions, but unit economics and customer value improvement are only modestly evident at this stage. The business model is becoming more self-reinforcing, but not yet at full scale. Guidance and backlog are positive but not exceptional. Revenue and EPS growth are likely in the 20-40% range, not above 40%. This is a strong growth business with clear upside, but not yet a breakout or dominant global franchise.
ServiceTitan (TTAN) Q2 2027: 21% Revenue Growth Accelerates AI-Driven Max Platform Adoption
ServiceTitan is showing strong growth with a disruptive AI-driven model and high reinvestment potential. However, some signals (unit economics, customer value, cash flow acceleration) are positive but not yet exceptional or at full scale, and growth rates, while solid, are not explosive. The strategy is sound, but the business is in transition with some moderation in top-line and lead growth.
Xenon Pharmaceuticals (XENE) Q2 2026: $1.2B Cash Extends Runway, AZK NDA Submission On Track
Xenon has a long reinvestment runway, a disruptive business model in CNS, and is at a critical inflection with NDA submission and a $1.2B cash runway. However, while there is strong growth potential, most clinical assets are pre-commercial and unit economics are not yet proven at scale. There is no evidence of 40%+ near-term growth, and the business is transitioning rather than fully in hypergrowth mode. Pipeline optionality and capital allocation are strong, but the signal is somewhat tempered by execution risk and the need for commercial validation.
CBOE (CBOE) Q4 2025: Derivatives Net Revenue Surges 38% as Zero DTE Drives Record Volumes
CBOE shows strong growth in core derivatives, especially zero DTE, with evidence of customer value expansion and revenue/EPS growth. However, as an established exchange, its reinvestment runway and disruptive potential are moderate compared to earlier-stage or less mature platforms. There are significant developments (zero DTE, international retail), but some elements (network effects, self-reinforcement) are only partially evident. The signal is strong but not at the highest possible level due to the business's maturity and competitive/regulatory risks.
Sabio Holdings (STAA) Q2 2025: Programmatic Sales Surge 94% as Platform Diversifies Ahead of Election Cycle
Sabio demonstrates a strong reinvestment runway, significant recent growth (especially programmatic and international), and improving unit economics. However, the business model, while evolving, is not yet fully self-reinforcing or disruptive versus larger peers. Customer value is improving but not consistently deepening, and cash flow is not yet accelerating. Growth rates are strong but not at the highest tier, and the business is in transition with growth characteristics. The signal is solid but not exceptional due to the competitive landscape and some execution risks.
InMune Bio (INMB) Q2 2026: R&D Expenses Drop 86% as Regulatory Milestones De-risk Platform
INMB has a long runway and is positioned at a key inflection, with regulatory and manufacturing de-risking, and a disruptive platform. However, the lack of current revenue, unproven commercial adoption, and dependence on future approvals/reimbursement temper the signal. Unit economics and customer value are not yet proven at scale, and near-term growth is contingent on approvals.
Verica Pharmaceuticals (VRCA) Q3 2025: YCAMP Dispensed Units Up 33% as Focused Commercial Model Drives Expansion
Verica has a credible reinvestment runway with high returns, a very strong sequential unit growth, and improving unit economics. The business model is semi-disruptive but not clearly compounding with scale yet. Customer value is improving, but not consistently deepening. Guidance and backlog are positive but not exceptional. The business is transitioning toward growth but hasn't achieved breakout status. Revenue and EPS growth are strong but not at the highest tier. Overall, signal is solid but not at the level of a truly exceptional, high-upside business.
Castle Biosciences (CSTL) Q2 2026: TissueCypher Volumes Surge 63% as Pipeline Expansion Accelerates
Castle Biosciences shows strong growth in a core product (TissueCypher), with a long runway and evidence of reinvestment at scale. However, some elements (unit economics, customer value, disruptive potential) are promising but not yet exceptional or fully proven across the portfolio. Margins are under pressure and pipeline assets are still early, so the upside is solid but not extraordinary.
Alarm.com (ALRM) Q2 2026: Growth Initiatives Now 35% of SaaS, Fueling 30%+ Expansion
Alarm.com demonstrates a solid reinvestment runway, recent high-growth developments in key segments, and improving unit economics. However, some aspects such as deepening customer value and exceptional future growth are present but not yet at the highest level. The business is transitioning toward growth, but not all elements are disruptive or compounding at scale.
Loop Industries (LOOP) Q1 2027: $28M Gujarat Subsidy Boosts India Project Economics, Modular Model Scales in Europe
Loop’s business model is disruptive with a long runway (India and Europe), and the modular/licensing pivot signals high optionality. The recent $28M subsidy and new contracts are significant, but growth is not yet explosive or at scale—unit economics are improving but not proven giant-level. Customer value is improving but still dependent on contract conversion. The business is transitioning to growth, but execution risk and reliance on external funding temper the signal score.
QSI Q1 2026: Proteus Read Length Doubles, Setting Stage for Commercial Launch
QSI is at a major technical inflection with the Proteus platform, suggesting a long runway and disruptive potential. However, recurring revenue and unit economics are not yet proven at scale, and while the business is transitioning to growth, near-term financials are muted and contingent on execution. The business model is disruptive, but some compounding advantages are still emerging rather than fully realized.
Rush Street Interactive (RSI) Q2 2026: Latin America Revenue Jumps 195%, Casino-First Model Accelerates Share Gains
RSI shows strong growth, particularly in Latin America, with improving unit economics and customer metrics. While there are significant positive developments and a clear growth trajectory, the business, while attractive, is not wholly disruptive or offering a uniquely long reinvestment runway. Some elements (network effects, disruptive model, cash flow acceleration) are present but not at the highest possible level for a truly exceptional signal score.
Xeris Biopharma (XERS) Q2 2026: Recorlev Soars 81%, Secures Durable Growth Platform
Xeris demonstrates strong commercial momentum, a clear growth runway, and significant pipeline optionality. However, while the business is high-growth and the quarter is exceptional, some elements (like self-reinforcement and customer value expansion) are present but not yet fully compounding or proven at scale. The model is not yet disruptive at a sector level, and growth, while robust, is not at hypergrowth levels across all metrics.
Artivion (AORT) Q4 2025: Stent Graft Revenue Jumps 36%, Propelling Double-Digit Growth Outlook
Artivion demonstrates a long reinvestment runway at high returns (Q1), recent significant growth (Q2), and improving unit economics (Q3). The business model is semi-self-reinforcing (Q4) and customers are modestly becoming more valuable (Q5). While backlog and guidance are strong, they are not exceptional (Q6). The model is semi-disruptive with lateral opportunities (Q7). Cash flow is moderately accelerating (Q8), and revenue/eps growth is in the 10-14% range (Q9). The business is a clear growth story (Q10). Signal is somewhat tempered by the business's niche and moderate scale, but overall remains strong.
Ocugen (OCGN) Q2 2026: $130M Financing Extends Cash Runway, Three Late-Stage Gene Therapy Programs Advance
Ocugen demonstrates a disruptive, platform-driven business model with a long reinvestment runway and several late-stage programs targeting large, underserved markets. The recent financing and pipeline progress are significant, but the business is still pre-commercial, and while growth potential is high, there is not yet evidence of accelerating cash flow, improving unit economics at scale, or deepening customer value. Risks remain around clinical outcomes and commercial execution.
NN, Inc. (NNBR) Q2 2026: $80M New Business Wins Signal Multi-Segment Ramp and Margin Upside
NNBR is showing strong growth signals with a clear runway, major new business wins, and margin expansion. However, while the business is evolving rapidly, some aspects (network effects, customer value deepening, and disruptive model) are present but not yet fully established or at the highest level of compounding. Revenue and EPS growth are likely above 20% but not clearly above 40%. The signal is solid but not at the absolute highest level for a less well-known industrial.
TK (TK) Q2 2026: Spot Tanker Rates Surge 50%, Fueling Record Cash and Strategic Optionality
TK is a cyclical, asset-intensive business experiencing a period of exceptional profitability due to market dislocation, but does not have a long-term, self-reinforcing growth model or disruptive business model. The current surge is significant but likely temporary. Cash flow is accelerating, and the business is in a growth phase, but the reinvestment runway is moderate and dependent on external factors.
OBOOK Holdings (OWLS) H1 2026: Stablecoin Payment Volume Nears $1B Milestone, Signaling Enterprise Network Scale-Up
OBOOK is at an early inflection with a long reinvestment runway and disruptive business model. The business is transitioning to higher-margin products with evidence of improving unit economics and accelerating client adoption. However, the scale and growth are not yet exceptional, and some metrics (unit economics, cash flow) are only modestly improving.
TK Group (TNK) Q2 2026: Spot Tanker Rates Surge 50%, Unlocking Record Cash and Fleet Renewal Leverage
The signal is strong due to record spot rates, all-time high cash generation, and clear evidence of business evolution (fleet renewal, asset sales at premiums). However, the business is highly cyclical and levered to spot rates, with the reinvestment runway limited by sector dynamics and lacking true structural disruption. Some self-reinforcing elements are present (balance sheet strength, asset renewal), but the tanker business remains exposed to exogenous factors and not a secular compounder.
Tonix Pharmaceuticals (TNXP) Q2 2026: TONMYA Sales Nearly Triple, Expanding Coverage and Pipeline Progress Drive Growth Potential
Tonix shows strong recent growth and pipeline momentum, with clear reinvestment opportunities and a disruptive product in a large market. However, network effects and customer value deepening are present but not yet fully proven, and while growth is rapid, it is not yet exceptional or at giant scale. Risks and cash burn temper the overall signal.
Fermi (FRMI) Q1 2026: $1.4B Infrastructure Build Secures 2.2 GW Power Lead as Leadership Overhaul Targets Binding Tenant in 90 Days
Fermi demonstrates a disruptive business model with a long runway and unique asset position, but has not yet converted those assets into revenue or proven improving unit economics. The business is at a critical inflection point, with exceptional future potential if it secures tenants and executes, but current results are not yet exceptional. The company is not yet a cash flow machine, and while the opportunity is large, execution risk remains high. The signal is strong but not at the maximum due to lack of current revenue conversion and proven customer value expansion.
TRX Gold (TRX) Q3 2026: Throughput Rises 60% as Mill Expansion Sets Up Next Phase of Growth
TRX Gold shows strong operational momentum, a self-funded growth strategy, and a large expansion runway. However, while improvements are notable, the business model is not highly disruptive and customer value deepening is moderate. Growth is robust but not at the extreme end, and some elements (network effects, exceptional acceleration) are present but not dominant.
Codexis (CDXS) Q2 2026: $25M Capital Raise Boosts Ecosynthesis Scale-Up Amid Growing siRNA Demand
Codexis demonstrates a long reinvestment runway and is positioned for high growth with disruptive potential in enzymatic siRNA manufacturing. There is clear evidence of strategic progress, margin improvement, and a capital raise to accelerate scale. However, the business is still in transition, with some metrics (unit economics, customer value, and cash flow) showing improvement but not yet at the highest level. The signal is strong but not at the level of a business with explosive, proven growth or fully compounding economics.
Cineverse (CNVS) Q4 2025: Matchpoint Targets $5M+ Studio Deals as Tech Division Matures
Cineverse demonstrates a clear pivot to a higher-margin, tech-driven model with significant optionality in enterprise SaaS and AI monetization. While the reinvestment runway and disruptive potential are present, the business is still transitioning and not yet showing blockbuster growth or fully compounding network effects. Unit economics and cash flow are improving, but customer value and future growth, while promising, are not yet exceptional or proven at scale. The story is thesis-worthy but not at the highest level of signal.
Big Sky Industrial (BSIN) Q2 2026: $130M 45Q Credit Stream Underpins Phase 1 De-Risking and Growth Path
Big Sky Industrial exhibits strong growth potential with a disruptive business model and multiple avenues for value creation, notably the monetizable 45Q tax credit stream and scalable helium operations. However, some elements (unit economics, customer value, and cash flow acceleration) are still in transition, and not all metrics show clear, exceptional upside yet.
Meridian Holdings (MRDN) Q2 2026: Net Debt Down 65% as New Customer Registrations Surge 37%
The business is showing strong growth, operational leverage, and deleveraging, but the reinvestment runway and self-reinforcing dynamics are notable but not exceptional. There are some disruptive elements and strong cash flow, but the business is not a clear outlier or household name with massive upside. Signal is solid but not extraordinary.
Alchemy Technologies (ALKT) Q2 2025: Mantle Adds 39 New Clients, Elevating Cross-Sell and ARR Visibility
The business demonstrates strong growth, improving unit economics, and high customer value with a robust ARR backlog and cross-sell momentum from the Mantle acquisition. However, while the business model is attractive and the runway is solid, it is not highly disruptive or unique within SaaS, and the reinvestment runway, while good, is not exceptional. Growth is strong but not hyper-scaling, and cash flow is improving but not yet a standout. The signal is strong but not at the highest level for uniqueness or market impact.
Sable Offshore Corp. (SOC) Q2 2026: 149% Growth in Oil Sales Signals Operational Momentum Amid Marketing Constraints
The business demonstrates a long reinvestment runway, rapid operational growth, and improving unit economics. However, some elements (self-reinforcing model, customer value expansion, and disruption) are present but not yet fully proven or exceptional. Growth is strong but constrained by external bottlenecks, and while the business is transitioning to growth, there remain uncertainties around marketing and infrastructure that cap the signal score.
UMC (UMC) Q2 2026: AI Revenue Set to Triple, $5B CapEx Fuels Silicon Photonics Expansion
UMC is showing a clear growth pivot with a large capex commitment and AI revenue set to triple, but the business remains somewhat mature and competitive. Unit economics and customer value are improving, but not at the level of a breakout giant. The business is transitioning toward growth, but not all signals are at the highest level.
ETORO (ETOR) Q2 2026: 18% Funded Accounts Growth and TradeZero Acquisition Signal U.S. Expansion Leap
eToro shows strong growth signals (funded accounts, U.S. expansion, AI/crypto innovation), but some metrics (unit economics, customer value, cash flow) are improving but not exceptional. The business is disruptive and has a long runway, but not all signals are at the highest level.
Axogen (AXGN) Q2 2026: Breast Segment Drives 47% Growth, Reshaping Margin Mix
Axogen shows a strong growth runway in the breast segment, with evidence of double-digit growth and expanding market opportunity. However, gross margin compression and some business model risks limit the score. The business is not disruptive at a platform level yet, and while growth is strong, it is not at hypergrowth levels. The signal is solid but not exceptional given the company's scale and margin profile.
Biodesic (BDSX) Q1 2026: Diagnostic Test Volumes Jump 29% as Primary Care Channel Expands Reach
Biodesic shows strong growth, margin expansion, and a credible path to profitability, with clear evidence of a reinvestment runway and operational leverage. However, while the business is growing, it is not a category-defining disruptor yet, and some metrics (customer value, business model self-reinforcement, cash flow acceleration) are improving but not exceptional. The business is not likely to deliver 40%+ sustained growth, and some signals are moderate rather than outstanding.
Wiley (WLY) Q4 2026: AI Revenue Doubles to $49M, Unlocking Recurring Growth Flywheel
Wiley is showing meaningful growth in AI recurring revenue, but the overall business is not yet a hyper-growth story. There is a clear inflection in a segment, but core research growth is single digits. The business model is evolving and has some self-reinforcing characteristics but is not yet a dominant compounding flywheel. Cash flow is improving, but not yet at an exceptional acceleration. The business is transitioning toward higher quality, but the overall signal is moderate-high, not exceptional.
Atomera (ATOM) Q2 2026: GaN on Silicon RF Linearity Surges 1000x, Unlocking New TAM
Atomera shows strong optionality and disruptive potential with a major technical breakthrough (GaN linearity), TAM expansion, and deepening pipeline. However, commercial revenue is still pre-scale, and unit economics, network effects, and customer value deepening are not yet proven at scale. Growth is promising but not yet exceptional, and the business remains in transition from technical validation to commercial execution.
NRG (NRG) Q2 2026: $3.2B Data Center Project Anchors 1.2 GW BYOP Expansion
The BYOP project and pipeline signal a structural shift to higher quality, contracted earnings and scalable growth, but NRG is a well-known, mature player and the business model, while evolving, is not fully disruptive. The growth is strong but not at the extreme end of the spectrum, and while the project is large, the reinvestment runway is somewhat capped by the regulated/utilities nature of the business. The signal is solid but not extraordinary for a fund manager seeking outlier returns.
Yatra (YTRA) Q2 2026: Corporate Travel Adds 34 Clients, Drives 48% Revenue Lift
Yatra demonstrates strong growth, margin expansion, and clear strategic execution in a high-growth, under-penetrated market. The corporate travel runway and digital adoption provide evidence of future upside. However, while the business is outpacing the industry, the model is not fully self-reinforcing or disruptive at platform scale, and some metrics (ARPU, unit economics) are improving but not exceptional. Risks around restructuring and competitive intensity temper the signal.
Supergroup (SGHC) Q2 2026: Africa Revenue Jumps 36% as Betway Expands EPL Partnerships
Supergroup shows strong growth in Africa and improving margins, with clear evidence of customer value deepening (cross-sell, persistency). However, the reinvestment runway and business model are not fully exceptional or disruptive compared to the best-in-class, and growth is strong but not at the highest levels. The business is a growth story with good optionality, but not a hyper-scaler or highly disruptive model.
Povella Therapeutics (PVLA) Q2 2026: $230M Raise Fuels 40-Rep Launch Surge for First-in-Disease Pipeline
Povella is at a clear inflection, with a long reinvestment runway, a disruptive platform business model, and a multi-indication pipeline. The $230M raise and aggressive commercial buildout signal high conviction, and regulatory progress is substantial. However, while growth is strong, the company is not yet at the stage of proven, accelerating unit economics or customer value expansion—these remain forward-looking. The business is not yet a cash flow machine, and while growth potential is high, the signal is moderated by execution risk and the pre-approval stage.
Dario Health (DRIO) Q1 2026: Channel Reach Expands to 175M Covered Lives, Unlocking Platform Scale
Dario Health is at a major inflection, with a strong channel-driven runway and disruptive model. However, unit economics, customer value, and cash flow are improving but not yet at 'giant' levels. The business is transitioning to high-margin growth, but not all signal criteria are fully met for maximum scores.
Fuel Tech (FTEK) Q2 2026: APC Backlog Surges 104% as Data Center Pipeline Expands
Fuel Tech exhibits a strong backlog surge and double-digit growth, indicating an inflection, but much of the growth is dependent on future backlog conversion and execution. The business model has some self-reinforcing elements but is not yet fully compounding. Customer value is improving, but with some concentration risk. The business is transitioning toward growth, but margin compression and timing risk temper the signal. There is a disruptive angle (DGI, data centers), but the overall business is not yet a clear high-multiple compounder.
ElectroMed (ELMD) Q3 2026: Operating Income Jumps 76% as SmartVest Penetration Accelerates
ElectroMed is demonstrating strong growth, margin expansion, and a long runway in an underpenetrated market, but some signal questions (network effects, customer value, disruption, cash flow acceleration) are not fully at the highest level—there is strong execution, but not all elements point to exceptional, compounding signal or disruptive business model.
IMDX (Insight Molecular Diagnostics) Q2 2026: FDA Review Advances with $2B+ Market Opportunity Expansion
IMDX offers a long reinvestment runway with a disruptive business model and expanding TAM, but unit economics and customer value deepening are not yet proven at scale. The business is pre-commercial, so cash flow and revenue growth are still projected, not demonstrated. Regulatory and reimbursement catalysts support a strong future outlook, but execution risk and market adoption remain open questions.
FTW Q1 2026: $1B ABS Facility Unlocks Acquisition Runway, Dividend Set to Rise 11%
Presidio's business model is disruptive for the sector (acquisition-focused, tech-enabled, non-drilling), has a long reinvestment runway, and is positioned for growth. However, not all signals are 'giant' level yet: unit economics and customer value are improving but not at the highest tier, and future growth is strong but not 40%+ annualized. Still, the model and capital structure provide clear, differentiated signal for investors.
A2Z (AZ) Q1 2026: Contracted Backlog Surges to $195M as Smart Cart Deployments Shift to Scale
A2Z shows a long reinvestment runway with a disruptive business model and a major backlog inflection, but some metrics (unit economics, customer value, cash flow acceleration) are still early or only moderately improving. Growth is strong but not yet at hypergrowth levels. Signal is strong but not at maximum due to the early stage and some execution risk.
Contango Silver & Gold (CTGO) Q4 2026: $250M+ Operating Cash Flow Potential at $5,000 Gold Anchors Multi-Asset Execution
While Contango demonstrates a strong reinvestment runway, operational discipline, and some disruptive qualities, the business is not a breakout growth story yet. Unit economics and customer value are improving but not exceptional. The growth outlook is solid but not explosive, and the business model, while robust, is not highly disruptive. Overall, the signal is above average but not at the highest tier for upside.
Tsakos Energy Navigation (TEN) Q2 2026: Profit Sharing Surges to $71M, Backing $1B Revenue Outlook
While the business demonstrates strong recent growth and profitability, and is clearly in a growth phase, the underlying tanker shipping model is not highly disruptive or self-reinforcing long term. The profit-sharing surge is notable, but the business is still exposed to cyclical/geopolitical risks and lacks truly exceptional reinvestment runway or network effects. The outlook is strong but not category-defining.
Lantern Pharma (LTRN) Q2 2026: 25% Operating Loss Reduction Amid AI Spin-Off and Clinical Advancements
Lantern Pharma demonstrates a compelling dual-engine model with a long runway in both precision oncology and AI. The AI spin-off and biomarker-driven trials signal disruptive potential and growth, but clinical-stage risk and capital needs temper the signal. Unit economics are improving, but not at a giant scale yet. The business model is semi-self-reinforcing, and customer value is deepening modestly. Growth is strong but not consistently at a 40%+ pace. The piece signals transition to a growth business, but with caveats.
CurbLine Properties (CURB) Q2 2026: Acquisition Pace Doubles to $1B Target, Scaling Convenience Real Estate Platform
CURB demonstrates a strong growth trajectory, capital efficiency, and a scalable platform with significant acquisition momentum. While the business is not a disruptive technology platform and some metrics (like customer value and business model self-reinforcement) are still developing, the company’s roll-up strategy, low capex, and improving national tenant engagement indicate above-average signal for sector investors.
Carrier (CARR) Q2 2026: Data Center Orders Quadruple, Backlog Surges to $8B+
Carrier's quadrupling data center orders and record backlog signal a major secular growth inflection, with guidance and backlog supporting a strong near-term outlook. However, margin pressure and the legacy nature of some segments temper the signal score. The business model is evolving, but some elements (unit economics, self-reinforcement, customer value deepening) are not yet fully proven or exceptional. The signal is strong but not at the highest level due to these caveats.
BitGo (BTGO) Q2 2026: Digital Asset Sales Jump 84% as Margins Compress on Mix Shift
BitGo demonstrates strong revenue growth, a disruptive business model, and platform expansion, but margin compression and profitability challenges temper the signal. The reinvestment runway is long, and the company is positioned for optionality, but near-term financial strength and compounding effects are still emerging rather than fully realized.
IQVIA (IQV) Q2 2026: R&D Bookings Surge 19%, Backlog Quality and AI Differentiation Drive Guidance Raise
IQVIA shows strong growth in bookings, backlog, and margin leverage, with AI as a differentiator and clear customer value expansion. However, the reinvestment runway, self-reinforcing model, and disruptive potential are somewhat capped by the CRO industry structure and mature client base. Growth is robust but not at the highest acceleration, so signal is solid but not exceptional.
Nektar Therapeutics (NKTR) Q2 2026: $1B Cash Fuels Phase 3 Launch for Rezpegaldesleukin in Atopic Dermatitis
Nektar Therapeutics is positioned at a critical inflection with a large cash runway, a potentially disruptive immunology candidate, and a broad Phase 3 program. However, unit economics and customer value are not yet proven at scale, and while the growth opportunity is large, the business is not yet a high-growth compounding machine. There is strong signal from the business model and pipeline, but commercial proof and accelerating cash flow are not yet evident.
Hyperion DeFi (HYPD) Q2 2026: Adjusted Gross Profit Surges 20% Amid Strategic Reallocation of $1M HYPE Tokens
The business demonstrates a long reinvestment runway, recent significant business developments, improving unit economics, and strong growth signals. However, while the business model has some self-reinforcing aspects and customers are becoming more valuable, these are not yet at the highest level of compounding. Growth is strong but not exceptional, and while the business is innovative, it is not a category-defining disruptor. Revenue and EPS growth is robust but not at the highest tier.
MDA Space (MDA) Q2 2026: Backlog Surges to $4 Billion with 34% Revenue Growth and Strategic Acquisitions Accelerate Expansion
MDA Space demonstrates a strong growth trajectory, with a surging backlog, major acquisition-driven expansion, and new business models in development. The business is not yet showing accelerating cash flow or exceptional customer value deepening, and some business model self-reinforcement is still emerging. Growth is strong but not at the highest acceleration tier, and some metrics (unit economics, cash flow) are not fully at the 'giant' level.
EHang (EH) Q2 2026: Revenues Surge 203% QoQ Amid Regulatory Caution and Global Expansion Efforts
EHang demonstrates a disruptive business model with a long reinvestment runway and global expansion optionality. There are significant recent developments—over 200% QoQ revenue growth and new international regulatory progress. However, regulatory risks and delayed domestic passenger commercialization temper the signal, with some uncertainty around unit economics and future growth rates. Non-passenger segments are growing but not yet dominant. The business is transitioning toward growth, but execution and regulatory hurdles remain material.
Watts Water (WTS) Q2 2026: Data Center Sales Triple, Now 8% of Total, Recasts Growth Trajectory
Watts Water is experiencing a significant business evolution, with data center sales tripling and now representing a material portion of total sales. The business has a long reinvestment runway and strong growth, but some aspects (network effects, customer value, disruptive model) are present but not deeply entrenched. Growth is strong but not at the highest acceleration, and some risks around volatility and reliance on new vectors temper the signal score.
Hyperfine (HYPR) Q2 2026: Model 2 Drives 50% Unit Growth, International and Office Verticals Gain Traction
Hyperfine demonstrates clear growth levers and disruptive potential, with strong recent unit growth and international expansion. However, while margin improvement and new verticals are promising, the business remains early-stage with cash burn and execution risks, and not every metric is at the highest level of signal for a fund manager seeking a giant compounding opportunity.
Liberty Energy (LBRT) Q2 2026: Power CapEx Surges 50% as 3 GW Buildout Accelerates
Liberty Energy is transitioning to a high-growth digital power infrastructure platform, with a long reinvestment runway and a disruptive business model. There are significant recent developments (3 GW buildout, CapEx surge), but margin and unit economics are pressured in the near term. Customer value and business model self-reinforcement are emerging but not yet fully proven. The business is not yet showing exceptional growth metrics (>40% YoY), but the trajectory is strong and the strategy is thesis-relevant for investors.
Enovix (ENVX) Q2 2026: 41% Drone Pipeline Growth Signals Expanding Defense Opportunity
Enovix demonstrates a long reinvestment runway with disruptive technology and strong growth signals, especially in the defense pipeline. However, some areas—like unit economics, customer value expansion, and cash flow acceleration—are still in early stages or not fully proven, tempering the total signal score.
Elutia (ELUT) Q2 2026: Secures $26M Funding, Validates Surgeons’ Demand Ahead of NXT-41x Launch
Elutia is positioned for high growth with a major new product launch and strong demand validation, but it is still pre-commercial for NXT-41x and has not yet demonstrated improving unit economics at scale or fully compounding business model effects. The business is transitioning with a focused runway and clear growth ambitions, but some elements (like disruptive model or cash flow acceleration) are not yet fully proven.
Live Oak Bancshares (LOB) Q2 2026: Efficiency Ratio Improves 8 Points as Deposit Mix Shifts
Live Oak shows a long reinvestment runway and strong recent developments (significant deposit mix shift, AI rollout, and record loan originations). Unit economics and efficiency are improving, and the business is growing with clear optionality. However, network effects and customer value deepening are present but not dominant, and while growth is strong, it is not at hypergrowth levels. The business is innovative but not fully disruptive, and cash flow is improving but not accelerating dramatically. Overall, signal is strong but not exceptional for a well-followed digital bank.
Delcath Systems (DCTH) Q2 2026: Hepsado Kit Volume Jumps 30% as Center Expansion Targets Top Cancer Hubs
Delcath demonstrates a solid reinvestment runway, recent volume growth, improving margins, and a clear academic center expansion strategy. However, while the business is growing and transitioning toward broader opportunities, some elements (network effects, customer value deepening, disruptive model) are emerging rather than fully entrenched, and near-term growth rates/guidance, while strong, do not signal an exceptional inflection.
Ideal Power (IPWR) Q2 2026: Sales Funnel Expands to $400M, Supply Agreement Secures Cost-Effective Scale
Ideal Power has a long reinvestment runway and disruptive business model, with a significant sales funnel and large market opportunities (AI data centers, EVs). However, revenue is still nascent, unit economics are not yet proven at scale, and customer value deepening is still emerging. Growth is expected but not at a giant scale yet, and execution risk is high.
ALT (Altimmune) Q2 2026: $519M Cash Fuels Late-Stage Liver Disease Franchise Expansion
Altimmune demonstrates a long reinvestment runway, recent significant clinical developments, and a disruptive dual-mechanism approach. However, unit economics and customer value depth are still emerging, and while growth is strong, it is not yet at an exceptional (40%+) level. The business is clearly growth-oriented but not yet a proven giant.
CoinCheck Group (CNCK) Q1 2027: Crypto as a Service Partnerships Jump, Driving 36% Revenue Surge
CoinCheck demonstrates a long reinvestment runway, recent major developments, and a disruptive, platform-based model with strong embedded partnerships. However, unit economics and customer value improvements are emerging but not yet exceptional, and near-term profitability remains elusive. Growth is strong but not explosive, and while the business is positioned for inflection, much depends on external regulatory catalysts.
LPA (LPA) Q2 2026: 26% Revenue Growth Accelerates Mexico Expansion Strategy
LPA demonstrates a strong growth profile with a clear reinvestment runway and recent significant revenue uptick. However, while unit economics and cash flow are improving, the business model is not fully disruptive and some aspects (customer value, business model self-reinforcement) are only modestly improving. The company is a growth business but not at the highest acceleration tier, and while the outlook is positive, it is not exceptional enough to warrant top scores across all signal dimensions.
Teledyne (TDY) Q2 2026: Backlog Surges to $5B, Digital Imaging Margin Hits 25%
Teledyne is a high-quality compounder with a strong backlog, margin expansion, and accelerating cash flow, but the business is relatively mature and well-followed. While digital imaging and unmanned systems provide some optionality and growth, the overall reinvestment runway is not exceptional. There are clear signals of growth, but not at a level that would suggest outsized near-term upside or a disruptive business model.
QuantumScape (QS) Q2 2026: Customer Billings Surpass 2025, Multi-Vertical Ramp Accelerates
QuantumScape shows a long reinvestment runway, disruptive model, and growth business characteristics. However, while there is strong commercial progress and vertical expansion, unit economics and customer value deepening are still emerging rather than fully proven, and financial performance is not yet exceptional. The business is not yet at the stage of explosive growth or cash flow, but the signal is above average due to the multi-vertical ramp and strategic partnerships.
ANI Pharmaceuticals (ANIP) Q2 2026: Cortofan Sales Surge 43% Amid Rare Disease Expansion
ANI is showing strong revenue and EBITDA growth with a rare disease runway (Cortofan, salesforce expansion), but the business is not fundamentally disruptive or network-driven. Unit economics are improving but not at a 'giant' scale, and while growth is high, the business model is not unique or likely to deliver outlier returns versus other specialty pharma. The signal is strong but not exceptional for a fund manager seeking unique upside.
NextNRG (NXXT) Q2 2026: 41% Revenue Growth Signals Strengthening Operating Foundation
NextNRG demonstrates strong revenue growth, a disruptive integrated energy platform, and improving operating leverage. There is a clear reinvestment runway with emerging technology, but some elements (unit economics, customer value, cash flow) are still in early stages or only modestly improving. The business is transitioning toward scale but is not yet a proven high-growth compounder.
Cibus (CBUS) Q2 2026: Platform Scalability Drives 35% Revenue Growth Amid Regulatory Tailwinds
Cibus demonstrates a long reinvestment runway, recent regulatory and commercial momentum, and a disruptive business model. However, the business is still transitioning; while growth is strong, it is not yet exceptional or at giant scale, and some metrics (unit economics, customer value) are improving but not yet compounding. The business is positioned for growth, but execution risk and visibility beyond 2027 remain.
MindWalk Holdings (HYFT) Q4 2025: Recurring Platform Revenue Debuts, Gross Margin Expands to 61%
MindWalk is at an inflection point with the debut of recurring SaaS revenue and strong gross margin expansion, suggesting a disruptive, high-optional business model. However, platform revenue is still nascent and the majority of revenue remains project-based, so the signal is not yet at the highest level. There is clear growth and some disruptive potential, but the business is not yet a scaled, high-velocity compounding platform.
Americas Gold and Silver (USAS) Q2 2026: 71% Revenue Surge Driven by Operational Advances and Strategic Upgrades
Americas Gold and Silver is showing strong growth, operational leverage, and a significant production ramp, but it is still a relatively small-scale producer with moderate optionality and only emerging self-reinforcing business model characteristics. While the revenue surge and cost improvements are notable, the business is not yet a clear outlier in terms of disruptive potential or exceptional growth (>40%), and some uncertainty remains around execution and commodity price volatility.
Atea Pharmaceuticals (AVIR) Q2 2026: Phase III Success and $219.5M Cash Position Set Stage for Hepatitis C Market Expansion
Atea demonstrates a long reinvestment runway with a differentiated product at a pivotal clinical stage, strong cash reserves, and pipeline diversification. The Phase III success and approaching regulatory milestones are strong signals, but the business is still pre-commercial and faces execution and reimbursement risks. There is some evidence of improving unit economics and strategic market positioning, but not all aspects (e.g., self-reinforcing business model, customer value deepening) are fully demonstrated yet. Growth potential is high but not yet proven in commercial outcomes.
Aya Gold & Silver (AYA) Q2 2026: 61% AgEq Production Surge Fuels Cash Flow and Growth Pipeline
Aya Gold & Silver is showing strong growth and cash flow acceleration, with notable production and revenue increases. However, as a mid-tier mining company, its reinvestment runway and business model disruptiveness are moderate rather than exceptional. While there are significant developments and clear growth, the business is not a category-defining disruptor or likely to post 40%+ annual growth for multiple years. Signal is strong but not at the highest level for a fund manager seeking outlier upside.
Alpha Cognition (ACOG) Q2 2026: Zunvale Sales Surge 71%, Commercial Momentum Builds Despite Payer Access Delays
Alpha Cognition demonstrates a strong growth trajectory with Zunvale, showing clear revenue and prescription increases, high repeat rates, and a path to profitability. However, the business model is not fully self-reinforcing yet (payer access is still a gating factor), and while growth is strong, it is not yet at an exceptional or disruptive level. The company is moving from transition to growth, but uncertainties around payer access, regulatory changes, and market expansion limit the signal score.
Allogene Therapeutics (ALLO) Q2 2026: Accelerated Site Activation to 100 Boosts Alpha 3 Enrollment Momentum
Allogene shows a long reinvestment runway and disruptive model with regulatory tailwinds and pipeline breadth. There is strong growth potential and clear operational execution, but some metrics (unit economics, customer value, cash flow, and near-term growth rates) are still emerging or not at the highest threshold. The business is transitioning toward pivotal validation, but not all signal criteria are at the maximum level.
BTQ Technologies (BTQ) Q2 2026: Quantum Product Validation Accelerates Commercial Path with $150M ATM Funding
BTQ is in a high-growth, disruptive quantum security space with a long reinvestment runway and clear strategic inflections (ATM raise, product validation, government mandates). However, some evidence for rapidly improving unit economics, self-reinforcement, and accelerating cash flow is still emerging rather than proven. Revenue growth is anticipated but not yet at the 40%+ level, and the business is transitioning from R&D to commercial execution. Signal is strong but not at the highest possible level due to the early stage and some execution risks.
Black Rock Coffee Bar (BRCB) Q2 2026: 25% Revenue Growth Fuels Raised Store Expansion and Margin Gains
Black Rock Coffee Bar demonstrates a strong reinvestment runway and high returns on capital, with 25% revenue growth and a raised store opening outlook. However, while the business is growing rapidly, it does not show signs of being highly disruptive or having deepening network effects (hence some 1s). Unit economics and margins are improving, and the growth trajectory is robust, but not at a level of hypergrowth or exceptional disruption. The business is solidly in the growth category, but the signal is somewhat tempered by its competitive, non-networked business model.
USA Rare Earth (USAR) Q2 2026: $1.5B Cash and Strategic Acquisitions Propel Rare Earth Supply Chain Leadership
USAR demonstrates a long reinvestment runway, recent significant developments, and a disruptive business model with government de-risking. However, unit economics, customer value, cash flow, and growth rates are not yet at the highest levels—reflecting an early-stage transition from build to delivery. Signal is high but not maximal due to execution and ramp risks.
Quantum Computing Inc. (QUBT) Q1 2026: Acquisitions Drive $3.7M Revenue Surge, Integration Expands Quantum Platform
QUBT shows a long reinvestment runway with high optionality due to the acquisitions and manufacturing buildout. There is a step-change in growth (acquisition-driven), but organic growth is still early. Unit economics and customer value are improving but not yet proven at scale. The business model is disruptive, and cash flow is improving but not yet accelerating. Growth is strong but not consistently above 40%. The business is transitioning to growth, but execution risk remains high.
Vertical Aerospace (EVTL) Q2 2026: $148M Cash Raised to Propel Certification and Hybrid Flight Milestones
Vertical Aerospace demonstrates a long reinvestment runway and recent significant developments (notably the large capital raise and flight milestones). However, unit economics, business model self-reinforcement, and customer value expansion are still emerging rather than fully realized. The business is disruptive with a hybrid model, but cash flow and growth rates are not yet exceptional. Execution risk and certification delays temper the overall signal score.
Picard Medical (PMI) Q4 2025: U.S. Revenue Jumps 34% as Artificial Heart Adoption Intensifies
Picard Medical is at a strategic inflection with a disruptive, innovation-led pipeline and a clear margin-expansion story. The U.S. market focus and Emperor platform create a long runway, but unit economics and self-reinforcing business model are still emerging. Growth is strong but not yet at hyper-scaler levels, and risks around execution and capital needs remain. The signal is high for a small-cap medtech, but not at the level of an established compounding giant.
AMBQ Q2 2025: China Revenue Falls to 12% as Edge AI Mix Drives Gross Margin to 43%
AMBQ is in a transitional but high-upside phase: long reinvestment runway, disruptive edge AI/IP model, and a significant pivot away from China. However, while margin and mix are improving, unit economics are not yet clearly scaling, and customer value deepening is still emerging. Growth is not yet at hyper-scale, and some execution risk remains, so signal is strong but not at the highest level.
Plexus (PLXS) Q3 2026: Funnel Expands 23% to $4.5B, Powering Multi-Year Growth Visibility
Plexus shows strong growth, a record funnel, and above-market revenue expansion with high ROIC, but its business model, while showing some sector leadership and operational leverage, is not deeply disruptive or self-reinforcing at the level of a true compounding giant. Customer value and cash flow are improving but not exceptional, and sector cyclicality remains a risk.
Autolus Therapeutics (AUTL) Q2 2026: AUCATZYL Sales Surge 119% Fuels Gross Margin Jump to 55%
Autolus demonstrates strong commercial momentum, margin expansion, and a robust pipeline—clear signals of a growth business with reinvestment opportunity. However, network effects and customer value deepening are present but not yet exceptional, and the business model, while innovative, is not fully disruptive. Revenue and EPS growth are strong but not at hypergrowth levels, and while backlog/guidance is positive, it is not exceptional. The signal is solid but not at the highest level for a truly unique or explosive business.
StreamX (STEX) Q1 2026: $50M Debt Retired, Institutional Partnerships Set Stage for Tokenized Asset Scale
StreamX displays a long reinvestment runway, disruptive business model, and clear inflection with debt retired and institutional partnerships secured. However, the business is still pre-revenue with only early proof of concept and modest AUM, so unit economics and customer value deepening are not yet fully demonstrated. Growth is expected but not yet proven at a high rate. The signal is above average for a new platform, but not yet at the level of a proven compounding flywheel.
Infinity Natural Resources (INR) Q2 2026: 75% Production Growth Drives Record $115M Adjusted EBITDAX
The business is showing strong production growth, margin expansion, and capital efficiency, with a long runway via midstream leverage and asset integration. However, some elements (network effects, customer value deepening, business model disruption) are present but not exceptional or unique, limiting the score. Growth is strong but not in the uppermost tier for signal.
Sol Strategies (STKE) Q3 2026: Houdini Acquisition Adds $1.2M Revenue in First Month, Accelerating Blockchain Infrastructure Growth
Sol Strategies demonstrates strong growth signals: a disruptive business model, revenue diversification, and a major acquisition with high margins. However, some metrics (unit economics, customer value, cash flow) are early-stage or only moderately improving, and the business is still exposed to crypto volatility. The company is growth-oriented with a long runway, but not all signals point to imminent hypergrowth.
Echo Wave Power (WAVE) Q2 2025: R&D Spend Jumps 25% as Portugal Megaproject Nears Launch
Echo Wave Power is a high-risk, high-upside early-stage business with a disruptive model and global partnerships. There is a long reinvestment runway and clear growth signals (R&D, pipeline, global deals). However, evidence of accelerating cash flow, consistent unit economics improvement, and customer value deepening is still nascent. Execution risk and unproven commercial conversion temper the signal score.
AAON (AAON) Q2 2026: Net Sales Double on 216% BASX Growth, Margin Pressure from Capacity Ramp
AAON is experiencing explosive growth in its BASX segment, with a long runway in data center cooling, strong backlog, and capacity expansion. However, while margins are expected to recover, current margin compression and the capital intensity of scaling temper the overall signal. The business is transitioning into a growth phase, but not all elements (e.g., network effects, disruptive model) are at the highest tier.
Ballard Power (BLDP) Q2 2026: GeoPura Deal Targets 3x Growth and 28-Point Margin Surge
Ballard's acquisition of GeoPura and the shift to an energy-as-a-service model present a significant strategic evolution with long-term growth runway and disruptive potential. The business is not yet a giant, and while margins and recurring revenue are improving, the pace and scale of improvement are not yet exceptional. The business model is becoming more self-reinforcing, but not at the scale of a dominant network-effect player. Revenue growth is strong but not at hypergrowth levels.
Firefly Aerospace (FLY) Q3 2025: Backlog Climbs to $1.3B as SciTech Acquisition Expands Defense Pipeline
Firefly shows a long reinvestment runway, a disruptive business model, and a large backlog driven by national security and lunar opportunities. However, unit economics and customer value deepening are still emerging, and while growth is strong, it's not yet at the exceptional level for signal. Cash flow is negative and risks remain around execution and government contract timing.
1&1 Green Technologies (YDDL) Q2 2025: Copper Ingot Sales Surge 125%, Margin Expands 340bps on Supply Chain Advantage
The business is showing strong growth, clear margin expansion, and benefits from a structural trade advantage. However, while the runway is promising and the business is transitioning to growth, there is some concentration risk (heavy reliance on copper) and not all aspects (customer value, business model disruption, cash flow) are exceptional or fully proven yet. Signal is strong for a smallcap industrial, but not at the highest level.
KORU Medical (KRMD) Q2 2026: International Revenue Jumps 59% as Platform Expansion Accelerates
KORU Medical demonstrates a long reinvestment runway, significant international revenue growth, improving unit economics, and a transition to a digital health platform. However, some self-reinforcing business model elements and customer value expansion are emerging rather than fully established. The business is growth-oriented but faces moderate volatility and execution risk, with some metrics (e.g., growth rates, cash flow) not at the highest threshold for a disruptive, high-velocity compounding business.
Warrior Met Coal (HCC) Q2 2026: Blue Creek Lifts Sales 65%, Ignites Margin Expansion
Blue Creek is a material new asset, driving volume and margin inflection, but the business remains exposed to commodity cycles and is not a disruptive or high-ROIC compounding model. Cash flow is accelerating, and the turnaround is real, but the upside is bounded by coal market realities. The signal is strong for a traditional operator, but not exceptional for a growth compounder.
IPG Photonics (IPGP) Q2 2026: Emerging Growth Products Hit 58% of Revenue, Signaling Value Chain Shift
IPG Photonics is showing a strong business evolution with a clear mix shift, double-digit growth, and a long runway in emerging products. However, some elements (network effects, customer value deepening, and disruptive model) are present but not dominant or fully proven, and the revenue growth, while strong, is not consistently above 20% in all areas. The business is clearly transitioning to growth, but some metrics (e.g., future guidance, margin structure) are still in flux.
Forum Markets (FRMM) Q1 2026: 28% Share Buyback Reshapes Capital Base, AI Asset Pipeline Accelerates
Forum Markets is in a high-growth, disruptive vertical (AI infrastructure financing, tokenization), and the 28% buyback is a major capital allocation event. However, while the business model has significant potential, the current scale and financials reflect a transition phase, with some uncertainty around execution and pace of recurring revenue growth. The signal is strong but not at the highest level due to these transitional risks and the early stage of some initiatives.
ARBE Robotics (ARBE) Q2 2026: 133% Revenue Growth Highlights Early Success in Defense and Robo-Taxi Markets
ARBE demonstrates high revenue growth, diversification, and a disruptive model with clear optionality, but the business is still early-stage with modest absolute revenues and some uncertainty around scale and profitability. The signal is strong for a niche/small-cap, but not at the level of a dominant compounding business.
Acadia Pharmaceuticals (ACAD) Q2 2026: Debut Stix Drives 30% Growth as EU Launch Nears
Acadia demonstrates a strong growth profile with new product launches, international expansion, and a pivotal pipeline catalyst. However, some elements—such as customer value deepening, business model self-reinforcement, and disruptive potential—are present but not exceptional or fully proven. The business is a growth story but not yet a clear outlier in terms of long-term compounding or disruptive potential.
Merlin (MRLN) Q1 2026: $183M Cash Infusion Extends Runway for Autonomous Aviation Platform
Merlin has a long reinvestment runway, disruptive platform potential, and strong capital position. However, current growth is modest, unit economics are not yet proven at scale, and recurring revenue is still early-stage. The business is transitioning to growth but lacks evidence of >20% top-line acceleration or exceptional customer monetization. Signal is above average due to platform optionality and industry paradigm shift, but not at the highest tier due to early-stage risk.
EOLS Q1 2026: Evelis Rewards Membership Surges 27%, Accelerating Platform Engagement
Evolus shows a long reinvestment runway, clear growth levers, and improving customer value, but the business is not highly disruptive and unit economics, while strong, are not yet at giant scale. The business is transitioning to growth with some acceleration, but not at an exceptional pace. The model is differentiated but not completely defensible against larger competitors, and while cash flow is improving, it is not yet a cash machine. The signal is solid but not extraordinary.
AXIL Brands (AXIL) Q4 2026: 49% Revenue Surge Driven by Retail Expansion and Product Innovation
AXIL demonstrates a strong reinvestment runway and significant recent growth, with a disruptive shift to multi-channel retail and robust margin improvement. However, some aspects—such as customer value deepening, self-reinforcing business model, and cash flow acceleration—are promising but not yet clearly exceptional or compounding at the highest level. The business is in strong growth mode but not yet at the highest signal tier for all strategic dimensions.
Wayfair (W) Q2 2026: Paragold Surges 35% as Specialty and Luxury Outpace Mass Segment
Wayfair shows strong specialty/luxury growth and margin inflection, but the core business is mature and international remains a drag. The business model is semi-disruptive with some self-reinforcing elements, but not a clear runaway compounding platform. Growth is solid but not at the highest levels, and while cash flow is improving, it's not yet a cash machine. The outlook is positive but not exceptional, warranting a conservative signal score.
Alnylam (ALNY) Q2 2026: Amvutra First-Line Penetration Drives 74% TTR Revenue Growth Amid Guidance Reset
Alnylam has a strong growth profile, a disruptive RNAi platform, and a long reinvestment runway. However, while first-line growth is strong, some metrics (unit economics, future guidance, customer value) are improving but not exceptional. The business is not in hypergrowth, and competitive/payer risks temper the signal.
Rigel Pharmaceuticals (RIGL) Q2 2026: Vepinu Launch Unlocks $1B Breast Cancer Opportunity
Rigel is transitioning from a niche to a broader oncology platform with a disruptive product launch (Vepinu) and pipeline optionality (R289). The business model is evolving with some self-reinforcing elements, but not all metrics (unit economics, customer value, cash flow) are proven at scale. Growth is strong but not yet in the hyper-growth category, and risks around execution and profitability remain. Signal is solid but not exceptional.
Velo3D (VELO) Q4 2025: Backlog Doubles to $31M, Signaling Accelerating Defense and Aerospace Demand
Velo3D shows a long reinvestment runway and disruptive model with strong backlog growth and a strategic pivot to high-margin services. However, some elements (unit economics, customer value deepening, and cash flow acceleration) are not yet fully proven or at scale, and backlog conversion risk tempers the signal. Growth is robust but not at the highest acceleration threshold.
Niagen Bioscience (NAGE) Q2 2026: E-Commerce Climbs 14% as Skincare and Pharma Bets Scale
Niagen has a long reinvestment runway and disruptive platform optionality, with recent growth in e-commerce and pipeline progress. However, unit economics and customer value are improving but not yet exceptional, and future cash flow acceleration is moderate. The business is transitioning to growth, but some signals (e.g., pharma pipeline, ingredient headwinds) are still emerging rather than fully realized.
Everest Medicines (EVEX) Q2 2026: Travere Deal Unlocks Multi-Indication Upside for BTK Franchise
Everest Medicines is transitioning from a regional to a global innovator with a disruptive, pipeline-in-a-product approach and clear growth levers. The Travere deal and platform innovation signal strong optionality and high growth potential, but some elements (unit economics, customer value, cash flow, and near-term growth rates) are promising but not yet exceptional or fully proven, warranting a conservative signal score.
Precipio (PRPO) Q2 2026: Revenue Surpasses $7M as Product Sales Surge 35%, Driving Positive EBITDA and Cash Flow
Precipio is showing strong sequential product sales growth and a positive inflection in EBITDA and cash flow, indicating a transition to self-funded growth. The business model shows some self-reinforcing aspects, but network effects and customer value deepening are only modest. The recent acceleration in product sales is significant, but overall growth rates, while impressive, are not yet at the highest tier. The company is transitioning from a legacy lab services business to a higher-margin, product-driven model, but the ultimate runway and disruptive potential remain to be proven.
Arrive AI (ARAI) Q2 2026: Pipeline Momentum Drives Supply Chain Expansion and Patent Leadership
Arrive AI is positioned at a key inflection point with a long reinvestment runway and disruptive business model, but is still in early commercialization with moderate improvements in unit economics and customer value. Growth is present but not yet at exceptional levels, and cash flow is not yet accelerating. The business is not yet a giant but shows strong optionality and vertical focus.
Nautilus Biotechnology (NAUT) Q2 2025: Operating Expenses Down 18% as Platform Validation Accelerates
Nautilus has a long reinvestment runway and disruptive platform, with strong recent validation and strategic collaborations. However, the business remains pre-revenue and unit economics, customer value expansion, and growth rates are not yet proven at scale. The signal is high for early-stage innovation, but near-term financial impact and upside are not yet clear, warranting a conservative score.
Iron Mountain (IRM) Q2 2026: Growth Businesses Surge to 35% of Revenue, ALM Up 88% as Data Center Pipeline Expands
Iron Mountain is transitioning from a legacy business to a growth-oriented platform, with significant uptick in growth segments and strong recent performance. However, the business is not truly disruptive, reinvestment runway is moderate (not exceptional), and while growth is strong, it is not at the extreme levels seen in the most explosive growth companies. There are clear improvements in unit economics and customer value, but the model is not self-reinforcing to the degree of the highest-scoring businesses.
Belite Bio (BLTE) Q2 2025: Dragon Phase 3 Nears 24-Month Endpoint, FDA Single-Study Approval Path in Focus
Belite Bio is a late-stage biotech with high optionality and a clear regulatory path, but lacks commercial proof points and recurring revenue. The business is not yet self-reinforcing, and while the runway and regulatory clarity are strong, there is still significant execution and trial readout risk. Signal is strong for a biotech, but not at the highest level due to pre-commercial status.
BranchOut Food (BOF) Q2 2026: Production Set to Double Driving Margin Expansion and Recurring Revenue Growth
BranchOut demonstrates a strong growth runway (production doubling, recurring orders), recent major developments (Sam's Club deal), and improving unit economics. However, network effects and customer value deepening are only modestly evident, and while growth is strong, it is not at the highest tier. The business is transitioning to growth but not yet a proven compounding machine.
ProMIS Neurosciences (PMN) Q2 2026: Zero ARIA-E Cases Validate Oligomer-Selective Alzheimer's Approach
ProMIS shows strong signs of a disruptive, high-upside biotech at a pivotal clinical inflection, with validated safety and early biomarker efficacy, a robust cash runway, and a diversified pipeline. However, some signal points are limited by the lack of full efficacy data, early stage of revenue generation, and the need for further proof of scalable economics and customer value. The business is not yet proven to be a cash flow machine or to have accelerating financials, but the strategic positioning and upcoming catalysts are significant.
Merlin, Inc. (MRLN) Q2 2026: $183.9M Cash Strength Fuels Autonomous Flight Certification and Market Expansion
Merlin is early-stage but shows strong reinvestment runway, disruptive potential, and a large addressable market. Recent developments are significant, but revenue and cash flow are not yet accelerating at a high rate, and unit economics are still in investment mode. The business model is self-reinforcing but not yet at scale, and customer value expansion is more prospective than proven. The company is a growth business, but execution and regulatory risk temper the signal score.
Keele Infrastructure (KEEL) Q1 2026: $533M Liquidity Fuels Three-Site Lease Push in Supply-Constrained Markets
Keele's pivot creates a long reinvestment runway with disruptive potential in digital infrastructure, ample liquidity, and clear growth levers. However, lease conversion and unit economics are not yet proven, and while the model is attractive, the business is not yet at escape velocity—execution risk remains high. The signal is strong for a transitioning, high-upside story, but not yet a proven compounder.
Health In Tech (HIT) Q2 2026: Contracted Revenue of $32.3M Signals Robust Growth Pipeline Despite GAAP Revenue Timing Shift
Health In Tech has a long reinvestment runway with high potential ROIC, recent significant developments (A-rated carrier, Hittrix launch), and is a growth business. However, unit economics and customer value are still emerging, not yet exceptional. The business model is disruptive and platform-based, but network effects and compounding advantages are not yet fully proven. Cash flow is not yet accelerating. Revenue and EPS growth are projected to be strong but not at the highest tier. Overall, signal is high but not at the maximum due to the early stage and some execution uncertainty.
Firefly Aerospace (FLY) Q2 2025: $1.3B Backlog and 25.7% Margin Signal National Security and Lunar Tailwinds
Firefly demonstrates a long reinvestment runway with high returns, recent significant backlog growth, and a disruptive business model with strong government and commercial tailwinds. However, while margin and data streams are improving, unit economics and customer value deepening are still emerging and not yet compounding at scale. Cash flow is improving but not yet accelerating, and revenue/earnings growth is likely to be strong but volatile due to milestone-based recognition. The business is transitioning from early-stage to growth, with high potential but some execution risk.
Generac (GNRC) Q2 2026: Data Center Backlog Jumps $1B, Tripling Capacity Runway
Generac demonstrates a significant strategic inflection with a $1.6B data center backlog and multi-year visibility, supporting a growth thesis. However, while the reinvestment runway and growth are strong, some signals (unit economics, self-reinforcing model, customer value) are promising but not yet at the highest level of compounding or disruption. The business is clearly transitioning to a higher-growth phase, but some risks and execution dependencies temper the upside.
Rivian (RIVN) Q2 2026: R2 Launch Drives 27% Revenue Jump, Sets Stage for Mass Market Expansion
Rivian is at an inflection point with the R2 launch and strong software growth, offering a long reinvestment runway and disruptive potential. However, margin and unit economics are not yet clearly improving, and some metrics (customer value, cash flow, growth rates) are positive but not exceptional. The business model has high potential, but execution risk and competitive threats remain, limiting the signal score.
Wilden Group (WLDN) Q2 2026: Commercial Revenue Climbs to 25% of Mix, Diversification Drives Margin Expansion
Wilden Group is showing strong growth, a business model shift, and expanding margins. There is clear evidence of reinvestment runway, acquisition-driven growth, and complex project wins. However, while the model is improving, network effects and customer value deepening are more moderate, and growth, while robust, is not at the most extreme levels. The business is transitioning toward a growth model, but not yet a hypergrowth or highly disruptive story.
AirJoule Technologies (AIRJ) Q2 2026: Kubota Partnership Unlocks Residential Water Scarcity Market with 2 Prime Systems Deployed
AirJoule is at an inflection point with disruptive technology and a long runway, but commercial revenue is not yet material and unit economics are still being validated at scale. The Kubota partnership and global expansion offer high potential, but the business is not yet a proven cash flow machine and growth, while promising, is not yet accelerating at >40%. Risks around execution and adoption remain.
PDF Solutions (PDFS) Q2 2026: SecureWise Eight-Figure Deal Expands Market Standardization
PDF Solutions demonstrates a long reinvestment runway, strong recent developments (SecureWise contract), and compounding business model attributes. However, some metrics (unit economics, customer value, cash flow growth) are positive but not exceptional, and growth, while robust, is not at the highest tier. The business is clearly a growth story with disruptive elements, but not at the extreme end of signal.
NUTEX Health (NUTX) Q2 2025: Arbitration Revenue Hits 71% of Hospital Segment, Fueling Cash Flow Surge
NUTEX exhibits strong recent growth and margin expansion driven by arbitration, with clear operational leverage and cash flow acceleration. However, the business is highly dependent on a single regulatory mechanism (NSA arbitration), limiting its reinvestment runway and compounding advantages. While the growth is robust, the sustainability and optionality are constrained by regulatory and collection risks. The model is disruptive for out-of-network providers but not broadly across healthcare, and customer value deepening is modest. The business is in a strong growth phase, but risk concentration tempers the signal score.
BrightSpring (BTSG) Q2 2026: Provider Services Up 30% as Margin Expansion Accelerates
BrightSpring is growing rapidly (30%+ in key segments, 23% overall), with clear margin expansion and strong cash flow conversion. However, the reinvestment runway is moderate due to regulatory headwinds and the business model, while some compounding advantages (network effects, customer value deepening) are present but not dominant. The M&A pipeline and integration success are notable, but the business is not exceptionally disruptive or offering 40%+ growth. The signal is strong but not at the highest tier for unique upside.
Unicure (QURE) Q2 2026: $188M Cash Infusion Extends Runway as AMT-130 BLA Nears Submission
Unicure is at a pivotal stage with a potentially transformative asset (AMT-130), a long cash runway, and regulatory clarity. However, while the reinvestment runway and disruption potential are strong, the business is not yet demonstrating accelerating cash flow or revenue growth, and unit economics/customer value are not fully proven. The model is disruptive, but the signal is capped by execution risk and the binary nature of the lead asset.
Corvex (MOVE) Q2 2026: Contracted Annualized Recurring Revenue on Live Compute Reaches $22 Million
Corvex has a long reinvestment runway and recent significant ARR growth, but its unit economics and business model compounding are still developing rather than fully proven. While disruptive and growth-oriented, some metrics (cash flow, ARPU, and backlog acceleration) are not yet exceptional. The business is promising and high-signal, but not at the highest tier of outsized upside based on current evidence.
Baidu (BIDU) Q2 2025: AI Cloud Revenue Jumps 27% as ApolloGo Scales Global Partnerships
Baidu demonstrates a long reinvestment runway and disruptive business model with strong growth in AI Cloud and ApolloGo. However, unit economics and customer value, while improving, are not yet exceptional. Growth is accelerating but not at the highest tier, and cash flow is pressured by heavy investment. The business is in a clear transition to growth, but risks and execution uncertainty temper the overall signal.
CBOE (CBOE) Q2 2026: Options Revenue Jumps 30% as Retail Surge and New Products Expand Growth Runway
CBOE is showing strong growth, especially in options and new product areas, with some disruptive potential (event contracts, prediction markets). However, as a large, established exchange, its reinvestment runway is not as long or high-ROIC as a true emerging disruptor, and some business model advantages are present but not deepening at the rate of a compounding platform. Growth is strong but not at hypergrowth levels, and some segments are more mature.
Epsilon Energy (EPSN) Q4 2025: Proved Reserves Surge 86% on Powder River Basin Acquisition
Epsilon now possesses a multi-year reinvestment runway with high-return inventory from the Peak acquisition. There is a significant uptick in reserves and production, but growth is not at hyper-scaler levels. Unit economics and cash flow are improving, but the business model is not fully self-reinforcing. Customer value and business model disruption are moderate. Cash flow is improving, but not dramatically accelerating. Growth is solid but not explosive, and the business is transitioning into a growth phase.
AIXC (AIXC) Q4 2025: $41M Capital Infusion Ignites AI-Blockchain Infrastructure Pivot
AIXC demonstrates a long reinvestment runway and disruptive business model with the AI-blockchain pivot and RWA focus (Q1, Q7). The $41M capital raise and user growth signal major business evolution (Q2), but commercial revenue is not yet proven and unit economics remain to be validated (Q3, Q5, Q8). The platform has emerging self-reinforcing elements (Q4), and the future outlook is positive but not yet exceptional (Q6, Q9). The business is clearly transitioning to growth (Q10), but execution risk and governance complexity temper the signal.
ABOS (Acumen Pharmaceuticals) Q2 2026: $110M Cash Position Supports Key Alzheimer’s Trial Readout and Pipeline Expansion
Acumen is pre-commercial but has a potentially long reinvestment runway if its Phase II trial is positive. The upcoming clinical readout is a major catalyst, and pipeline expansion provides some optionality. However, as a clinical-stage biotech, unit economics and customer value are not yet proven, and while the business model is disruptive, it is not yet self-reinforcing or cash-generative. Growth potential is significant but highly contingent on trial success.
Neuropace (NPCE) Q2 2026: RNS Revenue Grows 21%, AI Tools Enhance Clinical Adoption
Neuropace has a clear growth runway with expanding indications, strong revenue growth, and product innovation. However, while the business is not yet at the scale of a giant and some metrics (unit economics, customer value, cash flow) are improving but not exceptional, the company is executing well. The model is semi-disruptive with AI integration and regulatory catalysts, but some elements (e.g., margin expansion, cash flow) remain in progress rather than fully realized.
Enphase Energy (ENPH) Q2 2026: Europe Grows 35% as Battery and Data Center Bets Reshape Portfolio
Enphase has a long reinvestment runway (Europe, commercial, data centers) and is pivoting to higher growth segments. There is a 35% uptick in European growth and strong battery adoption, but overall company growth is more modest due to U.S. headwinds. Unit economics and customer value are improving in Europe, but less so in the U.S. The business model is becoming more self-reinforcing with financing and platform leverage, but still has limited recurring revenue. There is clear disruption potential and cash flow is positive, but not yet accelerating. Revenue growth is moderate, with some high-growth pockets, but the overall business is transitioning, not yet a pure growth engine.
Telesat (TSAT) Q2 2026: $2.7B ESCAPE Contract Drives 44% Lightspeed Constellation Expansion
Telesat demonstrates a long reinvestment runway with major government contract wins and a large, growing backlog. There is a significant business evolution with the ESCAPE contract and Lightspeed expansion. Some questions (unit economics, self-reinforcing model, customer value) are only moderately addressed, as much of the growth is still in backlog and not yet proven in operational metrics. The business is clearly transitioning to a growth phase with potential for high future returns, but some execution and competitive uncertainties remain.
Roll Mata Therapeutics (RLMD) Q2 2025: NDV-01 Achieves 91% Response Rate, Expands Bladder Cancer Opportunity
RLMD is pre-commercial but shows a long runway with a disruptive therapy in NMIBC and a novel neuropsychiatric asset. The 91% response rate is a major positive inflection, but the business is still in transition and not yet demonstrating compounding economics or accelerating cash flow. The business model is innovative but not yet self-reinforcing; customer value and future growth are promising but unproven at scale.
Exodus (EXOD) Q1 2026: Monovate Acquisition Targets 40% Revenue Mix Shift by 2027
Exodus is undergoing a major strategic pivot with significant potential for value creation, as evidenced by the Monovate acquisition and new recurring revenue streams. The business is moving toward a disruptive, high-optional model with a long runway, but current financials remain vulnerable to crypto cycles and recurring revenue is not yet scaled. While the future could be exceptional if execution succeeds, the present signal is limited by integration risk, lack of immediate growth acceleration, and early-stage adoption in new segments.
Terrestrial Energy (IMSR) Q1 2026: 7.8 GW Pipeline Anchors Commercial Path as Regulatory Milestones Accelerate
The business demonstrates a long reinvestment runway, disruptive model, and strong regulatory/commercial progress, but is still in a pre-revenue phase with execution risk and no evidence of accelerating cash flow or >40% growth yet. Unit economics and customer value are promising but not yet proven at scale. The signal is strong for a nuclear startup, but not at the highest level due to early stage and lack of concrete financial upside at this point.
INVZ (Everest Medicine) Q2 2026: Strategic Travere Partnership and mRNA Platform Propel Immune-Mediated Kidney Disease Pipeline
Everest Medicine demonstrates strong optionality and a disruptive, innovative pipeline with global expansion potential. The Travere partnership and mRNA/CAR-T platforms provide a long runway. However, some areas—such as proven unit economics and customer value deepening—are promising but not yet fully validated, warranting a slightly more conservative score.
Agilysys (AGYS) Q1 2027: Subscription Revenue Jumps 26%, PMS Outpaces POS for First Time
Agilysys demonstrates a strong growth runway, with recurring revenue, backlog, and margin expansion. PMS overtaking POS and accelerating AI adoption are important. However, while the business is transitioning to higher growth, the model is not highly disruptive and some metrics (unit economics, customer value, cash flow) are improving but not yet outstanding. The signal is strong but not exceptional for a vertical SaaS business of this scale.
NIO Inc. (NIO) Q2 2026: 49% Delivery Surge and 18.5% Vehicle Margin Sustain Premium EV Leadership
NIO demonstrates strong growth (49% YoY delivery, 80% sales growth), improving unit economics, and premium brand strength, but is not a highly disruptive business and the reinvestment runway, while solid, is not exceptional. The business model shows some self-reinforcement (battery swap network, brand), but not at the level of a platform giant. Forward guidance is robust but not hyper-accelerating, and the business is transitioning from growth to scale, not a new disruptor. Signal is strong but not at the very top end for upside.
Virgin Galactic (SPCE) Q2 2026: $50M in New Bookings as Commercial Launch Delayed to 2027
Virgin Galactic demonstrates strong pricing power, demand, and a potentially disruptive business model with a long runway. However, execution risk is high, unit economics are promising but not yet proven at scale, and cash flow is not yet accelerating. Growth potential is significant but contingent on operational milestones; thus, the signal is strong but not exceptional.
Evaxion (EVAX) Q3 2025: MSD Option Adds $7.5M, Extends Runway to 2027 as Pipeline Advances
Evaxion shows a strong reinvestment runway, a major external validation, and a disruptive platform business model. However, while the partnership and pipeline expansion are significant, there is not yet evidence of explosive growth in unit economics, customer value, or cash flow acceleration. The business is clearly growth-oriented and has potential for further upside, but some metrics (like recurring revenue growth and compounding model advantages) are still emerging rather than fully proven.
Ocean Power Technologies (OPTT) Q4 2026: Backlog Jumps 58% as Integrated Maritime Platform Strategy Takes Hold
OPT has a long reinvestment runway and a disruptive, platform-based model with a strong recent backlog uptick. However, unit economics and cash flow are not yet clearly improving, and recurring revenue/customer value is still in transition. Growth is strong but not explosive, and risk remains around execution and margin recovery.
Amneal (AMRX) Q2 2026: Biosimilar Pipeline Expands to Six Launches, Unlocking $14B Market Access
Amneal is transitioning toward defensible, higher-margin growth with a long runway in biosimilars and complex generics. While the business model shows some self-reinforcing traits, network effects and customer value deepening are not yet fully established. Growth is strong but not explosive, and the business is not disruptive at the highest level. The article surfaces a clear growth path, but the opportunity is not so exceptional as to warrant a top signal score.
Customers Bancorp (CUBI) Q2 2026: Non-Interest Deposits Hit 32%, AI-Driven Efficiency Targets Unlocked
The business is showing strong growth, margin expansion, and clear operational leverage, with AI and payments platform expansion providing moderate optionality and disruption. However, as a regional bank, the reinvestment runway and network effects are somewhat capped versus true platform businesses, and the business, while improving, is not at the highest level of disruptive growth or compounding.
QBTS Q2 2025: Cash Surges 170% QoQ, Fueling Accelerated R&D and M&A Ambitions
QBTS demonstrates a disruptive business model with a long reinvestment runway and recent transformative capital inflow. There are significant developments (170% QoQ cash increase, new technical milestones), but unit economics and customer value deepening are still emerging and not yet proven at scale. Growth is solid but not yet at the highest acceleration tier. The business is transitioning toward growth, but execution risk and the need for pilot-to-production conversion temper the overall signal.
BlackSky (BKSY) Q2 2025: International Backlog Surges to 85% on Gen 3 Satellite Demand
BlackSky shows a strong international growth inflection, major backlog expansion, and a path to recurring high-margin revenue, but its business model is not yet fully self-reinforcing or disruptive at scale. Unit economics and cash flow are improving but not yet exceptional, and the business, while growth-oriented, does not clearly demonstrate 40%+ top-line acceleration or a truly dominant, compounding model. Signal is strong but not at the highest possible level.
SBC (SBC) Q4 2025: Average Revenue Per Customer Jumps 11% as Clinic Model Rebounds
SBC shows signs of renewed growth, improving unit economics, and a multi-pronged strategic evolution. However, while the reinvestment runway is strong and there are clear growth levers, some elements (network effects, customer value deepening, and disruptive model) are emerging rather than fully established, and international expansion is still early-stage. The business is transitioning to growth but not yet at hypergrowth or exceptional disruption.
Sphere Entertainment (SPHR) Q2 2026: Sphere Segment Grows 30% as Content and Venue Expansion Accelerate
Sphere has a long runway with high optionality and disruptive business model, but some metrics (unit economics, customer value, cash flow acceleration) are improving but not yet exceptional. Growth is strong but not hyper-scaling, and some areas (e.g., MSG Networks drag, content pipeline risk) temper the overall signal.
APYX Q2 2026: Surgical Aesthetics Up 28% as AON Platform Drives Mix Shift
APYX demonstrates a strong growth runway in surgical aesthetics with high-margin, recurring revenue potential and a clear pivot away from legacy OEM. The business model is evolving but not yet fully self-reinforcing, and customer value is improving but not consistently deepening. The company is not yet a cash flow machine, and while growth is robust, it is not at the highest acceleration tier. The signal is strong for a small-cap medtech transition story, but not at the level of a disruptive giant.
UroGen Pharma (URGN) Q2 2026: Zesturi Drives 73% Sequential Launch Growth, Unlocking Community Practice Penetration
UroGen is showing strong growth and a clear inflection with Zesturi, but the business model is not fully self-reinforcing yet and customer value deepening is emerging but not consistent. Growth is robust but not exceptional, and while the business is transitioning to growth, some elements (runway, disruption, cash flow) are not yet at the highest tier for signal.
James Hardie (JHX) Q1 2027: Fiber Cement Organic Growth Surges 20% on Channel Expansion
James Hardie is executing well, with strong organic growth and channel expansion driving above-market results. However, the business is not highly disruptive and, while growth is strong, it is not at a hypergrowth or transformational level. The reinvestment runway is good but not exceptional, and the business model, while improving, is not fully self-reinforcing. The article signals solid but not extraordinary upside.
Trevi Therapeutics (TRVI) Q2 2026: $319M Cash Runway Anchors Chronic Cough Leadership Push
Trevi has a strong opportunity as a first-mover with a disruptive model in an orphan disease, but the ultimate upside is capped by the still unproven commercial model and lack of current revenue. The recent competitor exit and cash runway are significant, but the business is still pre-commercial and faces high execution risk. The signal is solid but not at the upper extreme due to these uncertainties.
Lexicon Pharmaceuticals (LXRX) Q2 2026: Sonata HCM Trial Over-Enrolled by 30%, Expanding Market Opportunity
Lexicon has clear near-term catalysts and a potentially large addressable market, but the business is still in transition with no current high-growth profile or proven compounding model. Over-enrollment and pipeline progress are notable, but the business is not yet a clear compounder or disruptive giant.
HII (HII) Q2 2026: Shipbuilding Revenue Jumps 16% as Throughput and Contract Wins Drive Guidance Raise
HII is showing strong growth and margin improvement, with a robust backlog and expanding opportunities in autonomy. However, as a large, established defense contractor, much of the growth is incremental and tied to government budgets rather than disruptive reinvestment or runaway economics. While Mission Technologies and unmanned systems provide some optionality, overall signal is moderate due to the industry’s mature dynamics and the company’s reliance on contract cadence.
ILPT Q2 2026: 5.4M SF Leased at 35% Spreads Drives Occupancy to 99%
ILPT demonstrates strong operational momentum and recent inflections (record leasing, 35% spreads, occupancy to 99%). However, as a REIT in a mature asset class with high leverage and some cash flow timing risks, its reinvestment runway and self-reinforcing business model are only moderate. The business is high-performing but not exceptional or disruptive, and growth is solid but not at hypergrowth levels.
Accelerate Energy (EE) Q2 2026: Dividend Up 13% as LNG Asset Tightness Extends Growth Runway
The business has a long reinvestment runway and recent significant developments, but some signal elements are moderate rather than exceptional. While there is evidence of growth and business evolution, the company operates in a somewhat established niche, and not all unit economics or disruptive model criteria are fully met. The business is solidly growth-oriented, but not at the highest level of signal for extreme upside.
Broadstone Net Lease (BNL) Q2 2026: Build-to-Suit Pipeline Swells to $645M, Unlocking 10% Forward Rent Growth
BNL exhibits a strong forward growth profile and a large build-to-suit pipeline, but as a REIT, its reinvestment runway is moderate and not truly exceptional. There is a significant development (data center), but the business model, while evolving, is not highly disruptive and is still exposed to execution and concentration risk. The company is transitioning to higher growth, but not at a level that would justify a top decile signal score.
LiveOne (LVO) Q4 2025: Podcast Revenue Jumps 37% as B2B Pipeline Expands Tenfold
While LiveOne shows strong growth in podcasting and B2B, the business is not yet at the scale or defensibility of a giant, and much of the upside is contingent on execution. There are clear signs of a strategic pivot and accelerating revenues, but the business model, while improving, is not fundamentally disruptive at scale, and some optionality (Web3, AI) remains unproven. Still, there is meaningful signal for investors tracking inflection points in digital audio.
Cactus (WHD) Q2 2026: Spoolable Technologies Orders Jump $80M, Triggering Capacity Expansion
Cactus shows a strong growth inflection with the $80M order and capacity expansion, indicating a long reinvestment runway and growth business profile. However, while there are signs of improving unit economics and business model evolution, the evidence for deepening self-reinforcement and customer value is moderate, and some risks (backlog volatility, tariffs) temper the signal. Growth is strong but not at the very highest tier, and the business, while attractive, is not uniquely disruptive.
Roblox (RBLX) Q2 2026: DAUs Up 10% as Algorithm Shift Drives Monetization Reset
Roblox demonstrates a long reinvestment runway, international growth, and a disruptive business model with AI-driven content expansion. However, current monetization and unit economics are under pressure, and while future potential is significant, near-term growth and cash flow are not accelerating at a level to warrant a top score. The business is a growth platform in transition, with signal moderated by execution risk and the need for evidence of successful monetization crossover.
Surf Air Mobility (SRFM) Q2 2026: 101% Surge in Private Charter Revenue Signals Platform Expansion
Surf Air Mobility shows evidence of a reinvestment runway and some disruptive potential, with a doubling of private charter revenue, a meaningful software contract, and improving financials. However, the business is not yet at the stage of exceptional growth or clear compounding network effects, and some metrics (unit economics, customer value, future guidance) are improving but not outstanding. Execution risk remains around software commercialization and margin expansion.
DXP Enterprises (DXPE) Q2 2026: Water Platform Sales Surge 86%, Cementing Margin Expansion Path
While the business is at an inflection with accelerating water platform sales and margin expansion, it is not a truly disruptive or high-optional business. The reinvestment runway is moderate, not exceptional, and while backlog/growth rates are strong, they are not at the level of a hypergrowth or network-effect business. Unit economics and cash flow are improving, but the business model remains evolutionary, not revolutionary. Signal is solid but not exceptional, reflecting a strong but not unique opportunity.
Texas Pacific Land (TPL) Q2 2026: $100M Land Bet Signals Data Center and Desalination Expansion
TPL shows a long reinvestment runway and is making a clear strategic pivot with the potential for high returns, but the business is not new or undiscovered and some optionality is still emerging. There is solid growth and expansion into new verticals, but not all metrics (e.g., unit economics, self-reinforcing advantages) are fully proven or exceptional at this stage.
NLIGHT (LASR) Q2 2026: Defense Revenue Jumps 41% as $600M JLWS Award Reframes Growth Path
NLIGHT demonstrates a strong defense-driven growth runway, a major contract win, and clear multi-year expansion potential. However, supply chain risk, margin volatility, and evolving business model temper the signal. While the business is transitioning to a growth trajectory, some elements (unit economics, customer value, business model self-reinforcement) are not yet fully proven or exceptional, warranting a conservative score.
Ventas (VTR) Q2 2026: SHOP Investments Jump to $4.5B, Cementing 60% Portfolio Pivot
Ventas is executing a significant pivot with accelerating investment and NOI growth in a segment with demographic tailwinds. However, while growth is robust and the business is transitioning to a higher-growth model, the runway is not as long or disruptive as a true platform business. Unit economics and margin expansion are strong, but customer value and business model self-reinforcement are only moderately improving. The business is growth-oriented but not a transformational compounder, which tempers the overall signal score.
Quantum Computing Inc. (QUBT) Q2 2025: $200M Capital Infusion Fuels Integrated Quantum-Photonic Ramp
QUBT demonstrates a long reinvestment runway with disruptive potential, a major capital infusion, and a clear roadmap toward integration and commercialization. The business is still early-stage with modest current revenue, so unit economics and customer value are not yet proven at scale. The business model is disruptive, and the industry is at an inflection, but growth rates are not yet extraordinary and the company remains in transition toward scale.
Neurocrine Biosciences (NBIX) Q2 2026: Pro Forma Sales Approach $1B as Portfolio Diversifies Beyond Ingreza
Neurocrine demonstrates a clear transition to a multi-product, growth-oriented business with a long reinvestment runway and strong commercial momentum. However, while there are strong growth signals and pipeline optionality, unit economics and self-reinforcing model features are not yet at the highest level, and the growth profile, while robust, is not extraordinary or disruptive enough to warrant full marks across all signal dimensions.
Bakkt (BKKT) Q2 2026: $410M Half-Year Transacting Volume Validates Platform Integration Progress
Bakkt shows a long reinvestment runway, recent meaningful business evolution (integrating payments and international assets), and is positioned as a growth business. However, some metrics (unit economics, self-reinforcing model, customer value, and cash flow) are improving but not yet exceptional or fully proven, capping the signal score. The business is interesting but not at the level of a breakout or highly disruptive platform yet.
BKV (BKV) Q1 2026: Power Platform CapEx Rises 21% as Data Center Demand Accelerates
BKV is showing strong reinvestment opportunity, a significant inflection in power platform growth, and a transition to a growth business. However, while the business model is partially self-reinforcing and disruptive, the evidence for compounding customer value and unit economics is not overwhelming. Growth is strong but not at the very highest tier, and while the outlook is positive, it is not exceptional across all dimensions.
LTH Q2 2026: In-Center Revenue Jumps 2.9% as DPT and CTR Fuel Member Spend
LTH demonstrates a long reinvestment runway, strong recent developments (notably in-center growth), and robust growth signals. However, while the business is transitioning to higher-value memberships and in-center monetization, the model is not fully disruptive, and some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional. The business is in a strong growth phase, but not at the highest level of signal for every dimension.
Crane (CR) Q2 2026: Acquisitions Add 20% to Sales, Accelerating Margin and Backlog Growth
Crane demonstrates strong growth and margin acceleration due to acquisitions, with some evidence of improving unit economics and backlog. However, as a well-established industrial, its reinvestment runway and disruptive potential are moderate, and while growth is robust, it is not at a truly exceptional or transformative level. The business is transitioning to higher growth and margin, but remains within the bounds of a mature industrial acquirer, limiting upside relative to the highest-signal opportunities.
Dragonfly Energy (DFLI) Q3 2025: $90M Capital Raise Reshapes Balance Sheet, Unlocks Growth Levers
The business shows a long reinvestment runway, recent significant developments, and a pivot to growth. However, unit economics and business model self-reinforcement are only partially evident, with DTC segment under pressure and margin improvement still in early stages. The business is moving toward growth, but most metrics are not yet at the exceptional or compounding level required for a higher signal score.
Mirion Technologies (MIR) Q2 2026: Backlog Climbs 40%, Locking in Nuclear Demand Visibility
Mirion is exposed to a strong, long-term nuclear growth trend with high backlog growth (40%), recurring revenue, and margin expansion. However, organic growth is only modest and some business model elements (unit economics, customer value, self-reinforcement) are improving but not exceptional. The business is well-positioned, but not a disruptive, hyper-growth story—it's a high-quality, visible growth compounder, but not at the highest signal tier.
Clean Harbors (CLH) Q2 2026: SKSS EBITDA Doubles to $275M, Unlocking Margin Upside
Clean Harbors demonstrates strong growth, margin expansion, and new vertical entry, but its core markets are industrial and somewhat cyclical, with some limitations to reinvestment runway and self-reinforcing advantages. The company is a growth business with some disruptive elements, but not a category-defining compounder. Signal is solid but not at the level of a transformative, high-optional business.
CCEC (CCEC) Q2 2026: Contracted Revenue Backlog Surges to $4.3B, Locking in Multi-Year Cash Flow Visibility
CCEC has a long reinvestment runway, recent surge in backlog, and is positioned for growth in emerging segments (LCO2, ammonia). However, the business is not a breakthrough disruptor, and while backlog is strong, unit economics and customer value deepening are only moderately improving. Model is somewhat self-reinforcing but not at tech platform levels. Growth is solid but not hyper-scaling. Overall, signal is above average but not extraordinary.
Roivant (ROIV) Q1 2026: $200M Buyback and Brepocitinib Launch Set Stage for Multi-Indication Expansion
Roivant has a long reinvestment runway with a diversified, late-stage pipeline and significant capital available. There are major upcoming catalysts (launches, data readouts, litigation proceeds) and a multi-indication platform strategy, but the business is not yet proven as a compounding, self-reinforcing model and unit economics are not yet improving at scale. Growth is expected but not at an exceptional rate, and the business is still in transition from pipeline to commercial revenue.
CareTrust REIT (CTRE) Q2 2026: $900M Record Investments Drive 44% FFO Growth and Pipeline Reload
While the company demonstrates strong growth, record investments, and a robust pipeline, the underlying REIT business model is not highly disruptive or likely to deliver exceptional compounding returns. The reinvestment runway is moderate, some elements (like customer value and self-reinforcement) are present but not dominant, and the future outlook is strong but not at the highest possible level of signal. The business is a clear growth story, but not an extraordinary or paradigm-shifting opportunity.
Wheaton Precious Metals (WPM) Q2 2026: 85% Revenue Surge Highlights Streaming Model Resilience Amid Strategic Expansion
Wheaton Precious Metals demonstrates strong growth, operational execution, and capital discipline, but as a large, established streaming company, its signal is somewhat capped by the maturity of the business model and competitive landscape. The recent Antamina deal and revenue surge are significant, but the business is not an undiscovered or highly disruptive growth story.
New Era Energy & Digital (NUAI) Q2 2026: Secures 757 MW Power Capacity, Advancing Permian Data Center Development
The business demonstrates a long reinvestment runway, recent significant developments, and a strong growth orientation with a disruptive model in a constrained market. However, while the growth potential is notable, evidence of compounding unit economics, deepening customer value, and accelerating cash flow is still emerging rather than fully proven, warranting a conservative signal score.
BlackBerry (BB) Q1 2027: QNX Revenue Surges 26% as GEM and Physical AI Expand TAM
BlackBerry demonstrates strong growth, margin expansion, and a clear pivot to profitable segments, but the business is not highly disruptive or unknown, and while the runway is expanding, it is not yet proven to be exceptionally long or high-ROIC. There are significant step-change developments, but some metrics (e.g., reinvestment, model self-reinforcement, customer value) are improving but not at the highest level.
MoneyHero Group (MNY) Q1 2026: Wealth & Insurance Revenue Jumps 31% as AI Reshapes Margin Profile
MoneyHero exhibits strong growth in core segments, a clear pivot to high-margin products, and AI-driven cost advantages, but does not demonstrate explosive, outsized growth or a disruptive business model with a massive reinvestment runway. The business is transitioning successfully to profitable scaling, but the signal is moderate rather than exceptional, especially given the competitive landscape and execution risks.
Ultragenyx (RARE) Q3 2025: $400M Royalty Monetization Extends Runway Ahead of Transformative Readouts
Ultragenyx has a credible reinvestment runway and is approaching pivotal clinical readouts that could transform its profile, but most commercial metrics are strong yet not explosive. The business model is robust but not uniquely self-reinforcing, and while growth is solid, it is not at the highest acceleration tier. The signal is good but not exceptional—more upside depends on successful execution of late-stage assets.
Ultragenyx (RARE) Q2 2025: Pipeline Drives 20% Revenue Growth as Phase III Programs Reach Inflection
Ultragenyx has a strong late-stage pipeline and growth trajectory, with double-digit revenue growth and approaching pivotal data. However, the business is not an undiscovered or underappreciated gem, and some aspects (unit economics, self-reinforcing model, customer value) are only moderately improving or not exceptional. The signal is strong but not at the level of a truly unique, high-upside opportunity.
Verica (VRCA) Q1 2026: YCANTH Applicator Units Jump 51% as Prescriber Base Expands
Verica shows strong commercial momentum and pipeline progress, with a 51% increase in dispensed units and expanding prescriber base. However, the reinvestment runway is moderate and not yet proven to deliver sustained 20%+ ROIC. There is a significant recent uptick in growth and backlog, but the business is not yet a clear category leader with deeply compounding self-reinforcing advantages. Unit economics are strong and improving, but customer value expansion is modest. The business is transitioning to growth, but future exceptional growth is not yet certain. The model is somewhat disruptive, but not fully proven as such. Cash flow is improving but not yet accelerating dramatically. Growth rates are above 20% but not yet at hypergrowth levels. Overall, the signal is solid for a specialty pharma in scaling mode, but not yet exceptional.
Electrovaya (ELVA) Q2 2026: Gross Margin Expands 230bps as Energy Storage Push Accelerates
ELVA shows a long reinvestment runway and strong margin expansion, but the business is not yet at giant scale and some compounding dynamics are emerging rather than fully realized. Growth is solid (20% YoY) but not explosive, and while vertical diversification is promising, the scale and competitive moat are not yet proven. The business is transitioning with potential for growth but lacks the exceptional signal of a breakout compounder.
WhiteFiber (WYFI) Q4 2025: $865M NC1 Contract Locks In Hyperscale Demand, Cloud Revenue Reset Near-Term
WhiteFiber demonstrates a strong growth runway, a major new contract, and clear evidence of operating leverage and margin improvement. However, while there is optionality and disruption, some elements (unit economics, business model self-reinforcement, customer value deepening, and cash flow acceleration) are present but not yet at the highest level of compounding or disruption. The business is in transition, with high growth potential but not yet a breakout category leader.
BingEx Limited (FLX) Q2 2026: Low-Altitude Logistics Order Volume Surges 169%, Signaling New Growth Vector
BingEx is demonstrating strong growth in a new business vector (drone logistics) and is investing in disruptive technologies (AI, drones). However, the core business is under revenue and margin pressure, and while there are signs of improvement and a long runway, the company is not showing broad-based 20%+ growth across the board nor is it yet a cash flow machine. The business model is disruptive and transitioning to higher-quality revenue streams, but risks and execution challenges remain.
Ultragenyx (RARE) Q1 2026: 64% Ex-U.S. FKESA Growth Signals Pipeline-Driven Revenue Inflection
Ultragenyx has a long reinvestment runway with a disruptive, pipeline-driven model and strong growth signals, but execution risk, high R&D burden, and pipeline binary outcomes temper the signal. Unit economics and self-reinforcement are present but not yet at the scale of a compounding giant. Growth is strong but not yet at hypergrowth levels.
Mammoth Energy (TUSK) Q2 2026: Revenue Surges 110% YoY, Aviation and Sand Drive Margin Turnaround
There is clear evidence of growth inflection and margin improvement, with double-digit revenue and EBITDA growth, and segmental turnaround. However, the business model, while improving, is not strongly disruptive or self-reinforcing, and recurring revenue is still building. The reinvestment runway is good but not exceptional, and while the outlook is positive, it is not a clear-cut 20%+ compounding story yet. The business is moving from transition to growth, but still faces cyclicality and execution risk.
Dragonfly Energy (DFLI) Q2 2025: OEM Sales Surge 50%, Margin Expansion Signals Manufacturing Leverage
Dragonfly Energy shows a long reinvestment runway via OEM expansion and innovation. There is a significant OEM growth uptick, but not a massive backlog increase. Unit economics are improving, but not yet giant-scale. The business model is moving toward self-reinforcement, but is not yet deeply entrenched. Customer value is improving with OEM wins, but not consistently deepening across all channels. Future growth is good but not exceptional (guidance at ~25% YoY). The business is semi-disruptive with some lateral opportunities, and cash flow is improving but not yet accelerating. Revenue growth is in the 20-40% range, and this is a growth business moving out of transition.
HERE (HERE) Q1 2026: Wacoku Drives 71% of Revenue, Cementing IP-Led Growth Strategy
HERE has a long reinvestment runway and is showing high growth, but unit economics, self-reinforcing model, and customer value deepening are still emerging and not yet fully proven. The business is transitioning to growth, but concentration risk and execution complexity temper the signal. The outlook is strong but not yet exceptional or fully derisked.
Coherus Oncology (CHRS) Q2 2025: Lactorzy Revenue Jumps 36% as Pipeline Readouts Near
Coherus has a strong reinvestment runway and recent high growth (Lactorzy up 36%), but the business is still transitioning from a single-product focus and faces execution risk in community adoption. Unit economics and self-reinforcing advantages are present but not yet at full scale. Pipeline catalysts are material but not guaranteed, and while the business is moving toward growth, it is not yet a clear high-growth compounding story.
Avino (ASM) Q2 2025: Revenue Climbs 47% as La Preciosa Development Shifts Growth Trajectory
While the business is showing strong growth and a clear step-change in scale and margin, it is not yet a giant or highly disruptive model, and some elements like reinvestment runway and customer value expansion are moderate rather than exceptional. The growth is solid but not explosive, and the business, while transitioning, is not at the frontier of sector transformation.
TeamShares (TMS) Q2 2026: 47% SME Segment EBITDA Growth Highlights Operating Leverage and Acquisition Momentum
TeamShares demonstrates a strong reinvestment runway, recent outsized EBITDA growth, and a disruptive acquisition model. However, organic unit economics and customer value deepening are only modest, and while growth is rapid, it is not yet at the level of a giant tech platform or 40%+ organic. The business is transitioning to growth and is investable, but the signal is dampened by the relatively traditional nature of the underlying SME businesses and the lack of clear evidence for self-reinforcing network effects or exceptional future guidance acceleration.
Firy Inc. (FIRY) Q2 2026: Razor Revenue Surpasses $10M, Driving Profitability Amid Litigation Wind-down
Razor shows strong growth, profitability, and a long runway, but the overall business is still transitioning with some legacy elements (Skills), and not all metrics are at the highest compounding levels. The business is interesting with some optionality and improving economics, but not yet a clear breakout or highly disruptive compounder. Signal is solid but not exceptional.
Gemini Space Station (GEMI) Q2 2026: Services Revenue Surges 149% Amid Crypto Market Softness
Gemini is showing a long reinvestment runway and a major business model shift, with strong growth in services and new product launches. However, some areas (unit economics, self-reinforcing model, customer value) are still developing and not yet at the highest level of compounding, and growth is not yet at the exceptional (40%+) level across the board. The business is in transition but positioned for growth, with moderate signal for exceptional upside.
Biodesix (BDSX) Q2 2025: Development Services Revenue Jumps 53% as Primary Care Push Gains Traction
Biodesix demonstrates a solid growth trajectory with a long reinvestment runway and recent significant developments, particularly in development services. However, while there are clear improvements and high growth in select segments, some elements (unit economics, business model defensibility, customer value deepening, and cash flow acceleration) are still emerging or not yet exceptional. The business is transitioning toward profitability and growth, but not all metrics suggest a giant or disruptive model yet.
LaFrost (LFS) Q1 2025: Social Business Revenue Climbs to 28% of Mix, Powered by Club Support Expansion
LaFrost is at a strategic inflection with policy-driven growth and a long runway for reinvestment, as evidenced by rapid social business expansion and strong guidance. However, while growth is robust, the business is not yet on track for truly exceptional (40%+) growth, and some aspects of the model (unit economics, self-reinforcement, ARPU) are promising but not yet clearly compounding at scale. The business is transitioning to a growth platform, but international optionality and disruptive potential are still emerging, warranting a conservative signal score.
China Automotive Systems (CAAS) H1 2026: EPS Sales Surge 32% Drives Record Profitability Amid Industry Headwinds
CAAS is demonstrating strong growth in a challenging market, with a clear pivot to higher-margin EPS products and international expansion. However, the business is not a highly disruptive model and does not have the clear hallmarks of a 20%+ ROIC compounding machine; growth is strong but not explosive. Some self-reinforcing dynamics and improving unit economics are evident, but the company is not likely to be a giant or generate sustained 40%+ growth. Signal is solid but not exceptional.
Enhanced Group (ENHA) Q2 2026: $32M Sponsorship Secures Global Footprint Amid Strategic Expansion
Enhanced Group is early-stage but has a credible path to growth with a differentiated business model. There is a long runway for reinvestment, recent sponsorship wins, and a disruptive approach to sports and personalized medicine. However, unit economics and customer value are still emerging, and regulatory risk tempers the signal. The business is not yet showing clear acceleration in cash flow or 40%+ growth, and while the model is novel, it is not yet proven to be self-reinforcing or a giant in the making. Overall, the upside is real but not exceptional by public market standards.
Realmada Therapeutics (RLMD) Q1 2026: $160M Capital Infusion Extends Runway for Phase III NMIBC Program
Realmada has a long reinvestment runway with a large capital infusion and pipeline optionality. There is a significant clinical inflection with strong Phase II data and a patent extension, but the business is still pre-revenue and not yet demonstrating compounding network effects or clear accelerating cash flow. Growth potential is high but not yet proven at scale, and the overall business model is promising but not clearly disruptive. The thesis is investable but not at the extreme end of signal.
PowerFleet (AIOT) Q3 2026: Recurring Services Hit 80% of Revenue as Landmark Public Sector Win Reshapes Growth Trajectory
PowerFleet demonstrates a long reinvestment runway, a major recent contract win, and a strong recurring revenue mix, but some elements (unit economics, self-reinforcing model, customer value deepening, and cash flow acceleration) are present but not yet exceptional. The business is in a growth phase but not a hypergrowth or disruptive outlier.
VENU (VENU) Q2 2026: $141M Asset Growth and $278M FireSuite Sales Highlight Expansion Momentum
VENU demonstrates a long reinvestment runway with high asset growth and innovative financing, and shows strong growth signals (asset and FireSuite sales). However, unit economics and self-reinforcing model are emerging but not yet proven at scale, and future growth, while strong, is not yet exceptional or disruptive on a broad industry scale. Recurring revenue and margin expansion are positive but not yet at the level of a cash flow machine or 40%+ annual growth. The business is clearly transitioning to growth, but still carries execution risk.
DAIO (Data I/O) Q2 2026: 59% Sequential Revenue Surge Signals Operational Inflection and Acquisition-Fueled Growth
While the sequential revenue growth and margin expansion are impressive and signal a business inflection, the company is still transitioning toward recurring revenue and broader diversification. There is evidence of improving unit economics and growth, but the business is not yet at a scale or with a moat to warrant the highest scores. The acquisitions could provide upside, but integration risk and market cyclicality temper the signal.
Hyperfine (HYPR) Q1 2026: Gross Margin Expands 940bps as Next-Gen Subsystem Drives Adoption
Hyperfine is at a commercial inflection with strong growth and margin expansion, but as a small-cap medical device company, its reinvestment runway and business model self-reinforcement are moderate, not exceptional. Growth is accelerating, but not at a scale or pace to merit the highest marks for disruptive potential or cash flow machine status. The business is transitioning to growth, but not yet a proven compounding giant.
GCT Semiconductor (GCTS) Q1 2026: 5G Chipset Shipments Surge 58% as Commercial Ramp Accelerates
GCT is at a commercialization inflection with a long runway, strong growth in 5G chipset shipments, and customer diversification. However, the business is still early-stage, with some uncertainty in unit economics and self-reinforcing model. Growth is strong but not yet exceptional, and while disruptive, the company is not yet a proven giant.
Spire Global (SPIR) Q2 2026: Core Revenue Rises 16% Excluding Maritime, Signaling Strong Back Half Growth
Spire shows a long reinvestment runway with strong government contract momentum and a disruptive model in a growing sector. However, while revenue growth is strong and margin expansion is anticipated, unit economics and self-reinforcing advantages are still emerging rather than fully proven. Backlog and guidance are positive but not yet exceptional, and the business, though transitioning to growth, is not yet at the scale or profitability of a true compounder.
Syntec Optics (OPTX) Q2 2025: Customer Demand Up to 200% Fuels Capacity Push Amid Filing Delays
The business is experiencing surging demand (200%+), suggesting a long runway and growth potential. However, lack of current financials, execution risk, and the early stage of diversification initiatives limit the score. Unit economics are targeted for improvement but not yet proven at scale. The business model has some integration advantages but is not clearly disruptive or self-reinforcing at this stage. Revenue and EPS growth are likely strong but not definitively over 40%. The company is a growth business, but execution and regulatory risks temper the signal.
PESI Q2 2026: 29% Backlog Growth Anchors Long-Term Hanford Tank Waste Opportunity
PESI has a long government contract runway and a meaningful backlog uptick, but unit economics and business model compounding are only moderately improving. The business is transitioning to growth, but not yet a clear high-growth compounding story. There is disruption risk and some cash flow improvement, but not at the highest possible level.
Marchex (MCHX) Q2 2026: Pro Forma Revenue Climbs 33% with AI-Driven Cross-Sell Expansion
While the business is at a strategic inflection with strong pro forma growth and disruptive AI-driven bundling, it is still moderately sized, has customer concentration risk, and does not yet demonstrate exceptional compounding or accelerating cash flow. The growth runway is promising but not yet proven to be long and high-ROIC. The business model is disruptive, and recent developments are significant, but the company remains in transition with execution risk and a need to validate the scalability of its cross-sell strategy.
Allot (ALLT) Q2 2026: SECaaS Revenue Jumps 47% as North America Surges to 31% of Mix
Allot is showing strong growth and business evolution, particularly with SECaaS and North America. However, the business is not yet a clear category leader with a massive, disruptive runway or 20%+ ROIC redeployment, and some elements (unit economics, self-reinforcing model) are emerging but not dominant. Growth is strong but not at the highest tier, and there are risks around concentration and deal timing.
Milestone Pharmaceuticals (MIST) Q2 2026: Commercial Coverage Doubles to 50%, Pivotal AFib-RVR Trial Launches
Milestone Pharmaceuticals shows a solid commercial inflection with coverage doubling and a pivotal trial launching into a larger market, suggesting a long reinvestment runway (Q1/Q2). However, as an early-stage biopharma, evidence of improving unit economics, self-reinforcing business model, and deepening customer value is still emerging (Q3-Q5). Guidance and backlog do not indicate exceptional near-term growth, and while the model is semi-disruptive, cash flow and revenue growth are not yet at breakout levels. The business is clearly in a growth phase but not yet demonstrating compounding or exceptional signal across all dimensions.
Crescendo (CXDO) Q3 2025: Software Solutions Surge 28%, AI and Cloud Fuel Multi-Year Growth Runway
Crescendo demonstrates a strong growth trajectory, high-margin software expansion, and a multi-year reinvestment runway. However, some elements (unit economics, network effects, customer value deepening) are positive but not yet exceptional or fully proven, and international/AI adoption is still in early stages.
Veru (VERU) Q3 2025: Phase IIb Data Drives 46% Reduction in Post-GLP-1 Weight Regain, FDA Clarity Looms
Veru has a disruptive late-stage asset with clear strategic inflection and a strong competitive/IP moat, but its financial runway is short and the business is not yet generating high returns or cash flow. The recent Phase IIb data is a major development, but the business is still transitioning and faces significant regulatory and capital risks. There is high growth potential, but not all the hallmarks of a compounding, self-reinforcing business are yet in place.
QT Imaging (QTI) Q1 2026: 133% Revenue Growth Anchored by 13-System Shipments and SaaS Platform Expansion
QTI demonstrates a long reinvestment runway and is at an inflection point with significant revenue growth and a SaaS transition. However, while growth is strong, margins are compressed and SaaS is early, so compounding effects and unit economics are not yet fully proven. The business is moving toward recurring revenue but is not yet a cash flow machine or at a level of disruptive dominance.
Gemini (GEMI) Q4 2025: Services Revenue Jumps 33% as Platform Diversifies Beyond Crypto Trading
Gemini is executing a notable business model pivot and showing strong services revenue growth, but the business is not yet a clear high-growth outlier or compounding machine. Some metrics are improving, but the overall signal is moderate given execution and regulatory risks.
Evolv Technology (EVLV) Q2 2026: 34% Revenue Growth Reflects Accelerating AI-Powered Security Adoption
Evolv shows strong growth, a long runway, and a disruptive business model with recurring revenue and AI-driven innovation. There is evidence of accelerating adoption, increased ARR, and expanding customer base. However, margin improvement is still developing, and while the business is not yet at giant scale, the signals are positive but not extraordinary. The signal is solid but not exceptional.
LENZ (LENZ) Q2 2026: 45% Prescription Growth Signals Early Commercial Momentum
LENZ shows strong early growth and a disruptive model in an emerging market, with a long reinvestment runway and international optionality. However, the business is still in early commercial phases; while prescription growth is high, scale and unit economics are not yet at 'giant' levels, and some metrics (ARPU, cash flow, global execution) require further validation. The signal is solid but not exceptional, as risks around channel mix, international execution, and sustained adoption remain.
BioHarvest Sciences (BHST) Q1 2026: CDMO Pipeline Adds 3–4 New Projects, Deepening Royalty and Margin Leverage
BioHarvest has a long reinvestment runway and is moving into a royalty-driven, high-margin model with new CDMO projects. Significant developments are present, but growth is not yet explosive. Unit economics and business model advantages are emerging but not fully proven. Customer value is improving, and the business is transitioning toward growth, but not yet at the level of a top-tier disruptor or hyper-growth story. The overall signal is strong but not exceptional.
EONR Q3 2025: $41M Debt Extinguished, Unlocks 92-Well Growth Pipeline
Eon Resources demonstrates a significant inflection with a clean balance sheet and a multi-year growth pipeline, suggesting a long reinvestment runway and a strong pivot to growth. However, while the business model is improving and the company is transitioning to a growth phase, there is not yet evidence of disruptive, compounding network effects, or exceptional acceleration in financial metrics. The signal is strong for an emerging small-cap growth story, but not yet at the highest level of transformative, high-velocity compounding.
Booted Juice (BUDA) Q1 2026: Walmart Rollout Expands Store Count 75%, Marking Nationwide Growth Inflection
BUDA is at a genuine inflection point with a major distribution expansion and a strong balance sheet, but the business is not yet proven as a high-ROIC compounder and is not (yet) showing exceptional acceleration in growth or economics. The business model is semi-disruptive, and while the Walmart rollout is a strong signal, execution and category creation risks remain.
Spectral AI (MDAI) Q2 2026: FDA De Novo Clearance Catalyzes Transition to Commercial Launch with $14M Cash Backing
Spectral AI is at a key inflection with a disruptive product, government-backed rollout, and a long runway, but the business is still early in commercial scale and faces execution risk. Unit economics and customer value are poised to improve but not yet proven at scale. Growth signals are strong but not exceptional, and the business model is promising but not yet compounding at the highest levels.
Dario Health (DRIO) Q3 2025: 31% Operating Expense Cut Accelerates Shift to High-Margin Recurring Revenue
Dario Health is in transition to a potentially high-growth, high-margin model, but near-term fundamentals are not yet exceptional. There is a long runway and disruptive potential, but execution and onboarding risks remain, and clear evidence of accelerating cash flow and compounding network effects is still developing. The business is growth-oriented, but not yet at the level of a transformative compounder.
Veru (VERU) Q2 2026: R&D Spend Falls 53% as Obesity Pipeline Focus Sharpens
Veru is a high-risk, high-reward clinical-stage biotech with a very long runway if successful, but currently only a single asset and no revenue. There is meaningful disruption potential and a large addressable market, but the business is binary and not yet demonstrating compounding economics, cash flow, or accelerating growth. The signal is moderate given the stage, with upside if clinical results are positive.
LWLG (LightWave Logic) Q2 2026: Five Stage 3 Customers Mark Commercialization Progress Amid $96M Cash Cushion
LWLG demonstrates a disruptive business model with a long runway, significant cash reserves, and clear customer engagement momentum. However, the business is still pre-scale with limited current revenue, and while growth potential is high, evidence of rapidly improving unit economics and customer value is still emerging. The outlook is strong but not yet exceptional, and recurring growth above 20% is not yet proven.
Cardinal Infrastructure Group (CDNL) Q2 2026: 114% Revenue Surge Highlights Rapid Platform Expansion Amid Margin Pressure
The business demonstrates a long runway with high reinvestment, significant recent growth, and aggressive expansion via acquisitions. However, margin compression, only moderate improvement in unit economics, and some operational growing pains limit the score. The business is growth-oriented and disruptive in its vertical, but not at the level of an exceptional, high-multiple compounding platform. The risk of margin volatility and integration headwinds temper the overall signal.
Broadwind (BWEN) Q2 2026: 67% Revenue Surge Anchored by Power Generation and Industrial Growth
The business is showing strong growth and backlog expansion, but it is not a disruptive or exceptional growth story with clear 20%+ ROIC redeployment or massive acceleration. While there is a strategic pivot and evidence of margin improvement and backlog growth, the business remains exposed to customer concentration and is not a widely underappreciated growth compounder. Signal is good but not exceptional.
NGS (NGS) Q2 2026: 34% Year-Over-Year Horsepower Utilization Boost Drives Record Rental Revenue
NGS demonstrates organic growth above peers, margin expansion, and accretive M&A, but the business model is not highly disruptive or uniquely self-reinforcing. While there are significant recent developments (acquisition, utilization boost), the reinvestment runway and customer value improvement are solid but not exceptional. The business is transitioning to higher-value segments and growing, but upside is moderate compared to more disruptive or high-growth names.
Vir Biotechnology (VIR) Q2 2026: $315M Astellas Inflow Extends Cash Runway, Sets Stage for Dual Program Milestones
Vir Biotechnology is transitioning from a development-stage to a late-stage/early commercial-stage company, with a strong balance sheet and multiple near-term catalysts. There is a long reinvestment runway, major inflections in both hepatitis delta and oncology, and growth potential if clinical milestones are met. However, the company remains reliant on non-recurring collaboration revenue, and while the business model is innovative, it is not yet clearly self-reinforcing or demonstrating compounding customer value. Execution, regulatory, and competitive risks temper the signal score.
DMAC (DiaMedica Therapeutics) Q2 2026: $43.5M Cash Supports Expansion in Preeclampsia and Stroke Trials
DMAC has a long reinvestment runway and is expanding into high unmet need indications, with disruptive potential and a strong cash position. However, the business is still pre-commercial, with no evidence of revenue or EPS growth, and unit economics/customer value are not yet proven. The signal is strong for a clinical-stage biotech, but not at the highest level due to the absence of commercial metrics and the inherent risk in clinical development.
NGL (NGL) Q1 2027: Water Solutions Volumes Jump 20%, Locking in Contracted Growth Visibility
NGL's water solutions business shows strong growth, high contract coverage, and improving economics, but the overall business is not highly disruptive or likely to deliver outsized compounding returns. There are positive signals in growth, margins, and capital allocation, but the company operates in a mature, infrastructure-heavy segment with moderate optionality and some execution risk.
Ameren (AEE) Q2 2026: Data Center Agreements Add 2.8 GW Upside, Sharpening Long-Term Load Growth
Ameren is a regulated utility, so reinvestment runway is moderate, not exceptional (score 1). There is a very significant growth inflection (score 2 for Q2). Unit economics are improving but not in a highly scalable, tech business sense (score 1). The business model has some self-reinforcing elements through regulatory and rate design, but not strong network effects (score 1). Customer value is improving but not dramatically (score 1). The future outlook is strong with clear acceleration (score 2). The model is semi-disruptive due to data center-driven demand (score 1). Cash flow is improving but not yet accelerating at a tech pace (score 1). Revenue/EPS growth is above 20% but not 40%+ (score 1). Ameren is transitioning into a growth phase (score 2).
Merck (MRK) Q2 2026: $5.7B Terns Charge Signals Relentless Pipeline Investment, Not Margin Retreat
Merck has a long reinvestment runway and is deploying capital into high-return opportunities, as evidenced by the Terns acquisition and pipeline acceleration. There is a significant business evolution with new launches and a raised guidance, but not a massive near-term growth inflection. Unit economics are improving with new product launches, but not yet at a 'giant' scale. The business model is becoming more self-reinforcing but is still transitioning. Customer value is improving but not rapidly deepening. The future is good, but not exceptional, as growth is guided at low single digits, not above 30%. The model is semi-disruptive with new therapies but remains anchored in traditional pharma. Cash flow is solid but not accelerating at a dramatic pace. Revenue and EPS growth is guided under 20%. Merck is a transitioning business, not full growth, as it manages the Keytruda LOE and portfolio shift.
Elutia (ELUT) Q3 2025: $88M Divestiture Fuels NXT41X Launch Path and Margin Reset
Elutia demonstrates a strong reinvestment runway and major business evolution with the divestiture and refocus on NXT41X. However, while the growth opportunity is significant, evidence for compounding self-reinforcement, rapidly improving unit economics, and disruptive business model is present but not overwhelming. The business is moving into a growth phase, but scale and exceptional acceleration are not yet fully proven.
Metallus (MTUS) Q2 2026: Order Book Surges 50%, Securing Multi-Year Demand Visibility
Metallus demonstrates clear backlog-driven growth, a strong balance sheet, and strategic positioning in high-value markets. However, while order book growth and certifications are notable, the business model is not highly disruptive, and some levers (unit economics, self-reinforcement, customer value) are improving but not yet exceptional or compounding at the highest level. The growth outlook is strong but not explosive, warranting a conservative approach to signal scoring.
Okeanis Eco Tankers (ECO) Q2 2026: Dividend Surges 90% as Spot Rates Outperform Peers by 50%
OET demonstrates strong recent growth and capital return, but its business model is highly cyclical and levered to volatile spot rates, limiting its reinvestment runway and long-term compounding potential. While recent results are exceptional, the sustainability of these dynamics is uncertain, and the business is not disruptive or highly scalable in a structural sense. The signal is solid but not exceptional.
AESI Q2 2026: Data Center Power Contracts Double Project Scale, Pricing Discipline Targets Margin Reset
Atlas Energy Solutions is at a strategic inflection, with a long runway in private power and signs of margin expansion and backlog growth. However, while the business is transitioning and showing growth signals, some elements (unit economics, self-reinforcement, customer value) are still emerging rather than fully compounding, and guidance does not yet point to exceptional growth rates.
Sunrun (RUN) Q2 2026: Direct Sales Surge 20% QoQ, Anchoring Shift to High-Margin Growth
Sunrun demonstrates a long reinvestment runway with high returns potential, recent significant developments (direct channel surge, storage attachment), and a transition toward a higher-margin model. However, some elements (unit economics, self-reinforcing model, customer value deepening, and disruptive potential) are present but not yet fully proven or exceptional. The business is clearly moving into a growth phase, but near-term risks and execution uncertainties moderate the overall signal.
Caterpillar (CAT) Q2 2026: Backlog Jumps $9B as Demand Extends Into 2030
While Caterpillar's backlog growth and order visibility are exceptional, the business is a well-followed industrial with moderate reinvestment runway and some legacy characteristics. There is strong growth and improvement in recurring revenue, but it is not a disruptive or high-velocity compounding story. Signal is solid but not at the level of a transformative, underappreciated opportunity.
eBay (EBAY) Q2 2026: Focus Category GMV Jumps 26%, Depop Acquisition Accelerates C2C Expansion
While eBay is showing strong growth in focus categories and C2C, its reinvestment runway and compounding model are not as deep or exceptional as true platform disruptors. The business is transitioning and showing growth, but the core marketplace remains mature. There are clear growth vectors (Depop, live commerce, AI tools), but the long-term optionality and network effects are moderate, not outstanding.
NextDecade (NEXT) Q2 2026: $4.6B Debt Refinancing Expands Capacity for Train 6 Build-Out
NextDecade is at a pivotal inflection with a long runway and capacity for reinvestment, but remains a project-driven business with execution risks and not yet proven cash flow compounding. Growth prospects are strong, but not at the level of an undiscovered or hyper-growth tech business. Unit economics and business model self-reinforcement are emerging but not fully proven. The story is investable but not exceptionally unique or disruptive.
Stoke Therapeutics (STOK) Q2 2026: EMPEROR Enrollment Hits 162, Extending Runway to 2028 Launch
Stoke is a high-growth, late-stage biotech with a potentially disruptive asset and strong execution, but the business is still pre-commercial and faces typical biotech risks. While there is a long runway and some exceptional developments (rapid enrollment, deep OLE data), the underlying economics and self-reinforcing advantages are not yet fully proven, and future growth is subject to regulatory and commercial execution.
Vishay (VSH) Q2 2026: Backlog Jumps 18% to $1.9B as AI and Industrial Demand Accelerate
Vishay is showing strong growth signals—backlog up 18%, double-digit revenue/segment growth, and margin improvement—but the business is not a disruptive platform and remains cyclical with moderate reinvestment optionality. While the inflection is clear and guidance is strong, the underlying model is not exceptional or compounding in the way of the highest-signal businesses.
Crane NXT (CXT) Q2 2026: Backlog Hits $757M as Margin Expansion Accelerates Portfolio Shift
Crane NXT is showing strong growth and margin expansion, with a record backlog and clear business evolution, but the business is not highly disruptive or unique in its sector, and its reinvestment runway is moderate rather than exceptional. Unit economics and backlog are improving, but the business is not on track to be a giant or generate 40%+ growth. Risks from legacy hardware and portfolio drag temper the overall signal.
MPTI Q2 2026: Backlog Surges 37% as Defense Programs Drive Growth Amid Margin Pressures
MPTI shows a strong growth profile with a record backlog (+37%), long-term supply agreements, and a clear multi-year runway in a structurally growing defense niche. However, while backlog and guidance are strong, margin pressure, only moderate improvement in unit economics, and some traditional elements of the business model limit the score. The business is not yet at the level of a disruptive, runaway compounder, but its growth and positioning are well above average.
EuroDry (EDRY) Q2 2026: EBITDA Surges 5x as Charter Rates Double, Fleet Renewal Accelerates
EuroDry is a cyclical business with strong recent inflection, but dry bulk shipping is not a secular compounder. The company exhibits some reinvestment runway with newbuilds and eco-fleet transition, but optionality is moderate. The recent EBITDA surge and rate-driven growth are material, but future growth is capped by industry cyclicality and order book trends. Some self-reinforcing elements (fleet renewal, balance sheet) are present but not dominant. Overall, signal is solid for a shipping cyclical, but not exceptional.
GDS (GDS) Q2 2026: Bookings Surge to 1 GW, Elevating Long-Term Growth Visibility
GDS demonstrates a long reinvestment runway and strong bookings growth, but some aspects such as unit economics, self-reinforcing model, and customer value are improving only modestly. The business is growth-oriented with some disruptive elements, but not all metrics point to exceptional or accelerating performance.
Akebia (AKBA) Q2 2026: Vafcio Patients Up 41%, Pipeline Drives Rare Disease Optionality
Akebia has a long reinvestment runway with high-ROIC opportunities in rare disease, and Vafcio’s recent growth and VOICE trial results are significant. However, unit economics and model self-reinforcement are not yet clearly compounding, and customer value growth is only modest. The business is transitioning, not yet a giant, and faces headwinds from legacy erosion and pricing resets. Signal is solid but not exceptional.
Veristem Oncology (VSTM) Q2 2026: $90M Non-Dilutive Funding Secures Pipeline Execution Through 2027
Veristem has a long reinvestment runway and just secured significant non-dilutive funding, with a potentially high-value pipeline catalyst in VS-7375. However, while commercial momentum is real, unit economics and self-reinforcing model signals are present but not exceptional. Growth is strong but not at hypergrowth levels, and the business, while promising, is not yet proven as a giant. The business is transitioning toward growth, but some signals are not fully mature.
Texas Instruments (TXN) Q2 2026: Industrial Revenue Jumps 30%, Broad-Based Demand Cycle Takes Hold
While the article describes a clear inflection and broad-based demand upcycle, Texas Instruments is a large, well-followed company and the business model, while strong, is not highly disruptive. The runway is solid but not exceptional, and growth is robust but not at hyper-growth levels. Some elements (pricing, margin, data center) are improving, but not all signal a transformational step change.
Amtech Systems (ASYS) Q3 2026: AI-Driven TPS Revenue Surges 25%, Backlog Extends Into FY27
Amtech is demonstrating a clear pivot to growth with AI-driven demand and margin expansion, but the business is not yet a category leader and the upside, while solid, is not at the level of the most exceptional growth stories. The reinvestment runway is moderate, with some optionality but not extreme. The backlog growth and recurring revenue are strong signals, but the business model is not fully self-reinforcing or highly disruptive, and revenue growth is in the 20–40% range rather than hypergrowth.
One Stop Systems (OSS) Q2 2026: Bookings Surge 62% as Multi-Year Defense and Edge AI Programs Scale
OSS is showing strong growth, a clear pivot to scalable, multi-year programs, and a long reinvestment runway, but the business is not yet at the level of a dominant platform or with 40%+ growth/exceptional backlog acceleration. Margins are improving but not yet at cash machine status, and network effects/self-reinforcing dynamics are emerging but not fully established. The business is transitioning into growth, with good—but not extraordinary—signal for outsized upside.
American Healthcare REIT (AHR) Q2 2026: 28.6% NFFO Growth Fuels Accelerated Senior Housing Expansion
AHR demonstrates strong growth and operational momentum, with clear evidence of accelerating financials and a robust acquisition pipeline. However, as a REIT in a mature but growing sector, the reinvestment runway and disruptive potential are moderate rather than exceptional. Unit economics and cash flow are improving, but the business model does not exhibit the deep self-reinforcing characteristics or disruptive lateral optionality of a true compounding outlier. Revenue and EPS growth are strong but not at hypergrowth levels. Overall, the signal is solid but not extraordinary.
Dycom Industries (DY) Q2 2027: 45.6% Revenue Surge Highlights Strategic Growth in Fiber and Building Systems
While Dycom shows strong growth, margin expansion, and backlog, the business is not highly disruptive or unique, and some growth (e.g., organic) is moderate. The reinvestment runway and self-reinforcing dynamics are present but not exceptional. The business is a clear growth story, but not a top-tier signal for extraordinary upside.
SCHMID Group (SHMD) H1 2026: Order Intake Nears €97M, Backlog Surges to €95M, Setting Stage for 2027 Growth
SCHMID has a long reinvestment runway and is at a business inflection with strong order growth and backlog. However, unit economics, self-reinforcing model, and customer value deepening are improving but not yet exceptional. The business is transitioning with signs of acceleration, but not yet at the level of a giant or disruptive platform. Revenue/EPS growth is strong but not at the highest tier.
Nordson Corporation (NDSN) Q3 2026: Advanced Technology Segment Drives 28% Sales Surge and Backlog Jumps 35%
Nordson is a solid growth business with a diversified portfolio and strong operational discipline, but it is not a highly disruptive or under-followed company. The ATS segment's growth is impressive (28% sales, 35% backlog), and profitability is robust, but reinvestment runway is moderate and some segments are at cycle peaks. The business is not likely to deliver 40%+ growth, and while there is some compounding, it is not at the level of a platform or network business. The signal is strong for a quality compounder, but not for an exceptional, highly asymmetric opportunity.
NovaBridge Biosciences (NBP) H1 2026: $216M Cash Fuels Dual-Track Growth in Oncology and Ophthalmology
NovaBridge demonstrates a strong cash position, clinical pipeline with potential for value inflection, and a dual-track strategy. However, while the business shows growth potential and optionality, there is not yet clear evidence of accelerating unit economics, self-reinforcing business model, or consistent deepening of customer value. The company is transitioning toward growth, but not yet at the level of a high-momentum compounder.
SQM (SQM) Q2 2026: $3B Salar Futuro Investment Signals Long-Term Lithium Growth and Sustainability Push
SQM has a long reinvestment runway and is making a transformative investment, with robust demand and capacity growth. However, while the business is growing and margins are stable, the evidence for exceptional improvement in unit economics, self-reinforcing dynamics, and customer value deepening is moderate. The business is not disruptive in the classic sense, and growth, while strong, is not at the hyper-growth level. The signal is solid but not extraordinary.
EQT (EQT) Q2 2026: Compression Projects Drive 90 BCFE Guidance Lift, Unlocking Structural Margin Upside
While EQT demonstrates strong operational momentum, margin expansion, and clear growth optionality, it remains a large, well-followed business in a mature sector. The reinvestment runway is solid but not exceptional, and while backlog and contract wins are notable, the business is not poised for hypergrowth. The business model is improving but not truly disruptive. Cash flow is growing, but the acceleration is moderate. Overall, the signal is strong but not at the highest level for a well-known, large-cap operator.
ReNew Energy Global Plc (RNW) Q1 2027: 26% Operating Portfolio Growth Drives Profitable Expansion Amid Grid Challenges
ReNew demonstrates a long reinvestment runway and is growing rapidly (26% YoY), with meaningful capacity expansion and capital recycling. However, some aspects (unit economics, self-reinforcing model, customer value) are improving but not exceptional or clearly compounding. The business is growth-oriented but faces operational and regulatory headwinds that temper the signal score.
VNET Group (VNET) Q2 2026: Wholesale IDC Capacity Surpasses 1GW, Driving 29% Revenue Growth
VNET demonstrates a strong reinvestment runway, significant recent growth, and leadership in its sector. However, while growth is robust, some aspects (unit economics, model self-reinforcement, customer value) are improving but not exceptional. The business is transitioning to growth, with good but not extraordinary acceleration, and the disruptive potential is emerging rather than fully realized. The signal is strong for a large, established player, but not at the highest possible level.
F5 (FFIV) Q3 2026: Product Revenue Jumps 19% as AI Security and Hybrid Cloud Drive Expansion
F5 shows solid growth and secular tailwinds, but its reinvestment runway and business model, while improving, are not at the level of a truly disruptive or compounding platform. Growth is strong but not hyper-scaling, and some drivers (hardware) remain cyclical. The signal is above average but not exceptional.
WidePoint (WYY) Q2 2026: $3.1B CWMS 3.0 Contract Sets Stage for Doubling Revenue Run Rate
WidePoint is at a strategic inflection with a major new contract and visible growth runway, but the business model is not highly disruptive and some aspects (unit economics, customer value, cash flow acceleration) are improving but not yet exceptional. The company is transitioning into a growth phase, but risks and uncertainties remain around execution, contract ramp, and protest resolution. Signal is solid but not at the level of a truly exceptional or disruptive growth business.
TLPH Q2 2026: 75% Enrollment Milestone and 21% Market Expansion Signal Commercial Inflection
Talphera is at a pivotal stage with a potentially large addressable market and guideline endorsement, but as a late-stage clinical biotech, the business model is not yet compounding or self-reinforcing. Unit economics and customer value are not proven, and while the market is expanding, growth is not yet exceptional or accelerating at the highest rates. The business is transitioning toward commercialization, but the long-term runway and disruptive potential remain to be validated.
Harmony Biosciences (HRMY) Q2 2026: WCAG Net Revenue Jumps 30% as BP205 Data Sets Up Pipeline Catalysts
Harmony Biosciences shows strong commercial growth and a promising pipeline, with high reinvestment potential and a long IP runway. However, while growth is robust, it is not at the extreme levels (40%+ annualized or exceptional acceleration) that would warrant top scores on all signal questions. The business model is partially self-reinforcing, and optionality exists, but the company is not yet a clear giant or fully disruptive. Risks around pipeline execution and eventual generic competition temper the signal.
KURA Oncology (KURA) Q2 2026: KOMZIFTI Sales Surge 57%, Cementing AML Market Leadership
KURA demonstrates strong commercial momentum and a pipeline with meaningful optionality, but the business is still early in its growth phase and faces significant execution and competitive risks. While KOMZIFTI's sequential growth and market share gains are notable, the company is not yet a cash flow machine, and long-term unit economics and customer value are still emerging. The business is transitioning from launch to growth, with some disruptive potential but not yet at scale to warrant a higher signal score.
CellCuity (CELC) Q2 2026: Launch Readiness and Clinical Advances Position Company for Multi-Billion Dollar Market Entry
CellCuity has a long reinvestment runway and is entering a large market, with significant recent developments (product launch, strong clinical data, major capital raise). However, while the business is transitioning to growth, evidence of compounding unit economics and self-reinforcing advantages is emerging but not yet proven at scale. Growth is expected but not yet at the highest acceleration, and pipeline expansion is positive but not yet transformative.
Capital One (COF) Q2 2026: Domestic Card Purchase Volume Jumps 26% as Discover Integration Drives Scale
Capital One is showing strong growth and integration-driven upside, with a major acquisition and expanding platform. However, the business, while evolving, is still a scaled incumbent with some capped legacy elements and not a pure disruptor. The reinvestment runway is solid but not exceptional. Growth is strong but not at the highest levels, and while the business is transitioning into a more tech-driven model, it is not yet a giant or highly disruptive. The article surfaces material signals, but the business is already well-followed and established, which tempers the upside.
MSCI (MSCI) Q2 2026: Hedge Fund Subscription Run Rate Triples, Index Net New Sales Up 41%
MSCI demonstrates a strong reinvestment runway, major growth in hedge fund and private asset segments, and is in the early innings of AI monetization. However, fee compression, sustainability headwinds, and some segments with modest rather than explosive growth temper the signal. The business is not wholly disruptive nor growing at hypergrowth rates, but it is solidly in a multi-year secular growth cycle with clear optionality.
Contango Silver & Gold (CTGO) Q2 2026: Manh Choh Investment Fully Repaid, Unlocking Free Cash Flow Upside
Contango shows a long reinvestment runway with clear avenues for redeployment, and the transition to free cash flow is a significant business evolution. However, while the company is moving to higher-grade ore and has a pipeline of projects, unit economics and self-reinforcing business model advantages are not yet at the level of a giant or highly compounding business. Customer value deepening is moderate, and while the business is transitioning into a growth phase, it is not yet demonstrating exceptional acceleration or disruptive scale. The signal is strong for a mid-cap mining company but not at the level of a truly exceptional or category-defining business.
Starling Oncology (STLN) Q2 2026: Capitated Revenue Growth Accelerates with $50 Million New Contracts Outside Florida
Starling Oncology demonstrates a long reinvestment runway and significant recent contract wins, with growth and margin expansion. However, while growth is notable, the business model—though scaling—is not yet self-reinforcing at network-effect levels, and customer value metrics are improving but not exceptional. Cash flow is improving, but not yet at a rapid acceleration. The business is transitioning to growth, but not at hyper-growth rates. Signal is solid but not extraordinary.
Allied Gold (AAUC) Q2 2026: Kurmuk Nears Production Start, Boosting Mid-Tier Growth Prospects
The business is transitioning into a growth phase, with meaningful production increases and cost improvements from new projects like Kurmuk. However, it remains a mid-tier gold producer without clear evidence of self-reinforcing network effects or extraordinary customer value deepening. There is strong growth but not at the disruptive or exceptional level, and reinvestment runway is moderate rather than long.
LanzaTech (LNZA) Q2 2026: 67% Operating Expense Reduction Reshapes Path to Commercialization
LanzaTech is transitioning to commercialization with evidence of cost discipline and potential for high returns, and is positioned in a disruptive, regulatory-driven segment. However, growth rates are not exceptional, and some aspects of the business model (unit economics, customer value) are still emerging, limiting the signal score.
York Space Systems (YSS) Q2 2026: $1.85B Contract Potential Highlights Shift to IDIQ Acquisition Model
York Space Systems has a long reinvestment runway and recent significant contract wins, but margin and cash flow improvements are not yet exceptional. The business model is becoming more self-reinforcing and disruptive, but not to the highest degree. Growth is strong but not at a hypergrowth (40%+) rate, and while the future outlook is positive, it is not yet exceptional or explosive.
Praxis Precision Medicines (PRAX) Q2 2026: Operating Expenses Jump 28% as Launch Preparations Accelerate
Praxis is entering a pivotal commercial phase with strong regulatory clarity, a long cash runway, and large underpenetrated markets, suggesting a meaningful reinvestment runway and growth opportunity. However, while the business is positioned for growth, there is not yet clear evidence of explosive (40%+) growth, self-reinforcing economics, or disruptive business model characteristics. Unit economics and customer value deepening are expected but not yet proven. The signal is solid but not exceptional for a biotech at this stage.
Maravai LifeSciences (MRVI) Q2 2026: GMP Consumables Up 55%, Margin Expansion Signals Structural Reset
The business is showing strong growth in GMP consumables and discovery mRNA, with clear evidence of margin expansion and operational leverage. There is a significant recent uptick in key product lines and a structural reset in profitability. However, the reinvestment runway and self-reinforcing model are not exceptional, and while the growth is solid, it is not disruptive or likely to deliver 40%+ annual revenue growth. Risks around order lumpiness and sector volatility limit the signal score.
RXO (RXO) Q2 2026: Spot Mix Hits 42%, Driving 11% Gross Profit Per Load Surge
RXO is showing strong business evolution with spot mix acceleration and AI-driven productivity, but the overall business is not a hypergrowth or highly disruptive model. The runway is decent but not exceptional, and while the company is outpacing peers, the signal is somewhat capped by the asset-light brokerage model's inherent limitations and exposure to cyclical headwinds.
Howard Hughes (HHH) Q2 2026: Vantage Equity Allocation Hits 40% as Capital Shift Accelerates
The business is undergoing a significant transformation with a clear reinvestment runway and capital allocation shift, which is strategic and signals upside. However, some elements—such as unit economics, business model self-reinforcement, and customer value deepening—are present but not yet proven at scale. Growth is strong but not yet explosive, and the business, while now a growth story, is not entirely disruptive or unique in the public markets context.
Globus Medical (GMED) Q2 2026: EBITDA Margin Jumps 740bps as Spine and Trauma Outpace Market
Globus Medical demonstrates a long reinvestment runway with high returns on capital, significant margin expansion, and clear growth in core segments. However, while growth is strong, it is not at the hyper-scaling level (e.g., >40% revenue/EPS growth), and some business model features (network effects, customer value deepening) are emerging but not dominant. The business is transitioning from integration to scalable growth, but not yet an exceptional, disruptive compounder.
Riley Exploration Permian (REPX) Q2 2026: Oil Production Exit Rate Hits 24.4K Bbl/Day, Infrastructure Drives 30% Growth Outlook
REPX demonstrates strong growth, operational efficiency, and infrastructure-driven upside, but as a Permian E&P, its reinvestment runway and business model are less disruptive and more traditional. Growth is notable (30%+), but not at the level of a unique, high-ROIC compounder. The business is transitioning from infrastructure-constrained to growth-enabled, but does not exhibit network effects or exceptional customer monetization. The outlook is strong, but not truly exceptional or disruptive.
Epsilon Energy (EPSN) Q2 2026: Oil Volume Growth Set to Triple as Powder River Basin Drives Production Surge
Epsilon is entering a growth phase with a significant inflection in oil volumes (nearly 200% growth), indicating strong near-term momentum. However, some elements (e.g., unit economics, business model defensibility, customer value deepening, and disruptive potential) are present but not outstanding or proven to be compounding at scale. The growth is notable but not in the league of a truly exceptional or disruptive business, and the overall reinvestment runway, while solid, is not extraordinary.
Enova (ENVA) Q3 2025: SMB Originations Jump 31% as Credit Quality Drives Expansion
Enova is demonstrating strong growth, especially in SMB originations, and improving operating leverage. However, while growth is robust, the business is not fundamentally disruptive or showing the kind of exceptional acceleration (over 40%) that would warrant the highest scores. There is some optionality and cash flow improvement, but the reinvestment runway and uniqueness are moderate, not extraordinary. The business is a growth story but not one with truly outsized signal or upside relative to the most compelling opportunities.
MLYS Q2 2026: $200M Royalty Buyback and Commercial Readiness Signal Strategic Launch Acceleration
MLYS is transitioning to commercialization with a potentially differentiated asset and long-term runway. However, as a second-mover with uncertain payer and competitive dynamics, the business does not yet demonstrate exceptional growth or disruption. Some signals (unit economics, model self-reinforcement, customer value) are only moderately strong at this stage.
SmartRent (SMRT) Q2 2026: SaaS Revenue Hits 40% of Mix as Installed IoT Base Nears 1 Million
SmartRent is demonstrating strong recurring revenue growth, margin expansion, and a growing installed base, indicating a meaningful business evolution. However, while the business is transitioning and growing, it is not yet exhibiting explosive growth or an exceptional future based on backlog/guidance. The business model is semi-disruptive, and while the trajectory is positive, it does not warrant the highest signal scores across all criteria.
CareDx (CDNA) Q2 2026: Revenue Soars 52% as NavDx and Transplant Volumes Expand Core Platform
CareDx is showing strong growth and transformation, with a significant recent uptick in revenue and volumes (Q2 revenue up 52%), and the NavDx acquisition adds a new growth vector. However, the reinvestment runway, while solid, is not yet proven to be exceptionally long or at extremely high ROICs. Some business model self-reinforcement is present, but not at the level of a true compounding platform. Customer value is improving, but not deeply evidenced as consistently accelerating. The business is clearly a growth business, but not at the very highest levels of disruption or acceleration.
Comstock Inc. (LODE) Q2 2026: Industry-Scale Solar Recycling Facility Nears Full Operations, Driving Strategic Shift
Comstock is moving from pilot to commercial scale with a new facility and has a long runway in a nascent market, supported by strong capital discipline. However, while the business model is potentially disruptive and growth-oriented, actual improvements in unit economics, customer value, and cash flow are still emerging and not yet fully proven at scale. The signal is solid but not exceptional due to execution and scaling risks.
Consumer Portfolio Services (CPSS) Q2 2026: Originations Surge 75% as Dealer Network Expansion Fuels Lending Scale
CPSS is showing strong growth and operational inflection, with a 75% surge in originations, improving credit, and expanding dealer network. However, it is a mature subprime lender with limited evidence of a long reinvestment runway or disruptive model. While growth is robust and metrics are improving, the business is not clearly compounding at a disruptive rate, and macro/funding risks remain significant.
United Therapeutics (UTHR) Q2 2026: Pipeline Advancements Set Stage for Multi-Billion Dollar IPF and PAH Launches
There is clear evidence of a long reinvestment runway and transformative pipeline opportunities, with significant upcoming launches and a large addressable market. However, some elements (unit economics, self-reinforcing model, customer value, and cash flow acceleration) are not yet fully proven or exceptional, and the business is not entirely disruptive. Growth is strong but not at the highest tier, and some risks remain around execution and competitive intensity.
Lesaka Technologies (LSAK) FY2026: 210% Adjusted EPS Surge Highlights Platform Momentum Amid Merchant Challenges
Lesaka demonstrates strong growth in Consumer and Enterprise, a major strategic acquisition, and improved profitability. However, Merchant segment pressures, only partially improving unit economics, and a business model that—while showing optionality—is not yet clearly disruptive or compounding at the highest level, warrant a more conservative signal score. The business is transitioning with some growth, but not at the most exceptional rates.
AMBQ Q1 2026: Non-Wearables Double, Diversification Lowers Top 3 Customer Concentration to 71%
AMBIC is diversifying and growing rapidly, with strong runway and some disruptive elements, but customer concentration and profitability lag keep the upside in check. Unit economics and business model self-reinforcement are improving but not yet at the highest level. The business is transitioning toward growth but not yet a breakout compounder.
Werner Enterprises (WERN) Q2 2026: One-Way Truckload Margin Expands 700bps, Supply Contraction Accelerates Upcycle
Werner is benefiting from a strong cyclical upturn, with clear margin expansion and operational leverage, but as a well-followed, mature trucking/logistics provider, the reinvestment runway and disruptive potential are moderate rather than exceptional. The business is transitioning to higher quality and profitability, but the underlying business model is not highly disruptive and growth, while strong, is not in the hypergrowth category.
Be Light Bio (BLTE) Q1 2026: SG&A Rises 179% as Commercial Launch Readiness Accelerates
BLTE is at a major inflection, moving from clinical to commercial stage with a large cash position and a potentially disruptive therapy in a rare disease with high pricing power. However, while the growth runway and business model are promising, true network effects and proven customer value deepening are not yet fully evident. Unit economics, future guidance, and cash flow are not yet proven at scale, and the business, while transitioning to growth, still faces significant execution and regulatory risks.
Bicara Therapeutics (BCAX) Q2 2026: Operating Expenses Surge 87% as Pivotal Trial Enrollment Accelerates Toward Mid-2027 Milestone
Bicara is at an inflection point with a potentially long runway if pivotal data is positive, but the business is still pre-commercial and subject to clinical and regulatory risks. There are signs of growth and disruption, but not all signals are exceptional or proven yet. The opportunity is significant but not yet de-risked or clearly compounding.
YPF (YPF) Q2 2026: EBITDA Surges 2.5x YoY as Shale Oil Drives Record Profitability
YPF is experiencing rapid growth and margin expansion from its shale pivot, with strong recent results and a large export project pipeline. However, the business is not a truly disruptive model, and while growth is strong, it is not at the highest echelon for reinvestment runway or compounding network effects. The signal is solid for a legacy energy company, but not at the level of a generational compounder.
ECARX (ECX) Q2 2026: 45% Revenue Growth Accelerates Global Expansion and Margin Gains Amid Memory Cost Challenges
The company demonstrates a strong reinvestment runway and recent significant growth, but some aspects (unit economics, self-reinforcement, customer value, cash flow, and growth rates) are improving but not yet exceptional or fully proven. The business is clearly in a growth phase with disruptive elements, but not all metrics support a maximum signal score.
Kopin (KOPN) Q2 2026: 51% Revenue Surge Anchored by MicroLED and FPV Drone Program Momentum
Kopin shows a long reinvestment runway, recent significant growth, and a shift toward profitability. However, while the opportunity is large, some business model elements (network effects, customer value deepening, disruptive potential) are emerging but not yet fully proven or exceptional. The signal is strong for a small-cap, but not at the level of a giant or dominant platform.
Be Light Bio (BLTE) Q3 2025: $140M Capital Infusion Extends Runway for Global Tinlaraban Launch
BLTE is not yet commercial, so some signal levers (unit economics, customer value, cash flow acceleration) are not fully proven—hence lower scores on those. However, the capital raise, coordinated regulatory momentum, and pipeline progress are strong signals of a high-upside, growth-stage biotech. The business is not yet at the inflection of a massive growth ramp, but the setup is strong for a rare disease asset approaching launch.
Integris (ENTG) Q4 2025: Free Cash Flow Margin Jumps 300 Basis Points as Node Transition Tailwinds Build
Integris demonstrates a long reinvestment runway (node transitions, local-for-local supply), and there are significant developments in margin and free cash flow. Unit economics are improving but not dramatically, and the business model shows some self-reinforcing elements but is not a pure compounding platform. Customer value is modestly improving, and guidance implies growth but not exceptional acceleration. The business is semi-disruptive given its position in advanced materials but not a true disruptor. Cash flow is improving but not accelerating at a dramatic rate. Revenue and EPS growth are likely in the 4-20% range, and the company is a growth business, not legacy or merely transitioning.
Immunovant (IMVT) Q1 2026: $200M R&D Outlay Fuels Five Major Readouts, Pivotal Launches Ahead
Immunovant has a long reinvestment runway and is entering a period of significant clinical catalysts, with multiple late-stage readouts and commercial launches ahead. However, as a pre-commercial biotech, improvements in unit economics and deepening customer value are not yet observable, and the business model—while promising—remains subject to clinical and regulatory risk. The signal is strong for optionality and inflection, but not all elements are proven or compounding yet.
Star Equity Holdings (STRR) Q2 2025: Backlog Soars 84% as Building Solutions Drives Margin Expansion
While the business shows strong recent momentum (backlog up 84%, margin expansion, and a major M&A catalyst), it is still a diversified holding company with some mature and cyclical elements. The reinvestment runway and disruptive potential are moderate but not exceptional; investments division adds optionality but also volatility. The business is transitioning to growth, but not at a scale or pace to warrant the highest signal scores.
Ormat Technologies (ORA) Q2 2026: Energy Storage Revenue Surges 195% as Merchant Pricing Lifts Margins
Ormat’s business shows strong recent growth and a robust pipeline, with a notable surge in energy storage revenue and margin. However, the reinvestment runway is somewhat capped by the capital intensity and regulatory nature of the sector. While there is innovation (EGS), the business model is not fully disruptive and optionality is moderate. Revenue and EPS growth are strong but not at the highest tier, and some risks (volatility, execution) limit the signal. The business is a clear growth story but not a transformational outlier.
Westrock Coffee (WEST) Q2 2026: Free Cash Flow Turns Positive, Conway Ramp Drives +39% EBITDA Surge
Westrock is transitioning into a cash-generating platform with improving economics and a disciplined capital allocation strategy. While the business is showing strong growth and margin improvement, the runway is moderate, with some disruption and AI leverage, but not at the level of a high-multiple, long-reinvestment compounding story. The business is not exceptionally high-growth, but the inflection and operational leverage are notable.
GeneDx (WGS) Q2 2026: Genome Coverage Jumps 40 Points, Unlocking Reimbursement Upside for 2027
GeneDx is at a structural inflection with a major TAM expansion and clear growth runway, but actual financial realization lags due to RCM and payer operationalization. The business is not yet a cash flow machine and while disruptive, faces industry-wide reimbursement headwinds. The signal is strong but not at the highest level due to timing and execution risk.
Fathom Pharmaceuticals (PHAT) Q2 2026: Operating Profit Turns Positive as Revenue Jumps 88%, GI-First Strategy Delivers
Fathom is showing strong revenue growth, a recent operating profit inflection, and potential for further expansion through pipeline and label expansion, but its business model is not deeply disruptive and reinvestment runway is moderate rather than exceptional. Some metrics (unit economics, cash flow) are improving but not yet at a 'giant' level. Growth is robust but not hyper-scale, and the company is transitioning from inflection to growth, not yet a clear long-term compounder.
EME Q3 2025: Data Center RPOs Surge 80% as Miller Electric Adds $700M Backlog
EMCOR is positioned for above-market growth with a strong backlog and secular tailwinds, particularly in data centers. The Miller Electric acquisition is significant, but the business is not highly disruptive or likely to deliver outsized, compounding returns typical of a platform with a long reinvestment runway. Margins are strong but management signals stability rather than further expansion. Growth is robust but not at hyper-growth levels, and the business, while a leader, is not a new or under-the-radar story.
Colliers (CIGI) Q2 2026: Engineering Revenue Jumps 30% as Platform Integration Deepens
Colliers is showing solid growth and a strategic shift toward recurring revenue, with clear signals of business model evolution and margin expansion. However, while there is a long runway and some disruptive elements, the business is not a pure high-growth or highly disruptive story, and some metrics (unit economics, self-reinforcement, customer value) are improving but not at a breakout pace. The business is attractive and thesis-relevant, but not at the highest level of signal for transformative upside.
Victory Capital (VCTR) Q2 2026: ETF AUM Surges 54%, Margin Guidance Raised on Integration Leverage
Victory Capital is a strong compounder with accelerating AUM growth, margin expansion, and a robust acquisition pipeline, but as a diversified asset manager, its reinvestment runway is moderate and not as disruptive as some tech names. There are clear improvements in unit economics and international expansion, but the business model is not fundamentally disruptive. Growth is strong but not at the hypergrowth levels that would justify a higher score.
Agnico Eagle (AEM) Q2 2026: Shareholder Returns Surge 48% of Free Cash Flow as Growth Pipeline Accelerates
Agnico Eagle is a sector leader with a credible multi-year growth pipeline, strong capital returns, and operational resilience. However, the business is relatively mature within the gold mining sector and faces execution and inflation risks. While there is growth and optionality, the business model is not highly disruptive, and unit economics are improving but not at a transformative pace. Revenue and EPS growth are solid but not exceptional, and the company is transitioning toward greater scale rather than being a hyper-growth story.
NetApp (NTAP) Q1 2027: 30% Revenue Growth Signals Durable AI and Cloud Demand Acceleration
NetApp demonstrates strong growth and a clear AI/cloud demand inflection, but as a mature, well-followed business, its reinvestment runway and disruptive potential are not as high as a true emerging compounder. Revenue growth is robust (30%+), and there are clear improvements in unit economics and backlog, but the business model is not fundamentally disruptive and customer value deepening is moderate. The signal is solid but not exceptional for a large-cap, established technology vendor.
InnoVEX (INVX) Q2 2026: TCO Acquisition Adds $15M Revenue, Unlocks Offshore and International Growth
InnoVEX demonstrates a strong reinvestment runway, capital-light model, and growth inflection driven by M&A and international expansion. However, while growth is robust, it's not at the highest acceleration levels, and some business model elements (network effects, customer value deepening) are present but not exceptional. The business is transitioning from integration to growth, with solid but not explosive revenue/EPS outlook. Risks from project timing and integration persist. Signal is good, but not at the highest possible level given industry context.
Modine (MOD) Q1 2027: Data Center Revenue Jumps 90% as Supply Chain Bottlenecks Delay Margin Recovery
Modine demonstrates a strong reinvestment runway and recent explosive growth (90% YoY in data center), but margin compression and supply chain bottlenecks limit the near-term signal. Unit economics are not clearly improving yet, and while the business model is shifting toward self-reinforcement, it is not fully compounding. Customer value is improving, but not exceptionally, and backlog/guidance is strong but not at an exceptional acceleration. The business is transitioning toward growth, but risks and execution challenges temper the overall signal.
Keele Infrastructure (KEEL) Q2 2026: $819M Liquidity and 2GW Expansion Capacity Advance Power-Scarce AI Data Center Strategy
Keele Infrastructure is positioned for growth with a long runway and capital strength, but the signal is tempered by the transitional nature of the business, lack of clear evidence of rapidly improving unit economics, and the absence of recent explosive growth or backlog conversion. The business is moving toward a growth profile, but not yet showing exceptional acceleration or disruptive network effects.
Waterdrop (WDH) Q1 2026: Insurance Income Jumps 74%, AI and User Acquisition Drive Expansion
Waterdrop demonstrates a strong growth runway, recent significant top-line acceleration, and a willingness to reinvest for scale. However, some aspects (unit economics, self-reinforcing model, customer value deepening) are promising but not yet exceptional or proven at scale. The business is transitioning toward a more disruptive, AI-driven model but remains highly dependent on insurance, with some concentration risk. Growth is robust but not at hypergrowth levels, and while cash flow is strong, it is not yet accelerating dramatically.
GE (GE) Q2 2026: Orders Surge 17% as $170B Services Backlog Anchors Multi-Year Growth
While GE Aerospace demonstrates strong execution, backlog-driven visibility, and improving unit economics, it is a large, mature business with moderate rather than exceptional reinvestment runway. The business model is self-reinforcing and recurring, but growth rates, while solid, are not hyper-scaling or disruptive. Margin expansion is gated by platform maturation, and while the company is transitioning into a more service-driven model, it is not a breakout growth story likely to deliver major upside from here. Signal is good but not extraordinary given GE's scale and profile.
Standard Lithium (SLI) Q2 2026: Southwest Arkansas Project Advances Toward $1.1B Debt Financing and FID
Standard Lithium is at an inflection point with a potentially long reinvestment runway and a large project pipeline, supported by advanced project financing and offtake agreements. However, as commercial production is still years away, there is limited evidence of improving unit economics or self-reinforcing business model dynamics at scale. Growth prospects are strong, but the business is not yet a cash flow machine, and some elements remain contingent on future execution.
Verica Pharmaceuticals (VRCA) Q2 2026: YCAMP Units Surge 28% as Global Expansion and Pipeline Advance
Verica shows a strong reinvestment runway, significant recent growth, and a disruptive model with global optionality. However, some signal elements are not yet at the highest level: unit economics are improving but not giant-scale, business model advantages are emerging but not fully compounding, and customer value is rising but not dramatically. Growth is strong but not yet at hypergrowth levels, and cash flow is not accelerating at a high rate. The business is a clear growth story, but not yet in the top decile for signal.
AudioCodes (AUDC) Q2 2026: Voice AI Revenue Jumps 50%, Accelerating Shift to Recurring
While AudioCodes is showing strong growth in recurring revenue and Voice AI, the business is not a category-defining disruptor and is still heavily reliant on the Microsoft Teams ecosystem. The growth rates are solid but not extraordinary, and while backlog and ARR are improving, the business is not yet on a path to hypergrowth or outsized returns on capital. Signal is above average but not exceptional.
Pennant Group (PNTG) Q2 2025: Home Health and Hospice Revenue Up 32%, Southeast Expansion Sets New Growth Platform
Pennant demonstrates strong double-digit growth, margin expansion, and a major new platform with the Southeast acquisition, but the underlying business is not exceptionally disruptive and faces regulatory headwinds that temper the reinvestment runway. The business is a solid consolidator, but not a category-defining growth story with extraordinary optionality or disruption. The signal is above average due to actionable developments, but not at the highest level for unique upside.
Scholar Rock (SRRK) Q2 2026: Dual Fill-Finish Strategy Secures Two Independent Approval Paths for Epidigromab
Scholar Rock presents a strong regulatory and launch setup with a long runway in rare disease, but the business is still pre-commercial with limited evidence of compounding network effects or rapidly improving unit economics. The pipeline is promising but not yet proven to be a giant. The business is transitioning to commercial stage and has high optionality, but the signal is capped by lack of current revenue and some execution risk.
LifeZone Metals (LZM) Q2 2026: $850M Construction Packages Out for Tender as Strategic Equity Close Nears
The business has a long reinvestment runway and is at a major inflection, but some elements (unit economics, self-reinforcement, customer value) are not yet proven at scale. The growth is strong but not yet exceptional, and while the model is semi-disruptive with optionality, it is still transitioning to full-scale operations. The outlook is promising but not yet at the level of a clear, compounding, high-growth platform.
Coda Octopus (CODA) Q2 2025: Revenue Jumps 32% as Ecoscope and David Drive Defense Adoption
Coda Octopus demonstrates a long reinvestment runway with defense adoption and new product launches, and recent revenue growth is significant. However, margin and unit economics have near-term volatility and are not yet clearly compounding. The business model has some self-reinforcing elements (ecosystem effects), but these are still developing. Customer value is improving, but not yet at a transformative pace. The outlook is positive, but not exceptional (no >30% growth guidance). The business is a growth story but not a category-defining disruptor at this stage.
Graham (GHM) Q1 2027: Backlog Hits $557M as Defense and Space Orders Drive Structural Upside
Graham shows a strong growth profile with record backlog, multi-year visibility, and expanding platforms in defense and space. However, while the growth is robust and the business is transitioning into a new phase, it is not yet a hyper-growth or disruptive model, and some levers (unit economics, business model self-reinforcement) are improving but not exceptional. The signal is strong for a small-cap industrial, but not at the highest level for disruptive or high-velocity growth.
Finance of America (FOA) Q2 2026: Funded Volume Climbs 21% as Proprietary Product Demand Outpaces HECM
FOA is showing strong growth, operational leverage, and proprietary product outperformance, but the business is not a breakout compounder or disruptive platform with a massive reinvestment runway. The growth is significant but not at the level of a transformational SaaS or marketplace business, and the sector is relatively mature. Signal is solid but not exceptional for a well-followed mortgage/financials name.
Reformation (REF) Q2 2026: 24% Revenue Growth Reinforces Durable Brand Momentum
Reformation demonstrates a long reinvestment runway, improving unit economics, and deepening customer value. The growth, while strong, is not at a hypergrowth or disruptive level (no >40% acceleration or clear step-change), and the business model, while modern and well-executed, is not truly disruptive. The company is a high-quality, growth business but does not display extraordinary signal or upside beyond a well-executed, premium retail roll-out.
VPG (VPG) Q2 2026: Sensors Book-to-Bill Hits 1.44 as AI and Robotics Orders Accelerate
VPG demonstrates a long reinvestment runway in secular growth markets (AI, robotics), with significant recent order uptick and backlog. Unit economics and business model compounding are present but not yet exceptional, as margin recovery is still in progress and much depends on execution. The business is transitioning toward higher growth, but is not yet a clear-cut disruptor or cash flow machine. Guidance and backlog signal growth, but not at an extraordinary rate.
Perimeter Solutions (PRM) Q2 2026: Monaco Acquisition Adds Sixth Platform as Specialty Revenue Doubles
PRM shows a long reinvestment runway, a step-change in specialty growth, and a growth business profile. However, unit economics and business model self-reinforcement are improving but not yet exceptional. Customer value and cash flow are trending positively but not at the highest level. The business is semi-disruptive with moderate growth, but not in the highest acceleration bands.
MITK Q3 2026: Check Fraud Defender ACV Surges 73% as SaaS Mix Approaches 50%
MITK shows strong SaaS growth and network effects, but the business is not a category-defining disruptor and faces secular headwinds in check verification. While Check Fraud Defender ACV and SaaS mix are accelerating, overall revenue growth is solid but not exceptional. The business is transitioning toward growth, but not at a scale or pace to warrant a higher signal score.
Gemini (GEMI) Q1 2026: Services Revenue Hits 49% of Total, Accelerating Diversification Beyond Crypto
Gemini demonstrates a credible pivot toward a more durable, recurring revenue model, with clear regulatory moats and new product traction. The reinvestment runway is long and the business is transitioning into a growth phase, but unit economics, self-reinforcing model elements, and customer value deepening are not yet fully proven. Growth is strong but not exceptional, and while the business is not legacy or stalling, it is still in the early innings of its transformation. Signal is solid but not extraordinary, especially given the company’s risk profile and the need for further execution.
Chimera Therapeutics (KYMR) Q2 2026: $65M Collaboration Revenue Signals Pipeline Acceleration and Early Phase 3 Readiness
Chimera shows strong signals of a growth business with a long reinvestment runway, significant recent developments (milestone revenue, trial acceleration), and a disruptive model in oral immunology. However, while unit economics and customer value are improving, they are not yet at the 'giant' stage. The business model is self-reinforcing but still emerging, and while the outlook is strong, growth is not yet exceptional or at massive scale. The score reflects strong but not extraordinary signal.
Evalyst (EOLS) Q2 2026: Portfolio Growth Bundle Drives 70% Cross-Sell, Expanding Share in Aesthetics
Evalyst is transitioning into a multi-vertical, international growth business with a long runway and strong topline growth, but not all signal indicators are at the highest level. Unit economics, business model defensibility, and customer value are improving but not yet exceptional. Growth is robust but not hyper-scaling, and some risks (regulatory, competition) remain.
Knightscope (KSCP) Q3 2025: Product Revenue Jumps 82% as K7 Launch Resets Growth Narrative
While Knightscope has a disruptive business model and is launching a major new product, the business remains in transition with some optionality and growth potential but not yet clear evidence of accelerating cash flow or consistent improvement in unit economics. The K7 launch and product revenue surge are notable, but recurring revenue and margin recovery are still unproven. The company is not yet a giant, but may be on the path if execution improves.
Alibaba (BABA) Q2 2026: Cloud Revenue Jumps 34% as AI Demand Outpaces Supply Chain Capacity
Alibaba demonstrates a long reinvestment runway and disruptive business model with strong cloud/AI growth and QuickCommerce momentum. However, margin and cash flow volatility, continued investment drag, and supply chain constraints temper the signal. Unit economics are improving but not yet exceptional, and while growth is strong, it is not at hypergrowth levels. The business is transitioning toward growth but not at the highest signal threshold.
American Integrity Insurance (AII) Q1 2025: Policy Count Surges 43% as Florida Reforms Reset Loss Ratios
While AII shows strong growth and a clear inflection from legislative reform, it remains a traditional insurance business with moderate reinvestment runway and no true disruptive model. The step change in loss ratios and policy growth are notable, but future growth rates are likely to normalize below hyper-growth levels as Citizens takeout fades. The business is transitioning to organic growth, and while margins are improved, the overall signal is solid but not exceptional or unique.
Constellium (CSTM) Q2 2026: Adjusted EBITDA Surges 88% as Recycling and Aerospace Drive Early Target Achievement
While Constellium is delivering record results and achieving targets ahead of schedule, it remains a mature, capital-intensive business with moderate reinvestment optionality. The recent growth is notable but largely driven by cyclical and commodity tailwinds (scrap spreads, aerospace demand) rather than unique, compounding business model advantages. The business is showing growth and strong execution, but lacks the disruptive, high-ROIC profile or runaway unit economics that would merit a higher signal score.
WPRT Q2 2026: Cespira Revenue Surges 125% Fueling Path to Break-Even in 2027
Cespira's 125% revenue growth and margin turnaround indicate a strong growth engine with a long reinvestment runway and credible path to break-even, but the overall business still faces transitional risks and cash flow challenges. The business model has some disruptive elements but is not fully self-reinforcing yet. Unit economics and customer value are improving, but not at an exceptional or giant scale. The company is in a growth phase, but the legacy segment's softness and ongoing funding needs limit the signal score.
Atlas Clear (ATCH) Q1 2026: Equity Swings Positive by $13M as Platform Build Accelerates
Atlas Clear is in a transitional phase with improved capital position, visible growth initiatives, and a recurring revenue base, but the business is still early in proving out self-reinforcing economics, deepening customer value, and exceptional growth. There are positive signals, but the platform's upside is not yet at the level of a clear, high-multiple compounding business.
PolyPid (PYPD) Q2 2026: $320M Azurity Partnership Secures Commercial Launch Path Ahead of FDA PDUFA Date
PolyPid is at a major inflection point with a large partnership, regulatory acceleration, and a clear growth runway. However, while the deal is significant, the company is not yet demonstrating compounding network effects or exceptional unit economics, and its disruptive potential remains to be proven in practice. Revenue and profit growth are likely to be strong but not at the highest tier. Overall, the signal is above average but not at the level of the most exceptional or well-known growth compounders.
Enova (ENVA) Q1 2026: SMB Originations Surge 42%, Sharpening Portfolio Mix and Margin Leverage
Enova demonstrates strong growth, particularly in SMB originations, and is executing a notable strategic pivot with the Grasshopper Bank acquisition. While unit economics and credit metrics are improving, the company's long-term reinvestment runway and self-reinforcing business model are solid but not exceptional. Revenue and EPS growth are strong but not at hypergrowth levels, and the business is more of a transitioning/growth story than a disruptive outlier.